WorldWideScience

Sample records for breast technical progress

  1. Preventing Breast Cancer: Making Progress

    Science.gov (United States)

    ... Navigation Bar Home Current Issue Past Issues Preventing Breast Cancer: Making Progress Past Issues / Fall 2006 Table of ... 000 women will have been diagnosed with invasive breast cancer, and nearly 41,000 women will die from ...

  2. Progress in breast cancer: overview.

    Science.gov (United States)

    Arteaga, Carlos L

    2013-12-01

    This edition of CCR Focus titled Research in Breast Cancer: Frontiers in Genomics, Biology, and Clinical Investigation reviews six topics that cover areas of translational research of high impact in breast cancer. These topics represent areas of breast cancer research where significant progress has occurred but also where very important challenges remain. The papers in this CCR Focus section are contributed by experts in the respective areas of investigation. Herein, key aspects of these contributions and the research directions they propose are reviewed.

  3. Quarterly Technical Progress Report

    Energy Technology Data Exchange (ETDEWEB)

    Ayman I. Hawari

    2002-12-30

    This report presents the progress made during the first quarter of phase 2 for the project entitled ''Development and Validation of Thermal Neutron Scattering Laws from Applications and Safety Implications in Generation IV Reactor Designs.'' (B204) THIS IS NOT A FINAL REPORT

  4. Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-10-01

    This report summarizes experimental and theoretical work in basic nuclear physics carried out between October 1, 1995, the closing of our last Progress Report, and September 30, 1996 at the Nuclear Physics Laboratory of the University of Colorado, Boulder, under contracts DE-FG03-93ER-40774 and DE-FG03-95ER-40913 with the United States Department of Energy. The experimental contract supports broadly-based experimental research in intermediate energy nuclear physics. This report includes results from studies of Elementary Systems involving the study of the structure of the nucleon via polarized high-energy positron scattering (the HERMES experiment) and lower energy pion scattering from both polarized and unpolarized nucleon targets. Results from pion- and kaon-induced reactions in a variety of nuclear systems are reported under the section heading Meson Reactions; the impact of these and other results on understanding the nucleus is presented in the Nuclear Structure section. In addition, new results from scattering of high-energy electrons (from CEBAF/TJNAF) and pions (from KEK) from a broad range of nuclei are reported in the section on Incoherent Reactions. Finally, the development and performance of detectors produced by the laboratory are described in the section titled Instrumentation.

  5. Interleukin-8 in breast cancer progression.

    Science.gov (United States)

    Todorović-Raković, Nataša; Milovanović, Jelena

    2013-10-01

    Interleukin-8 (IL-8) is a chemokine that has an autocrine and/or paracrine tumor-promoting role and significant potential as a prognostic and/or predictive cancer biomarker. In breast cancer, which is mostly determined by expression of estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2), IL-8 could play a specific role. IL-8 is highly expressed in ER- breast cancers, but it increases invasiveness and metastatic potential of both ER- and ER+ breast cancer cells. It is also highly expressed in HER2+ breast cancers. Because of the complex crosstalk between these receptors and IL-8, its role is mainly determined by delicate balance in their signaling pathways. Therefore, the main point of this review was to analyze the possible influence of IL-8 in breast cancer progression related to its interaction with ER and HER2 and the consequent therapeutic implications of these relations.

  6. Cell Polarity Proteins in Breast Cancer Progression.

    Science.gov (United States)

    Rejon, Carlis; Al-Masri, Maia; McCaffrey, Luke

    2016-10-01

    Breast cancer, one of the leading causes of cancer related death in women worldwide, is a heterogeneous disease with diverse subtypes that have different properties and prognoses. The developing mammary gland is a highly proliferative and invasive tissue, and some of the developmental programs may be aberrantly activated to promote breast cancer progression. In the breast, luminal epithelial cells exhibit apical-basal polarity, and the failure to maintain this organizational structure, due to disruption of polarity complexes, is implicated in promoting hyperplasia and tumors. Therefore, understanding the mechanisms underlying loss of polarity will contribute to our knowledge of the early stages leading to the pathogenesis of the disease. In this review, we will discuss recent findings that support the idea that loss of apical-basal cell polarity is a crucial step in the acquisition of the malignant phenotype. Oncogene induced loss of tissue organization shares a conserved cellular mechanism with developmental process, we will further describe the role of the individual polarity complexes, the Par, Crumbs, and Scribble, to couple cell division orientation and cell growth. We will examine symmetric or asymmetric cell divisions in mammary stem cell and their contribution to the development of breast cancer subtypes and cancer stem cells. Finally, we will highlight some of the recent advances in our understanding of the molecular mechanisms by which changes in epithelial polarity programs promote invasion and metastasis through single cell and collective cell modes. J. Cell. Biochem. 117: 2215-2223, 2016. © 2016 Wiley Periodicals, Inc.

  7. Bedtime misalignment and progression of breast cancer

    Science.gov (United States)

    Hahm, Bong-Jin; Jo, Booil; Dhabhar, Firdaus S.; Palesh, Oxana; Aldridge-Gerry, Arianna; Bajestan, Sepideh N.; Neri, Eric; Nouriani, Bita; Spiegel, David; Zeitzer, Jamie M.

    2016-01-01

    Disruption of circadian rhythms, which frequently occurs during night shift work, may be associated with cancer progression. The effect of chronotype (preference for behaviors such as sleep, work, or exercise to occur at particular times of day, with an associated difference in circadian physiology) and alignment of bedtime (preferred vs. habitual), however, have not yet been studied in the context of cancer progression in women with breast cancer. Chronotype and alignment of actual bedtime with preferred chronotype were examined using the Morningness–Eveningness Scale (MEQ) and sleep-wake log among 85 women with metastatic breast cancer. Their association with disease-free interval (DFI) was retrospectively examined using the Cox proportional hazards model. Median DFI was 81.9 months for women with aligned bedtimes (“going to bed at preferred bedtime”) (n=72), and 46.9 months for women with misaligned bedtimes (“going to bed later or earlier than the preferred bedtime”) (n=13) (log rank p=0.001). In a multivariate Cox proportional hazard model, after controlling for other significant predictors of DFI, including chronotype (morning type/longer DFI; HR=0.539, 95% CI=0.320–0.906, p=0.021), estrogen receptor (ER) status at initial diagnosis (negative/shorter DFI; HR=2.169, 95% CI=1.124–4.187, p=0.028) and level of natural-killer cell count (lower levels/shorter DFI; HR=1.641, 95% CI=1.000–2.695, p=0.050), misaligned bedtimes was associated with shorter DFI, compared to aligned bedtimes (HR=3.180, 95% CI=1.327–7.616, p=0.018). Our data indicate that a misalignment of bedtime on a daily basis, an indication of circadian disruption, is associated with more rapid breast cancer progression as measured by DFI. Considering the limitations of small sample size and study design, a prospective study with a larger sample is necessary to explore their causal relationship and underlying mechanisms. PMID:24156520

  8. Sludge Treatment Evaluation: 1992 Technical progress

    Energy Technology Data Exchange (ETDEWEB)

    Silva, L J; Felmy, A R; Ding, E R

    1993-01-01

    This report documents Fiscal Year 1992 technical progress on the Sludge Treatment Evaluation Task, which is being conducted by Pacific Northwest Laboratory. The objective of this task is to develop a capability to predict the performance of pretreatment processes for mixed radioactive and hazardous waste stored at Hanford and other US Department of Energy (DOE) sites. Significant cost savings can be achieved if radionuclides and other undesirable constituents can be effectively separated from the bulk waste prior to final treatment and disposal. This work is initially focused on chemical equilibrium prediction of water washing and acid or base dissolution of Hanford single-shell tank (SST) sludges, but may also be applied to other steps in pretreatment processes or to other wastes. Although SST wastes contain many chemical species, there are relatively few constituents -- Na, Al, NO[sub 3], NO[sub 2], PO[sub 4], SO[sub 4], and F -- contained in the majority of the waste. These constituents comprise 86% and 74% of samples from B-110 and U-110 SSTS, respectively. The major radionuclides of interest (Cs, Sr, Tc, U) are present in the sludge in small molal quantities. For these constituents, and other important components that are present in small molal quantities, the specific ion-interaction terms used in the Pitzer or NRTL equations may be assumed to be zero for a first approximation. Model development can also be accelerated by considering only the acid or base conditions that apply for the key pretreatment steps. This significantly reduces the number of chemical species and chemical reactions that need to be considered. Therefore, significant progress can be made by developing all the specific ion interactions for a base model and an acid dissolution model.

  9. Solar thermal power systems. Annual technical progress report, FY 1978

    Energy Technology Data Exchange (ETDEWEB)

    1979-06-01

    A technical progress report on the DOE Solar Thermal Power Systems Program is given. Emphasis is on the technical progress of the projects rather than on activities and individual contractor efforts. Each project description indicates its place in the prior to FY 1978 is given; the significant achievements and real progress of each project during FY 1978 are described; and future project activities as well as anticipated significant achievements for each project are forecast. (WHK)

  10. Diazepam use and progression of breast cancer.

    Science.gov (United States)

    Kleinerman, R A; Brinton, L A; Hoover, R; Fraumeni, J F

    1984-03-01

    The relationship between diazepam and breast cancer was evaluated using data from a case-control study of breast cancer, in which 1075 cases and 1146 controls who were participants in a breast cancer screening program were interviewed. Diazepam use was negatively associated with extent of disease and lymph node involvement, and this effect seemed greatest for long-term users of diazepam. It is not certain to what extent these data reflect an ascertainment bias, an association with the reasons for which the drug was prescribed, or chance. Whatever the explanation, the findings do not support a previous contention that diazepam promotes or accelerates breast cancer growth.

  11. Gene Expression Analysis of Breast Cancer Progression

    Science.gov (United States)

    2005-07-01

    Giri D, Chen B, Gerald W Molecular Diagnosis of Breast Cancer Therapeutic Biomarkers Using Oligonucleotide Arrays Abstract presentation USCAP 2005. 5...Bone Metastasis. Submitted Lal P, Donaton M, Girl D, Chen B, Gerald W Molecular Diagnosis of Breast Cancer Therapeutic Biomarkers Using Oligonucleotide

  12. Solar lease grant program. Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    1981-04-01

    Progress on a lease program for the installation of a solar water heater with no installation charge is reported. Information on the announcement of the program, the selection of participants, the contractural agreement, progress on installation of equipment, monitoring, and evaluation is summarized. The status of the budget concerned with the program is announced. Forms used for applications for the program and an announcement from Resource Alternatives for Cilco customers are presented.

  13. Technical progress and its factors in Russia’s economy

    Directory of Open Access Journals (Sweden)

    Simon György Jr.

    2010-01-01

    Full Text Available In this paper long-term growth in Russia’s economy is viewed in the context of technical progress, based on both neoclassical and endogenous theories. The dynamics of economic growth with some aspects of catch-up development are examined, as well as capital deepening. TFP is quantified in terms of both output and productivity increases to reveal the leading role of embodied technical progress in productivity growth. An endogenous growth model helped to discern three complex factors of technical progress in the Russian economy, to which at the macro level a factor related to natural wealth (oil and gas resources was added. This enabled the author to conclude that the most important macroeconomic factor of Russia’s technical progress in the half century from the early 1960s to the late 2000s was its immobile component. At the manufacturing level the situation was more complicated, as the initial leadership of creative technical progress was superseded by the dominance of the mobile factor. The collapse of the Soviet Union made the Russian economy more service-oriented and radically changed the conditions of economic modernization, in which technology transfer ensured by FDI began to play a more prominent part, particularly after the default of 1998.

  14. Final Technical Progress Report NANOSTRUCTURED MAGNETIC MATERIALS

    Energy Technology Data Exchange (ETDEWEB)

    Charles M. Falco

    2012-09-13

    This report describes progress made during the final phase of our DOE-funded program on Nanostructured Magnetic Materials. This period was quite productive, resulting in the submission of three papers and presentation of three talks at international conferences and three seminars at research institutions. Our DOE-funded research efforts were directed toward studies of magnetism at surfaces and interfaces in high-quality, well-characterized materials prepared by Molecular Beam Epitaxy (MBE) and sputtering. We have an exceptionally well-equipped laboratory for these studies, with: Thin film preparation equipment; Characterization equipment; Equipment to study magnetic properties of surfaces and ultra-thin magnetic films and interfaces in multi-layers and superlattices.

  15. Pathogenesis and progression of fibroepithelial breast tumors

    NARCIS (Netherlands)

    Kuijper, Arno

    2006-01-01

    Fibroadenoma and phyllodes tumor are fibroepithelial breast tumors. These tumors are biphasic, i.e. they are composed of stroma and epithelium. The behavior of fibroadenomas is benign, whereas phyllodes tumors can recur and even metastasize. Classification criteria for both tumors show considerable

  16. CHL1 is involved in human breast tumorigenesis and progression

    Energy Technology Data Exchange (ETDEWEB)

    He, Li-Hong [Medical Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Key Laboratory of Breast Cancer Prevention and Treatment of the Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Ma, Qin [Department of Oncology, The General Hospital of Tianjin Medical University, Tianjin (China); Shi, Ye-Hui [Medical Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Key Laboratory of Breast Cancer Prevention and Treatment of the Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Ge, Jie; Zhao, Hong-Meng [Key Laboratory of Breast Cancer Prevention and Treatment of the Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Li, Shu-Fen [Medical Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Key Laboratory of Breast Cancer Prevention and Treatment of the Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Tong, Zhong-Sheng, E-mail: 83352162@qq.com [Medical Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Key Laboratory of Breast Cancer Prevention and Treatment of the Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China)

    2013-08-23

    Highlights: •CHL1 is down-regulation in breast cancer tissues. •Down-regulation of CHL1 is related to high grade. •Overexpression of CHL1 inhibits breast cancer cell proliferation and invasion in vitro. •CHL1 deficiency induces breast cancer cell proliferation and invasion both in vitro and in vivo. -- Abstract: Neural cell adhesion molecules (CAM) play important roles in the development and regeneration of the nervous system. The L1 family of CAMs is comprised of L1, Close Homolog of L1 (CHL1, L1CAM2), NrCAM, and Neurofascin, which are structurally related trans-membrane proteins in vertebrates. Although the L1CAM has been demonstrated play important role in carcinogenesis and progression, the function of CHL1 in human breast cancer is limited. Here, we found that CHL1 is down-regulated in human breast cancer and related to lower grade. Furthermore, overexpression of CHL1 suppresses proliferation and invasion in MDA-MB-231 cells and knockdown of CHL1 expression results in increased proliferation and invasion in MCF7 cells in vitro. Finally, CHL1 deficiency promotes tumor formation in vivo. Our results may provide a strategy for blocking breast carcinogenesis and progression.

  17. Epithelial-mesenchymal transition in breast cancer progression and metastasis

    Institute of Scientific and Technical Information of China (English)

    Yifan Wang; Binhua P. Zhou

    2011-01-01

    Breast cancer is the most common cancer in women,and approximately 90% of breast cancer deaths are caused by local invasion and distant metastasis of tumor cells.Epithelial-mesenchymal transition (EMT) is a vital process for large-scale cell movement during morphogenesis at the time of embryonic development.Tumor cells usurp this developmental program to execute the multi-step process of tumorigenesis and metastasis.Several transcription factors and signals are involved in these events.In this review,we summarize recent advances in breast cancer researches that have provided new insights in the molecular mechanisms underlying EMT regulation during breast cancer progression and metastasis.We especially focus on the molecular pathways that control EMT.

  18. Embryonic morphogen nodal promotes breast cancer growth and progression.

    Directory of Open Access Journals (Sweden)

    Daniela F Quail

    Full Text Available Breast cancers expressing human embryonic stem cell (hESC-associated genes are more likely to progress than well-differentiated cancers and are thus associated with poor patient prognosis. Elevated proliferation and evasion of growth control are similarly associated with disease progression, and are classical hallmarks of cancer. In the current study we demonstrate that the hESC-associated factor Nodal promotes breast cancer growth. Specifically, we show that Nodal is elevated in aggressive MDA-MB-231, MDA-MB-468 and Hs578t human breast cancer cell lines, compared to poorly aggressive MCF-7 and T47D breast cancer cell lines. Nodal knockdown in aggressive breast cancer cells via shRNA reduces tumour incidence and significantly blunts tumour growth at primary sites. In vitro, using Trypan Blue exclusion assays, Western blot analysis of phosphorylated histone H3 and cleaved caspase-9, and real time RT-PCR analysis of BAX and BCL2 gene expression, we demonstrate that Nodal promotes expansion of breast cancer cells, likely via a combinatorial mechanism involving increased proliferation and decreased apopotosis. In an experimental model of metastasis using beta-glucuronidase (GUSB-deficient NOD/SCID/mucopolysaccharidosis type VII (MPSVII mice, we show that although Nodal is not required for the formation of small (<100 cells micrometastases at secondary sites, it supports an elevated proliferation:apoptosis ratio (Ki67:TUNEL in micrometastatic lesions. Indeed, at longer time points (8 weeks, we determined that Nodal is necessary for the subsequent development of macrometastatic lesions. Our findings demonstrate that Nodal supports tumour growth at primary and secondary sites by increasing the ratio of proliferation:apoptosis in breast cancer cells. As Nodal expression is relatively limited to embryonic systems and cancer, this study establishes Nodal as a potential tumour-specific target for the treatment of breast cancer.

  19. [Progress of ductoscopy of the breast].

    Science.gov (United States)

    Okazaki, A; Okazaki, M; Hirata, K; Tsumanuma, T

    1996-05-01

    Ductoscopy of the breast was initially performed utilizing a rigid scope. Improvements in endoscopic equipment and introduction of the silica-fiberscope have enabled observation of intraductal lesions. The silica-fiberscope can be gradually moved into peripheral sites, after which the endoscopic findings are compared with histological features and diagnostic imaging. The most common symptom dictating endoscopic examination is a discharge from the nipple in which no palpable mass is detected. The fiberscope is introduced through the duct orifice on the surface of the nipple. The characteristic feature of a cancerous lesion is a superficial spread along the surface of the ductal lumen, which differs from the typical features of intraductal papilloma. Microsampling methods such as tube curette cytology should be used to obtain a definitive diagnosis. Endoscopic examination can provide valuable information which will be helpful in the decision process such as; surgical methods, nipple-preservation, and breast conservation.

  20. Plan and Design Meticulously and Promoting Technical Progress

    Institute of Scientific and Technical Information of China (English)

    Miao Chengwu

    1994-01-01

    @@ Plan and design is the key link in captial construction, and the soul of engineering construction. China Petroleum Planning & Engineering Institute (CPPEI) is one of the main undertakers for planning and designing of petroleum industry,the only leading multi-functional institute with the first class design certificate. Now it has been an organization under the China National Petroleum Corporation(CNPC)for making development strategy planning, project evaluations and technical consulting, drawing up project development plan and providing technical recommendations. It can complete plan and design for the oil and gas field facilities, pipeline construction,petroleum relinery and petro-chemical industry engineering at home and abroad. It is also a center of servicing for new technical development and scientific research. Since CPPEI was established in 1978,it has meticulously conducted on planning and designing for the technical progress of petroleum engineering.

  1. Genome evolution during progression to breast cancer

    KAUST Repository

    Newburger, D. E.

    2013-04-08

    Cancer evolution involves cycles of genomic damage, epigenetic deregulation, and increased cellular proliferation that eventually culminate in the carcinoma phenotype. Early neoplasias, which are often found concurrently with carcinomas and are histologically distinguishable from normal breast tissue, are less advanced in phenotype than carcinomas and are thought to represent precursor stages. To elucidate their role in cancer evolution we performed comparative whole-genome sequencing of early neoplasias, matched normal tissue, and carcinomas from six patients, for a total of 31 samples. By using somatic mutations as lineage markers we built trees that relate the tissue samples within each patient. On the basis of these lineage trees we inferred the order, timing, and rates of genomic events. In four out of six cases, an early neoplasia and the carcinoma share a mutated common ancestor with recurring aneuploidies, and in all six cases evolution accelerated in the carcinoma lineage. Transition spectra of somatic mutations are stable and consistent across cases, suggesting that accumulation of somatic mutations is a result of increased ancestral cell division rather than specific mutational mechanisms. In contrast to highly advanced tumors that are the focus of much of the current cancer genome sequencing, neither the early neoplasia genomes nor the carcinomas are enriched with potentially functional somatic point mutations. Aneuploidies that occur in common ancestors of neoplastic and tumor cells are the earliest events that affect a large number of genes and may predispose breast tissue to eventual development of invasive carcinoma.

  2. Swallowable Wireless Capsule Endoscopy: Progress and Technical Challenges

    Directory of Open Access Journals (Sweden)

    Guobing Pan

    2012-01-01

    Full Text Available Wireless capsule endoscopy (WCE offers a feasible noninvasive way to detect the whole gastrointestinal (GI tract and revolutionizes the diagnosis technology. However, compared with wired endoscopies, the limited working time, the low frame rate, and the low image resolution limit the wider application. The progress of this new technology is reviewed in this paper, and the evolution tendencies are analyzed to be high image resolution, high frame rate, and long working time. Unfortunately, the power supply of capsule endoscope (CE is the bottleneck. Wireless power transmission (WPT is the promising solution to this problem, but is also the technical challenge. Active CE is another tendency and will be the next geneion of the WCE. Nevertheless, it will not come true shortly, unless the practical locomotion mechanism of the active CE in GI tract is achieved. The locomotion mechanism is the other technical challenge, besides the challenge of WPT. The progress about the WPT and the active capsule technology is reviewed.

  3. In situ quantification of genomic instability in breast cancer progression

    Energy Technology Data Exchange (ETDEWEB)

    Ortiz de Solorzano, Carlos; Chin, Koei; Gray, Joe W.; Lockett, Stephen J.

    2003-05-15

    Genomic instability is a hallmark of breast and other solid cancers. Presumably caused by critical telomere reduction, GI is responsible for providing the genetic diversity required in the multi-step progression of the disease. We have used multicolor fluorescence in situ hybridization and 3D image analysis to quantify genomic instability cell-by-cell in thick, intact tissue sections of normal breast epithelium, preneoplastic lesions (usual ductal hyperplasia), ductal carcinona is situ or invasive carcinoma of the breast. Our in situ-cell by cell-analysis of genomic instability shows an important increase of genomic instability in the transition from hyperplasia to in situ carcinoma, followed by a reduction of instability in invasive carcinoma. This pattern suggests that the transition from hyperplasia to in situ carcinoma corresponds to telomere crisis and invasive carcinoma is a consequence of telomerase reactivation afertelomere crisis.

  4. Morphine Promotes Tumor Angiogenesis and Increases Breast Cancer Progression

    Directory of Open Access Journals (Sweden)

    Sabrina Bimonte

    2015-01-01

    Full Text Available Morphine is considered a highly potent analgesic agent used to relieve suffering of patients with cancer. Several in vitro and in vivo studies showed that morphine also modulates angiogenesis and regulates tumour cell growth. Unfortunately, the results obtained by these studies are still contradictory. In order to better dissect the role of morphine in cancer cell growth and angiogenesis we performed in vitro studies on ER-negative human breast carcinoma cells, MDA.MB231 and in vivo studies on heterotopic mouse model of human triple negative breast cancer, TNBC. We demonstrated that morphine in vitro enhanced the proliferation and inhibited the apoptosis of MDA.MB231 cells. In vivo studies performed on xenograft mouse model of TNBC revealed that tumours of mice treated with morphine were larger than those observed in other groups. Moreover, morphine was able to enhance the neoangiogenesis. Our data showed that morphine at clinical relevant doses promotes angiogenesis and increases breast cancer progression.

  5. Cyr61 promotes breast tumorigenesis and cancer progression

    Energy Technology Data Exchange (ETDEWEB)

    Tsai, Miaw-Sheue; Bogart, Daphne F.; Castaneda, Jessica M.; Li, Patricia; Lupu, Ruth

    2002-01-16

    Cyr61, a member of the CCN family of genes, is an angiogenic factor. We have shown that it is overexpressed in invasive and metastatic human breast cancer cells and tissues. Here, we investigated whether Cyr61 is necessary and/or sufficient to bypass the ''normal'' estrogen (E2) requirements for breast cancer cell growth. Our results demonstrate that under E2-depleted condition, Cyr61 is sufficient to induce MCF-7 cells grow in the absence of E2. MCF-7 cells transfected with Cyr61 (MCF-7/Cyr61) became E2-independent but still E2-responsive. On the other hand, MCF-7/vector cells remain E2-dependent. MCF-7/Cyr61 cells acquire an antiestrogen-resistant phenotype, one of the most common clinical occurrences during breast cancer progression. MCF-7/Cyr61 cells are anchorage-independent and capable of forming Matrigel outgrowth patterns in the absence of E2. ERa expression in MCF-7/Cyr61 cells is decreased although still functional. Additionally, MCF-7/Cyr61 cells are tumorigenic in ovariectomized athymic nude mice. The tumors resemble human invasive carcinomas with increased vascularization and overexpression of vascular endothelial growth factor (VEGF). Our results demonstrate that Cyr61 is a tumor-promoting factor and a key regulator of breast cancer progression. This study provides evidence that Cyr61 is sufficient to induce E2-independence and anti-E2 resistance, and to promote invasiveness in vitro, and to induce tumorigenesis in vivo, all of which are characteristics of an aggressive breast cancer phenotype.

  6. Solar thermal power systems. Annual technical progress report, FY 1979

    Energy Technology Data Exchange (ETDEWEB)

    Braun, Gerald W.

    1980-06-01

    The Solar Thermal Power Systems Program is the key element in the national effort to establish solar thermal conversion technologies within the major sectors of the national energy market. It provides for the development of concentrating mirror/lens heat collection and conversion technologies for both central and dispersed receiver applications to produce electricity, provide heat at its point of use in industrial processes, provide heat and electricity in combination for industrial, commercial, and residential needs, and ultimately, drive processes for production of liquid and gaseous fuels. This report is the second Annual Technical Progress Report for the Solar Thermal Power Systems Program and is structured according to the organization of the Solar Thermal Power Systems Program on September 30, 1979. Emphasis is on the technical progress of the projects rather than on activities and individual contractor efforts. Each project description indicates its place in the Solar Thermal Power Systems Program, a brief history, the significant achievements and real progress during FY 1979, also future project activities as well as anticipated significant achievements are forecast. (WHK)

  7. International Linear Collider-A Technical Progress Report

    Energy Technology Data Exchange (ETDEWEB)

    Elsen, Eckhard; /DESY; Harrison, Mike; /Brookhaven; Hesla, Leah; /Fermilab; Ross, Marc; /Fermilab; Royole-Degieux, Perrine; /Paris, IN2P3; Takahashi, Rika; /KEK, Tsukuba; Walker, Nicholas; /DESY; Warmbein, Barbara; /DESY; Yamamoto, Akira; /KEK, Tsukuba; Yokoya, Kaoru; /KEK, Tsukuba; Zhang, Min; /Beijing, Inst. High Energy Phys.

    2011-11-04

    The International Linear Collider: A Technical Progress Report marks the halfway point towards the Global Design Effort fulfilling its mandate to follow up the ILC Reference Design Report with a more optimised Technical Design Report (TDR) by the end of 2012. The TDR will be based on much of the work reported here and will contain all the elements needed to propose the ILC to collaborating governments, including a technical design and implementation plan that are realistic and have been better optimised for performance, cost and risk. We are on track to develop detailed plans for the ILC, such that once results from the Large Hadron Collider (LHC) at CERN establish the main science goals and parameters of the next machine, we will be in good position to make a strong proposal for this new major global project in particle physics. The two overriding issues for the ILC R&D programme are to demonstrate that the technical requirements for the accelerator are achievable with practical technologies, and that the ambitious physics goals can be addressed by realistic ILC detectors. This GDE interim report documents the impressive progress on the accelerator technologies that can make the ILC a reality. It highlights results of the technological demonstrations that are giving the community increased confidence that we will be ready to proceed with an ILC project following the TDR. The companion detector and physics report document likewise demonstrates how detector designs can meet the ambitious and detailed physics goals set out by the ILC Steering Committee. LHC results will likely affect the requirements for the machine design and the detectors, and we are monitoring that very closely, intending to adapt our design as those results become available.

  8. Environmental Research Division technical progress report, January 1984-December 1985

    Energy Technology Data Exchange (ETDEWEB)

    1986-05-01

    Technical progress in the various research and assessment activities of Argonne National Laboratory's Environmental Research Division is reported for the period 1984 to 1985. Textual, graphic, and tabular information is used to briefly summarize (in separate chapters) the work of the Division's Atmospheric Physics, Environmental Effects Research, Environmental Impacts, Fundamental Molecular Physics and Chemistry, and Waste Management Programs. Information on professional qualifications, awards, and outstanding professional activities of staff members, as well as lists of publications, oral presentations, special events organized, and participants in educational programs, are provided in appendices at the end of each chapter.

  9. The role of S100 genes in breast cancer progression.

    LENUS (Irish Health Repository)

    McKiernan, Eadaoin

    2011-06-01

    The S100 gene family encode low molecular weight proteins implicated in cancer progression. In this study, we analyzed the expression of four S100 genes in one cohort of patients with breast cancer and 16 S100 genes in a second cohort. In both cohorts, the expression of S100A8 and S1009 mRNA level was elevated in high-grade compared to low-grade tumors and in estrogen receptor-negative compared to estrogen receptor-positive tumors. None of the S100 transcripts investigated were significantly associated with the presence of lymph node metastasis. Notably, multiple S100 genes, including S100A1, S100A2, S100A4, S100A6, S100A8, S100A9, S100A10, S100A11, and S100A14 were upregulated in basal-type breast cancers compared to non-basal types. Using Spearman\\'s correlation analysis, several S100 transcripts correlated significantly with each other, the strongest correlation has been found between S100A8 and S100A9 (r = 0.889, P < 0.001, n = 295). Of the 16 S100 transcripts investigated, only S100A11 and S100A14 were significantly associated with patient outcome. Indeed, these two transcripts predicted outcome in the cohort of patients that did not receive systemic adjuvant therapy. Based on our findings, we conclude that the different S100 genes play varying roles in breast cancer progression. Specific S100 genes are potential targets for the treatment of basal-type breast cancers.

  10. The role of S100 genes in breast cancer progression.

    LENUS (Irish Health Repository)

    McKiernan, Eadaoin

    2012-02-01

    The S100 gene family encode low molecular weight proteins implicated in cancer progression. In this study, we analyzed the expression of four S100 genes in one cohort of patients with breast cancer and 16 S100 genes in a second cohort. In both cohorts, the expression of S100A8 and S1009 mRNA level was elevated in high-grade compared to low-grade tumors and in estrogen receptor-negative compared to estrogen receptor-positive tumors. None of the S100 transcripts investigated were significantly associated with the presence of lymph node metastasis. Notably, multiple S100 genes, including S100A1, S100A2, S100A4, S100A6, S100A8, S100A9, S100A10, S100A11, and S100A14 were upregulated in basal-type breast cancers compared to non-basal types. Using Spearman\\'s correlation analysis, several S100 transcripts correlated significantly with each other, the strongest correlation has been found between S100A8 and S100A9 (r = 0.889, P < 0.001, n = 295). Of the 16 S100 transcripts investigated, only S100A11 and S100A14 were significantly associated with patient outcome. Indeed, these two transcripts predicted outcome in the cohort of patients that did not receive systemic adjuvant therapy. Based on our findings, we conclude that the different S100 genes play varying roles in breast cancer progression. Specific S100 genes are potential targets for the treatment of basal-type breast cancers.

  11. Catalog of genetic progression of human cancers: breast cancer.

    Science.gov (United States)

    Desmedt, Christine; Yates, Lucy; Kulka, Janina

    2016-03-01

    With the rapid development of next-generation sequencing, deeper insights are being gained into the molecular evolution that underlies the development and clinical progression of breast cancer. It is apparent that during evolution, breast cancers acquire thousands of mutations including single base pair substitutions, insertions, deletions, copy number aberrations, and structural rearrangements. As a consequence, at the whole genome level, no two cancers are identical and few cancers even share the same complement of "driver" mutations. Indeed, two samples from the same cancer may also exhibit extensive differences due to constant remodeling of the genome over time. In this review, we summarize recent studies that extend our understanding of the genomic basis of cancer progression. Key biological insights include the following: subclonal diversification begins early in cancer evolution, being detectable even in in situ lesions; geographical stratification of subclonal structure is frequent in primary tumors and can include therapeutically targetable alterations; multiple distant metastases typically arise from a common metastatic ancestor following a "metastatic cascade" model; systemic therapy can unmask preexisting resistant subclones or influence further treatment sensitivity and disease progression. We conclude the review by describing novel approaches such as the analysis of circulating DNA and patient-derived xenografts that promise to further our understanding of the genomic changes occurring during cancer evolution and guide treatment decision making.

  12. Prolonged time to progression with fulvestrant for metastatic breast cancer.

    Science.gov (United States)

    Mello, Celso A L; Chinen, Ludmilla T D; da Silva, Samantha Cabral Severino; do Nascimento Matias, Carolina; Benevides, Carlos Frederico; Gimenes, Daniel Luiz; Fanelli, Marcello F

    2011-06-01

    Although the incidence of breast cancer has been declining in recent years, the disease is still one of the leading causes of cancer deaths in women. Recently, breast cancer has been treated with innovative approaches that use hormone-sensitive therapies. This is because in at least one-third of breast cancers, estrogens mediated via the estrogen receptor pathway act as endocrine growth factors. Fulvestrant has been studied as both first- and second-line therapy for locally advanced and metastatic breast cancer, but few studies have shown its effect as third-line therapy alone. To observe the disease time to progression (TTP) obtained with fulvestrant when used on metastatic breast cancer as first-, second-, and also third-line therapy. We also aimed to correlate the TTP obtained with fulvestrant with hormone receptor, HER2 expression, and metastatic site. This was a cohort study that retrospectively examined medical records of 73 postmenopausal women with advanced breast cancer who were treated with fulvestrant (250 mg/month i.m. injection) and followed at the Department of Medical Oncology at Hospital do Cancer A. C. Camargo in São Paulo, Brazil from August 2003 to December 2006. The median TTP with fulvestrant was about 11 months. When used as the first-line therapy, TTP was about 13 months; when used as second-line, TTP was about 6 months; and when used as third-line, it was about 12 months. No statistically significant difference was observed regarding the therapy line. In patients with positive ER tumors, TTP was 11 months. No significant difference in TTP was observed in negative ER tumors (TTP = 10 months). In patients with positive PgR tumors, TTP was 13 months and for negative PgR, TTP was 6 months (P = 0.008). According to the HER2 status, the TTP was 5 months for HER2+ and 10 months for HER2-. Our findings indicate that fulvestrant is an effective alternative for treatment of metastatic breast cancer.

  13. Technical quality assessment of breast ultrasound according to American College of Radiology (ACR) Standards

    Energy Technology Data Exchange (ETDEWEB)

    Ko, Kyung Hee; Kim, Eun Kyung; Kim, Young Ah; Son, Eun Ju; Oh, Ki Keun [Yonsei University College of Medicine, Seoul (Korea, Republic of); Chung, Sun Yang [Pochon CHA University, Pochon (Korea, Republic of)

    2003-06-15

    To evaluate the technical quality of breast ultrasound based on American College of Radiology(ACR) standards. Between March 2002 and July 2002, ninety three breast sonograms obtained from 73 institutions were evaluated based on ACR standards for the hardware, technical settings, labeling of the images and identification. Of 93 breast sonograms, a satisfactory compliance with all ACR standards in the performance of breast US examinations was documented in 31% while the remaining 69% did not fully meet all ACR standards. 4.3% of breast US examinations were performed with a convex transducers, and the focal zone was inappropriately positioned in 14.2%. Gray-scale gain was subjectively characterized as inappropriate in 26.9%, and the size of lesion was not measured in 7.5%. Anatomic location of lesions was inappropriately described in 9.3%. The orientation of an US transducer was not properly labeled on any images in 33.3%. Inadequate recording of patient's information was noted in 43.3%. 50% of sonograms at University medical centers and larger general hospitals fully met all ACR standards while 36.8% at radiologic clinics and 12.1% at other private clinics met all ACR standards. Overall, 69% of breast sonograms failed to meet the quality criteria of the ACR standards. Therefore, it is essential to educate the basic technical details in performing breast US for the quality control.

  14. Progress in adjuvant chemotherapy for breast cancer: an overview.

    Science.gov (United States)

    Anampa, Jesus; Makower, Della; Sparano, Joseph A

    2015-01-01

    Breast cancer is the most common cause of cancer and cancer death worldwide. Although most patients present with localized breast cancer and may be rendered disease-free with local therapy, distant recurrence is common and is the primary cause of death from the disease. Adjuvant systemic therapies are effective in reducing the risk of distant and local recurrence, including endocrine therapy, anti-HER2 therapy, and chemotherapy, even in patients at low risk of recurrence. The widespread use of adjuvant systemic therapy has contributed to reduced breast cancer mortality rates. Adjuvant cytotoxic chemotherapy regimens have evolved from single alkylating agents to polychemotherapy regimens incorporating anthracyclines and/or taxanes. This review summarizes key milestones in the evolution of adjuvant systemic therapy in general, and adjuvant chemotherapy in particular. Although adjuvant treatments are routinely guided by predictive factors for endocrine therapy (hormone receptor expression) and anti-HER2 therapy (HER2 overexpression), predicting benefit from chemotherapy has been more challenging. Randomized studies are now in progress utilizing multiparameter gene expression assays that may more accurately select patients most likely to benefit from adjuvant chemotherapy.

  15. Thermal energy storage technical progress report, April 1992--March 1993

    Energy Technology Data Exchange (ETDEWEB)

    Olszewski, M.

    1993-05-01

    The Department of Energy (DOE) is supporting development of thermal energy storage (TES) as a means of efficiently coupling energy supplies to variable heating or cooling demands. Uses of TES include electrical demand-side management in buildings and industry, extending the utilization of renewable energy resources such as solar, and recovery of waste heat from periodic industrial processes. Technical progress to develop TES for specific diurnal and industrial applications under the Oak Ridge National Laboratory`s TES program from April 1992 to March 1993 is reported and covers research in the areas of low temperature sorption, thermal energy storage water heater, latent heat storage wallboard and latent/sensible heat regenerator technology development.

  16. Progress in systemic chemotherapy of primary breast cancer: an overview.

    Science.gov (United States)

    Hortobagyi, G N

    2001-01-01

    Substantial progress has been made in the multidisciplinary management of primary breast cancer during the last 30 years. Adjuvant chemotherapy has been shown to significantly reduce the annual risk of cancer recurrence and mortality, and these effects persist even 15 years after diagnosis. Combination chemotherapy is superior to single-agent therapy and anthracycline-containing regimens. Those that combine an anthracycline with 5-fluorouracil and cyclophosphamide are more effective than regimens without an anthracycline. Six cycles of a single regimen appear to provide optimal benefit. Dose reductions below the standard range are associated with inferior results. Dose increases that require growth factor or hematopoietic stem cell support are under investigation; at this time, the existing results provide no compelling reason to use this strategy outside a clinical trial. Regimens using fixed crossover designs with two non-cross-resistant regimens are being evaluated. The addition of a taxane to anthracycline-containing regimens is currently under intense scrutiny, and preliminary analysis of the first three clinical trials has shown encouraging, albeit not compelling, results. For patients with estrogen receptor-positive breast cancer, the sequential administration of chemotherapy and 5 years of tamoxifen therapy provides additive benefits. No compelling evidence exists to combine ovarian ablation with chemotherapy. Most side effects and toxic effects are self-limited, although premature menopause requires monitoring and preventive interventions to preserve bone mineral density. The small risk of acute leukemia is of concern, and additional research to develop safer regimens is clearly indicated. The overall effect of optimal local/regional treatment combined with an anthracycline-containing adjuvant chemotherapy and a taxane (and, for patients with estrogen receptor-positive tumors, 5 years of tamoxifen therapy) is a greater than 50% reduction in annual risks of

  17. Rotational flaps in oncologic breast surgery. Anatomical and technical considerations.

    Science.gov (United States)

    Acea Nebril, Benigno; Builes Ramírez, Sergio; García Novoa, Alejandra; Varela Lamas, Cristina

    2016-01-01

    Local flaps are a group of surgical procedures that can solve the thoracic closure of large defects after breast cancer surgery with low morbidity. Its use in skin necrosis complications after conservative surgery or skin sparing mastectomies facilitates the initiation of adjuvant treatments and reduces delays in this patient group. This article describes the anatomical basis for the planning of thoracic and abdominal local flaps. Also, the application of these local flaps for closing large defects in the chest and selective flaps for skin coverage by necrosis in breast conserving surgery.

  18. Technical, Psychological, and Economic Aspects of DIEP Flap Breast Reconstruction

    NARCIS (Netherlands)

    T.H.C. Damen (Tim)

    2011-01-01

    textabstractIn the Western world the incidence of breast cancer (BC) is high. In the Netherlands the lifetime risk for women to develop BC is around 13%, making it the most common form of cancer among women with approximately 12.000 women being diagnosed annually. Also, increasing numbers of women a

  19. Progress in diagnosis of breast cancer: Advances in radiology technology

    Directory of Open Access Journals (Sweden)

    J Mari Beth Linder

    2015-01-01

    Full Text Available Breast cancer is the leading cause of cancer in females between the ages of 15 and 54, and the second leading cause of cancer death in women in the United States. Diagnosis begins with detection by breast examination (clinical breast exam or breast self-exam or by radiologic studies, like mammography. Many advances in the diagnosis of breast cancer have taken place in recent years. This article will review the history of radiologic advances in the diagnosis of breast cancer. Use of technological advancements in digital breast tomosynthesis, magnetic resonance imaging, and ultrasound in breast cancer diagnosis will be presented. Advantages and disadvantages of these diagnostic interventions when compared to older, traditional X-ray films will be discussed. It is important for all nurses, including radiology and oncology nurses, to be well informed about these varied diagnostic modalities, and appreciate the fact that advances in radiologic imaging technologies can yield improved outcomes for breast cancer patients.

  20. Modern problems of technical progress and methodological support in medicine

    Science.gov (United States)

    Novyc'kyy, Victor V.; Lushchyk, Ulyana B.

    2001-06-01

    A rapid development of modern computer technologies gave a powerful incentive to technical progress as a whole and to medical equipment in particular. A range of medical diagnostic computer-based systems has recently appeared. There are various fields these techniques are used in: roentgenology, ultrasound diagnostic, neurophysiology, angiology etc. The advantages of the use of computer interface are undoubted: it gives possibility to enhance the functioning of the system itself, speed up all technological processes, carry out a reliable and easy archivation and exchange the information obtained. But the most important advantage of using PC in diagnostic system lies in an unlimited freedom of use mathematical algorithms and flexible mathematical models for processing information obtained. On the other hand, the absence of clinical techniques for interpretation of the data obtained is an obstacle to the use of software at its full potential. As a result, a close connection of a scientific development of hardware with high-informative techniques for clinical interpretation of the instrumental data obtained has become topical as never before. We see an optimal solution in introducing the interpretation patterns in conjunction with purely numerical computations into mathematical simulations.

  1. FY 1992 work plan and technical progress reports

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1992-11-01

    The Desert Research Institute (DRI) is a division of the University of Nevada System devoted to multidisciplinary scientific research. For more than 25 years, DRI has conducted research for the US Department of Energy`s Nevada Field Office (DOE/NV) in support of operations at the Nevada Test Site (NTS). During that time, the research program has grown from an early focus on hydrologic studies to include the areas of geology, archaeology, environmental compliance and monitoring, statistics, database management, public education, and community relations. The range of DRI`s activities has also expanded to include a considerable amount of management and administrative support in addition to scientific investigations. DRI`s work plan for FY 1992 reflects a changing emphasis in DOE/NV activities from nuclear weapons testing to environmental restoration and monitoring. Most of the environmental projects from FY 1991 are continuing, and several new projects have been added to the Environmental Compliance Program. The Office of Technology Development Program, created during FY 1991, also includes a number of environmental projects. This document contains the FY 1992 work plan and quarterly technical progress reports for each DRI project.

  2. Research progress of ultrasonic diagnosis for breast cancer%乳腺癌超声诊断研究进展

    Institute of Scientific and Technical Information of China (English)

    钟献凤

    2015-01-01

    The development of science and technology provides important technical support for medical diagnosis. Breast cancer is a common malignant tumor, which seriously endangers the life and health of the patients. It is the key to improve the prognosis of the early stage of breast cancer. Advances in medical technology provide the basis for diagnosis of breast cancer. The application of ultrasonic diagnosis improves the accuracy of diagnosis, and for early treatment of breast cancer, it has important significance. This paper mainly discusses the progress of ultrasonic diagnosis for breast cancer, and makes a review of the milestones in the progress of the ultrasonic diagnosis of breast cancer with the aim to lay the foundation for the use and promotion of the technology.%科学技术的发展,为医学诊断提供了重要的技术支持.乳腺癌是一种常见的恶性肿瘤,严重危害着患者的生命健康,在乳腺癌早期进行有效的诊断是提高其预后的关键.医疗技术的进步为乳腺癌诊断提供了依据,由于超声诊断的应用,提升了诊断的准确率,为及早治疗乳腺癌具有重要的意义.本文主要对乳腺癌超声诊断研究的进展进行探讨,明确乳腺癌超声诊断技术的研究进展,为技术的利用和推广奠定基础.

  3. Development of Ultrasound Tomography for Breast Imaging: Technical Assessment

    Energy Technology Data Exchange (ETDEWEB)

    Duric, N; Littrup, P; Babkin, A; Chambers, D; Azevedo, S; Arkady, K; Pevzner, R; Tokarev, M; Holsapple, E

    2004-09-30

    Ultrasound imaging is widely used in medicine because of its benign characteristics and real-time capabilities. Physics theory suggests that the application of tomographic techniques may allow ultrasound imaging to reach its full potential as a diagnostic tool allowing it to compete with other tomographic modalities such as X-ray CT and MRI. This paper describes the construction and use of a prototype tomographic scanner and reports on the feasibility of implementing tomographic theory in practice and the potential of US tomography in diagnostic imaging. Data were collected with the prototype by scanning two types of phantoms and a cadaveric breast. A specialized suite of algorithms was developed and utilized to construct images of reflectivity and sound speed from the phantom data. The basic results can be summarized as follows: (1) A fast, clinically relevant US tomography scanner can be built using existing technology. (2) The spatial resolution, deduced from images of reflectivity, is 0.4 mm. The demonstrated 10 cm depth-of-field is superior to that of conventional ultrasound and the image contrast is improved through the reduction of speckle noise and overall lowering of the noise floor. (3) Images of acoustic properties such as sound speed suggest that it is possible to measure variations in the sound speed of 5 m/s. An apparent correlation with X-ray attenuation suggests that the sound speed can be used to discriminate between various types of soft tissue. (4) Ultrasound tomography has the potential to improve diagnostic imaging in relation to breast cancer detection.

  4. Tight junctions: a barrier to the initiation and progression of breast cancer?

    LENUS (Irish Health Repository)

    Brennan, Kieran

    2010-01-01

    Breast cancer is a complex and heterogeneous disease that arises from epithelial cells lining the breast ducts and lobules. Correct adhesion between adjacent epithelial cells is important in determining the normal structure and function of epithelial tissues, and there is accumulating evidence that dysregulated cell-cell adhesion is associated with many cancers. This review will focus on one cell-cell adhesion complex, the tight junction (TJ), and summarize recent evidence that TJs may participate in breast cancer development or progression. We will first outline the protein composition of TJs and discuss the functions of the TJ complex. Secondly we will examine how alterations in these functions might facilitate breast cancer initiation or progression; by focussing on the regulatory influence of TJs on cell polarity, cell fate and cell migration. Finally we will outline how pharmacological targeting of TJ proteins may be useful in limiting breast cancer progression. Overall we hope to illustrate that the relationship between TJ alterations and breast cancer is a complex one; but that this area offers promise in uncovering fundamental mechanisms linked to breast cancer progression.

  5. NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/β-catenin pathway.

    Science.gov (United States)

    Lei, Jin-Ju; Peng, Rou-Jun; Kuang, Bo-Hua; Yuan, Zhong-Yu; Qin, Tao; Liu, Wen-Sheng; Guo, Yun-Miao; Han, Hui-Qiong; Lian, Yi-Fan; Deng, Cheng-Cheng; Zhang, Hao-Jiong; Chen, Li-Zhen; Feng, Qi-Sheng; Xu, Miao; Feng, Lin; Bei, Jin-Xin; Zeng, Yi-Xin

    2015-09-22

    NOP14, which is functionally conserved among eukaryotes, has been implicated in cancer development. Here, we show that NOP14 is poorly expressed in breast cancer cells and invasive breast cancer tissues. In vivo and in vitro studies indicated that NOP14 suppressed the tumorigenesis and metastasis of breast cancer cells. Further investigations revealed that NOP14 enhanced ERα expression and inhibited the Wnt/β-catenin pathway by up-regulating NRIP1 expression. Survival analysis indicated that low NOP14 expression was significantly associated with poor overall survival (P = 0.0006) and disease-free survival (P = 0.0007), suggesting that NOP14 is a potential prognostic factor in breast cancer. Taken together, our findings reveal that NOP14 may suppress breast cancer progression and provide new insights into the development of targeted therapeutic agents for breast cancer.

  6. Monitoring the Durability Performance of Concrete in Nuclear Waste Containment. Technical Progress Report No. 3

    Energy Technology Data Exchange (ETDEWEB)

    Ulm, Franz-Josef

    2000-03-31

    OAK-B135 Monitoring the Durability Performance of Concrete in Nuclear Waste Containment. Technical Progress Report No. 3(NOTE: Part II A item 1 indicates ''PAPER'', but a report is attached electronically)

  7. Responsive copolymers for enhanced petroleum recovery. Quarterly technical progress report, December 22, 1993--March 21, 1994

    Energy Technology Data Exchange (ETDEWEB)

    McCormick, C.; Hester, R.

    1994-06-01

    The overall goal of this research is the development of advanced water-soluble copolymers for use in enhanced oil recovery. This report summarizes technical progress for the following tasks: advanced copolymer synthesis; and characterization of molecular structure of copolymers.

  8. A role for ADAM12 in breast tumor progression and stromal cell apoptosis

    DEFF Research Database (Denmark)

    Kveiborg, Marie; Frohlich, Camilla; Albrechtsen, Reidar;

    2005-01-01

    of stromal fibroblasts in tumor initiation and progression has been elucidated. Here, we show that stromal cell apoptosis occurs in human breast carcinoma but is only rarely seen in nonmalignant breast lesions. Furthermore, we show that ADAM12, a disintegrin and metalloprotease up-regulated in human breast...... cancer, accelerates tumor progression in a mouse breast cancer model. ADAM12 does not influence tumor cell proliferation but rather confers both decreased tumor cell apoptosis and increased stromal cell apoptosis. This dual role of ADAM12 in governing cell survival is underscored by the finding that ADAM......12 increases the apoptotic sensitivity of nonneoplastic cells in vitro while rendering tumor cells more resistant to apoptosis. Together, these results show that the ability of ADAM12 to influence apoptosis may contribute to tumor progression....

  9. Potential Biomarker of L type Amino Acid Transporter 1 in Breast Cancer Progression

    Energy Technology Data Exchange (ETDEWEB)

    Liang, Zhongxing; Cho, Heidi T.; Williams, Larry; Zhu, Aizhi; Liang, Ke; Huang, Ke; Wu, Hui; Jiang, Chunsu; Hong, Samuel; Crowe, Ronald; Goodman, Mark M.; Shim, Hyunsuk [Emory Univ. School of Medicine, Atlanta (United States)

    2011-06-15

    L type amino acid transporter 1 (LAT1) is essential for the transport of large neutral amino acids. However, its role in breast cancer growth remains largely unknown. The purpose of the study is to investigate whether LAT1 is a potential biomarker for the diagnosis and treatment of breast cancer. LAT1 mRNA and protein levels in breast cancer cell lines and tissues were analyzed. In addition, the effects of targeting LAT1 for the inhibition of breast cancer cell tumorigenesis were assessed with soft agar assay. The imaging of xenograft with 1 amino 3 [{sup 18F}]fluorocyclo butane 1 carboxylic acid ([{sup 18F}]FACBC) PET was assessed for its diagnostic biomarker potential. Normal breast tissue or low malignant cell lines expressed low levels of LAT1 mRNA and protein, while highly malignant cancer cell lines and high grade breast cancer tissue expressed high levels of LAT1. In addition, higher expression levels of LAT1 in breast cancer tissues were consistent with advanced stage breast cancer. Furtermore, the blockade of LAT1 with its inhibitor, 2 amino bicyclo[2.2.1]heptane 2 carboxylic acid (BCH), or the knockdown of LAT1 with siRNA, inhibited proliferation and tumorigenesis of breast cancer cells. A leucine analog, [{sup 18F}]FACBC, has been demonstrated to be an excellent PET tracer for the non invasive imaging og malignant breast cancer using an orthotopic animal model. The overexpression of LAT1 is required for the progression of breast cancer. LAT1 represents a potential biomarker for therapy and diagnosis of breast cancer. [{sup 18F}]FACBC that correlates with LAT1 function is a potential PET tracer for malignant breast tumor imaging.

  10. Verification of Steelmaking Slags Iron Content Final Technical Progress Report

    Energy Technology Data Exchange (ETDEWEB)

    J.Y. Hwang

    2006-10-04

    The steel industry in the United States generates about 30 million tons of by-products each year, including 6 million tons of desulfurization and BOF/BOP slag. The recycling of BF (blast furnace) slag has made significant progress in past years with much of the material being utilized as construction aggregate and in cementitious applications. However, the recycling of desulfurization and BOF/BOP slags still faces many technical, economic, and environmental challenges. Previous efforts have focused on in-plant recycling of the by-products, achieving only limited success. As a result, large amounts of by-products of various qualities have been stockpiled at steel mills or disposed into landfills. After more than 50 years of stockpiling and landfilling, available mill site space has diminished and environmental constraints have increased. The prospect of conventionally landfilling of the material is a high cost option, a waste of true national resources, and an eternal material liability issue. The research effort has demonstrated that major inroads have been made in establishing the viability of recycling and reuse of the steelmaking slags. The research identified key components in the slags, developed technologies to separate the iron units and produce marketable products from the separation processes. Three products are generated from the technology developed in this research, including a high grade iron product containing about 90%Fe, a medium grade iron product containing about 60% Fe, and a low grade iron product containing less than 10% Fe. The high grade iron product contains primarily metallic iron and can be marketed as a replacement of pig iron or DRI (Direct Reduced Iron) for steel mills. The medium grade iron product contains both iron oxide and metallic iron and can be utilized as a substitute for the iron ore in the blast furnace. The low grade iron product is rich in calcium, magnesium and iron oxides and silicates. It has a sufficient lime value and

  11. An imbalance in progenitor cell populations reflects tumour progression in breast cancer primary culture models.

    LENUS (Irish Health Repository)

    Donatello, Simona

    2011-01-01

    Many factors influence breast cancer progression, including the ability of progenitor cells to sustain or increase net tumour cell numbers. Our aim was to define whether alterations in putative progenitor populations could predict clinicopathological factors of prognostic importance for cancer progression.

  12. Changes in intrinsic subtype of breast cancer during tumor progression in the same patient.

    Science.gov (United States)

    Kim, Chungyeul; Lee, Jungjoo; Lee, Wonyoung; Kim, Aeree

    2015-01-01

    Hormone receptor (HR), human epidermal growth factor receptor 2 (HER2) and Ki67 are important prognostic factors and key variables in classification of the intrinsic subtype, which is essential for choice of adjuvant therapy in breast cancer management. There has been earlier reports that instability of hormonal and HER2 status during progression of tumor. However, breast cancer treatment guidelines recently recommended using the intrinsic subtype that is determined by four immunohistochemical (IHC) assays, estrogen receptor (ER), progesterone receptor (PR), HER2 and Ki67. The purpose of study was to investigate whether the intrinsic subtype changes during the tumor progression from ductal carcinoma in situ (DCIS) to lymph node metastasis. The study included 90 patients with breast cancer in Korea University Guro Hospital, between 1992 and 2008. All individuals had DCIS, invasive carcinoma and lymph node metastasis lesion. IHC staining for ER, PR, HER2 and Ki67 as well as SISH assay for HER2 gene amplification was done with following standard method. Overall 25% of breast cancer changed their intrinsic phenotype during progression. Study demonstrated that a subset of breast cancers can change their intrinsic subtype during cancer progression. These changes have an impact on patient prognosis and management, because each breast cancer subtype has their own differently optimized treatment options according to St. Gallen and NCCN guideline.

  13. Evaporation by mechanical vapor recompression. Technical progress report, September 1-December 31, 1979

    Energy Technology Data Exchange (ETDEWEB)

    Iverson, C.H.; Coury, G.E.

    1979-01-01

    Progress to date in the development of a study of the application of the technologies of mechanical vapor recompression and falling film evaporators as applied to the beet sugar industry is reported. Progress is reported in the following areas: technical literature search and plant visitations of existing applications of VR/FFE.

  14. Technical progress of nuclear energy: economic and environmental prospects

    Energy Technology Data Exchange (ETDEWEB)

    Naudet, G.

    1994-12-31

    This document deals with three different aspects of the nuclear energy: first the operating and economic performances of nuclear power plants in the world, the French nuclear competitiveness. Then, the technical and economic perspectives about reactors and fuels cycle and the advantages towards atmospheric pollution are discussed to favour a new worldwide nuclear development. (TEC). 8 refs., 4 figs., 6 tabs.

  15. Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study

    DEFF Research Database (Denmark)

    von Minckwitz, Gunter; du Bois, Andreas; Schmidt, Marcus;

    2009-01-01

    : Patients with HER-2-positive breast cancer that progresses during treatment with trastuzumab were randomly assigned to receive capecitabine (2,500 mg/m(2) body-surface area on days 1 through 14 [1,250 mg/m(2) semi-daily]) alone or with continuation of trastuzumab (6 mg/kg body weight) in 3-week cycles...

  16. LANL technical progress update for US HJPRR working group

    Energy Technology Data Exchange (ETDEWEB)

    Dombrowski, David E [Los Alamos National Laboratory

    2011-01-06

    The outline of this presentation is: (1) Collaboration on Master Alloy Melting; (2) Data for Safety Analysis, (3) HIP can development status, (4) Bond strength quality, (5) Plasma spraying results, and (6) Bare Rolling Larger Rolling Ingots. Significant near term progress has been made in five areas: (1) Collaboration on Master Alloy Melting; (2) HIP can development status; (3) Bond strength quality; (4) Plasma spraying results; and (5) Bare Rolling Larger Rolling Ingots. Significant progress is expected in the next month on several important areas: (1) Intrinsic bond strength of plasma sprayed Zr (2) Advanced Cleaning; (3) Residual Stress Collaboration with INL; and (4) Cost Metric Assessment.

  17. Histone Demethylase RBP2 Is Critical for Breast Cancer Progression and Metastasis

    Directory of Open Access Journals (Sweden)

    Jian Cao

    2014-03-01

    Full Text Available Metastasis is a major clinical challenge for cancer treatment. Emerging evidence suggests that aberrant epigenetic modifications contribute significantly to tumor formation and progression. However, the drivers and roles of such epigenetic changes in tumor metastasis are still poorly understood. Using bioinformatic analysis of human breast cancer gene-expression data sets, we identified histone demethylase RBP2 as a putative mediator of metastatic progression. By using both human breast cancer cells and genetically engineered mice, we demonstrated that RBP2 is critical for breast cancer metastasis to the lung in multiple in vivo models. Mechanistically, RBP2 promotes metastasis as a pleiotropic positive regulator of many metastasis genes, including TNC. In addition, RBP2 loss suppresses tumor formation in MMTV-neu transgenic mice. These results suggest that therapeutic targeting of RBP2 is a potential strategy for inhibition of tumor progression and metastasis.

  18. FoxD3 deficiency promotes breast cancer progression by induction of epithelial–mesenchymal transition

    Energy Technology Data Exchange (ETDEWEB)

    Chu, Tian-Li [Department of General Surgery, The People’s Hospital of Wuqing, Tianjin (China); Zhao, Hong-Meng [Key Laboratory of Breast Cancer Prevention and Treatment of the Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Li, Yue [Department of Respiration, Affiliated Hospital of Medical College of Chinese People’s Armed Police Force, Tianjin (China); Chen, Ao-Xiang; Sun, Xuan [Key Laboratory of Breast Cancer Prevention and Treatment of the Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Ge, Jie, E-mail: gejie198003@163.com [Key Laboratory of Breast Cancer Prevention and Treatment of the Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China)

    2014-04-04

    Highlights: • FOXD3 is down-regulated in breast cancer tissues. • FOXD3 inhibits breast cancer cell proliferation and invasion. • FoxD3 deficiency induces epithelial–mesenchymal transition. - Abstract: The transcription factor forkhead box D3 (FOXD3) plays an important role in the development of neural crest and gastric cancer cells. However, the function and mechanisms of FOXD3 in the breast tumorigenesis and progression is still limited. Here, we report that FOXD3 is a tumor suppressor of breast cancer tumorigenicity and aggressiveness. We found that FOXD3 is down-regulated in breast cancer tissues. Patients with low FOXD3 expression have a poor outcome. Depletion of FOXD3 expression promotes breast cancer cell proliferation and invasion in vitro, whereas overexpression of FOXD3 inhibits breast cancer cell proliferation and invasion both in vitro and in vivo. In addition, depletion of FOXD3 is linked to epithelial–mesenchymal transition (EMT)-like phenotype. Our results indicate FOXD3 exhibits tumor suppressive activity and may be useful for breast therapy.

  19. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.

    Science.gov (United States)

    Fu, De-Yuan; Tan, Hao-Sheng; Wei, Jin-Li; Zhu, Chang-Ren; Jiang, Ji-Xin; Zhu, Yu-Xiang; Cai, Feng-Lin; Chong, Mei-Hong; Ren, Chuan-Li

    2015-09-01

    The SOX17 (SRY-related HMG-box) transcription factor is involved in a variety of biological processes and is related to the tumorigenesis and progression of multiple tumors. However, the clinical application of SOX17 for breast cancer prognosis is currently limited. The aim of this study was to investigate the clinicopathologic and prognostic significance of SOX17 expression in human breast cancer. qPCR and western blot assays were performed to measure the expression of SOX17 in breast cancer cell lines and 30 matched pairs of breast cancer and corresponding noncancerous tissues. A SOX17 overexpression cell model was used to examine changes in cell growth in vitro. Immunohistochemical analyses were performed to retrospectively examine the prognostic impact of SOX17 expression in 187 additional breast cancer patients. Our results showed that SOX17 expression was decreased at both the messenger RNA (mRNA) and protein levels in the breast cancer cell lines and tissues, and that SOX17 overexpression could strongly suppress cell growth in vitro. Furthermore, the lack of SOX17 protein expression was strongly correlated with higher tumor grade (P = 0.002), lymph node metastasis (P breast cancer. Our findings indicate that SOX17 expression is a useful prognostic biomarker for breast cancer.

  20. An atypical cause of rapidly progressing breast lump with abscess formation: Pure squamous cell carcinoma of the breast.

    Science.gov (United States)

    Cilekar, Murat; Erkasap, Serdar; Oner, Ulku; Akici, Murat; Ciftci, Evrim; Dizen, Hayrettin; Turel, Serkan; Kavak, Ozgu I; Yilmaz, Sezgin

    2015-01-01

    Squamous cell carcinoma (SCC) is a rare type of breast malignancy and little is known about long-term outcome. In the present report, the clinical features, histopathologic findings and postoperative course of a patient with squamous cell carcinoma are described. We have treated a 47-years-old woman who admitted for right breast mass without any discharge, bleeding and pain. The tumor was, 3 × 2 × 1.5 cm in size with central abscess formation. The result of surgical biopsy revealed large cell keratinizing type of SCC. The metastatic work-up studies ruled out any other probable sources of primary tumor. The patient was performed modified radical mastectomy and axillary dissection and received two cycles of chemotherapy. Squamous cell carcinoma of the breast (SCCB) is a rare entity and should be considered in patients with rapidly progressing breast mass. It should also be considered in breast lesions with abscess formation. The initial therapeutic approach should be surgical excision after histopathological diagnosis.

  1. Quarterly technical progress report, February 1, 1996--April 30, 1996

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-05-28

    This report from the Amarillo National REsource Center for PLutonium provides research highlights and provides information regarding the public dissemination of information. The center is a a scientific resource for information regarding the issues of the storage, disposition, potential utilization and transport of plutonium, high explosives, and other hazardous materials generated from nuclear weapons dismantlement. The center responds to informational needs and interpretation of technical and scientific data raised by interested parties and advisory groups. Also, research efforts are carried out on remedial action programs and biological/agricultural studies.

  2. Technical progress report, 1 April-30 June 1981

    Energy Technology Data Exchange (ETDEWEB)

    None

    1981-01-01

    This report describes the technical accomplishments during the quarter ending June 1981, on the commercial nuclear waste management programs under the direction of the Office of Nuclear Waste Isolation (ONWI). The ONWI program is organized into 8 tasks entitled: systems, waste package, site, repository, regulatory and institutional, test facilities and excavations, land acquisition, and program management. Principal investigators in each of these areas have submitted summaries of quarterly highlights for inclusion in this report. Separate abstracts have been prepared for 5 of these tasks for inclusion in the Energy Data Base. (DMC)

  3. Environmental Research Division technical progress report: January 1986--October 1987

    Energy Technology Data Exchange (ETDEWEB)

    1988-07-01

    Technical process in the various research activities of Argonne National Laboratory's Environmental Research Division is reported for the period 1986-1987. Textual, graphic, and tabular information is used to briefly summarize (in separate chapters) the work of the Division's Atmospheric Physics, Environmental Effects Research, Fundamental Molecular Physics and Chemistry, and Organic Geochemistry and Environmental Instrumentation Programs. Information on professional qualifications, awards, and outstanding professional activities of staff members, as well as lists of publications, oral presentations, special events organized, and participants in educational programs, are provided in appendices at the end of each chapter. Individual projects under each division are processed separately for the data bases.

  4. Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis

    DEFF Research Database (Denmark)

    Krøigård, Anne Bruun; Larsen, Martin Jakob; Lænkholm, Anne Vibeke;

    2015-01-01

    Evolution of the breast cancer genome from pre-invasive stages to asynchronous metastasis is complex and mostly unexplored, but highly demanded as it may provide novel markers for and mechanistic insights in cancer progression. The increasing use of personalized therapy of breast cancer necessita......Evolution of the breast cancer genome from pre-invasive stages to asynchronous metastasis is complex and mostly unexplored, but highly demanded as it may provide novel markers for and mechanistic insights in cancer progression. The increasing use of personalized therapy of breast cancer...... progression from one breast cancer patient, including two different regions of Ductal Carcinoma In Situ (DCIS), primary tumor and an asynchronous metastasis. We identify a remarkable landscape of somatic mutations, retained throughout breast cancer progression and with new mutational events emerging at each...

  5. The Role of Cytokines in Breast Cancer Development and Progression

    Science.gov (United States)

    Esquivel-Velázquez, Marcela; Ostoa-Saloma, Pedro; Palacios-Arreola, Margarita Isabel; Nava-Castro, Karen E.; Castro, Julieta Ivonne

    2015-01-01

    Cytokines are highly inducible, secretory proteins that mediate intercellular communication in the immune system. They are grouped into several protein families that are referred to as tumor necrosis factors, interleukins, interferons, and colony-stimulating factors. In recent years, it has become clear that some of these proteins as well as their receptors are produced in the organisms under physiological and pathological conditions. The exact initiation process of breast cancer is unknown, although several hypotheses have emerged. Inflammation has been proposed as an important player in tumor initiation, promotion, angiogenesis, and metastasis, all phenomena in which cytokines are prominent players. The data here suggest that cytokines play an important role in the regulation of both induction and protection in breast cancer. This knowledge could be fundamental for the proposal of new therapeutic approaches to particularly breast cancer and other cancer-related disorders. PMID:25068787

  6. Solar hot water space heating system. Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Van Dam, T

    1979-08-13

    A retrofit solar heating system was installed on Madison Hall at Jordan College, Cedar Springs, Michigan. The system provides heating and domestic water preheating for a campus dormitory. Freeze protection is provided by a draindown system. The building and solar system, construction progress, and design changes are described. Included in appendices are: condensate trap design, structural analysis, pictures of installation, operating instructions, maintenance instructions, and as-built drawings. (MHR)

  7. Monthly technical progress report, January 1, 1996 - January 28, 1996

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-02-24

    This is the January 1996 progress report contract DE-AC03-91SF18852 Radioisotope Thermoelectric Generators and Ancillary Activities, Cassini RTG Program. Included are discussions on the status of: (1) spacecraft integration and support, (2) engineering support, (3) safety, (4) qualified unicouple production, (5) ETG fabrication, Assembly, and Test, (6) ground support equipment, (7) RTG shipping and launch support, (8) designs, reviews, and mission applications, (9) project management, and (10) CAGO acquisition.

  8. Technical Progress Has Positive,Differentiated Effects on Energy Efficiency of Chinese Industries

    Institute of Scientific and Technical Information of China (English)

    李廉水; 周勇

    2007-01-01

    The rebound effects of technological advancement on energy consumption make it very complicated to measure the impact of technological advancement on energy efficiency.This article,taking 35 industries as samples,utilizes the non-parameter DEA-Malmquist productivity approach to subcategorise technological advancement into three parts:science-technological(sci-tech)progress,pure technical efficiency and efficiency of scale.The panel technique is then used to work out each subcategory’s contribution to energy efficiency individually.Findings show that technological efficiency (calculated by multiplying the results of pure technical efficiency and scale efficiency)is the principal factor in the improvement of energy efficiency while the contribution from sci-tech progress is comparatively less.Overtime,however,the effect of sci-tech progress is gradually heightened while the effect of technical efficiency slowly diminishes.

  9. miR-340 and ZEB1 negative feedback loop regulates TGF-β- mediated breast cancer progression

    Science.gov (United States)

    Xie, Ye-Gong; Wang, Jie; Mao, Jie-Fei; Zhang, Bin; Wang, Xin; Cao, Xu-Chen

    2016-01-01

    MicroRNAs act as key regulators in carcinogenesis and progression in various cancers. In present study, we explored the role of miR-340 in the breast cancer progression. Our results showed that overexpression of miR-340 inhibits breast cancer cell proliferation and invasion, whereas depletion of miR-340 promotes breast cancer progression. Molecularly, ZEB1 was identified as a target gene of miR-340 and miR-340 suppressed the expression of ZEB1 by directly binding to the 3′-UTR of ZEB1. Furthermore, ZEB1 transcriptionally suppresses miR-340 expression. The negative feedback loop regulated TGF-β-mediated breast cancer progression. In conclusion, our data suggested that miR-340 acted as a tumor suppressor in breast cancer progression. PMID:27036021

  10. A novel biomarker C6orf106 promotes the malignant progression of breast cancer.

    Science.gov (United States)

    Jiang, Guiyang; Zhang, Xiupeng; Zhang, Yong; Wang, Liang; Fan, Chuifeng; Xu, Hongtao; Miao, Yuan; Wang, Enhua

    2015-09-01

    C6orf106 (chromosome 6 open reading frame 106) is a recently discovered protein encoded by the 6th chromosome. Though many proteins encoded by chromosome 6 are reportedly related to cancer, schizophrenia, autoimmunity and many other diseases, the function of C6orf106 was not well demonstrated so far. As measured by immunohistochemical staining, C6orf106 was positive in normal breast duct myoepithelial cells (92.31 %, 72/78), but negative in normal breast duct glandular epithelial cells (3.85 %, 3/78). In breast ductal carcinoma in situ, C6orf106 showed weakly or moderately positive (77.97 %, 46/59), but it was significantly strongly positive in invasive ductal carcinoma (79.57 %, 148/186). The expression intensity of C6orf106 seemed increased significantly along with the malignancy of breast cancer (p breast cancer, respectively. Consistently, we found that the interference of C6orf106 was able to inhibit cell proliferation and invasion of two triple-negative breast cancer cell lines, MDA-MB-231 and BT-549, accompanied by the decrease of cyclin A2, cyclin B1, c-myc, and N-cadherin and the increase of E-cadherin. Collectively, these results indicate that C6orf106 may promote tumor progression in the invasive breast cancer, particularly in triple-negative breast cancer, and C6orf106 might serve as a novel therapeutic target of breast cancer, especially for triple-negative breast cancer.

  11. CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome

    Science.gov (United States)

    Zhang, Qunyuan; Ye, Jian; Wang, Fang; Zhang, Yanping; Hunborg, Pamela; Varvares, Mark A.; Hoft, Daniel F.; Hsueh, Eddy C.; Peng, Guangyong

    2015-01-01

    The Cancer Immunoediting concept has provided critical insights suggesting dual functions of immune system during the cancer initiation and development. However, the dynamics and roles of CD4+ and CD8+ T cells in the pathogenesis of breast cancer remain unclear. Here we utilized two murine breast cancer models (4T1 and E0771) and demonstrated that both CD4+ and CD8+ T cells were increased and involved in immune responses, but with distinct dynamic trends in breast cancer development. In addition to cell number increases, CD4+ T cells changed their dominant subsets from Th1 in the early stages to Treg and Th17 cells in the late stages of the cancer progression. We also analyzed CD4+ and CD8+ T cell infiltration in primary breast cancer tissues from cancer patients. We observed that CD8+ T cells are the key effector cell population mediating effective anti-tumor immunity resulting in better clinical outcomes. In contrast, intra-tumoral CD4+ T cells have negative prognostic effects on breast cancer patient outcomes. These studies indicate that CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcomes, which provides new insights relevant for the development of effective cancer immunotherapeutic approaches. PMID:25968569

  12. Quarterly technical progress report, April-June 1982

    Energy Technology Data Exchange (ETDEWEB)

    None

    1984-04-01

    Progress reports are presented for the following tasks: (1) preparation of low-rank coals; application of liquefaction processes to low-rank coals; (2) slagging fixed-bed gasification; (3) atmospheric fluidized-bed combustion of low-rank coal; (4) ash fouling and combustion modification for low-rank coal; (5) combined flue gas cleanup/simultaneous SO/sub x/-NO/sub x/ control; (6) particulate control and hydrocarbons and trace element emissions from low-rank coals; (7) waste characterization and disposal; and (9) exploratory research.

  13. Electronic refrigerant leak detector. Quarterly technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Talamas, E. Jr.

    1998-10-15

    The project comprises three main tasks. They are (1) Develop, design, and fabricate sensors, (2) Develop, design, and fabricate test instruments, (3) Testing and data analysis. The milestone includes 17 sub-tasks for the 52-weeks project period, starting on May 1, 1998 and ending on April 30, 1999. As stated in the Application for Federal Assistance, Micronic intended to relocate to a new office by June of 1998. This decision was delayed, since the first partial payment was transferred on August 12, 1998. Micronic plans to relocate this November. A second Provisional Application for a US patent has been filed. Progress made during this period is reported.

  14. ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression

    DEFF Research Database (Denmark)

    Frohlich, Camilla; Nehammer, Camilla; Albrechtsen, Reidar;

    2011-01-01

    hypothesized, however, that the tumor-associated stroma may stimulate ADAM12 expression in tumor cells, based on the fact that TGF-ß1 stimulates ADAM12 expression and is a well-known growth factor released from tumor-associated stroma. TGF-ß1 stimulation of ADAM12-negative Lewis lung tumor cells induced ADAM12...... synthesis, and growth of these cells in vivo induced a >200-fold increase in ADAM12 expression. Our observation that ADAM12 expression is significantly higher in the terminal duct lobular units (TDLUs) adjacent to human breast carcinoma compared with TDLUs found in normal breast tissue supports our......Expression of ADAM12 is low in most normal tissues, but is markedly increased in numerous human cancers, including breast carcinomas. We have previously shown that overexpression of ADAM12 accelerates tumor progression in a mouse model of breast cancer (PyMT). In the present study, we found...

  15. The associations between the environmental exposure to polychlorinated biphenyls (PCBs) and breast cancer risk and progression

    Institute of Scientific and Technical Information of China (English)

    2010-01-01

    Polychlorinated biphenyls(PCBs) are chlorinated biphenyl compounds with wide applications in the industry.In spite of a ban on their production in the late 1970s,PCBs,as a group of POPs,are still persistent and widely spread in the environment,posing potential threats to human health.The role of PCBs as etiologic agents for breast cancer has been intensively explored in a variety of in vivo,animal and epidemiologic studies.Initial investigations indicated higher levels of PCBs in mammary tissues or sera corresponded to the occurrence of breast cancer,but later studies showed no positive association between PCB exposure and breast cancer development.More recent data suggested that the CYP1A1 m2 polymorphisms might add increased risk to the etiology of breast cancer in women with environmental exposure to PCBs.PCBs are implicated in advancing breast cancer progression,and our unpublished data reveals that PCBs activate the ROCK signaling to enhance breast cancer metastasis.Therefore,the correlation between PCB exposure and breast cancer risk warrants further careful investigations.

  16. TECHNICAL TRAINING SEMINAR: High Temperature Superconductors: Progress and Issues

    CERN Multimedia

    Davide Vitè

    2002-01-01

    Monday 24 June from 14:30 to 15:30 - Training Centre Auditorium - bldg. 593-11 High Temperature Superconductors: Progress and Issues Prof. Jan Evetts / UNIVERSITY OF CAMBRIDGE, Department of Materials Science and Metallurgy, UK Grappling with grain boundaries: Current transport processes in granular High Temperature Superconductors (HTS) The development of High Temperature Superconductors, seen from a materials scientist's point of view, is relevant to the superconductivity community at CERN: their possible high current applications can include high performance magnets for future accelerators. There is an urgent need to develop a quantitative description of HTS conductors in terms of their complex anisotropy, inhomogeneity and dimensionality. This is essential both for the practical specification of a conductor and for charting routes to conductor optimisation. The critical current, the n-value, dissipation and quenching characteristics are amongst most important parameters that make up an engineering specifi...

  17. Texas Experimental Tokamak. Technical progress report, April 1990--April 1993

    Energy Technology Data Exchange (ETDEWEB)

    Wootton, A.J.

    1993-04-01

    This progress report covers the period from November 1, 1990 to April 30, 1993. During that period, TEXT was operated as a circular tokamak with a material limiter. It was devoted to the study of basic plasma physics, in particular to study of fluctuations, turbulence, and transport. The purpose is to operate and maintain TEXT Upgrade as a complete facility for applied tokamak physics, specifically to conduct a research program under the following main headings: (1) to elucidate the mechanisms of working gas, impurity, and thermal transport in tokamaks, in particular to understand the role of turbulence; (2) to study physics of the edge plasma, in particular the turbulence; (3) to study the physics or resonant magnetic fields (ergodic magnetic divertors, intra island pumping); and (4) to study the physics of electron cyclotron heating (ECRH). Results of studies in each of these areas are reported.

  18. Total RNA Sequencing Analysis of DCIS Progressing to Invasive Breast Cancer

    Science.gov (United States)

    2015-09-01

    AWARD NUMBER: W81XWH-14-1-0080 TITLE: Total RNA Sequencing Analysis of DCIS Progressing to Invasive Breast Cancer. PRINCIPAL INVESTIGATOR...extracts. All samples have undergone a comprehensive DNA methylome analysis using the Illumina 450K CpG arrays, with excellent call rates, the

  19. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay

    NARCIS (Netherlands)

    Kuijper, Arno; Buerger, H.; Simon, R.; Schaefer, K-L.; Croonen, A.; Boecker, W.; Wall, E. van der; Diest, P.J. van

    2002-01-01

    Fibroadenoma and phyllodes tumour of the breast are both fibroepithelial tumours. Although progression to epithelial malignancy has been described, the behaviour of most fibroadenomas is benign. Phyllodes tumours, on the other hand, can display locally destructive growth and can even metastasize. A

  20. Research Progress in the Use of Drugs for Breast Cancer Targeted Therapy

    Institute of Scientific and Technical Information of China (English)

    Shun'e Yang; Bing Zhao

    2008-01-01

    In recent years,many significant advances have been made on molecular target therapy to aim directly at epidermal growth factor receptors and vascular endothelial growth factor in breast cancers.Clinical studies of such agents as trastuzumab,lapatinib,erlotinib and bevacituzumab have been widely conducted.This paper will review the recent research progress related to targeted therapy.

  1. The Role of Cytokines in Breast Cancer Development and Progression

    OpenAIRE

    Esquivel-Velázquez, Marcela; Ostoa-Saloma, Pedro; Palacios-Arreola, Margarita Isabel; Karen E. Nava-Castro; Castro, Julieta Ivonne; Morales-Montor, Jorge

    2015-01-01

    Cytokines are highly inducible, secretory proteins that mediate intercellular communication in the immune system. They are grouped into several protein families that are referred to as tumor necrosis factors, interleukins, interferons, and colony-stimulating factors. In recent years, it has become clear that some of these proteins as well as their receptors are produced in the organisms under physiological and pathological conditions. The exact initiation process of breast cancer is unknown, ...

  2. Progressive APOBEC3B mRNA expression in distant breast cancer metastases

    Science.gov (United States)

    Dalm, Simone U.; de Weerd, Vanja; Moelans, Cathy B.; ter Hoeve, Natalie; van Diest, Paul J.; Martens, John W. M.; van Deurzen, Carolien H. M.

    2017-01-01

    Background APOBEC3B was recently identified as a gain-of-function enzymatic source of mutagenesis, which may offer novel therapeutic options with molecules that specifically target this enzyme. In primary breast cancer, APOBEC3B mRNA is deregulated in a substantial proportion of cases and its expression is associated with poor prognosis. However, its expression in breast cancer metastases, which are the main causes of breast cancer-related death, remained to be elucidated. Patients and methods RNA was isolated from 55 primary breast cancers and paired metastases, including regional lymph node (N = 20) and distant metastases (N = 35). APOBEC3B mRNA levels were measured by RT-qPCR. Expression levels of the primary tumors and corresponding metastases were compared, including subgroup analysis by estrogen receptor (ER/ESR1) status. Results Overall, APOBEC3B mRNA levels of distant metastases were significantly higher as compared to the corresponding primary breast tumor (P = 0.0015), an effect that was not seen for loco-regional lymph node metastases (P = 0.23). Subgroup analysis by ER-status showed that increased APOBEC3B levels in distant metastases were restricted to metastases arising from ER-positive primary breast cancers (P = 0.002). However, regarding ER-negative primary tumors, only loco-regional lymph node metastases showed increased APOBEC3B expression when compared to the corresponding primary tumor (P = 0.028). Conclusion APOBEC3B mRNA levels are significantly higher in breast cancer metastases as compared to the corresponding ER-positive primary tumors. This suggests a potential role for APOBEC3B in luminal breast cancer progression, and consequently, a promising role for anti-APOBEC3B therapies in advanced stages of this frequent form of breast cancer. PMID:28141868

  3. Technical Division quarterly progress report, January 1--March 31, 1977

    Energy Technology Data Exchange (ETDEWEB)

    Slansky, C.M. (ed.)

    1977-05-01

    Progress is reported in three categories: Fuel Cycle Research and Development, special materials production, and projects supporting energy development. Results are presented on the fluidized-bed calcination of high-level radioactive waste from the reprocessing of spent commercial nuclear fuel, on the post treatment of the calcine, and on the removal of actinide elements from the waste prior to calcination. Other projects include the development of storage technology for /sup 85/Kr waste; a study of the hydrogen mordenite catalyzed reaction between NO/sub x/ and NH/sub 3/; the adsorption and storage of /sup 129/I on silver exchanged mordenite; physical properties, materials of construction, and unit operations studies on the evaporation of high-level waste; the behavior of volatile radionuclides during the combustion of HTGR graphite-based fuel; and the use of fission product ruthenium in age-dating uranium ore bodies. The long-term management of defense waste from the ICPP covers post-calcination treatment of ICPP calcined waste. Improvements are reported on the Fluorinel head end process for Zircaloy-clad fuels. Studies are included on nuclear materials security; application of a liquid-solid fluidized-bed heat exchanger to the recovery of geothermal heat; inplant reactor source term measurements; burnup methods for fast breeder reactor fuels; research on analytical methods; and the behavior of environmental species of iodine.

  4. Technical Adequacy and Acceptability of Curriculum-Based Measurement and the Measures of Academic Progress

    Science.gov (United States)

    January, Stacy-Ann A.; Ardoin, Scott P.

    2015-01-01

    Curriculum-based measurement in reading (CBM-R) and the Measures of Academic Progress (MAP) are assessment tools widely employed for universal screening in schools. Although a large body of research supports the validity of CBM-R, limited empirical evidence exists supporting the technical adequacy of MAP or the acceptability of either measure for…

  5. FAST FLUX TEST FACILITY MONTHLY INFORMAL TECHNICAL PROGRESS REPORT FEBRUARY 1969

    Energy Technology Data Exchange (ETDEWEB)

    Astley, E. R.

    1969-03-07

    This report was prepared by Battelle-Northwest under Contract No. AT (45-1)-1830 for the Atomic Energy Commission, Division of Reactor Development and Technology, to summarize technical progress made in the Fast Flux Test Facility Program during February 1969.

  6. Amarillo National Resource Center for Plutonium. Quarterly technical progress report, May 1--July 31, 1998

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1998-09-01

    Progress is reported on research projects related to the following: Electronic resource library; Environment, safety, and health; Communication, education, training, and community involvement; Nuclear and other materials; and Reporting, evaluation, monitoring, and administration. Technical studies investigate remedial action of high explosives-contaminated lands, radioactive waste management, nondestructive assay methods, and plutonium processing, handling, and storage.

  7. FAST FLUX TEST FACILITY MONTHLY INFORMAL TECHNICAL PROGRESS REPORT MAY 1969

    Energy Technology Data Exchange (ETDEWEB)

    Astley, E. R.; Cabell, C. P.

    1969-06-06

    This report was prepared by Battelle-Northwest under Contract No. AT(45-1)-1830 for the Atomic Energy Commission, Division of Reactor Development and Technology, to summarize technical progress made in the Fast Flux Test Facility Program during May 1969 .

  8. FAST FLUX TEST FACILITY MONTHLY INFORMAL TECHNICAL PROGRESS REPORT SEPTEMBER 1969

    Energy Technology Data Exchange (ETDEWEB)

    Astely, E. R.; Cabell, C. P.

    1969-10-07

    This report was prepared by Battelle-Northwest under Contract No. AT(45-1)-1830 for the Atomic Energy Commission, Division of Reactor Development and Technology, to summarize technical progress made in the Fast Flux Test Facility Program during September 1969.

  9. Cassini RTG Program. Monthly technical progress report, 27 November--31 December 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-01-24

    This monthly technical progress report provided information on the following tasks: spacecraft integration and liaison; engineering support; safety analysis; qualified unicouple fabrication; ETG fabrication, assembly, and test; ground support equipment (GSE); RTG shipping and launch support; designs, reviews, and mission applications; project management, quality assurance, and reliability, and contractor acquired government owned (CAGO) property acquisition.

  10. Bioluminescence imaging of estrogen receptor activity during breast cancer progression.

    Science.gov (United States)

    Vantaggiato, Cristina; Dell'Omo, Giulia; Ramachandran, Balaji; Manni, Isabella; Radaelli, Enrico; Scanziani, Eugenio; Piaggio, Giulia; Maggi, Adriana; Ciana, Paolo

    2016-01-01

    Estrogen receptors (ER) are known to play an important regulatory role in mammary gland development as well as in its neoplastic transformation. Although several studies highlighted the contribution of ER signaling in the breast transformation, little is known about the dynamics of ER state of activity during carcinogenesis due to the lack of appropriate models for measuring the extent of receptor signaling in time, in the same animal. To this aim, we have developed a reporter mouse model for the non-invasive in vivo imaging of ER activity: the ERE-Luc reporter mouse. ERE-Luc is a transgenic mouse generated with a firefly luciferase (Luc) reporter gene driven by a minimal promoter containing an estrogen responsive element (ERE). This model allows to measure receptor signaling in longitudinal studies by bioluminescence imaging (BLI). Here, we have induced sporadic mammary cancers by treating systemically ERE-Luc reporter mice with DMBA (9,10-dimethyl 1,2-benzanthracene) and measured receptor signaling by in vivo imaging in individual animals from early stage until a clinically palpable tumor appeared in the mouse breast. We showed that DMBA administration induces an increase of bioluminescence in the whole abdominal area 6 h after treatment, the signal rapidly disappears. Several weeks later, strong bioluminescence is observed in the area corresponding to the mammary glands. In vivo and ex vivo imaging analysis demonstrated that this bioluminescent signal is localized in the breast area undergoing neoplastic transformation. We conclude that this non-invasive assay is a novel relevant tool to identify the activation of the ER signaling prior the morphological detection of the neoplastic transformation.

  11. Dipyridamole prevents triple-negative breast-cancer progression.

    Science.gov (United States)

    Spano, Daniela; Marshall, Jean-Claude; Marino, Natascia; De Martino, Daniela; Romano, Alessia; Scoppettuolo, Maria Nunzia; Bello, Anna Maria; Di Dato, Valeria; Navas, Luigi; De Vita, Gennaro; Medaglia, Chiara; Steeg, Patricia S; Zollo, Massimo

    2013-01-01

    Dipyridamole is a widely prescribed drug in ischemic disorders, and it is here investigated for potential clinical use as a new treatment for breast cancer. Xenograft mice bearing triple-negative breast cancer 4T1-Luc or MDA-MB-231T cells were generated. In these in vivo models, dipyridamole effects were investigated for primary tumor growth, metastasis formation, cell cycle, apoptosis, signaling pathways, immune cell infiltration, and serum inflammatory cytokines levels. Dipyridamole significantly reduced primary tumor growth and metastasis formation by intraperitoneal administration. Treatment with 15 mg/kg/day dipyridamole reduced mean primary tumor size by 67.5 % (p = 0.0433), while treatment with 30 mg/kg/day dipyridamole resulted in an almost a total reduction in primary tumors (p = 0.0182). Experimental metastasis assays show dipyridamole reduces metastasis formation by 47.5 % in the MDA-MB-231T xenograft model (p = 0.0122), and by 50.26 % in the 4T1-Luc xenograft model (p = 0.0292). In vivo dipyridamole decreased activated β-catenin by 38.64 % (p < 0.0001), phospho-ERK1/2 by 25.05 % (p = 0.0129), phospho-p65 by 67.82 % (p < 0.0001) and doubled the expression of IkBα (p = 0.0019), thus revealing significant effects on Wnt, ERK1/2-MAPK and NF-kB pathways in both animal models. Moreover dipyridamole significantly decreased the infiltration of tumor-associated macrophages and myeloid-derived suppressor cells in primary tumors (p < 0.005), and the inflammatory cytokines levels in the sera of the treated mice. We suggest that when used at appropriate doses and with the correct mode of administration, dipyridamole is a promising agent for breast-cancer treatment, thus also implying its potential use in other cancers that show those highly activated pathways.

  12. Delineating an Epigenetic Continuum for Initiation, Transformation and Progression to Breast Cancer

    Energy Technology Data Exchange (ETDEWEB)

    Chen, Kang Mei; Stephen, Josena K. [Department of Otolaryngology/Head and Neck Surgery, Henry Ford Hospital, 1 Ford Place, 1D, Detroit, MI 48202 (United States); Raju, Usha [Department of Pathology, Henry Ford Hospital, Detroit, 1 Ford Place, 1D, Detroit, MI 48202 (United States); Worsham, Maria J., E-mail: mworsha1@hfhs.org [Department of Otolaryngology/Head and Neck Surgery, Henry Ford Hospital, 1 Ford Place, 1D, Detroit, MI 48202 (United States)

    2011-03-29

    Aberrant methylation of promoter CpG islands is a hallmark of human cancers and is an early event in carcinogenesis. We examined whether promoter hypermethylation contributes to the pathogenesis of benign breast lesions along a progression continuum to invasive breast cancer. The exploratory study cohort comprised 17 breast cancer patients with multiple benign and/or in situ lesions concurrently present with invasive carcinoma within a tumor biopsy. DNA from tumor tissue, normal breast epithelium when present, benign lesions (fibroadenoma, hyperplasia, papilloma, sclerosing adenosis, apocrine metaplasia, atypical lobular hyperplasia or atypical ductal hyperplasia), and in situ lesions of lobular carcinoma and ductal carcinoma were interrogated for promoter methylation status in 22 tumor suppressor genes using the multiplex ligation-dependent probe amplification assay (MS-MLPA). Methylation specific PCR was performed to confirm hypermethylation detected by MS-MLPA. Promoter methylation was detected in 11/22 tumor suppressor genes in 16/17 cases. Hypermethylation of RASSF1 was most frequent, present in 14/17 cases, followed by APC in 12/17, and GSTP1 in 9/17 cases with establishment of an epigenetic monocloncal progression continuum to invasive breast cancer. Hypermethylated promoter regions in normal breast epithelium, benign, and premalignant lesions within the same tumor biopsy implicate RASSF1, APC, GSTP1, TIMP3, CDKN2B, CDKN2A, ESR1, CDH13, RARB, CASP8, and TP73 as early events. DNA hypermethylation underlies the pathogenesis of step-wise transformation along a monoclonal continuum from normal to preneoplasia to invasive breast cancer.

  13. Integrated extracellular matrix signaling in mammary gland development and breast cancer progression.

    Science.gov (United States)

    Zhu, Jieqing; Xiong, Gaofeng; Trinkle, Christine; Xu, Ren

    2014-09-01

    Extracellular matrix (ECM), a major component of the cellular microenvironment, plays critical roles in normal tissue morphogenesis and disease progression. Binding of ECM to membrane receptor proteins, such as integrin, discoidin domain receptors, and dystroglycan, elicits biochemical and biomechanical signals that control cellular architecture and gene expression. These ECM signals cooperate with growth factors and hormones to regulate cell migration, differentiation, and transformation. ECM signaling is tightly regulated during normal mammary gland development. Deposition and alignment of fibrillar collagens direct migration and invasion of mammary epithelial cells during branching morphogenesis. Basement membrane proteins are required for polarized acinar morphogenesis and milk protein expression. Deregulation of ECM proteins in the long run is sufficient to promote breast cancer development and progression. Recent studies demonstrate that the integrated biophysical and biochemical signals from ECM and soluble factors are crucial for normal mammary gland development as well as breast cancer progression.

  14. Overexpression of centromere protein H is significantly associated with breast cancer progression and overall patient survival

    Institute of Scientific and Technical Information of China (English)

    Wen-Ting Liao; Yan Feng; Men-Lin Li; Guang-Lin Liu; Man-Zhi Li; Mu-Sheng Zeng; Li-Bing Song

    2011-01-01

    Breast cancer is one of the leading causes of cancer death worldwide.This study aimed to analyze the expression of centromere protein H (CENP-H) in breast cancer and to correlate it with clinicopathologic data,including patient survival.Using reverse transcription-polymerase chain reaction and Westem blotting to detect the expression of CENP-H in normal mammary epithelial cells,immortalized mammary epithelial cell lines,and breast cancer cell lines,we observed that the mRNA and protein levels of CENP-H were higher in breast cancer cell lines and in immortalized mammary epithelial cells than in normal mammary epithelial cells.We next examined CENP-H expression in 307 paraffin-embedded archived samples of clinicopathologically characterized breast cancer using immunohistochemistry,and detected high CENP-H expression in 134 (43.6%) samples.Statistical analysis showed that CENP-H expression was related with clinical stage (P = 0.001),T classification (P = 0.032),N classification (P =0.018),and Ki-67 (P<0.001).Patients with high CENP-H expression had short overall survival.Multivariate analysis showed that CENP-H expression was an independent prognostic indicator for patient survival.Our results suggest that CENP-H protein is a valuable marker of breast cancer progression and prognosis.

  15. Development of superior asphalt recycling agency: Phase 1, Technical feasibility. Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Bullin, J.A.; Glover, C.J.; Davison, R.R.; Lin, Moon-Sun; Chaffin, J.; Liu, Meng; Eckhardt, C.

    1996-04-01

    About every 12 years, asphalt roads must be reworked, and this is usually done by placing thick layers (hot-mix overlays) of new material on top of failed material, resulting in considerable waste of material and use of new asphalt binder. A good recycling agent is needed, not only to reduce the viscosity of the aged material but also to restore compatibility. Objective is to establish the technical feasibility (Phase I) of determining the specifications and operating parameters for producing high quality recycling agents which will allow most/all the old asphalt-based road material to be recycled. It is expected that supercritical fractionation can be used. The advanced road aging simulation procedure will be used to study aging of blends of old asphalt and recycling agents.

  16. Progress with palbociclib in breast cancer: latest evidence and clinical considerations.

    Science.gov (United States)

    Rocca, Andrea; Schirone, Alessio; Maltoni, Roberta; Bravaccini, Sara; Cecconetto, Lorenzo; Farolfi, Alberto; Bronte, Giuseppe; Andreis, Daniele

    2017-02-01

    Deregulation of the cell cycle is a hallmark of cancer, and research on cell cycle control has allowed identification of potential targets for anticancer treatment. Palbociclib is a selective inhibitor of the cyclin-dependent kinases 4 and 6 (CDK4/6), which are involved, with their coregulatory partners cyclin D, in the G1-S transition. Inhibition of this step halts cell cycle progression in cells in which the involved pathway, including the retinoblastoma protein (Rb) and the E2F family of transcription factors, is functioning, although having been deregulated. Among breast cancers, those with functioning cyclin D-CDK4/6-Rb-E2F are mainly hormone-receptor (HR) positive, with some HER2-positive and rare triple-negative cases. Deregulation results from genetic or otherwise occurring hyperactivation of molecules subtending cell cycle progression, or inactivation of cell cycle inhibitors. Based on results of randomized clinical trials, palbociclib was granted accelerated approval by the US Food and Drug Administration (FDA) for use in combination with letrozole as initial endocrine-based therapy for metastatic disease in postmenopausal women with HR-positive, HER2-negative breast cancer, and was approved for use in combination with fulvestrant in women with HR-positive, HER2-negative advanced breast cancer with disease progression following endocrine therapy. This review provides an update of the available knowledge on the cell cycle and its regulation, on the alterations in cyclin D-CDK4/6-Rb-E2F axis in breast cancer and their roles in endocrine resistance, on the preclinical activity of CDK4/6 inhibitors in breast cancer, both as monotherapy and as partners of combinatorial synergic treatments, and on the clinical development of palbociclib in breast cancer.

  17. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.

    Directory of Open Access Journals (Sweden)

    Sandeep N Shah

    Full Text Available Emerging evidence suggests that tumor cells metastasize by co-opting stem cell transcriptional networks, although the molecular underpinnings of this process are poorly understood. Here, we show for the first time that the high mobility group A1 (HMGA1 gene drives metastatic progression in triple negative breast cancer cells (MDA-MB-231, Hs578T by reprogramming cancer cells to a stem-like state. Silencing HMGA1 expression in invasive, aggressive breast cancer cells dramatically halts cell growth and results in striking morphologic changes from mesenchymal-like, spindle-shaped cells to cuboidal, epithelial-like cells. Mesenchymal genes (Vimentin, Snail are repressed, while E-cadherin is induced in the knock-down cells. Silencing HMGA1 also blocks oncogenic properties, including proliferation, migration, invasion, and orthotopic tumorigenesis. Metastatic progression following mammary implantation is almost completely abrogated in the HMGA1 knock-down cells. Moreover, silencing HMGA1 inhibits the stem cell property of three-dimensional mammosphere formation, including primary, secondary, and tertiary spheres. In addition, knock-down of HMGA1 depletes cancer initiator/cancer stem cells and prevents tumorigenesis at limiting dilutions. We also discovered an HMGA1 signature in triple negative breast cancer cells that is highly enriched in embryonic stem cells. Together, these findings indicate that HMGA1 is a master regulator of tumor progression in breast cancer by reprogramming cancer cells through stem cell transcriptional networks. Future studies are needed to determine how to target HMGA1 in therapy.

  18. [Progress in immediate breast reconstruction with skin sparing mastectomy].

    Science.gov (United States)

    Garbay, J-R; Saouma, S; Marsiglia, H

    2008-04-01

    Skin sparing mastectomy (SSM) and subcutaneous mastectomy (SCM) are recent techniques. They are always associated with immediate breast reconstruction (IBR). Their safety from an oncologic point of view and indications are of great concern. In early breast cancer, SSM and SCM are associated with the same risk of local recurrence as a modified radical mastectomy, when correctly indicated. This has been validated by numerous studies. In these non-randomised studies, overall survival cannot be evaluated. Such techniques can now be validated in the oncologic setting when correctly indicated and when decision-making is always concerted and multidisciplinary. Skin-sparing techniques are obviously associated with better cosmetic results than secondary reconstructions. Thus SSM with IBR are ideally indicated for ductal carcinoma in situ, pure infiltrating or mixed carcinomas requiring mastectomy without subsequent radiotherapy. The selection criterion of no postoperative radiotherapy allows the right candidates to be chosen for SSM. But often this criterion cannot be obtained preoperatively. In such cases, performing a two-step operation could be a good option. The interval between operations can be used by the patient to obtain more information and to make a mature decision regarding her choice of treatment. It seems essential to be able to offer every patient SSM with IBR which are validated standardised indications. Such is not the case everywhere in France today. The organisation of primary care through professional networks should provide us with an opportunity to fulfil these needs.

  19. Appraisement on Contributive Ratio of Scientific and Technical Progresses in Milk Productive Enterprises by Model C2GS2

    Institute of Scientific and Technical Information of China (English)

    SUN Futian; SUN Liqun; YANG Guanglin

    2008-01-01

    Scientific and technical progress has been the driving forces of enterprises development. Milk productive enterprises are developing faster and growing better. It is very important to measure the contributive ratio of scientific and technical progress in milk productive enterprises. And the appraisement could help to develop milk productive enterprises. The model C2GS2 was established to appraise the contributive ratio of scientific and technical progress in milk productive enterprises in the research. And the appraisement on the contributive ratio of scientific and technical progress in milk productive enterprises was made by the model. In the results of appraisement, science and technology play a main role in milk productive enterprises. It is shown that our milk productive enterprises are developed by scientific and technical progress while not by input of productive factors.

  20. Examining the Technical Adequacy of Second-Grade Reading Comprehension Measures in a Progress Monitoring Assessment System. Technical Report # 08-08

    Science.gov (United States)

    Alonzo, Julie; Liu, Kimy; Tindal, Gerald

    2008-01-01

    This technical report describes the development of reading comprehension assessments designed for use as progress monitoring measures appropriate for 2nd Grade students. The creation, piloting, and technical adequacy of the measures are presented. The following are appended: (1) Item Specifications for MC [Multiple Choice] Comprehension - Passage…

  1. Clinical Significance of HER-2 Splice Variants in Breast Cancer Progression and Drug Resistance

    Directory of Open Access Journals (Sweden)

    Claire Jackson

    2013-01-01

    Full Text Available Overexpression of human epidermal growth factor receptor (HER-2 occurs in 20–30% of breast cancers and confers survival and proliferative advantages on the tumour cells making HER-2 an ideal therapeutic target for drugs like Herceptin. Continued delineation of tumour biology has identified splice variants of HER-2, with contrasting roles in tumour cell biology. For example, the splice variant 16HER-2 (results from exon 16 skipping increases transformation of cancer cells and is associated with treatment resistance; conversely, Herstatin (results from intron 8 retention and p100 (results from intron 15 retention inhibit tumour cell proliferation. This review focuses on the potential clinical implications of the expression and coexistence of HER-2 splice variants in cancer cells in relation to breast cancer progression and drug resistance. “Individualised” strategies currently guide breast cancer management; in accordance, HER-2 splice variants may prove valuable as future prognostic and predictive factors, as well as potential therapeutic targets.

  2. Emerging role of cell polarity proteins in breast cancer progression and metastasis

    Directory of Open Access Journals (Sweden)

    Chatterjee SJ

    2014-01-01

    Full Text Available Sudipa June Chatterjee, Luke McCaffrey Rosalind and Morris Goodman Cancer Centre, Department of Oncology, McGill University, Montreal, QC, Canada Abstract: Breast cancer is a heterogeneous group of diseases that frequently exhibits loss of growth control, and disrupted tissue organization and differentiation. Several recent studies indicate that apical–basal polarity provides a tumor-suppressive function, and that disrupting polarity proteins affects many stages of breast cancer progression from initiation through metastasis. In this review we highlight some of the recent advances in our understanding of the molecular mechanisms by which loss of apical–basal polarity deregulates apoptosis, proliferation, and promotes invasion and metastasis in breast cancer. Keywords: apical, basal, oncogene, tumor suppressor, proliferation, apoptosis

  3. Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer.

    Directory of Open Access Journals (Sweden)

    Malathi Banda

    Full Text Available TNBC is an aggressive breast cancer subtype that does not express hormone receptors (estrogen and progesterone receptors, ER and PR or amplified human epidermal growth factor receptor type 2 (HER2, and there currently exist no targeted therapies effective against it. Consequently, finding new molecular targets in triple negative breast cancer (TNBC is critical to improving patient outcomes. Previously, we have detected the expression of metabotropic glutamate receptor-1 (gene: GRM1; protein: mGluR1 in TNBC and observed that targeting glutamatergic signaling inhibits TNBC growth both in vitro and in vivo. In this study, we explored how mGluR1 contributes to TNBC progression, using the isogenic MCF10 progression series, which models breast carcinogenesis from nontransformed epithelium to malignant basal-like breast cancer. We observed that mGluR1 is expressed in human breast cancer and that in MCF10A cells, which model nontransformed mammary epithelium, but not in MCF10AT1 cells, which model atypical ductal hyperplasia, mGluR1 overexpression results in increased proliferation, anchorage-independent growth, and invasiveness. In contrast, mGluR1 knockdown results in a decrease in these activities in malignant MCF10CA1d cells. Similarly, pharmacologic inhibition of glutamatergic signaling in MCF10CA1d cells results in a decrease in proliferation and anchorage-independent growth. Finally, transduction of MCF10AT1 cells, which express c-Ha-ras, using a lentiviral construct expressing GRM1 results in transformation to carcinoma in 90% of resultant xenografts. We conclude that mGluR1 cooperates with other factors in hyperplastic mammary epithelium to contribute to TNBC progression and therefore propose that glutamatergic signaling represents a promising new molecular target for TNBC therapy.

  4. Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis.

    Directory of Open Access Journals (Sweden)

    Nigel P S Crawford

    2007-11-01

    Full Text Available A novel candidate metastasis modifier, ribosomal RNA processing 1 homolog B (Rrp1b, was identified through two independent approaches. First, yeast two-hybrid, immunoprecipitation, and functional assays demonstrated a physical and functional interaction between Rrp1b and the previous identified metastasis modifier Sipa1. In parallel, using mouse and human metastasis gene expression data it was observed that extracellular matrix (ECM genes are common components of metastasis predictive signatures, suggesting that ECM genes are either important markers or causal factors in metastasis. To investigate the relationship between ECM genes and poor prognosis in breast cancer, expression quantitative trait locus analysis of polyoma middle-T transgene-induced mammary tumor was performed. ECM gene expression was found to be consistently associated with Rrp1b expression. In vitro expression of Rrp1b significantly altered ECM gene expression, tumor growth, and dissemination in metastasis assays. Furthermore, a gene signature induced by ectopic expression of Rrp1b in tumor cells predicted survival in a human breast cancer gene expression dataset. Finally, constitutional polymorphism within RRP1B was found to be significantly associated with tumor progression in two independent breast cancer cohorts. These data suggest that RRP1B may be a novel susceptibility gene for breast cancer progression and metastasis.

  5. Breast cancer associated a2 isoform vacuolar ATPase immunomodulates neutrophils: potential role in tumor progression.

    Science.gov (United States)

    Ibrahim, Safaa A; Katara, Gajendra K; Kulshrestha, Arpita; Jaiswal, Mukesh K; Amin, Magdy A; Beaman, Kenneth D

    2015-10-20

    In invasive breast cancer, tumor associated neutrophils (TAN) represent a significant portion of the tumor mass and are associated with increased angiogenesis and metastasis. Identifying the regulatory factors that control TAN behavior will help in developing ideal immunotherapies. Vacuolar ATPases (V-ATPases), multi-subunit proton pumps, are highly expressed in metastatic breast cancer cells. A cleaved peptide from a2 isoform V-ATPase (a2NTD) has immunomodulatory role in tumor microenvironment. Here, we report for the first time the role of V-ATPase in neutrophils modulation. In invasive breast cancer cells, a2NTD was detected and a2V was highly expressed on the surface. Immunohistochemical analysis of invasive breast cancer tissues revealed that increased neutrophil recruitment and blood vessel density correlated with increased a2NTD levels. In order to determine the direct regulatory role of a2NTD on neutrophils, recombinant a2NTD was used for the treatment of neutrophils isolated from the peripheral blood of healthy volunteers. Neutrophils treated with a2NTD (a2Neuɸ) showed increased secretion of IL-1RA, IL-10, CCL-2 and IL-6 that are important mediators in cancer related inflammation. Moreover, a2Neuɸ exhibited an increased production of protumorigenic factors including IL-8, matrix metaloprotinase-9 and vascular endothelial growth factor. Further, functional characterization of a2Neuɸ revealed that a2Neuɸ derived products induce in vitro angiogenesis as well as increase the invasiveness of breast cancer cells. This study establishes the modulatory effect of breast cancer associated a2V on neutrophils, by the action of a2NTD, which has a positive impact on tumor progression, supporting that a2V can be a potential selective target for breast cancer therapy.

  6. Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis

    DEFF Research Database (Denmark)

    Krøigård, Anne Bruun; Larsen, Martin Jakob; Lænkholm, Anne Vibeke

    step. Our data, contrary to the proposed model of early dissemination of metastatic cells and parallel progression of primary tumors and metastases, provide evidence of linear progression of breast cancer with relatively late dissemination from the primary tumor. The genomic discordance between......Evolution of the breast cancer genome from pre-invasive stages to asynchronous metastasis is complex and mostly unexplored, but highly demanded as it may provide novel markers for and mechanistic insights in cancer progression. The increasing use of personalized therapy of breast cancer...... necessitates knowledge of the degree of genomic concordance between different steps of malignant progression as primary tumors often are used as surrogates of systemic disease. Based on exome sequencing we performed copy number profiling and point mutation detection on successive steps of breast cancer...

  7. Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis

    DEFF Research Database (Denmark)

    Krøigård, Anne Bruun; Larsen, Martin Jakob; Lænkholm, Anne Vibeke

    2015-01-01

    step. Our data, contrary to the proposed model of early dissemination of metastatic cells and parallel progression of primary tumors and metastases, provide evidence of linear progression of breast cancer with relatively late dissemination from the primary tumor. The genomic discordance between......Evolution of the breast cancer genome from pre-invasive stages to asynchronous metastasis is complex and mostly unexplored, but highly demanded as it may provide novel markers for and mechanistic insights in cancer progression. The increasing use of personalized therapy of breast cancer...... necessitates knowledge of the degree of genomic concordance between different steps of malignant progression as primary tumors often are used as surrogates of systemic disease. Based on exome sequencing we performed copy number profiling and point mutation detection on successive steps of breast cancer...

  8. miR-410-3p suppresses breast cancer progression by targeting Snail.

    Science.gov (United States)

    Zhang, Ya-Feng; Yu, Yue; Song, Wang-Zhao; Zhang, Rui-Ming; Jin, Shan; Bai, Jun-Wen; Kang, Hong-Bin; Wang, Xin; Cao, Xu-Chen

    2016-07-01

    miR-410-3p acts as an oncogene or tumor-suppressor gene in various types of cancer. However, its role in breast cancer remains unknown. In the present study, expression of miR-410-3p in 30 breast cancer and paired adjacent normal tissues was detected by RT-qPCR. The expression of miR-410-3p was downregulated in 76.7% of the breast cancer samples. To further validate the expression of miR-410-3p in breast cancer, we analyzed miR-410-3p expression profiling data set from The Cancer Genome Atlas (TCGA) including 683 breast cancer and 87 normal breast tissues. We observed that the expression of miR-410-3p was downregulated in breast cancer tissues. Next, we investigated the influence of miR-410-3p on cell proliferation by transiently transfecting the miR-410-3p mimic or inhibitor, as well as their corresponding controls in the MDA-MB-231 and MCF7 cell lines. miR-410-3p overexpression reduced cell growth, colony formation and the number of EdU-positive cells in the MDA-MB-231 cells. In contrast, inhibition of miR-410-3p in the MCF7 cells resulted in a higher proliferation rate as assessed by MTT assay, plate colony formation and EdU assays. Furthermore, miR-410-3p inhibited epithelial-mesenchymal transition. In addition, Snail was found to be a direct target of miR-410-3p based on a luciferase assay. Overexpression of Snail was able to rescue the effect of miR-410-3p in breast cancer cells. Moreover, miR‑410-3p was inversely expressed with Snail in breast cancer samples. Our data provide new knowledge regarding the role of miR-410-3p in breast cancer progression.

  9. Does Lactation Mitigate Triple Negative/Basal Breast Cancer Progression

    Science.gov (United States)

    2013-11-01

    Progression. March 6, 2012, Postdoctoral Seminar Series, University of Colorado Denver. 3. Tanya D. Russell. Pregnancy and Involution Promote...are DCIS, and standard treatment typically involves surgery and radiation. A better understanding of the role of the myoepithelium in early stage...Aurora, CO, USA 80045. 2 School of Medicine, Department of Pediatrics , B119, Bldg 406, Room 105 3University of Colorado Cancer Center, Bldg 500

  10. Monitoring the Durability Performance of Concrete in Nuclear Waste Containment. Technical Progress Report No. 4

    Energy Technology Data Exchange (ETDEWEB)

    Ulm, Franz-Josef

    2000-06-30

    OAK-B135 Monitoring the Durability Performance of Concrete in Nuclear Waste Containment. Technical Progress Report No. 4. The analysis of the effect of cracks on the acceleration of the calcium leaching process of cement-based materials has been pursued. During the last period (Technical Progress Report No 3), we have introduced a modeling accounting for the high diffusivity of fractures in comparison with the weak solid material diffusivity. It has been shown through dimensional and asymptotic analysis that small fractures do not significantly accelerate the material aging process. This important result for the overall structural aging kinetics of containment structure has been developed in a paper submitted to the international journal ''Transport in Porous Media''.

  11. CCR5 Expression Influences the Progression of Human Breast Cancer in a p53-dependent Manner

    OpenAIRE

    2003-01-01

    Chemokines are implicated in tumor pathogenesis, although it is unclear whether they affect human cancer progression positively or negatively. We found that activation of the chemokine receptor CCR5 regulates p53 transcriptional activity in breast cancer cells through pertussis toxin–, JAK2-, and p38 mitogen–activated protein kinase–dependent mechanisms. CCR5 blockade significantly enhanced proliferation of xenografts from tumor cells bearing wild-type p53, but did not affect proliferation...

  12. Cassini RTG Program monthly technical progress report, July 28--August 24, 1997

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1997-09-24

    The technical progress achieved during this period is described. This report is organized by program task structure: (1) spacecraft and integration liaison; (2) engineering support; (3) safety; (4) qualified unicouple production; (5) ETG fabrication, assembly, and test; (6) ground support equipment (GSE); (7) RTG shipping and launch support; (8) designs, reviews, and mission applications; (9) project management, quality assurance, reliability, contract changes, CAGO acquisition (operating funds), and CAGO maintenance and repair; and (10) CAGO acquisition (capital funds).

  13. Role of deregulated microRNAs in breast cancer progression using FFPE tissue.

    Directory of Open Access Journals (Sweden)

    Liang Chen

    Full Text Available MicroRNAs (miRNAs contribute to cancer initiation and progression by silencing the expression of their target genes, causing either mRNA molecule degradation or translational inhibition. Intraductal epithelial proliferations of the breast are histologically and clinically classified into normal, atypical ductal hyperplasia (ADH, ductal carcinoma in situ (DCIS and invasive ductal carcinoma (IDC. To better understand the progression of ductal breast cancer development, we attempt to identify deregulated miRNAs in this process using Formalin-Fixed, Paraffin-Embedded (FFPE tissues from breast cancer patients. Following tissue microdissection, we obtained 8 normal, 4 ADH, 6 DCIS and 7 IDC samples, which were subject to RNA isolation and miRNA expression profiling analysis. We found that miR-21, miR-200b/c, miR-141, and miR-183 were consistently up-regulated in ADH, DCIS and IDC compared to normal, while miR-557 was uniquely down-regulated in DCIS. Interestingly, the most significant miRNA deregulations occurred during the transition from normal to ADH. However, the data did not reveal a step-wise miRNA alteration among discrete steps along tumor progression, which is in accordance with previous reports of mRNA profiling of different stages of breast cancer. Furthermore, the expression of MSH2 and SMAD7, two important molecules involving TGF-β pathway, was restored following miR-21 knockdown in both MCF-7 and Hs578T breast cancer cells. In this study, we have not only identified a number of potential candidate miRNAs for breast cancer, but also found that deregulation of miRNA expression during breast tumorigenesis might be an early event since it occurred significantly during normal to ADH transition. Consequently, we have demonstrated the feasibility of miRNA expression profiling analysis using archived FFPE tissues, typically with rich clinical information, as a means of miRNA biomarker discovery.

  14. Decontamination Systems Information and Research Program. Quarterly technical progress report, January 1--March 31, 1994

    Energy Technology Data Exchange (ETDEWEB)

    1994-05-01

    West Virginia University (WVU) and the US DOE Morgantown Energy Technology Center (METC) entered into a Cooperative Agreement on August 29, 1992 entitled ``Decontamination Systems Information and Research Programs.`` Stipulated within the Agreement is the requirement that WVU submit to METC a series of Technical Progress Reports on a quarterly basis. This report comprises the first Quarterly Technical Progress Report for Year 2 of the Agreement. This report reflects the progress and/or efforts performed on the sixteen (16) technical projects encompassed by the Year 2 Agreement for the period of January 1 through March 31, 1994. In situ bioremediation of chlorinated organic solvents; Microbial enrichment for enhancing in-situ biodegradation of hazardous organic wastes; Treatment of volatile organic compounds (VOCs) using biofilters; Drain-enhanced soil flushing (DESF) for organic contaminants removal; Chemical destruction of chlorinated organic compounds; Remediation of hazardous sites with steam reforming; Soil decontamination with a packed flotation column; Use of granular activated carbon columns for the simultaneous removal of organics, heavy metals, and radionuclides; Monolayer and multilayer self-assembled polyion films for gas-phase chemical sensors; Compact mercuric iodide detector technology development; Evaluation of IR and mass spectrometric techniques for on-site monitoring of volatile organic compounds; A systematic database of the state of hazardous waste clean-up technologies; Dust control methods for insitu nuclear and hazardous waste handling; Winfield Lock and Dam remediation; and Socio-economic assessment of alternative environmental restoration technologies.

  15. The influence of HRT on technical recall in the UK Breast Screening Programme: are pain, compression force, and compressed breast thickness contributing factors?

    Energy Technology Data Exchange (ETDEWEB)

    Nimmo, L.J. [Division of Radiography, School of Health and Social Care, Glasgow Caledonian University, Glasgow (United Kingdom)]. E-mail: l.nimmo@gcal.ac.uk; Alston, L.A.C. [Division of Radiography, School of Health and Social Care, Glasgow Caledonian University, Glasgow (United Kingdom); McFadyen, A.K. [Division of Radiography, School of Health and Social Care, Glasgow Caledonian University, Glasgow (United Kingdom)

    2007-05-15

    Aim: To investigate recall for technical reasons within the UK Breast Screening Programme, and to determine whether differences exist in those women using hormone replacement therapy (HRT), considering potential associations with reported pain, compression force used and compressed breast thickness (CBT) obtained. Materials and method: A prospective cohort study of 2765 women attending for incident round breast screening appointments who were either HRT users, with a minimum of 1 year duration (n = 1077), or had never used HRT (n = 1688). Data were collected using technical recall records, a radiographer data-collection sheet, and a self-administered participant questionnaire. Results: Sixty-eight (2.5%) participants were recalled for technical reasons of whom 28 (2.6%) were HRT and 40 (2.4%) non-HRT users. This difference was not statistically significant (p = 0.80). Significant differences were found for CBT between those HRT users who were and were not recalled for technical reasons (p < 0.01) and for the similar categories of non-HRT users (p = 0.03). No significant differences were found for force between those HRT users who were recalled or not (p = 0.73) and for the similar categories of non-HRT users (p = 0.07). Similarly no significant differences were found for pain between those HRT users who were recalled or not (p = 0.75) and for the similar categories of non-HRT users (p = 0.73). Conclusion: CBT was the only variable to have both a statistically and a clinically significant relationship with technical recall.

  16. An Improved Syngeneic Orthotopic Murine Model of Human Breast Cancer Progression

    Science.gov (United States)

    Rashid, Omar M.; Nagahashi, Masayuki; Ramachandran, Suburamaniam; Dumur, Catherine; Schaum, Julia; Yamada, Akimitsu; Terracina, Krista P.; Milstien, Sheldon; Spiegel, Sarah; Takabe, Kazuaki

    2014-01-01

    Purpose Breast cancer drug development costs nearly $610 million and 37 months in preclinical mouse model trials with minimal success rates. Despite these inefficiencies, there are still no consensus breast cancer preclinical models. Methods Murine mammary adenocarcinoma 4T1-luc2 cells were implanted subcutaneous (SQ) or orthotopically percutaneous injection in the area of the nipple (OP), or surgically into the chest 2nd mammary fat pad under direct vision (ODV) in Balb/c immunocompetent mice. Tumor progression was followed by in vivo bioluminescence and direct measurements, pathology and survival determined, and tumor gene expression analyzed by genome-wide microarrays. Results ODV produced less variable sized tumors and was a reliable method of implantation. ODV implantation into the chest 2nd mammary pad rather than into the abdominal 4th mammary pad, the most common implantation site, better mimicked human breast cancer progression pattern, which correlated with bioluminescent tumor burden and survival. Compared to SQ, ODV produced tumors that differentially expressed genes whose interaction networks are of importance in cancer research. qPCR validation of 10 specific target genes of interest in ongoing clinical trials demonstrated significant differences in expression. Conclusions ODV implantation into the chest 2nd mammary pad provides the most reliable model that mimics human breast cancer compared from subcutaneous implantation that produces tumors with different genome expression profiles of clinical significance. Increased understanding of the limitations of the different preclinical models in use will help guide new investigations and may improve the efficiency of breast cancer drug development. PMID:25200444

  17. Role of interleukin-8 in the progression of estrogen receptor-negative breast cancer

    Institute of Scientific and Technical Information of China (English)

    YAO Chen; LIN Ying; YE Cai-sheng; BI Jiong; ZHU Yi-fan; WANG Shen-ming

    2007-01-01

    Background Estrogen receptor (ER) is a very important biomarker of breast cancer. ER deletion has been consistently associated with tumor progression, recurrence, metastasis and poor prognosis, but the biological mechanism is still unclear. ER negative breast cancer expresses high levels of interieukin-8 (IL-8). ER expression can downregulate IL-8 promotor activity. As a multifunctional cytokine, IL-8 has many important biological activities in tumor genesis and development. With the goal of investigating the role of IL-8 in ER-negative breast cancer progression, we applied RNA interference technology to specifically knockdown the IL-8 expression in ER-negative breast cancer cell line MDA-MB-231.Methods Interfering pRNA-IL-8 and the control was transfected into ER(-) MDA-MB-231. The proliferation, cell apotosis,and invasive ability were recorded in transfected, untransfected and negative transfected cells. These cells were injected into nude mice to assess tumorigenicity, proliferation, metastasis and microvessel density (MVD).Results In vitro, decreased expression of IL-8 was associated with reduced cell invasion (P<0.001), but had no effect on cell proliferation (P>0.05). In vivo, neutrophils infiltration was significantly inhibited in pRNA-IL-8 transfected cells compared with untransfected and negatively transfected cells (P=0.001, P<0.001). Less metastasis was found in transfected cells compared with negatively transfected cells (0% vs 80%, P=0.048). Nevertheless, we observed less MVD in transfected cells compared with control in nude mice (P<0.001).Conclusions IL-8 inhibits ER-negative breast cancer cell growth and promotes its metastasis in vivo, which may be correlated with neutrophils infiltration induced by IL-8.

  18. Population Based Assessment of MHC Class 1 Antigens Down Regulation as Marker in Increased Risk for Development and Progression of Breast Cancer From Benign Breast Lesions

    Science.gov (United States)

    2006-01-01

    Risk for Development and Progression of Breast Cancer from Benign Breast Lesions” antigen retrieval solution in the microwave . Lastly, tissue... Microwave and citrate buffer antigen-retrieval substitutions yielded comparable results. Lab 2 demonstrated that a negative control is useful as an...the infiltrating lymphocytes in germinal centers and dendritic cells as seen in case 1. Microsatellite Analysis Labs 1, 2, and 4 performed

  19. Regulator of G protein signaling 6 is a novel suppressor of breast tumor initiation and progression.

    Science.gov (United States)

    Maity, Biswanath; Stewart, Adele; O'Malley, Yunxia; Askeland, Ryan W; Sugg, Sonia L; Fisher, Rory A

    2013-08-01

    Breast cancer is a large global health burden and the most frequently diagnosed malignancy in women worldwide. Here, we utilize RGS6(-/-) mice to interrogate the role of regulator of G protein signaling 6 (RGS6), localized to the ductal epithelium in mouse and human breast, as a novel tumor suppressor in vivo. RGS6(-/-) mice exhibit accelerated 7,12-dimethylbenza[α]anthracene (DMBA)-induced tumor initiation and progression, as well as decreased overall survival. Analysis of carcinogenic aberrations in the mammary glands of DMBA-treated mice revealed a failure of the DNA damage response concurrent with augmented oncogenesis in RGS6(-/-) animals. Furthermore, RGS6 suppressed cell growth induced by either human epidermal growth factor receptor 2 or estrogen receptor activation in both MCF-7 breast cancer cells and mammary epithelial cells (MECs). MECs isolated from RGS6(-/-) mice also showed a deficit in DMBA-induced ATM/p53 activation, reactive oxygen species generation and apoptosis confirming that RGS6 is required for effective activation of the DNA damage response in these cells, a critical countermeasure against carcinogen-mediated genotoxic stress. The ability of RGS6 to simultaneously enhance DNA-damage-induced apoptotic signaling and suppress oncogenic cell growth likely underlie the accelerated tumorigenesis and cellular transformation observed in DMBA-treated RGS6(-/-) mice and isolated MECs, respectively. Unsurprisingly, spontaneous tumor formation was also seen in old female RGS6(-/-) but not in wild-type mice. Our finding that RGS6 is downregulated in all human breast cancer subtypes independent of their molecular classification indicates that obtaining a means to restore the growth suppressive and pro-apoptotic actions of RGS6 in breast might be a viable means to treat a large spectrum of breast tumors.

  20. Effects of clusterin over-expression on metastatic progression and therapy in breast cancer

    Directory of Open Access Journals (Sweden)

    Chatterjee Namita

    2010-03-01

    Full Text Available Abstract Background Clusterin is a secreted glycoprotein that is upregulated in a variety of cell lines in response to stress, and enhances cell survival. A second nuclear isoform of clusterin that is associated with cell death has also been identified. The aim of this study was to determine the role(s of the secretory isoform in breast tumor progression and metastasis. Methods To investigate the role of secretory clusterin in the biology of breast cancer tumor growth and resistance to therapy we have engineered an MCF-7 cell line (MCF-7CLU that over-expresses clusterin. We have measured the in vitro effects of clusterin over-expression on cell cycle, cell death, and sensitivity to TNFalpha and tamoxifen. Using an orthotopic model of breast cancer, we have also determined the effects of over-expression of clusterin on tumor growth and metastatic progression. Results In vitro, over-expression of secretory clusterin alters the cell cycle kinetics and decreases the rate of cell death, resulting in the enhancement of cell growth. Over-expression of secretory clusterin also blocks the TNFalpha-mediated induction of p21 and abrogates the cleavage of Bax to t-Bax, rendering the MCF-7CLU cells significantly more resistant to the cytokine than the parental cells. Orthotopic primary tumors derived from MCF-7CLU cells grow significantly more rapidly than tumors derived from parental MCF-7 cells and, unlike the parental cells, metastasize frequently to the lungs. Conclusions These data suggest that secretory clusterin, which is frequently up-regulated in breast cancers by common therapies, including anti-estrogens, may play a significant role in tumor growth, metastatic progression and subsequent drug resistance in surviving cells.

  1. Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis.

    Science.gov (United States)

    Yuan, Xun; Zhang, Mingsheng; Wu, Hua; Xu, Hanxiao; Han, Na; Chu, Qian; Yu, Shiying; Chen, Yuan; Wu, Kongming

    2015-01-01

    Various studies have evaluated the significance of Notch1 expression in breast cancer, but the results have ever been disputed. By using 21 studies involving 3867 patients, this meta-analysis revealed that the expression of Notch1 was significantly higher in breast cancer than in normal tissues (OR=7.21; 95%CI, 4.7-11.07) and that higher Notch1 expression was associated with transition from ductal carcinoma in situ (DCIS) to invasive cancer (OR=3.75; 95% CI, 1.8-7.78). Higher Notch1 activity was observed in the basal subtype of breast cancer (OR=2.53; 95% CI, 1.18-5.43). Moreover, patients with Notch1 overexpression exhibited significantly worse overall and recurrence-free survival. Our meta-analysis suggests that Notch inhibitors may be useful in blocking the early progression of DCIS and that the outcomes of clinical trials for Notch1-targeting therapeutics could be improved by the molecular stratification of breast cancer patients.

  2. Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis.

    Directory of Open Access Journals (Sweden)

    Xun Yuan

    Full Text Available Various studies have evaluated the significance of Notch1 expression in breast cancer, but the results have ever been disputed. By using 21 studies involving 3867 patients, this meta-analysis revealed that the expression of Notch1 was significantly higher in breast cancer than in normal tissues (OR=7.21; 95%CI, 4.7-11.07 and that higher Notch1 expression was associated with transition from ductal carcinoma in situ (DCIS to invasive cancer (OR=3.75; 95% CI, 1.8-7.78. Higher Notch1 activity was observed in the basal subtype of breast cancer (OR=2.53; 95% CI, 1.18-5.43. Moreover, patients with Notch1 overexpression exhibited significantly worse overall and recurrence-free survival. Our meta-analysis suggests that Notch inhibitors may be useful in blocking the early progression of DCIS and that the outcomes of clinical trials for Notch1-targeting therapeutics could be improved by the molecular stratification of breast cancer patients.

  3. Progress towards understanding heterotypic interactions in multi-culture models of breast cancer.

    Science.gov (United States)

    Regier, Mary C; Alarid, Elaine T; Beebe, David J

    2016-06-13

    Microenvironments in primary tumors and metastases include multiple cell types whose dynamic and reciprocal interactions are central to progression of the disease. However, the literature involving breast cancer studied in vitro is dominated by cancer cells in mono-culture or co-cultured with one other cell type. For in vitro studies of breast cancer the inclusion of multiple cell types has led to models that are more representative of in vivo behaviors and functions as compared to more traditional monoculture. Here, we review foundational co-culture techniques and their adaptation to multi-culture (including three or more cell types). Additionally, while macroscale methods involving conditioned media, direct contact, and indirect interactions have been informative, we examined many advances that have been made more recently using microscale systems with increased control over cellular and structural complexity. Throughout this discussion we consider the benefits and limitations of current multi-culture methods and the significant results they have produced.

  4. Analysis of breast cancer progression using principal component analysis and clustering

    Indian Academy of Sciences (India)

    G Alexe; G S Dalgin; S Ganesan; C DeLisi; G Bhanot

    2007-08-01

    We develop a new technique to analyse microarray data which uses a combination of principal components analysis and consensus ensemble -clustering to find robust clusters and gene markers in the data. We apply our method to a public microarray breast cancer dataset which has expression levels of genes in normal samples as well as in three pathological stages of disease; namely, atypical ductal hyperplasia or ADH, ductal carcinoma in situ or DCIS and invasive ductal carcinoma or IDC. Our method averages over clustering techniques and data perturbation to find stable, robust clusters and gene markers. We identify the clusters and their pathways with distinct subtypes of breast cancer (Luminal, Basal and Her2+). We confirm that the cancer phenotype develops early (in early hyperplasia or ADH stage) and find from our analysis that each subtype progresses from ADH to DCIS to IDC along its own specific pathway, as if each was a distinct disease.

  5. In Vitro Co-Culture Models of Breast Cancer Metastatic Progression towards Bone

    Directory of Open Access Journals (Sweden)

    Chiara Arrigoni

    2016-08-01

    Full Text Available Advanced breast cancer frequently metastasizes to bone through a multistep process involving the detachment of cells from the primary tumor, their intravasation into the bloodstream, adhesion to the endothelium and extravasation into the bone, culminating with the establishment of a vicious cycle causing extensive bone lysis. In recent years, the crosstalk between tumor cells and secondary organs microenvironment is gaining much attention, being indicated as a crucial aspect in all metastatic steps. To investigate the complex interrelation between the tumor and the microenvironment, both in vitro and in vivo models have been exploited. In vitro models have some advantages over in vivo, mainly the possibility to thoroughly dissect in controlled conditions and with only human cells the cellular and molecular mechanisms underlying the metastatic progression. In this article we will review the main results deriving from in vitro co-culture models, describing mechanisms activated in the crosstalk between breast cancer and bone cells which drive the different metastatic steps.

  6. In Vitro Co-Culture Models of Breast Cancer Metastatic Progression towards Bone

    Science.gov (United States)

    Arrigoni, Chiara; Bersini, Simone; Gilardi, Mara; Moretti, Matteo

    2016-01-01

    Advanced breast cancer frequently metastasizes to bone through a multistep process involving the detachment of cells from the primary tumor, their intravasation into the bloodstream, adhesion to the endothelium and extravasation into the bone, culminating with the establishment of a vicious cycle causing extensive bone lysis. In recent years, the crosstalk between tumor cells and secondary organs microenvironment is gaining much attention, being indicated as a crucial aspect in all metastatic steps. To investigate the complex interrelation between the tumor and the microenvironment, both in vitro and in vivo models have been exploited. In vitro models have some advantages over in vivo, mainly the possibility to thoroughly dissect in controlled conditions and with only human cells the cellular and molecular mechanisms underlying the metastatic progression. In this article we will review the main results deriving from in vitro co-culture models, describing mechanisms activated in the crosstalk between breast cancer and bone cells which drive the different metastatic steps. PMID:27571063

  7. Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression

    Science.gov (United States)

    Rangel, Roberto; Lee, Song-Choon; Hon-Kim Ban, Kenneth; Guzman-Rojas, Liliana; Mann, Michael B.; Newberg, Justin Y.; McNoe, Leslie A.; Selvanesan, Luxmanan; Ward, Jerrold M.; Rust, Alistair G.; Chin, Kuan-Yew; Black, Michael A.; Jenkins, Nancy A.; Copeland, Neal G.

    2016-01-01

    Triple-negative breast cancer (TNBC) has the worst prognosis of any breast cancer subtype. To better understand the genetic forces driving TNBC, we performed a transposon mutagenesis screen in a phosphatase and tensin homolog (Pten) mutant mice and identified 12 candidate trunk drivers and a much larger number of progression genes. Validation studies identified eight TNBC tumor suppressor genes, including the GATA-like transcriptional repressor TRPS1. Down-regulation of TRPS1 in TNBC cells promoted epithelial-to-mesenchymal transition (EMT) by deregulating multiple EMT pathway genes, in addition to increasing the expression of SERPINE1 and SERPINB2 and the subsequent migration, invasion, and metastasis of tumor cells. Transposon mutagenesis has thus provided a better understanding of the genetic forces driving TNBC and discovered genes with potential clinical importance in TNBC. PMID:27849608

  8. Contribution of endothelial precursors of adipose tissue to breast cancer: progression-link with fat graft for reconstructive surgery.

    Science.gov (United States)

    Bertolini, Francesco

    2013-05-01

    Obesity, an excess accumulation of adipose tissue occurring in mammalians when caloric intake exceeds energy expenditure, is associated with an increased frequency and progression of several types of neoplastic diseases including postmenopausal breast cancer. Recent studies have suggested that obesity-related disruption of the energy homeostasis results in inflammation and alterations of adipokine signalling that may foster cancer initiation and progression. Moreover, two populations of human white adipose tissue (WAT) progenitors cooperate in breast cancer angiogenesis, growth and metastatic progression. This raises the issue of lipotransfer in patients undergoing plastic or reconstructive surgery.

  9. Monthly technical progress report, 29 January 1996--25 Februray 1996

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-04-01

    This report discusses the technical progress made on the radioisotope thermoelectric generators and ancillary activities for the Cassini space probe mission to the planet Saturn. The probe is designated for launch in October of 1997. This report covers the project reporting period from 29 January 1996 through 25 February 1996. The report is organized by program task structure and includes activities for: spacecraft integration and liason; engineering support; safety; qualified unicouple production; ETG fabrication, assembly, and testing; RTG shipping and launch support; designs, reviews and mission applications; quality assurance, reliability and contract changes; and CAGO acquisition.

  10. Kaldor’s ‘technical progress function’ and Verdoorn’s law revisited

    OpenAIRE

    McCombie, John S. L.; Spreafico, Marta R. M.

    2015-01-01

    This is the accepted manuscript of a paper published in the Cambridge Journal of Economics (McCombie JSL, Spreafico MRM, Cambridge Journal of Economics, 2015, doi:10.1093/cje/bev030). The final version is available at http://dx.doi.org/10.1093/cje/bev030 Kaldor put forward his technical progress function as an alternative to the neoclassical aggregate production function. It is shown that Verdoorn?s law is its empirical counterpart, although allowing for increasing returns to scale. Howeve...

  11. Decontamination Systems Information and Research Program. Quarterly technical progress report, January 1--March 31, 1993

    Energy Technology Data Exchange (ETDEWEB)

    1993-04-01

    This reports reports the progress/efforts performed on six technical projects: 1. systematic assessment of the state of hazardous waste clean-up technologies; 2. site remediation technologies (SRT):drain- enhanced soil flushing for organic contaminants removal; 3. SRT: in situ bio-remediation of organic contaminants; 4. excavation systems for hazardous waste sites: dust control methods for in-situ nuclear waste handling; 5. chemical destruction of polychlorinated biphenyls; and 6. development of organic sensors: monolayer and multilayer self-assembled films for chemical sensors.

  12. Volatiles combustion in fluidized beds. [Quarterly] technical progress report, 4 December 1994--4 March 1995

    Energy Technology Data Exchange (ETDEWEB)

    Pendergrass II, R.A.; Mansker, L.D.; Hesketh, R.P.

    1995-08-01

    The goal of this project is to investigate the conditions in which volatiles will bum within both the dense and freeboard regions of fluidized beds. Experiments using a fluidized bed operated at incipient fluidization are being conducted to characterize the effect of particle surface area, initial fuel concentration, and particle type on the inhibition of volatiles within a fluidized bed. The work conducted during the period 4 December, 1994 through, 3 March 1995 is presented in this technical progress report. The research consists of the application of a detailed chemical kinetics model for propane combustion and planned improvements in the experimental system.

  13. An imbalance in progenitor cell populations reflects tumour progression in breast cancer primary culture models

    LENUS (Irish Health Repository)

    Donatello, Simona

    2011-04-26

    Abstract Background Many factors influence breast cancer progression, including the ability of progenitor cells to sustain or increase net tumour cell numbers. Our aim was to define whether alterations in putative progenitor populations could predict clinicopathological factors of prognostic importance for cancer progression. Methods Primary cultures were established from human breast tumour and adjacent non-tumour tissue. Putative progenitor cell populations were isolated based on co-expression or concomitant absence of the epithelial and myoepithelial markers EPCAM and CALLA respectively. Results Significant reductions in cellular senescence were observed in tumour versus non-tumour cultures, accompanied by a stepwise increase in proliferation:senescence ratios. A novel correlation between tumour aggressiveness and an imbalance of putative progenitor subpopulations was also observed. Specifically, an increased double-negative (DN) to double-positive (DP) ratio distinguished aggressive tumours of high grade, estrogen receptor-negativity or HER2-positivity. The DN:DP ratio was also higher in malignant MDA-MB-231 cells relative to non-tumourogenic MCF-10A cells. Ultrastructural analysis of the DN subpopulation in an invasive tumour culture revealed enrichment in lipofuscin bodies, markers of ageing or senescent cells. Conclusions Our results suggest that an imbalance in tumour progenitor subpopulations imbalances the functional relationship between proliferation and senescence, creating a microenvironment favouring tumour progression.

  14. Heber geothermal binary demonstration project quarterly technical progress report, October 1, 1981--December 31, 1981

    Energy Technology Data Exchange (ETDEWEB)

    Lacy, R.G.; Allen, R.F.; Alsup, R.A.; Liparidis, G.S.; Van De Mark, G.D.

    1983-08-01

    The purpose of this quarterly technical progress report is to document work completed on the nominal 65 Megawatt (Mwe gross) Heber Geothermal Binary Demonstration Project, located at Heber, California, during the period of October 1, 1981, through December 31, 1981. The work was performed by San Diego Gas and Electric Company under the support and cooperation of the U.S. Department of Energy, the Electric Power Research Institute, the Imperial Irrigation District, the California Department of Water Resources, and the Southern California Edison Company. Topics covered in this quarterly report include progress made in the areas of Wells and Fluid Production and Injection Systems, Power Plant Design and Construction, Power Plant Demonstration, and Data Acquisition and Dissemination.

  15. Expression of peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression.

    Science.gov (United States)

    Han, Zeqiu; Slack, Rebecca S; Li, Wenping; Papadopoulos, Vassilios

    2003-01-01

    High levels of peripheral-type benzodiazepine receptor (PBR), the alternative-binding site for diazepam, are part of the aggressive human breast cancer cell phenotype in vitro. We examined PBR levels and distribution in normal tissue and tumors from multiple cancer types by immunohistochemistry. Among normal breast tissues, fibroadenomas, primary and metastatic adenocarcinomas, there is a progressive increase in PBR levels parallel to the invasive and metastatic ability of the tumor (p cancers, such as those of breast, colon-rectum and prostate tissues, where elevated PBR expression is associated with tumor progression. Thus, we propose that PBR overexpression could serve as a novel prognostic indicator of an aggressive phenotype in breast, colorectal and prostate cancers.

  16. PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.

    Science.gov (United States)

    Guerrero-Zotano, Angel; Mayer, Ingrid A; Arteaga, Carlos L

    2016-12-01

    Anti-cancer cancer-targeted therapies are designed to exploit a particular vulnerability in the tumor, which in most cases results from its dependence on an oncogene and/or loss of a tumor suppressor. Mutations in the phosphoinositide 3-kinase (PI3K)/AKT/mTOR pathway are freqcuently found in breast cancers and associated with cellular transformation, tumorigenesis, cancer progression, and drug resistance. Several drugs targeting PI3K/ATK/mTOR are currently in clinical trials, mainly in combination with endocrine therapy and anti-HER2 therapy. These drugs are the focus of this review.

  17. Does Skeletal Muscle Mass Influence Breast Cancer? Evaluating Mammary Tumorigenesis and Progression in Genetically Hyper-Muscular Mice

    Science.gov (United States)

    2007-07-01

    preserve muscle in the end-stages of cancer, cancer cachexia . Up to 25% of breast cancer deaths may be attributed to muscle wasting from the complex... cachexia . 15. SUBJECT TERMS Breast cancer, skeletal muscle, myostatin, MPA, DMBA, Activin receptor, cachexia . 16. SECURITY CLASSIFICATION OF: 17...progress, we turned to another question relating skeletal muscle and cancer—pathological muscle wasting in cancer cachexia . (6) (7) (8) Cancer cachexia

  18. KAP1 promotes proliferation and metastatic progression of breast cancer cells.

    Science.gov (United States)

    Addison, Joseph B; Koontz, Colton; Fugett, James H; Creighton, Chad J; Chen, Dongquan; Farrugia, Mark K; Padon, Renata R; Voronkova, Maria A; McLaughlin, Sarah L; Livengood, Ryan H; Lin, Chen-Chung; Ruppert, J Michael; Pugacheva, Elena N; Ivanov, Alexey V

    2015-01-15

    KAP1 (TRIM28) is a transcriptional regulator in embryonic development that controls stem cell self-renewal, chromatin organization, and the DNA damage response, acting as an essential corepressor for KRAB family zinc finger proteins (KRAB-ZNF). To gain insight into the function of this large gene family, we developed an antibody that recognizes the conserved zinc fingers linker region (ZnFL) in multiple KRAB-ZNF. Here, we report that the expression of many KRAB-ZNF along with active SUMOlyated KAP1 is elevated widely in human breast cancers. KAP1 silencing in breast cancer cells reduced proliferation and inhibited the growth and metastasis of tumor xenografts. Conversely, KAP1 overexpression stimulated cell proliferation and tumor growth. In cells where KAP1 was silenced, we identified multiple downregulated genes linked to tumor progression and metastasis, including EREG/epiregulin, PTGS2/COX2, MMP1, MMP2, and CD44, along with downregulation of multiple KRAB-ZNF proteins. KAP1-dependent stabilization of KRAB-ZNF required direct interactions with KAP1. Together, our results show that KAP1-mediated stimulation of multiple KRAB-ZNF contributes to the growth and metastasis of breast cancer.

  19. Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases.

    Science.gov (United States)

    Nangia-Makker, Pratima; Raz, Tirza; Tait, Larry; Shekhar, Malathy P V; Li, Hong; Balan, Vitaly; Makker, Hemanckur; Fridman, Rafael; Maddipati, Krishnarao; Raz, Avraham

    2013-05-01

    Ocimum genus (a.k.a holy basil or tulsi) is a dietary herb used for its multiple beneficial pharmacologic properties including anti-cancer activity. Here we show that crude extract of Ocimum gratissimum (OG) and its hydrophobic and hydrophilic fractions (HB and HL) differentially inhibit breast cancer cell chemotaxis and chemoinvasion in vitro and retard tumor growth and temporal progression of MCF10ADCIS.com xenografts, a model of human breast comedo-ductal carcinoma in situ (comedo-DCIS). OG-induced inhibition of tumor growth was associated with decreases in basement membrane disintegration, angiogenesis and MMP-2 and MMP-9 activities as confirmed by in situ gelatin zymography and cleavage of galectin-3. There was also decrease in MMP-2 and MMP-9 activities in the conditioned media of OG-treated MCF10AT1 and MCF10AT1-EIII8 premalignant human breast cancer cells as compared with control. The MMP-2 and MMP-9 inhibitory activities of OG were verified in vitro using gelatin, a synthetic fluorogenic peptide and recombinant galectin-3 as MMP substrates. Mice fed on OG-supplemented drinking water showed no adverse effects compared with control. These data suggest that OG is non-toxic and that the anti-cancer therapeutic activity of OG may in part be contributed by its MMP inhibitory activity.

  20. Overexpression of the protein tyrosine phosphatase PRL-2 correlates with breast tumor formation and progression.

    Science.gov (United States)

    Hardy, Serge; Wong, Nau Nau; Muller, William J; Park, Morag; Tremblay, Michel L

    2010-11-01

    The PRL-1, PRL-2, and PRL-3 phosphatases are prenylated protein tyrosine phosphatases with oncogenic activity that are proposed to drive tumor metastasis. We found that PRL-2 mRNA is elevated in primary breast tumors relative to matched normal tissue, and also dramatically elevated in metastatic lymph nodes compared with primary tumors. PRL-2 knockdown in metastatic MDA-MB-231 breast cancer cells decreased anchorage-independent growth and cell migration, suggesting that the malignant phenotype of these cells is mediated at least in part through PRL-2 signaling. In different mouse mammary tumor-derived cell lines overexpressing PRL-2, we confirmed its role in anchorage-independent growth and cell migration. Furthermore, injection of PRL-2-overexpressing cells into the mouse mammary fat pad promoted extracellular signal-regulated kinase 1/2 activation and tumor formation. MMTV-PRL-2 transgenic mice engineered to overexpress the enzyme in mammary tissue did not exhibit spontaneous tumorigenesis, but they exhibited an accelerated development of mammary tumors initiated by introduction of an MMTV-ErbB2 transgene. Together, our results argue that PRL-2 plays a role in breast cancer progression.

  1. Advancement of flash hydrogasification. Quarterly technical progress report, January-March 1984

    Energy Technology Data Exchange (ETDEWEB)

    Falk, A.Y.

    1984-06-25

    This first quarterly report documents technical progress during the period 31 December 1983 through 30 March 1984. The technical effort is 17 months in duration and is divided into two major technical tasks: Task VII, Hardware Fabrication and PDU Modifications, and Task VIII, Performance Testing. The design of test hardware and process development unit modifications had been previously completed as part of Task VI of the current contract. Task VII involves the fabrication of test hardware and modification of an existing 1-ton/h hydroliquefaction PDU at Rockwell's facilities for use as a hydrogasifier test facility. During this report period, fabrication of the test hardware and modifications to the PDU were initiated. Test hardware fabrication is now approximately 80% complete and should be completed by the end of May 1984. PDU modifications are progressing well and should be completed by the end of June 1984. The completed test hardware fabrication and PDU modifications will allow the conduct of short duration (1 to 2 h) hydrogasification tests along with preburner assembly performance evaluation tests in order to fulfill the test program objectives. Separate supplies of hydrogen, oxygen, methane, carbon monoxide, and water (for steam generation) are provided for this purpose. The modified facility is designed to accommodate both 10- and 20-ft-long hydrogasifier reactors so that residence times will be in the range of 2 to 6 s when coal is fed at a nominal 1/2 ton/h into reactors at 1000 psia pressure. Provisions are being made for real-time analysis of the product gases using an on-line gas chromatograph system. Test planning was the only Task VIII effort active during this report period. An initial (preliminary) test matrix has been defined. Preparation of a data analysis plan is underway, and data reduction programs are being programmed. 17 references, 25 figures, 6 tables.

  2. Postmenopausal obesity promotes tumor angiogenesis and breast cancer progression in mice.

    Science.gov (United States)

    Gu, Jian-Wei; Young, Emily; Patterson, Sharla G; Makey, Kristina L; Wells, Jeremy; Huang, Min; Tucker, Kevan B; Miele, Lucio

    2011-05-15

    Obese postmenopausal women have a 50% higher risk of breast cancer than non-obese women. There is not an animal model that mimics postmenopausal obesity related to breast cancer progression. Using age-relevant C57BL/6 mice, this study determined whether postmenopausal obesity increases VEGF expression, tumor angiogenesis, and breast tumor growth. Ovariectomy (OVX) was performed in 12 sixty week-old female mice, then followed by a low-fat (5%, LF, n=6) or a high-fat (60%, HF, n=6) diet for 12 weeks. In the eighth week of the dietary program, 10(6) E0771 (mouse breast cancer) cells were injected in the left fourth mammary gland. Tumor size was monitored for 4 weeks. Body weights were monitored weekly. At the end of the experiment, blood samples, visceral fat and tumors were collected for measuring VEGF expression using ELISA and intratumoral microvessel density (IMD) using CD31 immunochemistry. Body weight was significantly increased in OVX/HF mice, compared to OVX/LF group (55.3±1.7 vs. 41.5±1.5 g; p < 0.01). There was a two-fold increase in the ratio of visceral fat/BW in OVX/HF mice, compared to those in OVX/LF group (0.062±0.005 vs. 0.032±0.003; p < 0.01). Postmenopausal obesity significantly increased breast tumor weight over the control (4.62±0.63 vs. 1.98±0.27 g; p < 0.01) and IMD (173±3.7 vs. 139±4.3 IM#/mm^2; p < 0.01). Tumor VEGF levels were higher in OVX/HF mice, compared to OVX/LF group (73.3±3.8 vs. 49.5±4.3 pg/mg protein; p < 0.01). Plasma VEGF levels (69±7.1 vs. 48±3.5 pg/ml) and visceral fat VEGF levels (424.4±39.5 vs. 208.5±22.4 pg/mg protein) were significantly increased in OVX/HF mice, compared to OVX/LF group, respectively (n=6; p < 0.01). Interestingly, adipose tissue primary culture showed that subcutaneous fat released more VEGF, compared to visceral fat (6.77±1.14 vs. 0.94±0.16 pg/mg tissue; n=6; p < 0.01). These findings support the hypothesis that postmenopausal obesity promotes tumor angiogenesis and breast cancer

  3. Epigenetic modifications, chromatin distribution and TP53 transcription in a model of breast cancer progression.

    Science.gov (United States)

    Santos, Gilson C; da Silva, Ana P A; Feldman, Lucas; Ventura, Grasiella M; Vassetzky, Yegor; de Moura Gallo, Claudia V

    2015-04-01

    In the present paper we aimed to characterize epigenetic aspects and analyze TP53 transcription in the 21 T series, composed of breast cell lines: non-cancerous H16N2; Atypical Ductal Hyperplasia 21PT; Ductal Carcinoma in situ 21NT and Invasive Metastatic Carcinoma 21MT1. We detected a global genomic hypomethylation in 21NT and 21MT1. The histone modification markers analysis showed an important global decrease of the active chromatin mark H4Ac in 21MT1 relative to the other cell lines while the repressive mark H3K9Me3 were not significantly altered. The mRNA levels of DNA methylation and histone modification key enzymes are consistent with the observed genomic hypomethylation and histone hypoacetylation. The expression of DNMT3A/B increased at the initial stages of oncogenesis and the expression of DNMT1 and HAT1 decreased at the advanced stages of breast cancer. Using a confocal immunofluorescent assay, we observed that H4Ac was mostly located at the periphery and the repressive mark H3K9Me3, at the center of 21NT and 21MT1 cells nuclei. TP53 P1 promoter was found to be in an open chromatin state, with a relatively high enrichment of H4Ac and similar TP53 transcription levels in all 21 T cell lines. In conclusion, we observed epigenetic alterations (global genome hypomethylation, global hypoacetylation and accumulation of pericentric heterochromatin) in metastatic breast cancer cells of the 21 T series. These alterations may act at later stages of breast cancer progression and may not affect TP53 transcription at the P1 promoter.

  4. Hormonally up-regulated neu-associated kinase: A novel target for breast cancer progression.

    Science.gov (United States)

    Zambrano, Joelle N; Neely, Benjamin A; Yeh, Elizabeth S

    2017-02-09

    Hormonally up-regulated neu-associated Kinase (Hunk) is a protein kinase that was originally identified in the murine mammary gland and has been shown to be highly expressed in Human Epidermal Growth Factor Receptor 2 positive (HER2(+)/ErbB2(+)) breast cancer cell lines as well as MMTV-neu derived mammary tumor cell lines. However, the physiological role of Hunk has been largely elusive since its identification. Though Hunk is predicted to be a Serine/Threonine (Ser/Thr) protein kinase with homology to the SNF1/AMPK family of protein kinases, there are no known Hunk substrates that have been identified to date. Recent work demonstrates a role for Hunk in HER2(+)/ErbB2(+) breast cancer progression, including drug resistance to HER2/ErbB2 inhibitors, with Hunk potentially acting downstream of HER2/ErbB2 and the PI3K/Akt pathway. These studies have collectively shown that Hunk plays a vital role in promoting mammary tumorigenesis, as Hunk knockdown via shRNA in xenograft tumor models or crossing MMTV-neu or Pten-deficient genetically engineered mouse models into a Hunk knockout (Hunk-/-) background impairs mammary tumor growth in vivo. Because the majority of HER2(+)/ErbB2(+) breast cancer patients acquire drug resistance to HER2/ErbB2 inhibitors, the characterization of novel drug targets like Hunk that have the potential to simultaneously suppress tumorigenesis and potentially enhance efficacy of current therapeutics is an important facet of drug development. Therefore, work aimed at uncovering specific regulatory functions for Hunk that could contribute to this protein kinase's role in both tumorigenesis and drug resistance will be informative. This review focuses on what is currently known about this under-studied protein kinase, and how targeting Hunk may prove to be a potential therapeutic target for the treatment of breast cancer.

  5. Loss of circadian clock gene expression is associated with tumor progression in breast cancer.

    Science.gov (United States)

    Cadenas, Cristina; van de Sandt, Leonie; Edlund, Karolina; Lohr, Miriam; Hellwig, Birte; Marchan, Rosemarie; Schmidt, Marcus; Rahnenführer, Jörg; Oster, Henrik; Hengstler, Jan G

    2014-01-01

    Several studies suggest a link between circadian rhythm disturbances and tumorigenesis. However, the association between circadian clock genes and prognosis in breast cancer has not been systematically studied. Therefore, we examined the expression of 17 clock components in tumors from 766 node-negative breast cancer patients that were untreated in both neoadjuvant and adjuvant settings. In addition, their association with metastasis-free survival (MFS) and correlation to clinicopathological parameters were investigated. Aiming to estimate functionality of the clockwork, we studied clock gene expression relationships by correlation analysis. Higher expression of several clock genes (e.g., CLOCK, PER1, PER2, PER3, CRY2, NPAS2 and RORC) was found to be associated with longer MFS in univariate Cox regression analyses (HR<1 and FDR-adjusted P < 0.05). Stratification according to molecular subtype revealed prognostic relevance for PER1, PER3, CRY2 and NFIL3 in the ER+/HER2- subgroup, CLOCK and NPAS2 in the ER-/HER2- subtype, and ARNTL2 in HER2+ breast cancer. In the multivariate Cox model, only PER3 (HR = 0.66; P = 0.016) and RORC (HR = 0.42; P = 0.003) were found to be associated with survival outcome independent of established clinicopathological parameters. Pairwise correlations between functionally-related clock genes (e.g., PER2-PER3 and CRY2-PER3) were stronger in ER+, HER2- and low-grade carcinomas; whereas, weaker correlation coefficients were observed in ER- and HER2+ tumors, high-grade tumors and tumors that progressed to metastatic disease. In conclusion, loss of clock genes is associated with worse prognosis in breast cancer. Coordinated co-expression of clock genes, indicative of a functional circadian clock, is maintained in ER+, HER2-, low grade and non-metastasizing tumors but is compromised in more aggressive carcinomas.

  6. Real-time motion analysis reveals cell directionality as an indicator of breast cancer progression.

    Directory of Open Access Journals (Sweden)

    Michael C Weiger

    Full Text Available Cancer cells alter their migratory properties during tumor progression to invade surrounding tissues and metastasize to distant sites. However, it remains unclear how migratory behaviors differ between tumor cells of different malignancy and whether these migratory behaviors can be utilized to assess the malignant potential of tumor cells. Here, we analyzed the migratory behaviors of cell lines representing different stages of breast cancer progression using conventional migration assays or time-lapse imaging and particle image velocimetry (PIV to capture migration dynamics. We find that the number of migrating cells in transwell assays, and the distance and speed of migration in unconstrained 2D assays, show no correlation with malignant potential. However, the directionality of cell motion during 2D migration nicely distinguishes benign and tumorigenic cell lines, with tumorigenic cell lines harboring less directed, more random motion. Furthermore, the migratory behaviors of epithelial sheets observed under basal conditions and in response to stimulation with epidermal growth factor (EGF or lysophosphatitic acid (LPA are distinct for each cell line with regard to cell speed, directionality, and spatiotemporal motion patterns. Surprisingly, treatment with LPA promotes a more cohesive, directional sheet movement in lung colony forming MCF10CA1a cells compared to basal conditions or EGF stimulation, implying that the LPA signaling pathway may alter the invasive potential of MCF10CA1a cells. Together, our findings identify cell directionality as a promising indicator for assessing the tumorigenic potential of breast cancer cell lines and show that LPA induces more cohesive motility in a subset of metastatic breast cancer cells.

  7. Sonic enhanced ash agglomeration and sulfur capture. Technical progress report: January 1993--March 1993

    Energy Technology Data Exchange (ETDEWEB)

    1993-12-31

    This 15th Quarterly Technical Progress Report presents the results of work accomplished during the period January 4, 193 through March 28, 1993 under Contract No. DE-AC21-88MC26288 entitled {open_quotes}Sonic Enhanced Ash Agglomeration and Sulfur Capture.{close_quotes} The fundamental studies conducted by West Virginia University and Pennsylvania State University are provided in subsections of this report. Shakedown testing continued through this period resulting in a series of required modifications for the coal-feed system, coal injector, installation of a water-cooling jacket at the bottom of the agglomeration chamber, and finally, the installation of an additional flow sensor and rate meter. Coal-fired bimodal tests were initiated at the end of the period. The unit was run at 2 atm pressure for 3 hours with steady-state operation for 2 hours. Then, the pressure was increased to 3 atm with steady-state operation for 2 hours.

  8. Redwood Community Action Agency: Technical progress report, 3rd quarter, 1986

    Energy Technology Data Exchange (ETDEWEB)

    1986-01-01

    Since the second quarter, at which time venture feasibility activities were well underway by Redwood Community Action Agency (RCAA) to develop a shared-savings energy business plan, significant progress has been made. Nearly all consultant reports on the technical feasibility analysis have been completed, initial market research has begun and capitalization strategy has been investigated. Additionally, RCAA received an award of a substantial grant from the California Dept. of Economic Opportunity to develop a series of business ventures with a consortium of Northern California community providers. Fifteen thousand dollars of equity capital has been allocated for the energy-related business venture being investigated under this grant. If all plans go as anticipated, this money, combined with agency unrestricted funds, will provide the initial seed capital for the venture.

  9. Energy conservation in citrus processing. Technical progress report, October 1, 1979-March 31, 1980

    Energy Technology Data Exchange (ETDEWEB)

    1980-06-15

    The Sunkist Citrus Plant in Ontario, California, processes about 6 million pounds of citrus fruit per day to make products which include frozen concentrated juice; chilled, pasteurized, natural strength juice; molasses from peel; dried meal from peel; pectin; citrus oil; and bioflavonoids. The energy intensive operations at the plant include concentration, drying, and refrigeration. The objective of the two-year two-phase project is to identify an economically viable alternative to the existing method of meeting energy requirements. Progress on the technical work of Phase I is reported. The following are summarized: requirements (energy price projection, atmospheric emission requirements, citrus juice quality constraints, economic evaluations); characterization (basic citrus processing operations, energy consumption and fruit processed vs time, identification and measurement of energy uses, energy balance for a typical citrus juice evaporator); and thermodynamic analysis (heat pump model, thermal evaporator, and co-generation model).

  10. Power systems development facility. Quarterly technical progress report, January 1, 1994--March 31, 1994

    Energy Technology Data Exchange (ETDEWEB)

    1994-07-01

    This quarterly technical progress report summarizes work completed during the last quarter of the Second Budget Period, January 1 through March 31, 1994, entitled {open_quotes}Hot Gas Cleanup Test Facility for Gasification and Pressurized Combustion.{close_quotes} The objective of this project is to evaluate hot gas particulate control technologies using coal-derived gas streams. This will entail the design, construction, installation, and use of a flexible test facility which can operate under realistic gasification and combustion conditions. The major particulate control device issues to be addressed include the integration of the particulate control devices into coal utilization systems, on-line cleaning techniques, chemical and thermal degradation of components, fatigue or structural failures, blinding, collection efficiency as a function of particle size, and scale-up of particulate control systems to commercial size.

  11. MHD Integrated Topping Cycle Project. Seventeenth quarterly technical progress report, August 1, 1991--October 31, 1991

    Energy Technology Data Exchange (ETDEWEB)

    1992-07-01

    This seventeenth quarterly technical progress report of the MHD Integrated Topping Cycle Project presents the accomplishments during the period August 1, 1991 to October 31, 1991. Manufacturing of the prototypical combustor pressure shell has been completed including leak, proof, and assembly fit checking. Manufacturing of forty-five cooling panels was also completed including leak, proof, and flow testing. All precombustor internal components (combustion can baffle and swirl box) were received and checked, and integration of the components was initiated. A decision was made regarding the primary and backup designs for the 1A4 channel. The assembly of the channel related prototypical hardware continued. The cathode wall electrical wiring is now complete. The mechanical design of the diffuser has been completed.

  12. MHD air heater technology development. Annual technical progress report, January 1, 1980-December 31, 1980

    Energy Technology Data Exchange (ETDEWEB)

    None

    1981-03-01

    Progress on the technology development of the directly-fired high temperature air heater (HTAH) for MHD power plants is described in detail. The objective of task 1 is to continue development of ceramic materials technology for the directly-fired HTAH. The objectives of task 2 are to demonstrate the technical feasibility of operating a directly-fired HTAH (including both the heater matrix and valves), to continue obtaining information on life and corrosion resistance of HTAH materials, and to obtain design information for full-scale studies and future design work. The objectives of task 3 are to begin the identification of HTAH control requirements and control system needs, and to continue full-scale study efforts incorporating updated materials and design information in order to identify development needs for the HTAH development program. (WHK)

  13. Quarterly technical progress report, October-December 1982 on Energy Conversion Research and Development Programs

    Energy Technology Data Exchange (ETDEWEB)

    1983-10-01

    In this quarterly technical progress report, UTSI reports on the continued design work for the low mass flow train superheater. The detailed design of this component continued and the overall arrangement drawing for the superheater and air heater was finalized. The air heater procurement reached the point of contract award, but the actual purchase order award was held up pending receipt of additional funding from the Department of Energy. Testing activity reported includes two additional tests in the LMF1C series, which concludes this test series. Test data are presented, along with preliminary analyses for the combustor, nozzle, diagnostic channel, diffuser, radiant furnace/secondary combustor and Materials Test Module. In addition to the nitrogen oxide test measurements, corrosion and erosion rates for the boiler tube specimens and the materials test module are reported.

  14. Spray forming -- Aluminum: Third annual report (Phase 2). Technical progress -- Summary

    Energy Technology Data Exchange (ETDEWEB)

    Kozarek, R.L.

    1998-04-20

    Commercial production of aluminum sheet and plate by spray atomization and deposition is a potentially attractive manufacturing alternative to conventional ingot metallurgy/hot-milling and to continuous casting processes because of reduced energy requirements and reduced cost. To realize the full potential of the technology, the Aluminum Company of America (Alcoa), under contract by the US Department of Energy, is investigating currently available state-of-the-art atomization devices to develop nozzle design concepts whose spray characteristics are tailored for continuous sheet production. This third technical progress report will summarize research and development work conducted during the period 1997 October through 1998 March. Included are the latest optimization work on the Alcoa III nozzle, results of spray forming runs with 6111 aluminum alloy and preliminary rolling trials of 6111 deposits.

  15. A progressive processing method for breast cancer detection via UWB based on an MRI-derived model

    Science.gov (United States)

    Xiao, Xia; Song, Hang; Wang, Zong-Jie; Wang, Liang

    2014-07-01

    Ultra-wideband (UWB) microwave imaging is a promising method for breast cancer detection based on the large contrast of electric parameters between the malignant tumor and its surrounded normal breast organisms. In the case of multiple tumors being present, the conventional imaging approaches may be ineffective to detect all the tumors clearly. In this paper, a progressive processing method is proposed for detecting more than one tumor. The method is divided into three stages: primary detection, refocusing and image optimization. To test the feasibility of the approach, a numerical breast model is developed based on the realistic magnetic resonance image (MRI). Two tumors are assumed embedded in different positions. Successful detection of a 3.6 mm-diameter tumor at a depth of 42 mm is achieved. The correct information of both tumors is shown in the reconstructed image, suggesting that the progressive processing method is promising for multi-tumor detection.

  16. Progressive strength training to prevent LYmphoedema in the first year after breast CAncer - the LYCA feasibility study

    DEFF Research Database (Denmark)

    Ammitzbøll, Gunn; Lanng, Charlotte; Kroman, Niels;

    2017-01-01

    BACKGROUND: Lymphoedema is a common late effect after breast cancer (BC) that has no effective cure once chronic. Accumulating evidence supports progressive strength training (PRT) as a safe exercise modality in relation to the onset and exacerbation of lymphoedema. In the 'preventive intervention...

  17. MHD Integrated Topping Cycle Project. Fourteenth quarterly technical progress report, November 1, 1990-- January 31, 1991

    Energy Technology Data Exchange (ETDEWEB)

    1992-02-01

    This fourteenth quarterly technical progress report of the MHD Integrated Topping Cycle Project presents the accomplishments during the period November 1, 1990 to January 31, 1991. Testing of the High Pressure Cooling Subsystem electrical isolator was completed. The PEEK material successfully passed the high temperature, high pressure duration tests (50 hours). The Combustion Subsystem drawings were CADAM released. The procurement process is in progress. An equipment specification and RFP were prepared for the new Low Pressure Cooling System (LPCS) and released for quotation. Work has been conducted on confirmation tests leading to final gas-side designs and studies to assist in channel fabrication.The final cathode gas-side design and the proposed gas-side designs of the anode and sidewall are presented. Anode confirmation tests and related analyses of anode wear mechanisms used in the selection of the proposed anode design are presented. Sidewall confirmation tests, which were used to select the proposed gas-side design, were conducted. The design for the full scale CDIF system was completed. A test program was initiated to investigate the practicality of using Avco current controls for current consolidation in the power takeoff (PTO) regions and to determine the cause of past current consolidation failures. Another important activity was the installation of 1A4-style coupons in the 1A1 channel. A description of the coupons and their location with 1A1 channel is presented herein.

  18. Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression

    Science.gov (United States)

    Cohen-Dvashi, Hadas; Ben-Chetrit, Nir; Russell, Roslin; Carvalho, Silvia; Lauriola, Mattia; Nisani, Sophia; Mancini, Maicol; Nataraj, Nishanth; Kedmi, Merav; Roth, Lee; Köstler, Wolfgang; Zeisel, Amit; Yitzhaky, Assif; Zylberg, Jacques; Tarcic, Gabi; Eilam, Raya; Wigelman, Yoav; Will, Rainer; Lavi, Sara; Porat, Ziv; Wiemann, Stefan; Ricardo, Sara; Schmitt, Fernando; Caldas, Carlos; Yarden, Yosef

    2015-01-01

    Dissemination of primary tumor cells depends on migratory and invasive attributes. Here, we identify Navigator-3 (NAV3), a gene frequently mutated or deleted in human tumors, as a regulator of epithelial migration and invasion. Following induction by growth factors, NAV3 localizes to the plus ends of microtubules and enhances their polarized growth. Accordingly, NAV3 depletion trimmed microtubule growth, prolonged growth factor signaling, prevented apoptosis and enhanced random cell migration. Mathematical modeling suggested that NAV3-depleted cells acquire an advantage in terms of the way they explore their environment. In animal models, silencing NAV3 increased metastasis, whereas ectopic expression of the wild-type form, unlike expression of two, relatively unstable oncogenic mutants from human tumors, inhibited metastasis. Congruently, analyses of > 2,500 breast and lung cancer patients associated low NAV3 with shorter survival. We propose that NAV3 inhibits breast cancer progression by regulating microtubule dynamics, biasing directionally persistent rather than random migration, and inhibiting locomotion of initiated cells. PMID:25678558

  19. Final Technical Progress Report: Development of Low-Cost Suspension Heliostat; December 7, 2011 - December 6, 2012

    Energy Technology Data Exchange (ETDEWEB)

    Bender, W.

    2013-01-01

    Final technical progress report of SunShot Incubator Solaflect Energy. The project succeeded in demonstrating that the Solaflect Suspension Heliostat design is viable for large-scale CSP installations. Canting accuracy is acceptable and is continually improving as Solaflect improves its understanding of this design. Cost reduction initiatives were successful, and there are still many opportunities for further development and further cost reduction.

  20. 乳腺癌手术治疗进展%Progress of operation therapy in breast cancer

    Institute of Scientific and Technical Information of China (English)

    乔海朋; 于琦; 高超英

    2008-01-01

    Operation is one of the important ways in breast cancer treatment.With the deep basic medical research,new theory,new concept and new technology improve the operation therapy in breast cancer in more scientific and rational way Breast-conserving therapy and sentinel lymph node bipsy (SLNB) are applied,and the neoadjuvant chemotherapy make breast-conserving therapy more feasible.The progress of operation therapy in breast cancer make it critical to emphasize the individualized treatment in breast cancer.%手术是治疗乳腺癌的主要手段之一.随着医学基础研究的深入,新理论,新观念,新技术使乳腺癌的外科治疗向更科学、更合理的方向迈进.保乳手术广泛开展,前哨淋巴结活检技术亦开始在临床应用,同时新辅助化疗能够增加乳腺癌保乳治疗的机会.乳腺癌外科治疗的新进展使得我们必须重视乳腺癌的个体化手术治疗.

  1. Jointly sponsored research program quarterly technical progress report, January--March 1994

    Energy Technology Data Exchange (ETDEWEB)

    1994-08-01

    Progress reports are presented for the following tasks: Development and demonstration of a practical electric downhole steam generator for thermal recovery of heavy oil and tar; wetting behavior of selected crude oil/brine/rock systems; coal gasification, power generation, and product market study; impact of leachate from clean coal technology waste on the stability of clay liners; investigation of coprocessing of heavy oil, automobile shredder residue, and coal; injection into coal seams for simultaneous CO{sub 2} mitigation and enhanced recovery of coalbed methane; optimization of carbonizer operations in the FMC coke process; chemical sensor and field screening technology development; demonstration of the Koppelman ``Series C`` Power River Basin coal as feed; remote chemical sensor development; market assessment and technical feasibility study of PFBC ash use; solid-state NMR analysis and interpretation of naturally and artificially matured kerogens; Crow{trademark} field demonstration with Bell Lumber and Pole; ``B`` series pilot plant tests; and in-situ treatment of manufactured gas plant contaminated soils demonstration program.

  2. MHD air heater development technology. Technical progress report, April 1, 1980-June 30, 1980

    Energy Technology Data Exchange (ETDEWEB)

    None

    1980-07-01

    Technology development for the directly-fired high temperature air heater (HTAH) for MHD power plants is described. Work is being done under three tasks as described in the following. (1) materials selection, evaluation, and development: The objective of this task is to continue development of ceramic materials technology for the directly-fired HTAH. The scope of the work will include compilation of materials data, materials selection for testing and design studies, materials property determination, liaison with refractory manufacturers and other organizations to encourage development of materials and fabrication technology, establishment of preliminary HTAH material specifications, analyses of test materials, and development of criteria for thermal stress limits for crack-tolerant refractory materials. (2) operability, performance, and materials testing: The objectives of this task are to demonstrate the technical feasibility of operating a directly-fired HTAH (including both the heater matrix and valves), to continue obtaining information on life and corrosion resistance of HTAH materials, and to obtain design information for full-scale studies and future design work. (3) full-scale design concepts: The objectives of this task are to begin the identification of HTAH control requirements and control system needs, and to continue full-scale study efforts incorporating updated materials and design information in order to identify development needs for the HTAH development program. Progress is described. (WHK)

  3. Coal liquefaction process streams characterization and evaluation. Quarterly technical progress report, January 1--March 31, 1992

    Energy Technology Data Exchange (ETDEWEB)

    Robbins, G.A.; Brandes, S.D.; Winschel, R.A.; Burke, F.P.

    1992-08-01

    This is the tenth Quarterly Technical Progress Report under DOE Contract DE-AC22-89PC89883. Process oils from Wilsonville Run 262 were analyzed to provide information on process performance. Run 262 was operated from July 10 through September 30, 1991, in the thermal/catalytic Close-Coupled Integrated Two-Stage Liquefaction (CC-ITSL) configuration with ash recycle. The feed coal was Black Thunder Mine subbituminous coal. The high/low temperature sequence was used. Each reactor was operated at 50% of the available reactor volume. The interstage separator was in use throughout the run. The second-stage reactor was charged with aged Criterion 324 catalyst (Ni/Mo on 1/16 inch alumina extrudate support). Slurry catalysts and sulfiding agent were fed to the first-stage reactor. Molyvan L is an organometallic compound which contains 8.1% Mo, and is commercially available as an oil-soluble lubricant additive. It was used in Run 262 as a dispersed hydrogenation catalyst precursor, primarily to alleviate deposition problems which plagued past runs with Black Thunder coal. One test was made with little supported catalyst in the second stage. The role of phenolic groups in donor solvent properties was examined. In this study, four samples from direct liquefaction process oils were subjected to O-methylation of the phenolic groups, followed by chemical analysis and solvent quality testing.

  4. Technical Progress of Domestic Iron & Steel Industry and Its Influence on the Development of Refractories

    Institute of Scientific and Technical Information of China (English)

    XINGShouwei; LIUJiehua

    2001-01-01

    The quick increase of domestic iron and steel output,the great improvement of steel quality and variety,the improtation of advanced equipment and the diminution and elimination of some backward technology and facilities have brought about great influence on the development of refracetories.In order to meet the technical progress of iron and steel industry,domestic refractories industry has,in the last industry,domestic refractories industry has,in the last decades ,concentrated its efforts on the development and production of new Sialon bonded SiC bricks and micropore carbon blocks for giant blast furnaces;new refractories for coke oven and non-coke iron making furnaces;MgO-C bricks for converters and electric conductive refractories for UHP EAF;refractories for slag splashing technology;and the highy technology-intensive refractories for continuous casting facilities.The paper reviews the great change occurred in the industries of iron-and steel-making and refratories during the last decaldes.

  5. Critical contributions in MHD power generation. Quarterly technical progress report, December 1, 1977-February 28, 1978

    Energy Technology Data Exchange (ETDEWEB)

    Louis, J.F.

    1978-03-01

    Research and development in open-cycle coal-fired MHD power generation is described. The scope and objectives of the MIT program are: (1) establish chemical, thermal, and electrical data to guide materials selection, develop improved detail designs, and support performance analyses of MHD electrode modules and insulator materials; (2) parametrically investigate selected electrode properties of critical design importance in chemical, thermal, and electrical environments simulating a coal-fired MHD generator; (3) develop combustion data pertinent to the design of MHD combustors; (4) establish techniques for the analysis and understanding of critical MHD phenomena which have an important bearing on MHD generator performance; such phenomena include inter-electrode breakdown, time-dependent behavior, effective plasma properties and plasma inhomogeneities; (5) establish the operating characteristics of an MHD disk generator; (6) continue work on computer techniques for modeling and for design and cost analysis of MHD components and the overall system; (7) integrate the engineering data and design criteria, as applicable, which are developed in the listed tasks into a model of the MHD channel; (8) participate in the US/USSR Cooperative Program in MHD Power Generation; and (9) participate in technical support of the DOE MHD Project Office. Progress in each of these areas is reported. (WHK)

  6. Critical contributions in MHD power generation. Quarterly technical progress report, September 1--November 30, 1977

    Energy Technology Data Exchange (ETDEWEB)

    Louis, J.F.

    1977-12-01

    Research and development in open-cycle coal-fired MHD power generation at Massachusetts Institute of Technology (MIT) is summarized. Progress is reported on the following tasks: (1) Establish chemical, thermal, and electrical data to guide materials selection, develop improved detail designs, and support performance analyses of MHD electrode modules and insulator materials; (2) parametrically investigate selected electrode properties of critical design importance in chemical, thermal, and electrical environments simulating a coal-fired MHD generator; (3) develop combustion data pertinent to the design of MHD combustors; this work is intended to determine the combustion characteristics of selected coal feedstock in terms of devolatilization kinetics, char characteristics, and combustion gas chemistry; (4) establish techniques for the analysis and understanding of critical MHD phenomena which have an important bearing on MHD generator performance; such phenomena include inter-electrode breakdown, time-dependent behavior, effective plasma properties and plasma inhomogeneities; (5) establish the operating characteristics of an MHD disk generator; (6) continue work on computer techniques for modeling and for design and cost analysis of MHD components and the overall system; (7) integrate the engineering data and design criteria, as applicable, which are developed in the above-listed tasks into a model of the MHD channel; (8) participate in technical support of the DOE MHD Project Office.

  7. PFBC HGCU Test Facility. Technical progress report No. 24, Third quarter, CY 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-10-01

    This is the twenty-fourth and final Technical Progress Report submitted to the Department of Energy (DOE) in connection with the cooperative agreement between the DOE and Ohio Power Company for the Tidd PFBC Hot Gas Clean Up Test Facility. This report covers the work completed during the Third Quarter of CY 1995. All activity this quarter was directed toward the completion of the program final report. A draft copy of the final report was forwarded to DOE during this quarter, and DOE submitted their comments on the report to AEPSC. DOE requested that Westinghouse write an appendix to the report covering the performance of the fail-safe regenerator devices during Tad operation, and Westinghouse subsequently prepared the appendix. Additional DOE comments were incorporated into the report, and it will be issued in camera-ready form by the end of October, 1995, which is the program end date. Appendix 1 presents the results of filter candle posttest examination by Westinghouse performed on selected filter candles following final shutdown of the system.

  8. Coal liquefaction process streams characterization and evaluation. Quarterly technical progress report, April 1--June 30, 1992

    Energy Technology Data Exchange (ETDEWEB)

    Brandes, S.D.; Lancet, M.S.; Robbins, G.A.; Winschel, R.A.; Burke, F.P.

    1992-11-01

    This is the eleventh Quarterly Technical Progress Report under DOE Contract DE-AC22-89PC89883. Major topics reported are: (1) The results of a study designed to determine the effects of the conditions employed at the Wilsonville slurry preheater vessel on coal conversion is described. (2) Stable carbon isotope ratios were determined and used to source the carbon of three product samples from Period 49 of UOP bench-scale coprocessing Run 37. The results from this coprocessing run agree with the general trends observed in other coprocessing runs that we have studied. (3) Microautoclave tests and chemical analyses were performed to ``calibrate`` the reactivity of the standard coal used for determining donor solvent quality of process oils in this contract. (4) Several aspects of Wilsonville Close-Coupled Integrated Two-Stage Liquefaction (CC-ITSL) resid conversion kinetics were investigated; results are presented. Error limits associated with calculations of deactivation rate constants previously reported for Runs 258 and 261 are revised and discussed. A new procedure is described that relates the conversions of 850{degrees}F{sup +} , 1050{degrees}F{sup +}, and 850 {times} 1050{degrees}F material. Resid conversions and kinetic constants previously reported for Run 260 were incorrect; corrected data and discussion are found in Appendix I of this report.

  9. Technical Progress of Rubber Additives%橡胶助剂技术进展

    Institute of Scientific and Technical Information of China (English)

    齐琳; 梁诚

    2013-01-01

    In this review, the development and application of rubber additives are presented, including antioxidant 4030, antioxidant 4050, accelerator TBSI and TBZTD, anti-reversion agent Perkalink900, peptizer, homogenizing agent and resorcinol resin. The technical progress of production processes of several rubber additives is reviewed, for example, 4-aminodiphenylamine from nitrobenzene, antioxidant DTPD from mixed amine, and thiazole accelerators through clean process. The growth of China rubber additive industry relies strongly on continuous technological innovation.%介绍防老剂4030和4050等防护体系助剂,促进剂TBSI和TBZTD、抗硫化返原剂Perkalink900等硫化体系助剂,以及塑解剂、均匀剂、间苯二酚树脂等加工助剂的开发和应用。综述对氨基二苯胺硝基苯法工艺、混合胺合成防老剂DTPD工艺、噻唑类促进剂清洁工艺等进展。我国橡胶助剂工业应不断科技创新,才能够做大做强。

  10. Advanced Coal Conversion Process Demonstration Project. Technical progress report, January 1, 1993--December 31, 1993

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-02-01

    This report describes the technical progress made on the Advanced Coal Conversion Process (ACCP) Demonstration Project from January 1, 1993, through December 31, 1993. This project demonstrates an advanced, thermal, coal drying process, coupled with physical cleaning techniques, that is designed to upgrade high-moisture, low- rank coals to a high-quality, low-sulfur fuel, registered as the SynCoal{reg_sign} process. The coal is processed through three stages (two heating stages followed by an inert cooling stage) of vibrating fluidized bed reactors that remove chemically bound water, carboxyl groups, and volatile sulfur compounds. After thermal processing, the coal is put through a deep-bed stratifier cleaning process to separate the pyrite-rich ash from the coal. Rosebud SynCoal Partnership`s ACCP Demonstration Facility entered Phase III, Demonstration Operation, in April 1992 and operated in an extended startup mode through August 10, 1993, when the facility became commercial. Rosebud SynCoal Partnership instituted an aggressive program to overcome startup obstacles and now focuses on supplying product coal to customers. Significant accomplishments in the history of the SynCoal{reg_sign} process development are shown in Appendix A.

  11. MHD Integrated Topping Cycle Project. Sixteenth quarterly technical progress report, May 1991--July 1991

    Energy Technology Data Exchange (ETDEWEB)

    1992-03-01

    The Magnetohydrodynamics (MHD) Integrated Topping Cycle (ITC) Project represents the culmination of the proof-of-concept (POC) development stage in the US Department of Energy (DOE) program to advance MHD technology to early commercial development stage utility power applications. The project is a joint effort, combining the skills of three topping cycle component developers: TRW, Avco/TDS, and Westinghouse. TRW, the prime contractor and system integrator, is responsible for the 50 thermal megawatt (50 MW{sub t}) slagging coal combustion subsystem. Avco/TDS is responsible for the MHD channel subsystem (nozzle, channel, diffuser, and power conditioning circuits), and Westinghouse is responsible for the current consolidation subsystem. The ITC Project will advance the state-of-the-art in MHD power systems with the design, construction, and integrated testing of 50 MW{sub t} power train components which are prototypical of the equipment that will be used in an early commercial scale MHD utility retrofit. Long duration testing of the integrated power train at the Component Development and Integration Facility (CDIF) in Butte, Montana will be performed, so that by the early 1990`s, an engineering data base on the reliability, availability, maintainability and performance of the system will be available to allow scaleup of the prototypical designs to the next development level. This Sixteenth Quarterly Technical Progress Report covers the period May 1, 1991 to July 31, 1991.

  12. Circulating low IL-23: IL-35 cytokine ratio promotes progression associated with poor prognosisin breast cancer.

    Science.gov (United States)

    Chen, Guanghui; Liang, Yanfang; Guan, Xin; Chen, Hui; Liu, Qiankun; Lin, Bihua; Chen, Can; Huang, Mingyuan; Chen, Jianan; Wu, Weiquan; Liang, Yi; Zhou, Keyuan; Zeng, Jincheng

    2016-01-01

    The interleukin (IL)-12 family, composed of heterodimeric cytokines including IL-12 (formed by IL-12p35 and IL-12p40 subunits), IL-23 (formed by IL-23p19 and IL-12p40 subunits), IL-27 (formed by IL-27p28 and EBI3 subunits) and IL-35 (formed by IL-12p35 and EBI3 subunits), establishes a link between innate and adaptive immunity that involves different immune effector cells and cytokines to tumors. However, the role of IL-12 family in breast cancer (BC) progression and prognosis remains unclear. In the present study, we demonstrated evidence indicating that EBI3, IL-12p35 and IL-12p40 but not IL-23p19 or IL-27p28 were highly expressed in BC tissues, suggested that tumor derived EBI3, IL-12p35 and IL-12p40 were associated with tumor progression. Circulating IL-12 and IL-23 low expressed, but IL-27 and IL-35 high expressed in BC patients, especially circulating IL-23 associated with IL-35 to mediate BC tumor resection. Ki-67, p53 and EGFR expression on BC tissues, as well as CA125, CA153 and CA199 levels on BC bloods increased when circulating IL-23: IL-35 ratio decreased. Together, for the first time, our data suggest that circulating IL-23: IL-35 ratio may be an important indicator association with BC progression and prognosis. However, further research should be carried out to assess the implications of circulating IL-23: IL-35 ratio in a larger sample size.

  13. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.

    Science.gov (United States)

    Rashidian, Juliet; Le Scolan, Erwan; Ji, Xiaodan; Zhu, Qingwei; Mulvihill, Melinda M; Nomura, Daniel; Luo, Kunxin

    2015-02-10

    Ski, the transforming protein of the avian Sloan-Kettering retrovirus, inhibits transforming growth factor-β (TGF-β)/Smad signaling and displays both pro-oncogenic and anti-oncogenic activities in human cancer. Inhibition of TGF-β signaling is likely responsible for the pro-oncogenic activity of Ski. We investigated the mechanism(s) underlying the tumor suppressor activity of Ski and found that Ski suppressed the activity of the Hippo signaling effectors TAZ and YAP to inhibit breast cancer progression. TAZ and YAP are transcriptional coactivators that can contribute to cancer by promoting proliferation, tumorigenesis, and cancer stem cell expansion. Hippo signaling activates the the Lats family of kinases, which phosphorylate TAZ and YAP, resulting in cytoplasmic retention and degradation and inhibition of their transcriptional activity. We showed that Ski interacted with multiple components of the Hippo pathway to facilitate activation of Lats2, resulting in increased phosphorylation and subsequent degradation of TAZ. Ski also promoted the degradation of a constitutively active TAZ mutant that is not phosphorylated by Lats, suggesting the existence of a Lats2-independent degradation pathway. Finally, we showed that Ski repressed the transcriptional activity of TAZ by binding to the TAZ partner TEAD and recruiting the transcriptional co-repressor NCoR1 to the TEAD-TAZ complex. Ski effectively reversed transformation and epithelial-to-mesenchyme transition in cultured breast cancer cells and metastasis in TAZ-expressing xenografted tumors. Thus, Ski inhibited the function of TAZ through multiple mechanisms in human cancer cells.

  14. Quantitative DNA hypomethylation of ligand Jagged1 and receptor Notch1 signifies occurrence and progression of breast carcinoma.

    Science.gov (United States)

    Cao, Yuwen; Li, Yixiao; Zhang, Na; Hu, Jianming; Yin, Liang; Pan, Zemin; Li, Yucong; Du, Xiaoming; Zhang, Wenjie; Li, Feng

    2015-01-01

    Methylation alterations of Jagged1 and Notch1 genes have been reported in non-tumor lesions and a few cancers. However, methylation profiles of Jagged1 promoter and Notch1 exon25 in breast cancer and matched normal tissue and the association of methylation with clinicopathological characteristics still remain unclear. To explore the potential effects of aberrant DNA methylation of Jagged1 and Notch1 on occurrence and progression of breast cancer, we detected the quantitative DNA methylation of Jagged1 and Notch1 in 73 breast cancer (BC) and 20 adjacent normal breast tissues (ANBT) by using MassARRAY spectrometry. The methylation level of overall and majority individual CpG sites of the two genes were synergistically significantly lower in BC than in ANBT. The overall hypomethylation of the two genes, particularly of Jagged1 CpG_8.9.10 and Notch1 CpG_14.15.16 in primary tumors, were markedly associated with lymph node metastasis, advanced stage and high grade. The protein expressions of the both genes were examined by immunohistochemical staining in same cohorts. The expression was significantly inverse correlation with methylation. The two proteins in primary tumor were synergistically up-regulated and dramatically related to lymph node metastasis, advanced stage and high grade. Our findings suggest that the synergetic hypomethylation of Jagged1 and Notch1 genes, especially of Jagged1 CpG_8.9.10 and Notch1 CpG_14.15.16, may involve tumorigenesis and development of breast cancer. The negative relationship between methylation and expression indicates methylation role for expression regulation. The synergetic overexpression of the two proteins further indicates the effects on occurrence and progression of breast cancer.

  15. n-Butyl benzyl phthalate promotes breast cancer progression by inducing expression of lymphoid enhancer factor 1.

    Directory of Open Access Journals (Sweden)

    Tsung-Hua Hsieh

    Full Text Available Environmental hormones play important roles in regulating the expression of genes involved in cell proliferation, drug resistance, and breast cancer risk; however, their precise role in human breast cancer cells during cancer progression remains unclear. To elucidate the effect of the most widely used industrial phthalate, n-butyl benzyl phthalate (BBP, on cancer progression, we evaluated the results of BBP treatment using a whole human genome cDNA microarray and MetaCore software and selected candidate genes whose expression was changed by more than ten-fold by BBP compared with controls to analyze the signaling pathways in human breast cancer initiating cells (R2d. A total of 473 genes were upregulated, and 468 were downregulated. Most of these genes are involved in proliferation, epithelial-mesenchymal transition, and angiogenesis signaling. BBP induced the viability, invasion and migration, and tube formation in vitro, and Matrigel plug angiogenesis in vivo of R2d and MCF-7. Furthermore, the viability and invasion and migration of these cell lines following BBP treatment was reduced by transfection with a small interfering RNA targeting the mRNA for lymphoid enhancer-binding factor 1; notably, the altered expression of this gene consistently differentiated tumors expressing genes involved in proliferation, epithelial-mesenchymal transition, and angiogenesis. These findings contribute to our understanding of the molecular impact of the environmental hormone BBP and suggest possible strategies for preventing and treating human breast cancer.

  16. Tumor-induced inflammation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer progression.

    Science.gov (United States)

    Benesch, Matthew G K; Tang, Xiaoyun; Dewald, Jay; Dong, Wei-Feng; Mackey, John R; Hemmings, Denise G; McMullen, Todd P W; Brindley, David N

    2015-09-01

    Compared to normal tissues, many cancer cells overexpress autotaxin (ATX). This secreted enzyme produces extracellular lysophosphatidate, which signals through 6 GPCRs to drive cancer progression. Our previous work showed that ATX inhibition decreases 4T1 breast tumor growth in BALB/c mice by 60% for about 11 d. However, 4T1 cells do not produce significant ATX. Instead, the ATX is produced by adjacent mammary adipose tissue. We investigated the molecular basis of this interaction in human and mouse breast tumors. Inflammatory mediators secreted by breast cancer cells increased ATX production in adipose tissue. The increased lysophosphatidate signaling further increased inflammatory mediator production in adipose tissue and tumors. Blocking ATX activity in mice bearing 4T1 tumors with 10 mg/kg/d ONO-8430506 (a competitive ATX inhibitor, IC90 = 100 nM; Ono Pharma Co., Ltd., Osaka, Japan) broke this vicious inflammatory cycle by decreasing 20 inflammatory mediators by 1.5-8-fold in cancer-inflamed adipose tissue. There was no significant decrease in inflammatory mediator levels in fat pads that did not bear tumors. ONO-8430506 also decreased plasma TNF-α and G-CSF cytokine levels by >70% and leukocyte infiltration in breast tumors and adjacent adipose tissue by >50%. Hence, blocking tumor-driven inflammation by ATX inhibition is effective in decreasing tumor growth in breast cancers where the cancer cells express negligible ATX.

  17. Role of Protein Synthesis Initiation Factors in Dietary Soy Isoflavone-Mediated Effects on Breast Cancer Progression

    Science.gov (United States)

    2012-03-01

    Manuscript s • Submitted to the Journal of Nutritional Biochemistry (Feb 21, 2012) “The soy isoflavone equol may increase cancer malignancy via upregulation...29] Ko KP, Park SK, Park B et al. Isoflavones from phytoestrogens and gastric cancer risk: a nested case-control study within the Korean...Dietary Soy Isoflavone-Mediated Effects on Breast Cancer Progression. PRINCIPAL INVESTIGATOR: Columba de la Parra Simental CONTRACTING

  18. Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.

    Directory of Open Access Journals (Sweden)

    Tiziana Triulzi

    Full Text Available We recently showed that differential expression of extracellular matrix (ECM genes delineates four subgroups of breast carcinomas (ECM1, -2, -3- and -4 with different clinical outcome. To further investigate the characteristics of ECM signature and its impact on tumor progression, we conducted unsupervised clustering analyses in 6 additional independent datasets of invasive breast tumors from different platforms for a total of 643 samples. Use of four different clustering algorithms identified ECM3 tumors as an independent group in all datasets tested. ECM3 showed a homogeneous gene pattern, consisting of 58 genes encoding 43 structural ECM proteins. From 26 to 41% of the cases were ECM3-enriched, and analysis of datasets relevant to gene expression in neoplastic or corresponding stromal cells showed that both stromal and breast carcinoma cells can coordinately express ECM3 genes. In in vitro experiments, β-estradiol induced ECM3 gene production in ER-positive breast carcinoma cell lines, whereas TGFβ induced upregulation of the genes leading to ECM3 gene classification, especially in ER-negative breast carcinoma cells and in fibroblasts. Multivariate analysis of distant metastasis-free survival in untreated breast tumor patients revealed a significant interaction between ECM3 and histological grade (p = 0.001. Cox models, estimated separately in grade I-II and grade III tumors, indicated a highly significant association between ECM3 and worse survival probability only in grade III tumors (HR = 3.0, 95% CI = 1.3-7.0, p = 0.0098. Gene Set Enrichment analysis of ECM3 compared to non-ECM3 tumors revealed significant enrichment of epithelial-mesenchymal transition (EMT genes in both grade I-II and grade III subsets of ECM3 tumors. Thus, ECM3 is a robust cluster that identifies breast carcinomas with EMT features but with accelerated metastatic potential only in the undifferentiated (grade III phenotype. These findings support the

  19. Critical contributions in MHD power generation. Quarterly technical progress report, December 1, 1976--February 28, 1977

    Energy Technology Data Exchange (ETDEWEB)

    Louis, J.F.

    1977-08-01

    Research progress in open-cycle coal-fired MHD power generation at Massachusetts Institute of Technology (MIT) is reported. The scope and objectives of the MIT program are to: (1) Establish chemical, thermal, and electrical data to guide materials selection, develop improved detail designs, and support performance analyses of MHD electrode modules and insulator materials; (2) establish basic mechanical properties to guide detail design and fabrication of high field strength superconducting magnets for MHD applications; (3) parametrically investigate selected electrode properties of critical design importance in chemical, thermal, and electrical environments simulating a coal-fired MHD generator; (4) develop combustion data pertinent to the design of MHD combustors; (5) establish techniques for the analysis and understanding of critical MHD phenomena which have an important bearing on MHD generator performance; such phenomena include inter-electrode breakdown, time-dependent behavior, effective plasma properties and plasma inhomogeneities; (6) establish the operating characteristics of an MHD disk generator; (7) continue work on computer techniques for modeling and for design and cost analysis of MHD components and the overall system; (8) integrate the engineering data and design criteria, as applicable, which are developed in the above-listed tasks into a model of the MHD channel; (9) Participate in technical support of the ERDA MHD Project Office; (10) participate in the US/USSR Cooperative Program in MHD Power Generation. (11) During the summer of 1976, a short-term task in U-25 electrode screening was temporarily added to the scope of the contract. This effort involved screening tests, in the MIT MHD simulation facility of electrode modules and configurations intended for tests in the Soviet U-25 generator.

  20. Instrumentation of dynamic gas pulse loading system. Technical progress report, first quarter 1992

    Energy Technology Data Exchange (ETDEWEB)

    Mohaupt, H.

    1992-04-14

    The overall goal of this work is to further develop and field test a system of stimulating oil and gas wells, which increases the effective radius of the well bore so that more oil can flow into it, by recording pressure during the gas generation phase in real time so that fractures can be induced more predictably in the producing formation. Task 1: Complete the laboratory studies currently underway with the prototype model of the instrumentation currently being studied. Task 2: Perform field tests of the model in the Taft/Bakersfield area, utilizing operations closest to the engineers working on the project, and optimize the unit for various conditions encountered there. Task 3: Perform field test of the model in DGPL jobs which are scheduled in the mid-continent area, and optimize the unit for downhole conditions encountered there. Task 4: Analyze and summarize the results achieved during the complete test series, documenting the steps for usage of downhole instrumentation in the field, and compile data specifying use of the technology by others. Task 5: Prepare final report for DOE, and include also a report on the field tests completed. Describe and estimate the probability of the technology being commercialized and in what time span. The project has made substantial technical progress, though we are running about a month behind schedule. Expenditures are in line with the schedule. Increased widespread interest in the use of DGPL stimulation has kept us very busy. The computer modeling and test instrumentation developed under this program is already being applied to commercial operations.

  1. Advanced Coal Conversion Process Demonstration Project. Final technical progress report, January 1, 1995--December 31, 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1997-05-01

    This report describes the technical progress made on the Advanced Coal Conversion Process (ACCP) Demonstration Project from January 1, 1995 through December 31, 1995. This project demonstrates an advanced, thermal, coal upgrading process, coupled with physical cleaning techniques, that is designed to upgrade high-moisture, low-rank coals to a high-quality, low-sulfur fuel, registered as the SynCoal Process. The coal is processed through three stages (two heating stages followed by an inert cooling stage) of vibrating fluidized bed reactors that remove chemically bound water, carboxyl groups, and volatile sulfur compounds. After thermal upgrading, the coal is put through a deep-bed stratifier cleaning process to separate the pyrite-rich ash from the coal. The SynCoal Process enhances low-rank, western coals, usually with a moisture content of 25 to 55 percent, sulfur content of 0.5 to 1.5 percent, and heating value of 5,5000 to 9,000 British thermal units per pound (Btu/lb), by producing a stable, upgraded, coal product with a moisture content as low as 1 percent, sulfur content as low as 0.3 percent, and heating value up to 12,000 Btu/lb. During this reporting period, the primary focus for the ACCP Demonstration Project team was to expand SynCoal market awareness and acceptability for both the products and the technology. The ACCP Project team continued to focus on improving the operation, developing commercial markets, and improving the SynCoal products as well as the product`s acceptance.

  2. Power systems development facility. Quarterly technical progress report, July 1--September 30, 1993

    Energy Technology Data Exchange (ETDEWEB)

    1993-12-31

    This quarterly technical progress report summarizes work completed during the Second Quarter of the Second Budget Period, July 1 through September 30, 1993, under the Department of Energy (DOE) Cooperative Agreement No. DE-FC21-90MC25140 entitled ``Hot Gas Cleanup Test Facility for Gasification and Pressurized Combustion.`` The objective of this project is to evaluate hot gas particle control technologies using coal-derived gas streams. This will entail the design, construction, installation, and use of a flexible test facility which can operate under realistic gasification and combustion conditions. The major particulate control device issues to be addressed include the integration of the particulate control devices into coal utilization systems, on-line cleaning techniques, chemical and thermal degradation of components, fatigue or structural failures, blinding, collection efficiency as a function of particle size, and scaleup of particulate control systems to commercial size. The conceptual design of the facility was extended to include a within scope, phased expansion of the existing Hot Gas Cleanup Test Facility Cooperative Agreement to also address systems integration issues of hot particulate removal in advanced coal-based power generation systems. This expansion included the consideration of the following modules at the test facility in addition to the existing Transport Reactor gas source and Hot Gas Cleanup Units: Carbonizer/Pressurized Circulating Fluidized Bed Gas Source. Hot Gas Cleanup Units to mate to all gas streams; Combustion Gas Turbine; and Fuel Cell and associated gas treatment. This expansion to the Hot Gas Cleanup Test Facility is herein referred to as the Power Systems Development Facility (PSDF). The major emphasis during this reporting period was continuing the detailed design of the facility.

  3. PFBC HGCU test facility technical progress report. First Quarter, CY 1994

    Energy Technology Data Exchange (ETDEWEB)

    1994-04-01

    This is the eighteenth Technical Progress Report submitted in connection with the cooperative agreement between the DOE and Ohio Power Company for the Tidd PFBC Hot Gas Clean Up Test Facility. During this quarter, the Tidd Hot Gas Clean Up System operated for 835 hours during six separate test runs. The system was starting into a seventh run at the end of the quarter. Highlights of this period are summarized below: the longest run during the quarter was approximately 333 hours; filter pressure drop was stable during all test runs this quarter using spoiling air to the primary cyclone upstream of the Advanced Particle Filter (APF); the tempering air system was commissioned this quarter which enabled the unit to operate at full load conditions while limiting the gas temperature in the APF to 1,400 F; during a portion of the one run, the tempering air was removed and the filter operated without problems up to 1,450 F; ash sampling was performed by Battelle personnel upstream and downstream of the APF and ash loading and particle size distribution data were obtained, a summary report is included; a hot area on the APF head was successfully repaired in service; a hot spot on the top of an expansion joint was successfully repaired by drilling holes from the inside of the pipe and pumping in refractory insulation; a corrosion inspection program for the HGCU system was issued giving recommendations for points to inspect; filter internal inspections following test runs 13 and 17 revealed a light coating (up to 1/4 inch thick) of residual ash on the candles and some ash bridging between the dust sheds and inner rows of candles. Data from these inspections are included with this report.

  4. Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.

    Science.gov (United States)

    Pradeep, C-R; Zeisel, A; Köstler, W J; Lauriola, M; Jacob-Hirsch, J; Haibe-Kains, B; Amariglio, N; Ben-Chetrit, N; Emde, A; Solomonov, I; Neufeld, G; Piccart, M; Sagi, I; Sotiriou, C; Rechavi, G; Domany, E; Desmedt, C; Yarden, Y

    2012-08-01

    The HER2/neu oncogene encodes a receptor-like tyrosine kinase whose overexpression in breast cancer predicts poor prognosis and resistance to conventional therapies. However, the mechanisms underlying aggressiveness of HER2 (human epidermal growth factor receptor 2)-overexpressing tumors remain incompletely understood. Because it assists epidermal growth factor (EGF) and neuregulin receptors, we overexpressed HER2 in MCF10A mammary cells and applied growth factors. HER2-overexpressing cells grown in extracellular matrix formed filled spheroids, which protruded outgrowths upon growth factor stimulation. Our transcriptome analyses imply a two-hit model for invasive growth: HER2-induced proliferation and evasion from anoikis generate filled structures, which are morphologically and transcriptionally analogous to preinvasive patients' lesions. In the second hit, EGF escalates signaling and transcriptional responses leading to invasive growth. Consistent with clinical relevance, a gene expression signature based on the HER2/EGF-activated transcriptional program can predict poorer prognosis of a subgroup of HER2-overexpressing patients. In conclusion, the integration of a three-dimensional cellular model and clinical data attributes progression of HER2-overexpressing lesions to EGF-like growth factors acting in the context of the tumor's microenvironment.

  5. Development of a solar desiccant dehumidifier. Volume 1. Summary. Volume 2. Detailed technical information. Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Gunderson, M.E.; Hwang, K.C.; Railing, S.M.

    1978-03-31

    Research and development work aimed at the development of a solar desiccant dehumidifier is described in detail. The system features a rotary bed of granular silica gel and a rotary regenerator. The dehumidifier can be used for air conditioning through adiabatic saturation of the process airstream. Detailed technical information is presented in the appendices: (A) management, (B) review of the literature: state-of-the-art survey and SERI meeting, (C) review of the literature: adsorbent survey, (D) design requirements and evaluation criteria, (E) design requirements and evaluation criteria, single-family house model, (F) design requirements and evaluation criteria, economic model, (G) design requirements and evaluation criteria: conventional system models for comparison, (H) candidate cooling subsystems, (I) subsystem computer model, (J) subsystem performance map, and (K) subsystem preliminary design. (WHK)

  6. Savannah River Plant, Works Technical Department monthly progress report for March 1956

    Energy Technology Data Exchange (ETDEWEB)

    None

    1956-04-18

    This document details activities of the Works Technical Department during the month of March 1956. It covers reactor technology, separations technology, engineering assistance and heavy water technology.

  7. Evaluation of Genomic Instability as an Early Event in the Progression of Breast Cancer

    Science.gov (United States)

    2008-04-01

    instability allows additional classifying of the known aneuploid, diploid, and tetraploid categories of primary breast adenocarcinomas into low and high...expression analysis using stromal and epithelial cell RNA from CHN tissues by microarray hybridization . Determine molecular signatures as a function of...microarray hybridization experiments where performed on “bulk” breast tissues 1cm from tumor margin (N=5), breast tissues 5cm from tumor margin (N=5), and

  8. Hydrogen production by supercritical water gasification of biomass. Phase 1 -- Technical and business feasibility study, technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1997-12-01

    The nine-month Phase 1 feasibility study was directed toward the application of supercritical water gasification (SCWG) for the economical production and end use of hydrogen from renewable energy sources such as sewage sludge, pulp waste, agricultural wastes, and ultimately the combustible portion of municipal solid waste. Unique in comparison to other gasifier systems, the properties of supercritical water (SCW) are ideal for processing biowastes with high moisture content or contain toxic or hazardous contaminants. During Phase I, an end-to-end SCWG system was evaluated. A range of process options was initially considered for each of the key subsystems. This was followed by tests of sewage sludge feed preparation, pumping and gasification in the SCW pilot plant facility. Based on the initial process review and successful pilot-scale testing, engineering evaluations were performed that defined a baseline system for the production, storage and end use of hydrogen. The results compare favorably with alternative biomass gasifiers currently being developed. The results were then discussed with regional wastewater treatment facility operators to gain their perspective on the proposed commercial SCWG systems and to help define the potential market. Finally, the technical and business plans were developed based on perceived market needs and the projected capital and operating costs of SCWG units. The result is a three-year plan for further development, culminating in a follow-on demonstration test of a 5 MT/day system at a local wastewater treatment plant.

  9. HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer

    KAUST Repository

    Boulbes, Delphine R.

    2014-11-11

    Resistance to HER2-targeted therapies remains a major obstacle in the treatment of HER2-overexpressing breast cancer. Understanding the molecular pathways that contribute to the development of drug resistance is needed to improve the clinical utility of novel agents, and to predict the success of targeted personalized therapy based on tumor-specific mutations. Little is known about the clinical significance of HER family mutations in breast cancer. Because mutations within HER1/EGFR are predictive of response to tyrosine kinase inhibitors (TKI) in lung cancer, we investigated whether mutations in HER family kinase domains are predictive of response to targeted therapy in HER2-overexpressing breast cancer. We sequenced the HER family kinase domains from 76 HER2-overexpressing invasive carcinomas and identified 12 missense variants. Patients whose tumors carried any of these mutations did not respond to HER2 directed therapy in the metastatic setting. We developed mutant cell lines and used structural analyses to determine whether changes in protein conformation could explain the lack of response to therapy. We also functionally studied all HER2 mutants and showed that they conferred an aggressive phenotype and altered effects of the TKI lapatinib. Our data demonstrate that mutations in the finely tuned HER kinase domains play a critical function in breast cancer progression and may serve as prognostic and predictive markers.

  10. Learning Progressions: Tools for Assessment and Instruction for All Learners. Technical Report #1307

    Science.gov (United States)

    Sáez, Leilani; Lai, Cheng-Fei; Tindal, Gerald

    2013-01-01

    Conceptually, learning progressions hold promise for improving assessment and instruction by precisely outlining what students know and don't know at particular stages of knowledge and skill development. Based upon a synthesis of the literature, a rationale for the use of learning progressions maps to clarify how learning progresses in…

  11. Progress on chemotherapy for triple negative breast cancer%三阴性乳腺癌化疗进展

    Institute of Scientific and Technical Information of China (English)

    倪晨; 李婷; 吴振华; 胡夕春

    2014-01-01

    三阴性乳腺癌作为乳腺癌的一种特殊亚型,对内分泌治疗和现有靶向治疗无效,并且通常复发较早、进展迅速、预后较差。现就三阴性乳腺癌的分子分型及其临床价值、化疗药物和化疗方案以及化疗和潜在的新靶点药物联合方面的最新进展作一综述。%Triple negative breast cancer (TNBC), as a special molecular subtype of breast cancer, is non-responsive to endocrine therapy or commercially available targeted therapy. It is characterized by early recurrence, rapid progression and poor prognosis. This systemic and comprehensive overview was focused on recent progress on molecular subtyping of triple negative breast cancer and its possible clinical value, chemotherapeutic agents and chemotherapy regimens, and combination of chemotherapy with potential molecular targeting agents.

  12. Loss of cadherin-based cell adhesion and the progression of Invasive Lobular Breast Cancer

    NARCIS (Netherlands)

    Vlug, E.J.

    2015-01-01

    Lobular breast cancer is a type of breast cancer that is histologically characterized by a noncohesive growth pattern of small regular cells, where single cells infiltrate as one-layered strands of cells. This noncohesive growth pattern is due to inactivation of the E-cadherin complex and a subseque

  13. Circulating Tumor Cells in Breast Cancer Patients: An Evolving Role in Patient Prognosis and Disease Progression

    Directory of Open Access Journals (Sweden)

    Holly Graves

    2011-01-01

    Full Text Available In this paper, we examine the role of circulating tumor cells (CTCs in breast cancer. CTCs are tumor cells present in the peripheral blood. They are found in many different carcinomas but are not present in patients with benign disease. Recent advances in theories regarding metastasis support the role of early release of tumor cells in the neoplastic process. Furthermore, it has been found that phenotypic variation exists between the primary tumor and CTCs. Of particular interest is the incongruency found between primary tumor and CTC HER2 status in both metastatic and early breast cancer. Overall, CTCs have been shown to be a poor prognostic marker in metastatic breast cancer. CTCs in early breast cancer are not as well studied, however, several studies suggest that the presence of CTCs in early breast cancer may also suggest a poorer prognosis. Studies are currently underway looking at the use of CTC level monitoring in order to guide changes in therapy.

  14. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions Vitamin D pathways unbalanced in breast lesions

    Directory of Open Access Journals (Sweden)

    Lopes Nair

    2010-09-01

    Full Text Available Abstract Background Breast cancer is a heterogeneous disease associated with different patient prognosis and responses to therapy. Vitamin D has been emerging as a potential treatment for cancer, as it has been demonstrated that it modulates proliferation, apoptosis, invasion and metastasis, among others. It acts mostly through the Vitamin D receptor (VDR and the synthesis and degradation of this hormone are regulated by the enzymes CYP27B1 and CYP24A1, respectively. We aimed to study the expression of these three proteins by immunohistochemistry in a series of breast lesions. Methods We have used a cohort comprising normal breast, benign mammary lesions, carcinomas in situ and invasive carcinomas and assessed the expression of the VDR, CYP27B1 and CYP24A1 by immunohistochemistry. Results The results that we have obtained show that all proteins are expressed in the various breast tissues, although at different amounts. The VDR was frequently expressed in benign lesions (93.5% and its levels of expression were diminished in invasive tumours (56.2%. Additionally, the VDR was strongly associated with the oestrogen receptor positivity in breast carcinomas. CYP27B1 expression is slightly lower in invasive carcinomas (44.6% than in benign lesions (55.8%. In contrast, CYP24A1 expression was augmented in carcinomas (56.0% in in situ and 53.7% in invasive carcinomas when compared with that in benign lesions (19.0%. Conclusions From this study, we conclude that there is a deregulation of the Vitamin D signalling and metabolic pathways in breast cancer, favouring tumour progression. Thus, during mammary malignant transformation, tumour cells lose their ability to synthesize the active form of Vitamin D and respond to VDR-mediated Vitamin D effects, while increasing their ability to degrade this hormone.

  15. Hypoxia-inducible factor-mediated induction of WISP-2 contributes to attenuated progression of breast cancer

    Directory of Open Access Journals (Sweden)

    Fuady JH

    2014-03-01

    Full Text Available Jerry H Fuady,1,* Mattia R Bordoli,1,* Irene Abreu-Rodríguez,1,* Glen Kristiansen,2 David Hoogewijs,1,** Daniel P Stiehl,1,** Roland H Wenger1,**1Institute of Physiology and Zurich Center for Human Physiology, University of Zurich, Zurich, Switzerland; 2University Hospital Bonn, Institute of Pathology, Bonn, Germany*,**These authors contributed equally to this workAbstract: Hypoxia and the hypoxia-inducible factor (HIF signaling pathway trigger the expression of several genes involved in cancer progression and resistance to therapy. Transcriptionally active HIF-1 and HIF-2 regulate overlapping sets of target genes, and only few HIF-2 specific target genes are known so far. Here we investigated oxygen-regulated expression of Wnt-1 induced signaling protein 2 (WISP-2, which has been reported to attenuate the progression of breast cancer. WISP-2 was hypoxically induced in low-invasive luminal-like breast cancer cell lines at both the messenger RNA and protein levels, mainly in a HIF-2α-dependent manner. HIF-2-driven regulation of the WISP2 promoter in breast cancer cells is almost entirely mediated by two phylogenetically and only partially conserved functional hypoxia response elements located in a microsatellite region upstream of the transcriptional start site. High WISP-2 tumor levels were associated with increased HIF-2α, decreased tumor macrophage density, and a better prognosis. Silencing WISP-2 increased anchorage-independent colony formation and recovery from scratches in confluent cell layers of normally low-invasive MCF-7 cancer cells. Interestingly, these changes in cancer cell aggressiveness could be phenocopied by HIF-2α silencing, suggesting that direct HIF-2-mediated transcriptional induction of WISP-2 gene expression might at least partially explain the association of high HIF-2α tumor levels with prolonged overall survival of patients with breast cancer.Keywords: invasion, metastasis, motility, oxygen, tumor, transcriptional

  16. Long-chain fatty acid analogues suppress breast tumorigenesis and progression.

    Science.gov (United States)

    Gluschnaider, Udi; Hertz, Rachel; Ohayon, Sarit; Smeir, Elia; Smets, Martha; Pikarsky, Eli; Bar-Tana, Jacob

    2014-12-01

    Obesity and type 2 diabetes (T2D) are associated with increased breast cancer incidence and mortality, whereas carbohydrate-restricted ketogenic diets ameliorate T2D and suppress breast cancer. These observations suggest an inherent efficacy of nonesterified long-chain fatty acids (LCFA) in suppressing T2D and breast tumorigenesis. In this study, we investigated novel antidiabetic MEDICA analogues consisting of methyl-substituted LCFA that are neither β-oxidized nor esterified to generate lipids, prompting interest in their potential efficacy as antitumor agents in the context of breast cancer. In the MMTV-PyMT oncomouse model of breast cancer, in which we confirmed that tumor growth could be suppressed by a carbohydrate-restricted ketogenic diet, MEDICA treatment suppressed tumor growth, and lung metastasis, promoting a differentiated phenotype while suppressing mesenchymal markers. In human breast cancer cells, MEDICA treatment attenuated signaling through the STAT3 and c-Src transduction pathways. Mechanistic investigations suggested that MEDICA suppressed c-Src-transforming activity by elevating reactive oxygen species production, resulting in c-Src oxidation and oligomerization. Our findings suggest that MEDICA analogues may offer therapeutic potential in breast cancer and overcome the poor compliance of patients to dietary carbohydrate restriction.

  17. Technical and clinical breast cancer screening performance indicators for computed radiography versus direct digital radiography

    Energy Technology Data Exchange (ETDEWEB)

    Bosmans, Hilde; Lemmens, Kim; Zanca, Federica; Ongeval, Chantal van; Steen, Andre van [University Hospitals Leuven, Department of Radiology, Leuven (Belgium); Hauwere, An de; Thierens, Hubert [Ghent University, QCC, Ghent (Belgium); Herck, Koen van; Bleyen, Luc; Mortier, Griet [Ghent University, Centrum voor Preventie en Vroegtijdige Opsporing van Kanker, Department of Public Health, Ghent (Belgium); Martens, Patrick [Vroegtijdige Opsporing Borstklierkanker West-Vlaanderen vzw, Bruges (Belgium); Putte, Gretel vande; Kellen, Eliane; Limbergen, Erik van [Leuven University Center of Cancer Screening, Leuven (Belgium)

    2013-10-15

    To compare technical and clinical screening performance parameters between computed radiography (CR) and direct digital radiography (DR) systems. The number of women screened with CR was 73,008 and with DR 116,945. Technical and patient dose survey data of 25 CR and 37 DR systems were available. Technical performance was expressed by threshold thickness values at the mean glandular dose (MGD) level of routine practice. Clinical indicators included recall rate (RR), cancer detection rate (CDR), percentage of ductal carcinoma in situ (DCIS), percentage of cancers with T-scores smaller than 1 cm and positive predictive value (PPV). Contrast threshold values for the 0.1-mm gold disk were 1.44 {mu}m (SD 0.13 {mu}m) for CR and 1.20 {mu}m (SD 0.13 {mu}m for DR). MGD was 2.16 mGy (SD 0.36 mGy) and 1.35 mGy (SD 0.32 mGy) for CR and DR respectively. We obtained for CR, respectively DR, the following results: RR in the first round of 5.48 % versus 5.61 %; RR in subsequent rounds of 2.52 % versus 2.65 %; CDR of 0.52 % versus 0.53 %; DCIS of 0.08 % versus 0.11 %; a rate of cancers with T-scores smaller than 1 cm of 0.11 % versus 0.11 %; PPV of 18.45 % versus 18.64 %; none of them was significantly different. Our screening indicators are reassuring for the use of CR and DR, with CR operating at 60 % higher MGD. (orig.)

  18. Progress of transcription factor Twist expression in breast cancer and its biological effect

    Institute of Scientific and Technical Information of China (English)

    Tian Qian

    2016-01-01

    Breast cancer is the most common malignant tumor in women and the pathogenesis is not fully elucidated. Proliferation, invasion, epithelial-mesenchymal transition and angiogenesis are the links closely related to the occurrence and development of breast cancer. Twist is a type of basic helix-loop-helix transcription factor that can affect cell proliferation and invasion process, epithelial-mesenchymal transition process and angiogenesis process through regulating the transcription of downstream target genes. In the research, the study of transcription factor Twist expression in breast cancer and its biological effect is reviewed.

  19. Savannah River Ecology Laboratory, Annual Technical Progress Report of Ecological Research, June 30, 2002

    Energy Technology Data Exchange (ETDEWEB)

    Paul M. Bertsch, (Director)

    2002-06-30

    The Savannah River Ecology Laboratory (SREL) is a research unit of The University of Georgia (UGA) and has been conducting ecological research on the Savannah River Site (SRS) near Aiken, South Carolina for 50 years. The overall mission of the Laboratory is to acquire and communicate knowledge of ecological processes and principles. SREL conducts fundamental and applied ecological research, as well as education and outreach programs, under a Cooperative Agreement with the U.S. Department of Energy (DOE). The Laboratory's research mission during the 2002 fiscal year was fulfilled with the publication of 76 journal articles and book chapters by faculty, technical staff, students, and visiting scientists. An additional 50 journal articles have been submitted or are in press. Other noteworthy events took place as faculty members, staff, and graduate students received awards. These are described in the section titled Special Accomplishments of Faculty, Staff, Students, and Administration on page 51. Notable scientific accomplishments include work conducted on contaminant transport, stable isotopes, sandhills ecology, and phytoremediation: (1) A collaborative study between Dr. Tom Hinton at SREL and scientists at SRTC demonstrated the feasibility of using illite clay to sequester 137Cs in sediments along the P and R reactor cooling canal system, where approximately 3,000 acres of land are contaminated. Overall, the study showed significant decreases in cesium concentrations and bioavailability following the addition of illite with no sign of harm to the ecosystem. While the cesium remains sequestered from the biosphere, its radioactivity decays and the process progresses from contaminant immobilization to remediation. (2) SREL's stable isotope laboratory is now fully functional. Stable isotope distributions in nature can provide important insights into many historical and current environmental processes. Dr. Christopher Romanek is leading SREL's research

  20. Krüppel-like factor 4 induces apoptosis and inhibits tumorigenic progression in SK-BR-3 breast cancer cells.

    Science.gov (United States)

    Wang, Bing; Zhao, Ming-Zhi; Cui, Nai-Peng; Lin, Dan-Dan; Zhang, An-Yi; Qin, Yan; Liu, Cai-Yun; Yan, Wei-Tao; Shi, Jian-Hong; Chen, Bao-Ping

    2015-01-01

    Krüppel-like factor 4 (KLF4) functions as either a tumor suppressor or an oncogene in different tissues by regulating the expression of various genes. The aim of this study was to reveal the functions of KLF4 in regulating breast cancer apoptosis, proliferation, and tumorigenic progression. KLF4 expression levels in breast cancer tissues and breast cancer cell lines were found to be much lower than those in nontumorous tissues and a nontransformed mammary epithelial cell line. KLF4 was upregulated in the tumor necrosis factor-α-induced SK-BR-3 breast cancer cell apoptotic process. Overexpression of KLF4 promoted SK-BR-3 breast cancer cell apoptosis and suppressed SK-BR-3 cell tumorigenicity in vivo.

  1. NRL Technical Year End Progress Report for MCSC PM-ICE FY11 SOW Tasks 1 and 2 - Hearing Loss

    Science.gov (United States)

    2012-05-18

    2 — Hearing Loss Research May 18, 2012 Approved for public release; distribution is unlimited. Peter C. HerdiC James W. mCmaHon daniel l. amon...Technical Year End Progress Report for MCSC PM-ICE FY11 SOW Tasks 1 and 2 — Hearing Loss Research Peter C. Herdic, James W. McMahon, Daniel L. Amon...deemed relevant to the warfighter. 18-05-2012 Memorandum Report Hearing loss Human ear Small weapons fire Shooter’s notch Program Manager, Infantry Combat

  2. THE OPTIMAL ALLOCATION ABOUT CAPITAL AND LABOR IN THE ECONOMIC GROWTH WITH AN ENDOGENOUS TECHNICAL PROGRESS MODEL

    Institute of Scientific and Technical Information of China (English)

    刘金山; 李楚霖; 胡适耕

    2002-01-01

    In this paper, the balanced economic growth path was considered in a new growth model with endogenous technical progress. It is not only obtained the optimal allocation about capital and labor between a goods-producing sector and a R&D Sector,but also the optimal value of saving rates. By discussing the effect of parameters, it are also got the following results: When the rate of time preference (discount factor) rising, the fractions of Capital and labor in the goods-producing sector will increase , the fractions in R&D sector and the saving rates will decrease; When the population grows rapidly, the result will be contrary.

  3. [Tattooing of the nipple-areola complex in breast reconstruction: Technical note].

    Science.gov (United States)

    Riot, S; Devinck, F; Aljudaibi, N; Duquennoy-Martinot, V; Guerreschi, P

    2016-04-01

    The reconstruction of the nipple-areola complex is an essential step in breast reconstruction. It announces the end of the reconstruction process, which is often long and sometimes difficult to live for the patient and will significantly improve the perception of body image. Concerning the reconstruction of the areola, tattooing is one of the preferred techniques. It's a simple, quick and safe procedure with a high satisfaction rate. This technique is still perfectible in our opinion, because the random lifetime of pigmentation is a recognized disadvantage of this procedure. We propose a modification of the conventional technique for improving the quality of dermopigmentation while reducing its completion time. Our method is to perform a dermabrasion before starting the tattoo. Indeed, dermabrasion allows better penetration of the pigments inside the dermis and thus offers two advantages: a more durable result over time and reduced operation time by reducing the number of passing of the machine tattoo. Finally, our tattooing technique seems relevant and totally appropriate: its realization is simple, reproducible, does not increase the overall cost of reconstruction, provides timesavings and gives a better long-term result.

  4. Index to Nuclear Safety: a technical progress review by chrology, permuted title, and author, Volume 11(1) through Volume 20(6)

    Energy Technology Data Exchange (ETDEWEB)

    Cottrell, W B; Passiakos, M

    1980-06-01

    This index to Nuclear Safety, a bimonthly technical progress review, covers articles published in Nuclear Safety, Volume II, No. 1 (January-February 1970), through Volume 20, No. 6 (November-December 1979). It is divided into three sections: a chronological list of articles (including abstracts) followed by a permuted-title (KWIC) index and an author index. Nuclear Safety, a bimonthly technical progress review prepared by the Nuclear Safety Information Center (NSIC), covers all safety aspects of nuclear power reactors and associated facilities. Over 600 technical articles published in Nuclear Safety in the last ten years are listed in this index.

  5. Current status of gene therapy for breast cancer: progress and challenges

    Directory of Open Access Journals (Sweden)

    McCrudden CM

    2014-11-01

    Full Text Available Cian M McCrudden, Helen O McCarthySchool of Pharmacy, Queen’s University Belfast, Belfast, UKAbstract: Breast cancer is characterized by a series of genetic mutations and is therefore ideally placed for gene therapy intervention. The aim of gene therapy is to deliver a nucleic acid-based drug to either correct or destroy the cells harboring the genetic aberration. More recently, cancer gene therapy has evolved to also encompass delivery of RNA interference technologies, as well as cancer DNA vaccines. However, the bottleneck in creating such nucleic acid pharmaceuticals lies in the delivery. Deliverability of DNA is limited as it is prone to circulating nucleases; therefore, numerous strategies have been employed to aid with biological transport. This review will discuss some of the viral and nonviral approaches to breast cancer gene therapy, and present the findings of clinical trials of these therapies in breast cancer patients. Also detailed are some of the most recent developments in nonviral approaches to targeting in breast cancer gene therapy, including transcriptional control, and the development of recombinant, multifunctional bio-inspired systems. Lastly, DNA vaccines for breast cancer are documented, with comment on requirements for successful pharmaceutical product development.Keywords: breast cancer, gene therapy, nonviral, clinical trial

  6. Proceedings of the technical review on advances in geothermal reservoir technology---Research in progress

    Energy Technology Data Exchange (ETDEWEB)

    Lippmann, M.J. (ed.)

    1988-09-01

    This proceedings contains 20 technical papers and abstracts describing most of the research activities funded by the Department of Energy (DOE's) Geothermal Reservoir Technology Program, which is under the management of Marshall Reed. The meeting was organized in response to several requests made by geothermal industry representatives who wanted to learn more about technical details of the projects supported by the DOE program. Also, this gives them an opportunity to personally discuss research topics with colleagues in the national laboratories and universities.

  7. Measurements of scattering processes in negative ion - atom collisions. Technical progress report - year 1, April 1, 1995--March 31, 1996

    Energy Technology Data Exchange (ETDEWEB)

    Kvale, T.J.

    1995-12-01

    This Technical Progress Report describes the progress made on the research objectives during the past twelve months. The objective of this research project is to provide absolute cross section measurements of various scattering processes which occur in negative ion collisions with atomic (specifically, noble gas and atomic hydrogen) targets at intermediate energies. These processes include: elastic scattering, single- and double-electron detachment, and target-inelastic processes of excitation and ionization. Total cross sections for single- and double-electron detachment were recently published in Physical Review A from this research project. The researchers were successful this past year in acquiring the first cross section measurements of target excitation for H{sup -} impact on helium target atoms.

  8. Space Power MHD (magnetohydrodynamic) System: Third quarterly technical progress report, 1 November 1987-31 January 1988

    Energy Technology Data Exchange (ETDEWEB)

    1988-03-15

    This progress report of the Space Power MHD System project presents the accomplishments during 1 November 1987 through 31 January 1988. The scope of work covered encompasses the definition of an MHD power system conceptual design and development plan (Task 1). Progress included the following: Subcontracts were issued to the MIT Plasma Fusion Center and the Westinghouse R and D Center. The performance of the 100 MW 500 sec. power system was optimized and the design concept finalized, including mass and energy balances. Mass and cost estimates were prepared. A design review was held at DOE/PETC. This also included the review of the technical issues definition and of the R and D Plan. Following the review, a final iteration on the conceptual design was initiated. Formulation of the R and D Plan was continued. Preparation of the Task 1 R and D Report was initiated. 12 figs.

  9. Krüppel-like factor 4 induces apoptosis and inhibits tumorigenic progression in SK-BR-3 breast cancer cells

    OpenAIRE

    Wang, Bing; Zhao, Ming-zhi; Cui, Nai-peng; Lin, Dan-Dan; Zhang, An-yi; Qin, Yan; Liu, Cai-yun; Yan, Wei-tao; Shi, Jian-hong; Chen, Bao-Ping

    2015-01-01

    Krüppel-like factor 4 (KLF4) functions as either a tumor suppressor or an oncogene in different tissues by regulating the expression of various genes. The aim of this study was to reveal the functions of KLF4 in regulating breast cancer apoptosis, proliferation, and tumorigenic progression. KLF4 expression levels in breast cancer tissues and breast cancer cell lines were found to be much lower than those in nontumorous tissues and a nontransformed mammary epithelial cell line. KLF4 was upregu...

  10. Atmospheric Effects of Nuclear Energy Centers (AENEC) Program. Annual technical progress report, July 1975--September 1976

    Energy Technology Data Exchange (ETDEWEB)

    Patrinos, A. A.; Hoffman, H. W. [comps.

    1977-04-01

    The Technical Memorandum contains information of a preliminary nature from the six participants of the Program describing their activities and presenting the results obtained during the reporting period. The birth of the Program, its definition and evolution are described, and a complete breakdown of responsibilities and tasks assigned to the six AENEC participants is presented.

  11. Developing Technical Writing Skills in the Physical Chemistry Laboratory: A Progressive Approach Employing Peer Review

    Science.gov (United States)

    Gragson, Derek E.; Hagen, John P.

    2010-01-01

    Writing formal "journal-style" lab reports is often one of the requirements chemistry and biochemistry students encounter in the physical chemistry laboratory. Helping students improve their technical writing skills is the primary reason this type of writing is a requirement in the physical chemistry laboratory. Developing these skills is an…

  12. Technical progress report for the quarter 1 October-31 December 1980

    Energy Technology Data Exchange (ETDEWEB)

    1981-01-01

    This report describes the technical accomplishments on the commercial nuclear waste management programs and on the geologic disposal of nuclear wastes. The program is organized into eight tasks: systems, waste package, site, repository, regulatory and institutional, test facilities and excavations, land acquisition, and program management. (DLC)

  13. Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development.

    Science.gov (United States)

    Whyte, Jacqueline; Bergin, Orla; Bianchi, Alessandro; McNally, Sara; Martin, Finian

    2009-01-01

    Seven classes of mitogen-activated protein kinase (MAPK) intracellular signalling cascades exist, four of which are implicated in breast disease and function in mammary epithelial cells. These are the extracellular regulated kinase (ERK)1/2 pathway, the ERK5 pathway, the p38 pathway and the c-Jun N-terminal kinase (JNK) pathway. In some forms of human breast cancer and in many experimental models of breast cancer progression, signalling through the ERK1/2 pathway, in particular, has been implicated as being important. We review the influence of ERK1/2 activity on the organised three-dimensional association of mammary epithelial cells, and in models of breast cancer cell invasion. We assess the importance of epidermal growth factor receptor family signalling through ERK1/2 in models of breast cancer progression and the influence of ERK1/2 on its substrate, the oestrogen receptor, in this context. In parallel, we consider the importance of these MAPK-centred signalling cascades during the cycle of mammary gland development. Although less extensively studied, we highlight the instances of signalling through the p38, JNK and ERK5 pathways involved in breast cancer progression and mammary gland development.

  14. The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries

    Science.gov (United States)

    Grasso, Silvia; Chapelle, Jennifer; Salemme, Vincenzo; Aramu, Simona; Russo, Isabella; Vitale, Nicoletta; Verdun di Cantogno, Ludovica; Dallaglio, Katiuscia; Castellano, Isabella; Amici, Augusto; Centonze, Giorgia; Sharma, Nanaocha; Lunardi, Serena; Cabodi, Sara; Cavallo, Federica; Lamolinara, Alessia; Stramucci, Lorenzo; Moiso, Enrico; Provero, Paolo; Albini, Adriana; Sapino, Anna; Staaf, Johan; Di Fiore, Pier Paolo; Bertalot, Giovanni; Pece, Salvatore; Tosoni, Daniela; Confalonieri, Stefano; Iezzi, Manuela; Di Stefano, Paola; Turco, Emilia; Defilippi, Paola

    2017-01-01

    The docking protein p140Cap negatively regulates tumour cell features. Its relevance on breast cancer patient survival, as well as its ability to counteract relevant cancer signalling pathways, are not fully understood. Here we report that in patients with ERBB2-amplified breast cancer, a p140Cap-positive status associates with a significantly lower probability of developing a distant event, and a clear difference in survival. p140Cap dampens ERBB2-positive tumour cell progression, impairing tumour onset and growth in the NeuT mouse model, and counteracting epithelial mesenchymal transition, resulting in decreased metastasis formation. One major mechanism is the ability of p140Cap to interfere with ERBB2-dependent activation of Rac GTPase-controlled circuitries. Our findings point to a specific role of p140Cap in curbing the aggressiveness of ERBB2-amplified breast cancers and suggest that, due to its ability to impinge on specific molecular pathways, p140Cap may represent a predictive biomarker of response to targeted anti-ERBB2 therapies. PMID:28300085

  15. Estrogen-mediated upregulation of Noxa is associated with cell cycle progression in estrogen receptor-positive breast cancer cells.

    Science.gov (United States)

    Liu, Wensheng; Swetzig, Wendy M; Medisetty, Rajesh; Das, Gokul M

    2011-01-01

    Noxa is a Bcl-2-homology domain (BH3)-only protein reported to be a proapoptotic member of the Bcl-2 family. Estrogen has been well documented to stimulate cell growth and inhibit apoptosis in estrogen receptor (ER)-positive breast cancer cells. Intriguingly, recent reports have shown that 17β-estradiol (E2) induces Noxa expression, although the mechanisms underlying E2-mediated induction of Noxa and its functional significance are unknown. Using MCF7 human breast cancer cells as an experimental model, we show that Noxa is upregulated by E2 via p53-independent processes that involve c-Myc and ERα. Experiments using small interfering ribonucleic acids (siRNA) to specifically knock down p53, c-Myc, and ERα demonstrated that c-Myc and ERα, but not p53, are involved in the transcriptional upregulation of Noxa following E2 treatment. Furthermore, while E2 promoted the recruitment of c-Myc and ERα to the NOXA promoter in chromatin immunoprecipitation (ChIP) assays, E2 did not induce p53 recruitment. Interestingly, E2-mediated upregulation of Noxa was not associated with apoptosis. However, siRNA-mediated knockdown of Noxa resulted in cell cycle arrest in G(0)/G(1)-phase and significantly delayed the G(1)-to-S-phase transition following E2 treatment, indicating that Noxa expression is required for cell cycle progression in ER-positive breast cancer cells.

  16. Estrogen-mediated upregulation of Noxa is associated with cell cycle progression in estrogen receptor-positive breast cancer cells.

    Directory of Open Access Journals (Sweden)

    Wensheng Liu

    Full Text Available Noxa is a Bcl-2-homology domain (BH3-only protein reported to be a proapoptotic member of the Bcl-2 family. Estrogen has been well documented to stimulate cell growth and inhibit apoptosis in estrogen receptor (ER-positive breast cancer cells. Intriguingly, recent reports have shown that 17β-estradiol (E2 induces Noxa expression, although the mechanisms underlying E2-mediated induction of Noxa and its functional significance are unknown. Using MCF7 human breast cancer cells as an experimental model, we show that Noxa is upregulated by E2 via p53-independent processes that involve c-Myc and ERα. Experiments using small interfering ribonucleic acids (siRNA to specifically knock down p53, c-Myc, and ERα demonstrated that c-Myc and ERα, but not p53, are involved in the transcriptional upregulation of Noxa following E2 treatment. Furthermore, while E2 promoted the recruitment of c-Myc and ERα to the NOXA promoter in chromatin immunoprecipitation (ChIP assays, E2 did not induce p53 recruitment. Interestingly, E2-mediated upregulation of Noxa was not associated with apoptosis. However, siRNA-mediated knockdown of Noxa resulted in cell cycle arrest in G(0/G(1-phase and significantly delayed the G(1-to-S-phase transition following E2 treatment, indicating that Noxa expression is required for cell cycle progression in ER-positive breast cancer cells.

  17. Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression.

    Science.gov (United States)

    Suárez-Arroyo, Ivette J; Rios-Fuller, Tiffany J; Feliz-Mosquea, Yismeilin R; Lacourt-Ventura, Mercedes; Leal-Alviarez, Daniel J; Maldonado-Martinez, Gerónimo; Cubano, Luis A; Martínez-Montemayor, Michelle M

    2016-01-01

    The high incidence of resistance to Tyrosine Kinase Inhibitors (TKIs) targeted against EGFR and downstream pathways has increased the necessity to identify agents that may be combined with these therapies to provide a sustained response for breast cancer patients. Here, we investigate the therapeutic potential of Ganoderma lucidum extract (GLE) in breast cancer, focusing on the regulation of the EGFR signaling cascade when treated with the EGFR TKI, Erlotinib. SUM-149, or intrinsic Erlotinib resistant MDA-MB-231 cells, and a successfully developed Erlotinib resistant cell line, rSUM-149 were treated with increasing concentrations of Erlotinib, GLE, or their combination (Erlotinib/GLE) for 72h. Treatment effects were tested on cell viability, cell proliferation, cell migration and invasion. To determine tumor progression, severe combined immunodeficient mice were injected with SUM-149 cells and then treated with Erlotinib/GLE or Erlotinib for 13 weeks. We assessed the protein expression of ERK1/2 and AKT in in vitro and in vivo models. Our results show that GLE synergizes with Erlotinib to sensitize SUM-149 cells to drug treatment, and overcomes intrinsic and developed Erlotinib resistance. Also, Erlotinib/GLE decreases SUM-149 cell viability, proliferation, migration and invasion. GLE increases Erlotinib sensitivity by inactivating AKT and ERK signaling pathways in our models. We conclude that a combinatorial therapeutic approach may be the best way to increase prognosis in breast cancer patients with EGFR overexpressing tumors.

  18. Amarillo National Resource Center for Plutonium. Quarterly technical progress report, May 1, 1997--July 31, 1997

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1997-09-01

    Progress summaries are provided from the Amarillo National Center for Plutonium. Programs include the plutonium information resource center, environment, public health, and safety, education and training, nuclear and other material studies.

  19. University of Florida, University research program in robotics. Annual technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Crane, C.D. III; Tulenko, J.S.

    1994-05-01

    Progress is reported in the areas of environmental hardening, database, world modeling, vision, man-machine interface, advanced liquid metal reactor inspection robot, and articulated transporter/manipulator system (ATMS) development.

  20. Information and Communications Technical Support Services to the Office of Environment, Safety, and Health. Progress report

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1993-12-01

    Progress is reported on the following tasks: development of safety publications, conference support, planning and reporting, MORT A/I video, print products, special graphics, and SAFE software development.

  1. Comparison of a flexible versus a rigid breast compression paddle: pain experience, projected breast area, radiation dose and technical image quality

    NARCIS (Netherlands)

    Broeders, M.J.; Voorde, M. Ten; Veldkamp, W.J.H.; Engen, R.E. van; Landsveld-Verhoeven, C. van; Jong-Gunneman, M.N. t; Win, J. de; Greve, K.D.; Paap, E.; Heeten, GJ. den

    2015-01-01

    PURPOSE: To compare pain, projected breast area, radiation dose and image quality between flexible (FP) and rigid (RP) breast compression paddles. METHODS: The study was conducted in a Dutch mammographic screening unit (288 women). To compare both paddles one additional image with RP was made, consi

  2. Weight loss reversed obesity-induced HGF/c-Met pathway and basal-like breast cancer progression

    Directory of Open Access Journals (Sweden)

    Sneha eSundaram

    2014-07-01

    Full Text Available Epidemiologic studies demonstrate that obesity is associated with an aggressive subtype of breast cancer called basal-like breast cancer (BBC. Using the C3(1-TAg murine model of BBC, we previously demonstrated that mice displayed an early onset of tumors when fed obesogenic diets in the adult window of susceptibility. Obesity was also shown to elevate mammary gland expression and activation of hepatocyte growth factor (HGF/c-Met compared to lean controls, a pro-tumorigenic pathway associated with BBC in patients. Epidemiologic studies estimate that weight loss could prevent a large proportion of BBC. We sought to investigate whether weight loss in adulthood prior to tumor onset would protect mice from accelerated tumorigenesis observed in obese mice. Using a life-long model of obesity, C3(1-TAg mice were weaned onto and maintained on an obesogenic high fat diet. Obese mice displayed significant elevations in tumor progression, but not latency or burden. Tumor progression was significantly reversed when obese mice were induced to lose weight by switching to a control low fat diet prior to tumor onset compared to mice maintained on obesogenic diet. It is likely that other factors regulated tumor progression, hence we investigated the HGF/c-Met pathway known to regulate tumorigenesis. Importantly, HGF/c-Met expression in normal mammary glands and c-Met in tumors was elevated with obesity and was significantly reversed with weight loss. Changes in tumor growth could not be explained by measures of HGF action including phospho-AKT or phospho-S6. Other mediators associated with oncogenesis such as hyperinsulinemia and a high leptin/adiponectin ratio were elevated by obesity and reduced with weight loss. In sum, weight loss significantly blunted the obesity-responsive pro-tumorigenic HGF/c-Met pathway and improved several metabolic risk factors associated with BBC, which together may have contributed to the dramatic reversal of obesity-driven tumor

  3. [Vincristine, adriamycin, mitomycin-C and UFT (VAM-UFT) therapy in progressive or recurrent breast cancer].

    Science.gov (United States)

    Yasutake, K; Imamura, Y; Yoshimura, Y; Oya, M; Matsushita, K; Hozumi, T; Katou, J; Okutani, T; Irie, K

    1989-07-01

    Since June 1984, 23 cases of progressive or recurrent breast cancers were treated with combination chemotherapy of VAM-UFT consisting of vincristine, adriamycin, mitomycin C and UFT. Clinical effects of VAM-UFT therapy were 3 CR, 12 PR, and the response rate was 65.2%. Its effective interval was 3 months. But the patients treated with over 4 cycles of VAM-UFT therapy showed an 85% response rate, with a 5-month effective interval. In each patient's background, a shorter disease free interval tended to be more highly effective, but other factors were not significant. Scirrhous carcinoma of pathology evidenced slightly high response rate. Compared with the survival time of patients treated with under 3 cycles and over 4 cycles of this therapy, the latter was significantly longer. Toxicity involved leukocytopenia (74%), thrombocytopenia (22%), anemia (30%), alopecia (91%), nausea and vomiting (87%) and stomatitis (35%), but cases in which the treatment was stopped were not observed. Therefore VAM-UFT therapy had a highly therapeutic effect, reflected in an 85% response rate, for progressive or recurrent breast cancers.

  4. Being Overweight or Obese Increases the Risk of Progression in Triple-Negative Breast Cancer after Surgical Resection.

    Science.gov (United States)

    Choi, Yunseon; Park, Sung Kwang; Ahn, Ki Jung; Cho, Heunglae; Kim, Tae Hyun; Yoon, Hye Kyoung; Lee, Yun-Han

    2016-06-01

    This study aimed to evaluate the association between body mass index (BMI) and progression in triple-negative breast cancer (TNBC). We retrospectively reviewed the medical records of 50 patients with TNBC who underwent breast-conserving surgery or mastectomy between 2007 and 2014. All patients were classified according to BMI (median 23.5 kg/m(2), range 17.2-31.6 kg/m(2)): 31 patients (62%) were classified as being overweight or obese (BMI ≥ 23 kg/m(2)) and 19 patients (38%) were classified as having a normal body weight (BMI overweight or obese patients (P = 0.035), while none of the normal weight patients showed progression. The 3-year disease-free survival (DFS) and overall survival (OS) rates were 85.0% and 87.7%, respectively. DFS was significantly reduced in overweight or obese patients compared to that in normal weight patients (P = 0.035). However, OS was not significantly compromised by being overweight or obese (P = 0.134). In conclusion, being overweight or obese negatively affects DFS in TNBC patients.

  5. Experimental Program Final Technical Progress Report: 15 February 2007 to 30 September 2012

    Energy Technology Data Exchange (ETDEWEB)

    Kinney, Edward R. [University of Colorado, Boulder, CO

    2014-09-12

    This is the final technical report of the grant DE-FG02-04ER41301 to the University of Colorado at Boulder entitled "Intermediate Energy Nuclear Physics" and describes the results of our funded activities during the period 15 February 2007 to 30 September 2012. These activities were primarily carried out at Fermilab, RHIC, and the German lab DESY. Significant advances in these experiments were carried out by members of the Colorado group and are described in detail.

  6. Association Euratom - DTU, Technical University of Denmark, Department of Physics - Annual Progress Report 2012

    OpenAIRE

    2013-01-01

    The programme of the Research Unit of the Fusion Association Euratom – DTU, Technical University of Denmark covers work in fusion plasma physics and in fusion technology. The fusion plasma physics research focuses on turbulence and transport, and its interaction with the plasma equilibrium and particles. The effort includes both first principles based modelling, and experimental observations of turbulence and of fast ion dynamics by collective Thomson scattering. Within fusion technology ther...

  7. Association Euratom - DTU, Technical University of Denmark, Department of Physics - Annual Progress Report 2013

    OpenAIRE

    2014-01-01

    The programme of the Research Unit of the Fusion Association Euratom – DTU, Technical University of Denmark covers work in fusion plasma physics and in fusion technology. The fusion plasma physics research focuses on turbulence and transport, and its interaction with the plasma equilibrium and particles. The effort includes both first principles based modelling, and experimental observations of turbulence and of fast ion dynamics by collective Thomsonscattering. Within fusion technology there...

  8. Association Euratom - DTU, Technical University of Denmark, Department of Physics - Annual Progress Report 2011

    OpenAIRE

    2012-01-01

    The programme of the Research Unit of the Fusion Association Euratom – DTU, Technical University of Denmark (until 31-12- 2011: Association Euratom – Risø DTU) covers work in fusion plasma physics and in fusion technology. The fusion plasma physics research focuses on turbulence and transport, and its interaction with the plasma equilibrium and particles. The effort includes both first principles based modelling, and experimental observations of turbulence and of fast ion dynamics by collecti...

  9. Instrumentation and process control for fossil demonstration plants. Quarterly technical progress report, January--March 1977

    Energy Technology Data Exchange (ETDEWEB)

    LeSage, L.G.; O' Fallon, N.M.

    1977-09-01

    Progress during the quarter of January through March 1977 on ANL 189a 49622R2, Instrumentation and Process Control for Fossil Demonstration Plants (FDP) is reported. Work has been performed on updating the study of the state-of-the-art of instrumentation for Fossil Demonstration Plants (FDP), on development of mass-flow and other on-line instruments for FDP, process control analysis for FDP, and organization of a symposium on instrumentation and control for FDP. Progress in these areas is described.

  10. Amarillo National Resource Center for Plutonium. Quarterly technical progress report, November 1, 1997--January 31, 1998

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1998-03-01

    This report provides information on projects conducted by the Amarillo National Resource Center for Plutonium, a consortium of Texas A&M University, Texas Tech University, and the University of Texas. Progress is reported for four major areas: (1) plutonium information resource; (2) environmental, safety, and health; (3) communication, education, training, and community involvement; and (4) nuclear and other material studies. Environmental, safety, and health projects reported include a number of studies on high explosives. Progress reported for nuclear material studies includes storage and waste disposal investigations.

  11. Projects at the Western Environmental Technology Office. Quarterly technical progress report, January 1--March 31, 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-06-01

    This quarterly report briefly describes recent progress in eight projects. The projects are entitled Biomass Remediation Project; Heavy Metal-Contaminated Soil Project; MHD Shutdown; Mine Waste Technology Program; Plasma Projects; Resource Recovery Project; Spray Casting Project; and Watervliet Arsenal Project.

  12. [Radioisotope thermoelectric generators and ancillary activities]. Monthly technical progress report, 1 April--28 April 1996

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-06-01

    Tehnical progress achieved during this period on radioisotope thermoelectric generators is described under the following tasks: engineering support, safety analysis, qualified unicouple fabrication, ETG fabrication/assembly/test, RTG shipping/launch support, design/review/mission applications, and project management/quality assurance/reliability.

  13. Great Basin paleoenvironmental studies project; Technical progress report: First quarter (January--August 1993)

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1993-12-31

    Project goals, project tasks, progress on tasks, and problems encountered are described and discussed for each of the studies that make up the Great Basin Paleoenvironmental Studies Project for Yucca Mountain. These studies are: Paleobotany, Paleofauna, Geomorphology, and Transportation. Budget summaries are also given for each of the studies and for the overall project.

  14. Energy conservation in citrus processing. Technical progress report No. 2, April 1, 1980-February 28, 1981

    Energy Technology Data Exchange (ETDEWEB)

    Leo, M.A.; Lari, R.I.; Moore, N.R.; Broussard, M.R.; Gyamfi, M.

    1981-03-15

    Systems that reduce energy usage and are economically viable in the citrus fruit processing industry are identified. The preliminary results of Phase I are presented. Alternative systems to be considered are classified and denoted as central, modular, integrated, and combined. Progress is reported on the central and modular systems. (MCW)

  15. Dissolved organic matter and lake metabolism. Technical progress report, 1 July 1975--30 June 1976

    Energy Technology Data Exchange (ETDEWEB)

    Wetzel, R. G.

    1976-01-01

    Progress is reported in the following areas of research: interactions of dissolved organic matter with inorganic nutrient cycling; regulation of the photosynthetic and decompositional metabolism of micro- and macroflora; regulatory mechanisms of growth and rates of carbon cycling; and fate of detrital dissolved and particulate organic matter. (HLW)

  16. Electrostatic beneficiation of coal. Quarterly technical progress report, April 1, 1996--June 30, 1996

    Energy Technology Data Exchange (ETDEWEB)

    Mazumder, M.K.; Lindquist, D.; Tennal, K.B.

    1996-07-01

    Progress reports are presented for the following: modification to the electrostatic separator; review of DOE specifications for minimum beneficiation and calculations of grinding requirements based on washability; two-pass beneficiation; analysis of different sieve fractions; measurement of charge to mass ratio as a function of height of deposition; and charging of coal against different materials.

  17. Savannah River Ecology Laboratory annual technical progress report of ecological research, period ending July 31, 1993

    Energy Technology Data Exchange (ETDEWEB)

    Vaitkus, M.R.; Wein, G.R. [eds.; Johnson, G.

    1993-11-01

    This progress report gives an overview of research programs at the Savannah River Site. Topics include; environmental operations support, wood stork foraging and breeding, defense waste processing, environmental stresses, alterations in the environment due to pollutants, wetland ecology, biodiversity, pond drawdown studies, and environmental toxicology.

  18. Review of technical program and progress. LBL geothermal exploration technology development program, FY 1982

    Energy Technology Data Exchange (ETDEWEB)

    Goldstein, N.E.

    1982-01-01

    The objectives, method of approach, main program elements, and progress through FY 1982 for Geothermal Exploration Technology Program at LBL are reviewed. Current tasks include controlled-source electromagnetic research, seismological research, magnetotelluric research, and electromagnetic technique evaluation and numerical modeling.

  19. Hypoxia-Inducible Factor-1α in carcinogenesis and progression of breast cancer

    NARCIS (Netherlands)

    Bos, R.

    2004-01-01

    This thesis is primarily focused on the previously hardly explored role of HIF-1 in breast cancer. HIF-1 is a transcription factor induced by hypoxia, but also by some oncogenes, tumor suppressor genes and growth factors. Activated HIF-1 can induce angiogenesis, glycolysis, erythropoiesis, and other

  20. The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression

    Science.gov (United States)

    Littlepage, Laurie E.; Adler, Adam S.; Kouros-Mehr, Hosein; Huang, Guiqing; Chou, Jonathan; Krig, Sheryl R.; Griffith, Obi L.; Korkola, James E.; Qu, Kun; Lawson, Devon A.; Xue, Qing; Sternlicht, Mark D.; Dijkgraaf, Gerrit J. P.; Yaswen, Paul; Rugo, Hope S.; Sweeney, Colleen A.; Collins, Colin C.; Gray, Joe W.; Chang, Howard Y.; Werb, Zena

    2013-01-01

    The transcription factor ZNF217 is a candidate oncogene in the amplicon on chromosome 20q13 that occurs in 20% to 30% of primary human breast cancers and that correlates with poor prognosis. We show that Znf217 overexpression drives aberrant differentiation and signaling events, promotes increased self-renewal capacity, mesenchymal marker expression, motility, and metastasis, and represses an adult tissue stem cell gene signature downregulated in cancers. By in silico screening, we identified candidate therapeutics that at low concentrations inhibit growth of cancer cells expressing high ZNF217. We show that the nucleoside analogue triciribine inhibits ZNF217-induced tumor growth and chemotherapy resistance and inhibits signaling events [e.g., phospho-AKT, phospho-mitogen-activated protein kinase (MAPK)] in vivo. Our data suggest that ZNF217 is a biomarker of poor prognosis and a therapeutic target in patients with breast cancer and that triciribine may be part of a personalized treatment strategy in patients overexpressing ZNF217. Because ZNF217 is amplified in numerous cancers, these results have implications for other cancers. SIGNIFICANCE This study finds that ZNF217 is a poor prognostic indicator and therapeutic target in patients with breast cancer and may be a strong biomarker of triciribine treatment efficacy in patients. Because previous clinical trials for triciribine did not include biomarkers of treatment efficacy, this study provides a rationale for revisiting triciribine in the clinical setting as a therapy for patients with breast cancer who overexpress ZNF217. PMID:22728437

  1. The Functional Effect of an Amphiregulin Autocrine Loop on Inflammatory Breast Cancer Progression

    Science.gov (United States)

    2008-03-01

    Betacellulin: a mitogen from pancreatic h cell tumors. Science 1993;259:1604 –7. 8. Strachan L, Murison JG, Prestidge RL, Sleeman MA, Watson JD...of transforming growth factor a, amphiregulin and CRIPTO in human normal and malignant breast tissues. Int J Cancer 1996;65:51 –6. 44. Ma L, Gauville

  2. Microarray methods to identify factors determining breast cancer progression : Potentials, limitations, and challenges

    NARCIS (Netherlands)

    van der Vegt, B.; de Bock, G. H.; Hollema, H.; Wesseling, J.

    2009-01-01

    65-80% of the patients with breast cancer might not benefit from the adjuvant therapy they receive based on 'classical' markers used for the selection for adjuvant therapy. Therefore it is necessary to develop new markers that are able to tailor treatment for an individual patient. A number of micro

  3. Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression

    DEFF Research Database (Denmark)

    Nairismägi, Maarja-Liisa; Vislovukh, Andrii; Meng, Q

    2012-01-01

    TWIST1 is a highly conserved basic helix-loop-helix transcription factor that promotes epithelial–mesenchymal transition (EMT). Its misregulation has been observed in various types of tumors. Using the MCF-10A-series of cell lines that recapitulate the early stages of breast cancer formation...

  4. Unraveling the microenvironmental influences on the normal mammary gland and induction and progression of breast cancer

    Energy Technology Data Exchange (ETDEWEB)

    Weigelt, Britta; Bissell, Mina J.

    2008-06-26

    The normal mammary gland and invasive breast cancer are both complex 'organs' composed of multiple cell types as well as extracellular matrix (ECM) in three-dimensional (3D) space. Conventionally, both normal and malignant breast cells are studied in vitro as two-dimensional (2D) monolayers of epithelial cells, which results in the loss of structure and tissue function. Many laboratories are now investigating regulation of signaling function in normal mammary gland using 3D cultures. However, it is important also to assay malignant breast cells ex vivo in a physiologically relevant environment to more closely mimic tumor architecture, signal transduction regulation and tumor behavior in vivo. Here we present the potential of these 3D models for drug testing, target validation and guidance of patient selection for clinical trials. We argue also that in order to get full insight into the biology of the normal and malignant breast, and to create in vivo-like models for therapeutic approaches in humans, we need to continue to create more complex heterotypic models to approach the full context the cells encounter in the human body.

  5. Measurements of scattering processes in negative ion-atom collisions. Technical progress report, 1 September 1992--31 August 1993

    Energy Technology Data Exchange (ETDEWEB)

    Kvale, T.J.

    1993-05-01

    This Technical Progress Report describes the progress made on the research objectives during the past twelve months. This research project is designed to provide measurements of various scattering processes which occur in H{sup {minus}} collisions with atomic (specifically, noble gas and atomic hydrogen) targets at intermediate energies. These processes include elastic scattering, single- and double-electron detachment, and target excitation/ionization. For the elastic and target inelastic processes where H{sup {minus}} is scattered intact, the experimental technique of Ion Energy-Loss Spectroscopy (IELS) will be employed to identify the final target state(s). In most of the above processes, cross sections are unknown both experimentally and theoretically. The measurements in progress will provide either experimentally determined cross sections or set upper limits to those cross sections. In either case, these measurements will be stringent tests of our understanding in energetic negative ion - atom collisions. In addition secondary negative particle emission yields for H{sup 0} on Cu in the 3 to 50 keV range are shown.

  6. Measurements of scattering processes in negative ion-atom collisions. Technical progress report, 1 September 1991--31 August 1992

    Energy Technology Data Exchange (ETDEWEB)

    Kvale, T.J.

    1992-04-01

    This Technical Progress Report describes the progress made on the research objectives during the past twelve months. This research project is designed to provide measurements of various scattering processes which occur in H{sup {minus}} collisions with atomic (specifically, noble gas and atomic hydrogen) targets at intermediate energies. These processes include: elastic scattering,single- and double-electron detachment, and target excitation/ionization. For the elastic and target inelastic processes where H{sup {minus}} is scattered intact, the experimental technique of Ion Energy-Loss Spectroscopy (IELS) will be employed to identify the final target state(s). In most of the above processes, cross sections are unknown both experimentally and theoretically. The measurements in progress will provide either experimentally-determined cross sections or set upper limits to those cross sections. In either case, these measurements will be stringent tests of our understanding in energetic negative ion-atom collisions. This series of experiments required the construction of a new facility and the initial ion beam was accelerated through the apparatus in April 1991.

  7. "Optimal design and routing of power lines; ecological, technical and economic perspectives” (OPTIPOL). Progress Report 2009

    OpenAIRE

    Bevanger, Kjetil Modolv; Bartzke, Gundula; Brøseth, Henrik; Gjershaug, Jan Ove; Hanssen, Frank Ole; Jacobsen, Karl Otto; Kvaløy, Pål; May, Roelof Frans; Nygård, Torgeir; Pedersen, Hans-Christian; Reitan, Ole; Refsnæs, Steinar; Stokke, Sigbjørn; Vang, Roald

    2009-01-01

    From 2009 inclusive, NINA has received economic support for research on power lines and wildlife from the Norwegian Research Council (NFR) through the RENERGI Programme. The project is named “Optimal design and routing of power lines; ecological, technical and eco-nomic perspectives” (OPTIPOL). It is scheduled for 5 years (2009-1013) and is part of the ac-tivities within CEDREN, i.e. the Centre for environmental design of renewable energy (cf. http://www.cedren.no). With a grid close to 200 0...

  8. New infrared photon absorption processes. Final technical progress report, August 1, 1988--February 1, 1993

    Energy Technology Data Exchange (ETDEWEB)

    Bayfield, J.E.

    1993-05-01

    The fast ionization of atoms by very short laser pulses, and its possible suppression at extreme pulse intensities, is an active new field of investigation at present. Described is an investigation of whether past techniques for infrared laser multiphoton ionization of excited hydrogen atoms and of one-dimensional microwave ionization of highly excited hydrogen atoms can be combined and extended to address the new issues. Although technically difficult and requiring further improvement of apparatus, intense-field infrared laser experiments on excited hydrogen atoms are possible and can directly test theoretical and numerical results.

  9. Association Euratom - DTU, Technical University of Denmark, Department of Physics - Annual Progress Report 2011

    DEFF Research Database (Denmark)

    The programme of the Research Unit of the Fusion Association Euratom – DTU, Technical University of Denmark (until 31-12- 2011: Association Euratom – Risø DTU) covers work in fusion plasma physics and in fusion technology. The fusion plasma physics research focuses on turbulence and transport......, and its interaction with the plasma equilibrium and particles. The effort includes both first principles based modelling, and experimental observations of turbulence and of fast ion dynamics by collective Thomson scattering. Within fusion technology there are activities related to development of high...

  10. [Tampa Electric Company IGCC project]. Final public design report; Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-07-01

    This final Public Design Report (PDR) provides completed design information about Tampa Electric Company`s Polk Power Station Unit No. 1, which will demonstrate in a commercial 250 MW unit the operating parameters and benefits of the integration of oxygen-blown, entrained-flow coal gasification with advanced combined cycle technology. Pending development of technically and commercially viable sorbent for the Hot Gas Cleanup System, the HGCU also is demonstrated. The report is organized under the following sections: design basis description; plant descriptions; plant systems; project costs and schedule; heat and material balances; general arrangement drawings; equipment list; and miscellaneous drawings.

  11. Molecular biological enhancement of coal biodesulfurization. Fourth quarterly technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Litchfield, J.H.; Fry, I.; Wyza, R.E.; Palmer, D.T.; Zupancic, T.J.; Conkle, H.N.

    1990-06-14

    The objective of this project is to produce one or more microorganisms capable of removing the organic and inorganic sulfur in coal. The original specific technical objectives of the project were to: clone and characterize the genes encoding the enzymes of the ``4S`` pathway (sulfoxide/sulfone/sulfonate/sulfate) for release of organic sulfur from coal; return multiple copies of genes to the original host to enhance the biodesulfurization activity of that organism; transfer this pathway into a fast-growing chemolithotropic bacterium; conduct a batch-mode optimization/analysis of scale-up variables.

  12. Molecular biological enhancement of coal biodesulfurization. Ninth quarterly technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Litchfield, J.H.; Zupancic, T.J.; Baker, B.; Palmer, D.T.; Fry, I.J.; Tranuero, C.G.; Wyza, R.E.; Schweitzer, A.; Conkle, H.N. [Battelle, Columbus, OH (United States); Chakravanty, L.; Tuovinen, O.H. [Ohio State Univ., Columbus, OH (United States)

    1991-09-13

    The objective of this project is to produce one or more microorganisms capable of removing the organic and inorganic sulfur in coal. The original specific technical objectives of the project were to: clone and characterize the genes encoding the enzymes of the ``4S`` pathway (sulfoxide/sulfone/sulfonate/sulfate) for release of organic sulfur from coal; return multiple copies of genes to the original host to enhance the biodesulfurization activity of that organism; transfer this pathway into a fast-growing chemolithotropic bacterium; conduct a batch-mode optimization/analysis of scale-up variables.

  13. Retrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patients

    Directory of Open Access Journals (Sweden)

    Yu Elaine

    2011-06-01

    Full Text Available Abstract Background This retrospective study evaluated the impact of disease progression and of specific sites of metastasis on patient reported outcomes (PROs that assess symptom burden and health related quality of life (HRQoL in women with metastatic breast cancer (mBC. Methods HER-2 negative mBC patients (n = 102 were enrolled from 7 U.S. community oncology practices. Demographic, disease and treatment characteristics were abstracted from electronic medical records and linked to archived Patient Care Monitor (PCM assessments. The PCM is a self-report measure of symptom burden and HRQoL administered as part of routine care in participating practices. Linear mixed models were used to examine change in PCM scores over time. Results Mean age was 57 years, with 72% of patients Caucasian, and 25% African American. Median time from mBC diagnosis to first disease progression was 8.8 months. Metastasis to bone (60%, lung (28% and liver (26% predominated at initial metastatic diagnosis. Results showed that PCM items assessing fatigue, physical pain and trouble sleeping were sensitive to either general effects of disease progression or to effects associated with specific sites of metastasis. Progression of disease was also associated with modest but significant worsening of General Physical Symptoms, Treatment Side Effects, Acute Distress and Impaired Performance index scores. In addition, there were marked detrimental effects of liver metastasis on Treatment Side Effects, and of brain metastasis on Acute Distress. Conclusions Disease progression has a detrimental impact on cancer-related symptoms. Delaying disease progression may have a positive impact on patients' HRQoL.

  14. Effects of ARHI on cell cycle progression and apoptosis levels of breast cancer cells.

    Science.gov (United States)

    Li, Ying; Shi, Li; Han, Chun; Wang, Yishang; Yang, Junlan; Cao, Cheng; Jiao, Shunchang

    2012-10-01

    The purposes of this study were to investigate the role of Aplysia Ras Homolog I (ARHI) on cell growth, proliferation, apoptosis, and other biological characteristics of HER2-positive breast cancer cells. Our goal was to provide experimental evidence for the development of future effective treatments of HER2-positive breast cancer. A pcDNA3.1-ARHI eukaryotic expression vector was constructed and transfected into the human HER2-positive breast cancer cell lines SK-BR-3 and JIMT-1. Then, various experimental methods were utilized to analyze the biological characteristics of ARHI-expressing breast cancer cells and to examine the impact of expression of the ARHI gene on cyclin D1, p27(Kip1), and calpain1 expression. We further analyzed the cells in each group after treatment with trastuzumab to examine the effects of this drug on various cellular characteristics. When we compared pcDNA3.1-ARHI-expressing SK-BR-3 and JIMT-1 cells to their respective empty vector and control groups, we found that cell viability was significantly lower (p SK-BR-3 cells, trastuzumab treatment significantly decreased cell growth (p SK-BR-3 cells and JIMT-1 cells, while it promoted p27(Kip1) and calpain1 expression in these cells. ARHI expression inhibits the growth and proliferation of HER2-positive breast cancer cells, while it also promotes apoptosis in these cells. ARHI expression also improves the sensitivity of JIMT-1 cells to trastuzumab by inducing apoptosis.

  15. Notch3 overexpression causes arrest of cell cycle progression by inducing Cdh1 expression in human breast cancer cells.

    Science.gov (United States)

    Chen, Chun-Fa; Dou, Xiao-Wei; Liang, Yuan-Ke; Lin, Hao-Yu; Bai, Jing-Wen; Zhang, Xi-Xun; Wei, Xiao-Long; Li, Yao-Chen; Zhang, Guo-Jun

    2016-01-01

    Uncontrolled cell proliferation, genomic instability and cancer are closely related to the abnormal activation of the cell cycle. Therefore, blocking the cell cycle of cancer cells has become one of the key goals for treating malignancies. Unfortunately, the factors affecting cell cycle progression remain largely unknown. In this study, we have explored the effects of Notch3 on the cell cycle in breast cancer cell lines by 3 methods: overexpressing the intra-cellular domain of Notch3 (N3ICD), knocking-down Notch3 by RNA interference, and using X-ray radiation exposure. The results revealed that overexpression of Notch3 arrested the cell cycle at the G0/G1 phase, and inhibited the proliferation and colony-formation rate in the breast cancer cell line, MDA-MB-231. Furthermore, overexpressing N3ICD upregulated Cdh1 expression and resulted in p27(Kip) accumulation by accelerating Skp2 degradation. Conversely, silencing of Notch3 in the breast cancer cell line, MCF-7, caused a decrease in expression levels of Cdh1 and p27(Kip) at both the protein and mRNA levels, while the expression of Skp2 only increased at the protein level. Correspondingly, there was an increase in the percentage of cells in the G0/G1 phase and an elevated proliferative ability and colony-formation rate, which may be caused by alterations of the Cdh1/Skp2/p27 axis. These results were also supported by exposing MDA-MB-231 cells or MCF-7 treated with siN3 to X-irradiation at various doses. Overall, our data showed that overexpression of N3ICD upregulated the expression of Cdh1 and caused p27(Kip) accumulation by accelerating Skp2 degradation, which in turn led to cell cycle arrest at the G0/G1 phase, in the context of proliferating breast cancer cell lines. These findings help to illuminate the precision therapy targeted to cell cycle progression, required for cancer treatment.

  16. Technical Note: Skin thickness measurements using high-resolution flat-panel cone-beam dedicated breast CT

    Energy Technology Data Exchange (ETDEWEB)

    Shi Linxi; Vedantham, Srinivasan; Karellas, Andrew [Department of Radiology, University of Massachusetts Medical School, Worcester, Massachusetts 01655 (United States); O' Connell, Avice M. [Department of Radiology, University of Rochester Medical Center, Rochester, New York 14642 (United States)

    2013-03-15

    Purpose: To determine the mean and range of location-averaged breast skin thickness using high-resolution dedicated breast CT for use in Monte Carlo-based estimation of normalized glandular dose coefficients. Methods: This study retrospectively analyzed image data from a clinical study investigating dedicated breast CT. An algorithm similar to that described by Huang et al.['The effect of skin thickness determined using breast CT on mammographic dosimetry,' Med. Phys. 35(4), 1199-1206 (2008)] was used to determine the skin thickness in 137 dedicated breast CT volumes from 136 women. The location-averaged mean breast skin thickness for each breast was estimated and the study population mean and range were determined. Pathology results were available for 132 women, and were used to investigate if the distribution of location-averaged mean breast skin thickness varied with pathology. The effect of surface fitting to account for breast curvature was also studied. Results: The study mean ({+-} interbreast SD) for breast skin thickness was 1.44 {+-} 0.25 mm (range: 0.87-2.34 mm), which was in excellent agreement with Huang et al. Based on pathology, pair-wise statistical analysis (Mann-Whitney test) indicated that at the 0.05 significance level, there were no significant difference in the location-averaged mean breast skin thickness distributions between the groups: benign vs malignant (p= 0.223), benign vs hyperplasia (p= 0.651), hyperplasia vs malignant (p= 0.229), and malignant vs nonmalignant (p= 0.172). Conclusions: Considering this study used a different clinical prototype system, and the study participants were from a different geographical location, the observed agreement between the two studies suggests that the choice of 1.45 mm thick skin layer comprising the epidermis and the dermis for breast dosimetry is appropriate. While some benign and malignant conditions could cause skin thickening, in this study cohort the location-averaged mean breast skin

  17. Field-simulation analysis for disposal of liquefaction solid waste. Third quarterly technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    1982-08-27

    The tasks to be performed in this study are: (1) review applicable RCRA documents; (2) select waste and site-related parameters of interest; (3) compare and recommend leachate test methods; (4) review predictive simulation models and select one or more for further development; (5) identify required field verification data; and (6) develop a field monitoring program to obtain these data. This report represents the third quarterly progress report and contains the text prepared to date under Task 4.

  18. U.C. Davis high energy particle physics research: Technical progress report -- 1990

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1990-12-31

    Summaries of progress made for this period is given for each of the following areas: (1) Task A--Experiment, H1 detector at DESY; (2) Task C--Experiment, AMY detector at KEK; (3) Task D--Experiment, fixed target detectors at Fermilab; (4) Task F--Experiment, PEP detector at SLAC and pixel detector; (5) Task B--Theory, particle physics; and (6) Task E--Theory, particle physics.

  19. Index to Nuclear Safety. A technical progress review by chronology, permuted title, and author. Vol. 11, No. 1--Vol. 17, No. 6

    Energy Technology Data Exchange (ETDEWEB)

    Cottrell, W.B.; Klein, A.

    1977-02-23

    This index to Nuclear Safety covers articles in Nuclear Safety Vol. 11, No. 1 (Jan.-Feb. 1970), through Vol. 17, No. 6 (Nov.-Dec. 1976). The index includes a chronological list of articles (including abstract) followed by KWIC and Author Indexes. Nuclear Safety, a bimonthly technical progress review prepared by the Nuclear Safety Information Center, covers all safety aspects of nuclear power reactors and associated facilities. The index lists over 350 technical articles in the last six years of publication.

  20. Advanced coal conversion process demonstration. Technical progress report for the period July 1, 1995--September 30, 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1997-05-01

    This report describes the technical progress made on the Advanced Coal Conversion Process (ACCP) Demonstration Project from July 1, 1995 through September 30, 1995. The ACCP Demonstration Project is a US Department of Energy (DOE) Clean Coal Technology Project. This project demonstrates an advanced, thermal, coal upgrading process, coupled with physical cleaning techniques, that is designed to upgrade high-moisture, low-rank coals to a high-quality, low-sulfur fuel, registered as the SynCoal process. The coal is processed through three stages (two heating stages followed by an inert cooling stage) of vibrating fluidized bed reactors that remove chemically bound water, carboxyl groups, and volatile sulfur compounds. After thermal upgrading, the cola is put through a deep-bed stratifier cleaning process to separate the pyrite-rich ash from the coal.

  1. Engineering support services for the DOE/GRI coal gasification research program. Quarterly technical progress report, January-March 1982

    Energy Technology Data Exchange (ETDEWEB)

    Bostwick, L.E.; Ethridge, T.R.; Starr, D.W.; Koneru, P.B.; Hubbard, D.A.; Shah, K.V.; Smith, M.R.; Ward, W.E.; Wong, E.W.

    1982-05-01

    Kellogg continued to actively monitor operations at BI-GAS, Westinghouse and IGT (for peat gasification). Pilot plant/PDU test runs which were monitored and reported included BI-GAS Tests G-18, G-18A and G-18B; Westinghouse PDU Test TP-032-1 and CFSF Test TP-M003; and Peatgas Pilot Plant Test No. 5. Kellogg also monitored winterization/maintenance activities at BI-GAS and Westinghouse and precommissioning of the IGT Wet Carbonization PDU. The final report on the Hygas Data Base Evaluation was issued, while final revisions were completed for the reports concerning PDU data base evaluations of Peatgas and single-stage peat gasification. Efforts toward completion of the brochure describing the DOE/GRI Joint Program proceeded. Normal MPC activities continued. Several technical progress reports were issued during this quarter.

  2. The Progression of Podcasting/Vodcasting in a Technical Physics Class

    Science.gov (United States)

    Glanville, Y. J.

    2010-11-01

    Technology such as Microsoft PowerPoint presentations, clickers, podcasting, and learning management suites is becoming prevalent in classrooms. Instructors are using these media in both large lecture hall settings and small classrooms with just a handful of students. Traditionally, each of these media is instructor driven. For instance, podcasting (audio recordings) provided my technical physics course with supplemental notes to accompany a traditional algebra-based physics lecture. Podcasting is an ideal tool for this mode of instruction, but podcasting/vodcasting is also an ideal technique for student projects and student-driven learning. I present here the various podcasting/vodcasting projects my students and I have undertaken over the last few years.

  3. West Hackberry Tertiary Project. Quarterly technical progress report, September 3, 1993--December 3, 1993

    Energy Technology Data Exchange (ETDEWEB)

    Fassihi, M.R.; Gillham, T.H.

    1993-11-30

    The goal of the West Hackberry Tertiary Project is to demonstrate the technical and economic feasibility combining air injection with the Double Displacement Process for tertiary oil recovery. The Double Displacement Process is the gas displacement of a water invaded oil column for the purpose of recovering oil through gravity drainage. The novel aspect of this project is the use of air as the injection fluid. The target reservoirs for the project are the Camerina C- 1,2,3 Sands located on the west flank of West Hackberry Field in Cameron Parish, Louisiana. If successful, this project win demonstrate that the use of air injection in the Double Displacement Process can economically recover oil in reservoirs where tertiary oil recovery is presently uneconomical.

  4. West Hackberry Tertiary Project. Quarterly technical progress report, March 3, 1993--June 3, 1994

    Energy Technology Data Exchange (ETDEWEB)

    Gillham, T.H.

    1994-09-01

    The goal of the West Hackberry Tertiary Project is to demonstrate the technical and economic feasibility of combining air injection with the Double Displacement Process for tertiary oil recovery. The Double Displacement Process is the gas displacement of a water invaded oil column for the purpose of recovering oil through gravity drainage. The novel aspect of this project is the use of air as the injection fluid. The target reservoir for the project is the Camerina C-1,2,3 Sand located on the West Flank of West Hackberry Field in Cameron Parish, Louisiana. This reservoir has been unitized and is designated as the WH Cam C RI SU. If successful, this project will demonstrate that the use of air injection in the Double Displacement Process can economically recover oil in reservoirs where tertiary oil recovery is presently uneconomic.

  5. Association Euratom - Risoe National Laboratory, Technical Univ. of Denmark. Annual progress report 2007

    Energy Technology Data Exchange (ETDEWEB)

    Michelsen, P.K.; Korsholm, S.B.; Rasmussen, J.J. (eds.)

    2008-04-15

    The programme of the Research Unit of the Fusion Association Euratom - Risoe National Laboratory, Technical University of Denmark, covers work in fusion plasma physics and in fusion technology. The fusion plasma physics research focuses on turbulence and transport, and its interaction with the plasma equilibrium and particles. The effort includes both first principles based modelling, and experimental observations of turbulence and of fast ion dynamics by collective Thomson scattering. The activities in technology on investigations of radiation damage of fusion reactor materials have been phased out during 2007. Minor activities are system analysis, initiative to involve Danish industry in ITER contracts and public information. A summary is presented of the results obtained in the Research Unit during 2007. (Author)

  6. Redwood Community Action Agency: Technical progress report, 4th quarter, 1986

    Energy Technology Data Exchange (ETDEWEB)

    1986-01-01

    Redwood Community Action Agency (RCAA) has been developing a business plan for a shared-savings energy business under this grant since January, 1986. At this time RCAA is nearing completion of the research activities, although a 90 day no-cost extension has been requested and received to complete activities on this grant. All consultant reports on the technical feasibility analysis and market research activities have been completed at this time. Fifteen thousand dollars of equity capital has been allocated for the business venture being investigated under this grant through an equity grant from the California Department of Economic Opportunity. This money, combined with agency unrestricted funds, will provide the initial seed capital for the venture.

  7. Association Euratom - Risoe National Laboratory for Sustainable Energy, Technical University of Denmark. Annual progress report 2010

    Energy Technology Data Exchange (ETDEWEB)

    Korsholm, S.B.; Michelsen, P.K.; Rasmussen, J.J.; Westergaard, C.M. (eds.)

    2011-04-15

    The programme of the Research Unit of the Fusion Association Euratom - Risoe National Laboratory for Sustainable Energy, Technical University of Denmark, covers work in fusion plasma physics and in fusion technology. The fusion plasma physics research focuses on turbulence and transport, and its interaction with the plasma equilibrium and particles. The effort includes both first principles based modelling, and experimental observations of turbulence and of fast ion dynamics by collective Thomson scattering. Within fusion technology there are activities related to development of high temperature superconductors. Other activities are system analysis, initiative to involve Danish industry in ITER contracts and public information. A summary is presented of the results obtained in the Research Unit during 2010. (Author)

  8. Association Euratom - Risoe National Laboratory for Sustainable Energy, Technical University of Denmark. Annual progress report 2009

    Energy Technology Data Exchange (ETDEWEB)

    Korsholm, S.B.; Michelsen, P.K.; Rasmussen, J.J.; Westergaard, C.M. (eds.)

    2010-04-15

    The programme of the Research Unit of the Fusion Association Euratom - Risoe National Laboratory for Sustainable Energy, Technical University of Denmark, covers work in fusion plasma physics and in fusion technology. The fusion plasma physics research focuses on turbulence and transport, and its interaction with the plasma equilibrium and particles. The effort includes both first principles based modelling, and experimental observations of turbulence and of fast ion dynamics by collective Thomson scattering. Within fusion technology there are activities related to development of high temperature superconductors. Minor activities are system analysis, initiative to involve Danish industry in ITER contracts and public information. A summary is presented of the results obtained in the Research Unit during 2009. (Author)

  9. Association Euratom - Risoe National Laboratory for Sustainable Energy, Technical University of Denmark. Annual progress report 2008

    Energy Technology Data Exchange (ETDEWEB)

    Korsholm, S.B.; Michelsen, P.K.; Rasmussen, J.J.; Westergaard, C.M. (eds.)

    2009-04-15

    The programme of the Research Unit of the Fusion Association Euratom - Risoe National Laboratory for Sustainable Energy, Technical University of Denmark, covers work in fusion plasma physics and in fusion technology. The fusion plasma physics research focuses on turbulence and transport, and its interaction with the plasma equilibrium and particles. The effort includes both first principles based modelling, and experimental observations of turbulence and of fast ion dynamics by collective Thomson scattering. New activities in technology related to development of high temperature superconductors have been initiated in 2008. Minor activities are system analysis, initiative to involve Danish industry in ITER contracts and public information. A summary is presented of the results obtained in the Research Unit during 2008. (Author)

  10. Estrogen Receptor (ER)α-regulated Lipocalin 2 Expression in Adipose Tissue Links Obesity with Breast Cancer Progression*

    Science.gov (United States)

    Drew, Brian G.; Hamidi, Habib; Zhou, Zhenqi; Villanueva, Claudio J.; Krum, Susan A.; Calkin, Anna C.; Parks, Brian W.; Ribas, Vicent; Kalajian, Nareg Y.; Phun, Jennifer; Daraei, Pedram; Christofk, Heather R.; Hewitt, Sylvia C.; Korach, Kenneth S.; Tontonoz, Peter; Lusis, Aldons J.; Slamon, Dennis J.; Hurvitz, Sara A.; Hevener, Andrea L.

    2015-01-01

    Obesity is associated with increased breast cancer (BrCA) incidence. Considering that inactivation of estrogen receptor (ER)α promotes obesity and metabolic dysfunction in women and female mice, understanding the mechanisms and tissue-specific sites of ERα action to combat metabolic-related disease, including BrCA, is of clinical importance. To study the role of ERα in adipose tissue we generated fat-specific ERα knock-out (FERKO) mice. Herein we show that ERα deletion increased adipocyte size, fat pad weight, and tissue expression and circulating levels of the secreted glycoprotein, lipocalin 2 (Lcn2), an adipokine previously associated with BrCA development. Chromatin immunoprecipitation and luciferase reporter studies showed that ERα binds the Lcn2 promoter to repress its expression. Because adipocytes constitute an important cell type of the breast microenvironment, we examined the impact of adipocyte ERα deletion on cancer cell behavior. Conditioned medium from ERα-null adipocytes and medium containing pure Lcn2 increased proliferation and migration of a subset of BrCA cells in culture. The proliferative and promigratory effects of ERα-deficient adipocyte-conditioned medium on BrCA cells was reversed by Lcn2 deletion. BrCA cell responsiveness to exogenous Lcn2 was heightened in cell types where endogenous Lcn2 expression was minimal, but components of the Lcn2 signaling pathway were enriched, i.e. SLC22A17 and 3-hydroxybutyrate dehydrogenase (BDH2). In breast tumor biopsies from women diagnosed with BrCA we found that BDH2 expression was positively associated with adiposity and circulating Lcn2 levels. Collectively these data suggest that reduction of ERα expression in adipose tissue promotes adiposity and is linked with the progression and severity of BrCA via increased adipocyte-specific Lcn2 production and enhanced tumor cell Lcn2 sensitivity. PMID:25468909

  11. Technical Progress Report on Application and Development of Appropriate Tools and Technologies for Cost-Effective Carbon Sequestration

    Energy Technology Data Exchange (ETDEWEB)

    Bill Stanley; Patrick Gonzalez; Sandra Brown; Jenny Henman; Ben Poulter; Sarah Woodhouse Murdock; Neil Sampson; Tim Pearson; Sarah Walker; Zoe Kant; Miguel Calmon; Gilberto Tiepolo

    2006-06-30

    The Nature Conservancy is participating in a Cooperative Agreement with the Department of Energy (DOE) National Energy Technology Laboratory (NETL) to explore the compatibility of carbon sequestration in terrestrial ecosystems and the conservation of biodiversity. The title of the research project is ''Application and Development of Appropriate Tools and Technologies for Cost-Effective Carbon Sequestration''. The objectives of the project are to: (1) improve carbon offset estimates produced in both the planning and implementation phases of projects; (2) build valid and standardized approaches to estimate project carbon benefits at a reasonable cost; and (3) lay the groundwork for implementing cost-effective projects, providing new testing ground for biodiversity protection and restoration projects that store additional atmospheric carbon. This Technical Progress Report discusses preliminary results of the six specific tasks that The Nature Conservancy is undertaking to answer research needs while facilitating the development of real projects with measurable greenhouse gas reductions. The research described in this report occurred between April 1st and July 30th 2006. The specific tasks discussed include: Task 1: carbon inventory advancements; Task 2: emerging technologies for remote sensing of terrestrial carbon; Task 3: baseline method development; Task 4: third-party technical advisory panel meetings; Task 5: new project feasibility studies; and Task 6: development of new project software screening tool. Work is being carried out in Brazil, Belize, Chile, Peru and the USA.

  12. Automated Discovery of Long Intergenic RNAs Associated with Breast Cancer Progression

    Science.gov (United States)

    2012-02-01

    Baren MJ, Salzberg SL, Wold BJ, Pachter L. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching...cancers. Nature, 471, 377–381. Tomlins,S.A. et al. (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science ...17 | NUMBER 12 | DECEMBER 2011 NATURE MEDICINE Breast cancer is a heterogeneous disease that has a wide range of molecular aberrations and clinical

  13. ATM suppresses SATB1-induced malignant progression in breast epithelial cells.

    Directory of Open Access Journals (Sweden)

    Ellen Ordinario

    Full Text Available SATB1 drives metastasis when expressed in breast tumor cells by radically reprogramming gene expression. Here, we show that SATB1 also has an oncogenic activity to transform certain non-malignant breast epithelial cell lines. We studied the non-malignant MCF10A cell line, which is used widely in the literature. We obtained aliquots from two different sources (here we refer to them as MCF10A-1 and MCF10A-2, but found them to be surprisingly dissimilar in their responses to oncogenic activity of SATB1. Ectopic expression of SATB1 in MCF10A-1 induced tumor-like morphology in three-dimensional cultures, led to tumor formation in immunocompromised mice, and when injected into tail veins, led to lung metastasis. The number of metastases correlated positively with the level of SATB1 expression. In contrast, SATB1 expression in MCF10A-2 did not lead to any of these outcomes. Yet DNA copy-number analysis revealed that MCF10A-1 is indistinguishable genetically from MCF10A-2. However, gene expression profiling analysis revealed that these cell lines have significantly divergent signatures for the expression of genes involved in oncogenesis, including cell cycle regulation and signal transduction. Above all, the early DNA damage-response kinase, ATM, was greatly reduced in MCF10A-1 cells compared to MCF10A-2 cells. We found the reason for reduction to be phenotypic drift due to long-term cultivation of MCF10A. ATM knockdown in MCF10A-2 and two other non-malignant breast epithelial cell lines, 184A1 and 184B4, enabled SATB1 to induce malignant phenotypes similar to that observed for MCF10A-1. These data indicate a novel role for ATM as a suppressor of SATB1-induced malignancy in breast epithelial cells, but also raise a cautionary note that phenotypic drift could lead to dramatically different functional outcomes.

  14. The Role of Adipose-Derived Stem Cells in Breast Cancer Progression and Metastasis

    OpenAIRE

    2015-01-01

    Conventional breast cancer extirpation involves resection of parts of or the whole gland, resulting in asymmetry and disfiguration. Given the unsatisfactory aesthetic outcomes, patients often desire postmastectomy reconstructive procedures. Autologous fat grafting has been proposed for reconstructive purposes for decades to restore form and anatomy after mastectomy. Fat has the inherent advantage of being autologous tissue and the most natural-appearing filler, but given its inconsistent eng...

  15. The role of adipose-derived stem cells in breast cancer progression and metastasis

    OpenAIRE

    2015-01-01

    Conventional breast cancer extirpation involves resection of parts of or the whole gland, resulting in asymmetry and disfiguration. Given the unsatisfactory aesthetic outcomes, patients often desire postmastectomy reconstructive procedures. Autologous fat grafting has been proposed for reconstructive purposes for decades to restore form and anatomy after mastectomy. Fat has the inherent advantage of being autologous tissue and the most natural-appearing filler, but given its inconsistent engr...

  16. ATM suppresses SATB1-induced malignant progression in breast epithelial cells.

    Science.gov (United States)

    Ordinario, Ellen; Han, Hye-Jung; Furuta, Saori; Heiser, Laura M; Jakkula, Lakshmi R; Rodier, Francis; Spellman, Paul T; Campisi, Judith; Gray, Joe W; Bissell, Mina J; Kohwi, Yoshinori; Kohwi-Shigematsu, Terumi

    2012-01-01

    SATB1 drives metastasis when expressed in breast tumor cells by radically reprogramming gene expression. Here, we show that SATB1 also has an oncogenic activity to transform certain non-malignant breast epithelial cell lines. We studied the non-malignant MCF10A cell line, which is used widely in the literature. We obtained aliquots from two different sources (here we refer to them as MCF10A-1 and MCF10A-2), but found them to be surprisingly dissimilar in their responses to oncogenic activity of SATB1. Ectopic expression of SATB1 in MCF10A-1 induced tumor-like morphology in three-dimensional cultures, led to tumor formation in immunocompromised mice, and when injected into tail veins, led to lung metastasis. The number of metastases correlated positively with the level of SATB1 expression. In contrast, SATB1 expression in MCF10A-2 did not lead to any of these outcomes. Yet DNA copy-number analysis revealed that MCF10A-1 is indistinguishable genetically from MCF10A-2. However, gene expression profiling analysis revealed that these cell lines have significantly divergent signatures for the expression of genes involved in oncogenesis, including cell cycle regulation and signal transduction. Above all, the early DNA damage-response kinase, ATM, was greatly reduced in MCF10A-1 cells compared to MCF10A-2 cells. We found the reason for reduction to be phenotypic drift due to long-term cultivation of MCF10A. ATM knockdown in MCF10A-2 and two other non-malignant breast epithelial cell lines, 184A1 and 184B4, enabled SATB1 to induce malignant phenotypes similar to that observed for MCF10A-1. These data indicate a novel role for ATM as a suppressor of SATB1-induced malignancy in breast epithelial cells, but also raise a cautionary note that phenotypic drift could lead to dramatically different functional outcomes.

  17. X Chromosome Inactivation and Breast Cancer: Epigenetic Alteration in Tumor Initiation and Progression

    Science.gov (United States)

    2007-09-01

    types of mammary tumors, but not others. For instance, X chromosomal abnormalities appear to be associated with basal-like human breast cancer (BLC...andDNA damage-repair pathways to ensure genome integrity (Deng, 2006; Venkitaraman, 2002). In addition, BRCA1 plays a role in meiotic XY inactivation...find- ing that meiotic XY silencing proceeds by a mechanism involving silencing of unsynapsed DNA (Turner et al., 2006), which is distinct from X

  18. GPHS-RTGs in support of the Cassini RTG Program. Semi annual technical progress report, September 26, 1994--April 2, 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-04-20

    The technical progress achieved during the period 26 September 1994 through 2 April 1995 on Contract DE-AC03-91SF18852 Radioisotope Thermoelectric Generators and Ancillary Activities is described herein. Monthly technical activity for the period 27 February 1995 through 2 April 1995 is included in this progress report. The report addresses tasks, including: spacecraft integration and liaison; engineering support; safety; qualified unicouple production; ETG Fabrication, assembly, and test; ground support equipment; RTG shipping and launch support; designs, reviews, and mission applications; project management, quality assurance, reliability, contract changes, CAGO acquisition (operating funds), and CAGO maintenance and repair; and CAGO acquisition (capital funds).

  19. The mitochondrial calcium uniporter regulates breast cancer progression via HIF-1α.

    Science.gov (United States)

    Tosatto, Anna; Sommaggio, Roberta; Kummerow, Carsten; Bentham, Robert B; Blacker, Thomas S; Berecz, Tunde; Duchen, Michael R; Rosato, Antonio; Bogeski, Ivan; Szabadkai, Gyorgy; Rizzuto, Rosario; Mammucari, Cristina

    2016-05-02

    Triple-negative breast cancer (TNBC) represents the most aggressive breast tumor subtype. However, the molecular determinants responsible for the metastatic TNBC phenotype are only partially understood. We here show that expression of the mitochondrial calcium uniporter (MCU), the selective channel responsible for mitochondrial Ca(2+) uptake, correlates with tumor size and lymph node infiltration, suggesting that mitochondrial Ca(2+) uptake might be instrumental for tumor growth and metastatic formation. Accordingly, MCU downregulation hampered cell motility and invasiveness and reduced tumor growth, lymph node infiltration, and lung metastasis in TNBC xenografts. In MCU-silenced cells, production of mitochondrial reactive oxygen species (mROS) is blunted and expression of the hypoxia-inducible factor-1α (HIF-1α) is reduced, suggesting a signaling role for mROS and HIF-1α, downstream of mitochondrial Ca(2+) Finally, in breast cancer mRNA samples, a positive correlation of MCU expression with HIF-1α signaling route is present. Our results indicate that MCU plays a central role in TNBC growth and metastasis formation and suggest that mitochondrial Ca(2+) uptake is a potential novel therapeutic target for clinical intervention.

  20. AZU-1: A Candidate Breast Tumor Suppressor and Biomarker for Tumor Progression

    Energy Technology Data Exchange (ETDEWEB)

    Chen, Huei-Mei; Schmeichel, Karen L; Mian, I. Saira; Lelie`vre, Sophie; Petersen, Ole W; Bissell, Mina J

    2000-02-04

    To identify genes misregulated in the final stages of breast carcinogenesis, we performed differential display to compare the gene expression patterns of the human tumorigenic mammary epithelial cells, HMT-3522-T4-2, with those of their immediate premalignant progenitors, HMT-3522-S2. We identified a novel gene, called anti-zuai-1 (AZU-1), that was abundantly expressed in non- and premalignant cells and tissues but was appreciably reduced in breast tumor cell types and in primary tumors. The AZU-1 gene encodes an acidic 571-amino-acid protein containing at least two structurally distinct domains with potential protein-binding functions: an N-terminal serine and proline-rich domain with a predicted immunoglobulin-like fold and a C-terminal coiled-coil domain. In HMT-3522 cells, the bulk of AZU-1 protein resided in a detergent-extractable cytoplasmic pool and was present at much lower levels in tumorigenic T4-2 cells than in their nonmalignant counterparts. Reversion of the tumorigenic phenotype of T4-2 cells, by means described previously, was accompanied by the up-regulation of AZU-1. In addition, reexpression of AZU-1 in T4-2 cells, using viral vectors, was sufficient to reduce their malignant phenotype substantially, both in culture and in vivo. These results indicate that AZU-1 is a candidate breast tumor suppressor that may exert its effects by promoting correct tissue morphogenesis.

  1. Decontamination Systems Information and Research Program. Quarterly technical progress report, July 1--September 30, 1993

    Energy Technology Data Exchange (ETDEWEB)

    1993-10-01

    Progress reports are presented for the following projects: systematic assessment of the state of hazardous waste clean-up technologies; site remediation technologies--drain-enhanced soil flushing (DESF) for organic contaminants removal; excavation systems for hazardous waste sites; chemical destruction of polychlorinated biphenyls; development of organic sensors--monolayer and multilayer self-assembled films for chemical sensors; Winfield Lock and Dam remediation; Winfield cleanup survey; assessment of technologies for hazardous waste site remediation--non-treatment technologies and pilot scale test facility implementation; assessment of environmental remediation storage technology; assessment of environmental remediation excavation technology; assessment of environmental remediation monitoring technology; and remediation of hazardous sites with steam reforming.

  2. Base program on energy related research. Quarterly technical progress report, February--April 1993

    Energy Technology Data Exchange (ETDEWEB)

    1993-10-01

    Progress reports are briefly described for the following areas of research: oil and gas; advanced systems applications; environmental technologies; and applied energy science. Oil and gas research includes: CROW {sup TM} process modeling; and miscible-immiscible gas injection processes. Advanced systems applications covers: development and optimization of a process for the production of a premium sold fuel from western US coals; development of an on-line alkali monitoring probe; optimization of the recycle oil process for eastern oil shale; and process support and development. Environmental technologies has solid waste management; and remediation of contaminated soils.

  3. Silicon ribbon growth by a capillary action shaping technique. Quarterly technical progress report No. 2

    Energy Technology Data Exchange (ETDEWEB)

    Schwuttke, G.H.; Ciszek, T.F.; Kran, A.

    1975-01-01

    Progress during the second quarter of the contractual effort is described. The work performed related mainly to ribbon growth by a capillary action shaping technique and to ribbon characterization. Actual progress in the crystal growth area includes the evaluation of 10 potential die materials other than carbon and the process development for 25-mm-wide ribon. From the die study it is concluded that boron carbide, silicon carbide, and silicon nitride may warrant further investigation as die materials. Process development for 25-mm ribbon growth resulted in ribbons of superior surface quality. Potential ribbongrowth problems encountered and discussed include a boron doping anomaly and frozen-in stresses in ribbons. The characterization effort concentrated on the development of a solar-cell process to be used for ribbon characterization. Material requirements and detailed process procedures are given. Solar cells fabricated by this process are compared with commercially available solar cells and compare favorably. A transmission electron microscopy study of planar boundaries frequently observed in ribbon crystals is reported. (auth)

  4. Nationwide survey of glandular tissue doses for the establishment of a breast cancer screening system using mammography. Analysis of technical parameters affecting the glandular tissue dose

    Energy Technology Data Exchange (ETDEWEB)

    Higashida, Yoshiharu [Kyushu Univ., Fukuoka (Japan). School of Health Sciences; Hagiwara, Akira; Asahara, Masaki [and others

    2000-09-01

    The effects of technical parameters, such as screen-film combinations, antiscatter grids, processing conditions and X-ray beam qualities, on the average glandular tissue dose of radiation were analyzed under two exposure conditions: The standard radiographic condition for an RMI 156 phantom at each facility (Standard Radiographic Condition). The radiographic condition needed to obtain a radiographic density of 1.20 to 1.40 with an RMI 156 phantom (Canonical Radiographic Condition). The analysis included 208 dose measurements at 104 facilities. The results showed that the average glandular tissue dose depends strongly on the grid types and screen-film combinations used. There were also significant differences in radiographic density between the Standard Radiographic Condition and the Canonical Radiographic Condition. This analysis of the technical parameters affecting the glandular tissue dose will be useful in establishing a standardized mammographic breast cancer screening system. (author)

  5. The rs4646 and rs12592697 Polymorphisms in CYP19A1 Are Associated with Disease Progression among Patients with Breast Cancer from Different Racial/Ethnic Backgrounds

    Science.gov (United States)

    Armamento-Villareal, Reina; Shah, Vallabh O.; Aguirre, Lina E.; Meisner, Angela L. W.; Qualls, Clifford; Royce, Melanie E.

    2016-01-01

    Given the racial/ethnic disparities in breast cancer, we evaluated the association between CYP19A1 single nucleotide polymorphisms (SNPs) on disease progression in women with breast cancer from different racial/ethnic backgrounds. This is a cross-sectional analysis of data from 327 women with breast cancer in the Expanded Breast Cancer Registry program of the University of New Mexico. Stored DNA samples were analyzed for CYP19A1 SNPs using a custom designed microarray panel. Genotype-phenotype correlations were analyzed. Of the 384 SNPs, 2 were associated with clinically significant outcomes, the rs4646 and rs12592697. The T allele for the rs4646 was associated with advanced stage of the disease at the time of presentation (odds ratio [OR]:1.8, confidence intervals [CI]: 1.05–3.13, p < 0.05) and a more progressive disease (OR: 2.1 [CI: 1.1–4.0], p = 0.04). For the rs12592697, the variant T allele was more frequent in Hispanic women and associated with a more progressive disease (OR: 2.05 [CI: 1.0–4.0], p = 0.04). However, further analysis according to menopausal status showed that the association between these 2 SNPs with disease progression or the stage at diagnosis are confined only to postmenopausal women. The odds ratios of disease progression among postmenopausal women carrying the T allele for the rs4646 and rs12592697 are 3.05 (1.21, 7.74, p = 0.02) and 3.80 (1.24, 11.6, p = 0.02), respectively. Regardless, differences in disease progression among the different genotypes for both SNPs disappeared after adjustment for treatment. In summary, the rs4646 and the rs12592697 SNPs in CYP19A1 are associated with differences in disease progression in postmenopausal women. However, treatment appears to mitigate the differences in genetic risk. PMID:27994616

  6. Savannah River Ecology Laboratory. Annual technical progress report of ecological research

    Energy Technology Data Exchange (ETDEWEB)

    Smith, M.H.

    1996-07-31

    The Savannah River Ecology Laboratory (SREL) is a research unit of the University of Georgia (UGA). The overall mission of the Laboratory is to acquire and communicate knowledge of ecological processes and principles. SREL conducts basic and applied ecological research, as well as education and outreach programs, under a contract with the U.S. Department of Energy (DOE) at the Savannah River Site (SRS) near Aiken, South Carolina. Significant accomplishments were made during the past year in the areas of research, education and service. The Laboratory`s research mission was fulfilled with the publication of two books and 143 journal articles and book chapters by faculty, technical and students, and visiting scientists. An additional three books and about 80 journal articles currently are in press. Faculty, technician and students presented 193 lectures, scientific presentations, and posters to colleges and universities, including minority institutions. Dr. J Vaun McArthur organized and conducted the Third Annual SREL Symposium on the Environment: New Concepts in Strewn Ecology: An Integrative Approach. Dr. Michael Newman conducted a 5-day course titled Quantitative Methods in Ecotoxicology, and Dr. Brian Teppen of The Advanced Analytical Center for Environmental Sciences (AACES) taught a 3-day short course titled Introduction to Molecular Modeling of Environmental Systems. Dr. I. Lehr Brisbin co-hosted a meeting of the Crocodile Special Interest Group. Dr. Rebecca Sharitz attended four symposia in Japan during May and June 1996 and conducted meetings of the Executive Committee and Board of the International Association for Ecology (ENTECOL).

  7. Research progress in pregnancy-associated breast cancer%妊娠期乳腺癌的研究进展

    Institute of Scientific and Technical Information of China (English)

    杨帆; 罗龙吉; 唐金海

    2016-01-01

    Pregnancy-associated breast cancer(PABC)refers to the breast cancer diagnosed during pregnancy or within one year of childbirth.At present PABC incidence rate showed a clear upward trend,and physiological changes during pregnancy and lactation in-crease the difficulty of clinical and radiological examination and evaluation of the breast tissue,therefore,delayed diagnosis and poor prognosis are likely to occur.Considering the safety of fetus and babies,diagnosis and treatment of PABC should be highly valued.Based on literature review,this paper further promotes the clinicians’understanding of PABC and knowledge of its research progress,enables a clinician to select an appropriate standardized and individualized comprehensive treatment programs according tothe specific conditions of different patients,improve the prognosis of patients,prolong survival,and improve patients’quality of life.%妊娠期乳腺癌(Pregnancy-associated breast cancer,PABC)是指在妊娠期或分娩后1年内确诊的乳腺癌,如今 PABC 发病率呈明显的上升趋势,妊娠和哺乳期的生理学改变增加了临床及影像学对乳腺组织进行检查和评价的难度,因此容易出现诊断的推迟以及随之而产生的不良预后,考虑胎婴儿的安全因素,PABC 的诊疗具有其特殊性。该文通过文献综述,使临床医生对 PABC 有更进一步的了解,掌握最近的研究进展,针对不同患者的具体情况,选择合适的规范化、个体化综合治疗方案,改善患者预后,延长生存期,提高生活质量。

  8. [Geothermal system temperature-depth database and model for data analysis]. 5. quarterly technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Blackwell, D.D.

    1998-04-25

    During this first quarter of the second year of the contract activity has involved several different tasks. The author has continued to work on three tasks most intensively during this quarter: the task of implementing the data base for geothermal system temperature-depth, the maintenance of the WWW site with the heat flow and gradient data base, and finally the development of a modeling capability for analysis of the geothermal system exploration data. The author has completed the task of developing a data base template for geothermal system temperature-depth data that can be used in conjunction with the regional data base that he had already developed and is now implementing it. Progress is described.

  9. Dissolved organic matter and lake metabolism. Technical progress report, 1 July 1976--30 June 1977

    Energy Technology Data Exchange (ETDEWEB)

    Wetzel, R.G.

    1977-01-01

    Progress is reported on investigations on the qualitative and quantitative cycling of particulate and dissolved organic matter within lakes and their drainage basins. Interactions of dissolved organic matter with inorganic nutrient cycling and regulation of the photosynthetic and decompositional metabolism of micro- and macroflora remain the focal point of these studies. Major efforts were directed towards the sources fates, pathways, and interactions of dissolved organic matter in inorganic chemical cycling; allochthonous sources, metabolism en route, and inputs to the lake systems of increasing stages of eutrophication; and the relationships of these compounds to the nutrient physiology and metabolism of phytoplankton, sessile algae, macrophytes, and bacterial populations. Results of studies carried out in a freshwater lake in Michigan (Lawrence Lake) are reported. 165 references.

  10. New imaging systems in nuclear medicine. Technical progress report, October 1, 1976--May 31, 1977

    Energy Technology Data Exchange (ETDEWEB)

    Brownell, G.L.

    1977-01-01

    Work carried out on the development of instrumentation and techniques for positron scintigraphy is discussed. Progress in positron imaging instrumentation and applications is detailed. The assembly and initial evaluation of the new multicrystal positron camera, PC-II, has been completed. Images have been obtained in both two and three-dimensions which demonstrate the basic physical properties of the instrument. Successful measurements using transverse section imaging have been carried out on animals and human volunteers. Physiological investigation using PC-II is proceeding. A flexible and accurate computer program has been developed for transverse section reconstruction of data acquired by PC-II. This program makes it possible to reconstruct both the activity distribution and the distribution of absorption. The program has been developed in such a way that it can handle variations in the data collection procedure. Clinical studies using PC-I and PC-II are being carried on in areas of heart, lung and brain.

  11. Waste Isolation Safety Assessment Program. Technical progress report for FY-1978

    Energy Technology Data Exchange (ETDEWEB)

    Brandstetter, A.; Harwell, M.A.; Howes, B.W.; Benson, G.L.; Bradley, D.J.; Raymond, J.R.; Serne, R.J.; Schilling, A.H.

    1979-07-01

    Associated with commercial nuclear power production in the United States is the generation of potentially hazardous radioactive wastes. The Department of Energy (DOE) is seeking to develop nuclear waste isolation systems in geologic formations that will preclude contact with the biosphere of waste radionuclides in concentrations which are sufficient to cause deleterious impact on humans or their environments. Comprehensive analyses of specific isolation systems are needed to assess the expectations of meeting that objective. The Waste Isolation Safety Assessment Program (WISAP) has been established at the Pacific Northwest Laboratory (operated by Battelle Memorial Institute) for developing the capability of making those analyses. Progress on the following tasks is reported: release scenario analysis, waste form release rate analysis, release consequence analysis, sorption-desorption analysis, and societal acceptance analysis. (DC)

  12. Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines.

    Directory of Open Access Journals (Sweden)

    Mitsutaka Kadota

    Full Text Available To gain insight into the role of genomic alterations in breast cancer progression, we conducted a comprehensive genetic characterization of a series of four cell lines derived from MCF10A. MCF10A is an immortalized mammary epithelial cell line (MEC; MCF10AT is a premalignant cell line generated from MCF10A by transformation with an activated HRAS gene; MCF10CA1h and MCF10CA1a, both derived from MCF10AT xenografts, form well-differentiated and poorly-differentiated malignant tumors in the xenograft models, respectively. We analyzed DNA copy number variation using the Affymetrix 500 K SNP arrays with the goal of identifying gene-specific amplification and deletion events. In addition to a previously noted deletion in the CDKN2A locus, our studies identified MYC amplification in all four cell lines. Additionally, we found intragenic deletions in several genes, including LRP1B in MCF10CA1h and MCF10CA1a, FHIT and CDH13 in MCF10CA1h, and RUNX1 in MCF10CA1a. We confirmed the deletion of RUNX1 in MCF10CA1a by DNA and RNA analyses, as well as the absence of the RUNX1 protein in that cell line. Furthermore, we found that RUNX1 expression was reduced in high-grade primary breast tumors compared to low/mid-grade tumors. Mutational analysis identified an activating PIK3CA mutation, H1047R, in MCF10CA1h and MCF10CA1a, which correlates with an increase of AKT1 phosphorylation at Ser473 and Thr308. Furthermore, we showed increased expression levels for genes located in the genomic regions with copy number gain. Thus, our genetic analyses have uncovered sequential molecular events that delineate breast tumor progression. These events include CDKN2A deletion and MYC amplification in immortalization, HRAS activation in transformation, PIK3CA activation in the formation of malignant tumors, and RUNX1 deletion associated with poorly-differentiated malignant tumors.

  13. Co-expression module analysis reveals biological processes, genomic gain, and regulatory mechanisms associated with breast cancer progression

    Directory of Open Access Journals (Sweden)

    Derow Catherine K

    2010-05-01

    Full Text Available Abstract Background Gene expression signatures are typically identified by correlating gene expression patterns to a disease phenotype of interest. However, individual gene-based signatures usually suffer from low reproducibility and interpretability. Results We have developed a novel algorithm Iterative Clique Enumeration (ICE for identifying relatively independent maximal cliques as co-expression modules and a module-based approach to the analysis of gene expression data. Applying this approach on a public breast cancer dataset identified 19 modules whose expression levels were significantly correlated with tumor grade. The correlations were reproducible for 17 modules in an independent breast cancer dataset, and the reproducibility was considerably higher than that based on individual genes or modules identified by other algorithms. Sixteen out of the 17 modules showed significant enrichment in certain Gene Ontology (GO categories. Specifically, modules related to cell proliferation and immune response were up-regulated in high-grade tumors while those related to cell adhesion was down-regulated. Further analyses showed that transcription factors NYFB, E2F1/E2F3, NRF1, and ELK1 were responsible for the up-regulation of the cell proliferation modules. IRF family and ETS family proteins were responsible for the up-regulation of the immune response modules. Moreover, inhibition of the PPARA signaling pathway may also play an important role in tumor progression. The module without GO enrichment was found to be associated with a potential genomic gain in 8q21-23 in high-grade tumors. The 17-module signature of breast tumor progression clustered patients into subgroups with significantly different relapse-free survival times. Namely, patients with lower cell proliferation and higher cell adhesion levels had significantly lower risk of recurrence, both for all patients (p = 0.004 and for those with grade 2 tumors (p = 0.017. Conclusions The ICE

  14. Innovative Clean Coal Technology (ICCT). Technical progress report, first quarter, 1993, January 1993--March 1993

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-09-01

    The objective of this project is to demonstrate and evaluate commercially available Selective Catalytic Reduction (SCR) catalysts from U.S., Japanese and European catalyst suppliers on a high-sulfur U.S. coal-fired boiler. SCR is a post-combustion nitrogen oxide (NOx) control technology that involves injecting ammonia into the flue gas generated from coal combustion in an electric utility boiler. The flue gas containing ammonia is then passed through a reactor that contains a specialized catalyst. In the presence of the catalyst, the ammonia reacts with NOx to convert it to nitrogen and water vapor. Although SCR is widely practiced in Japan and Europe on gas-, oil-, and low-sulfur coal-fired boilers, there are several technical uncertainties associated with applying SCR to U.S. coals. These uncertainties include: (1) potential catalyst deactivation due to poisoning by trace metal species present in U.S. coals that are not present in other fuels; (2) performance of the technology and effects on the balance-of-plant equipment in the presence of high amounts of SO{sub 2} and SO{sub 3}; and (3) performance of a wide variety of SCR catalyst compositions, geometries and methods of manufacture under typical high-sulfur coal-fired utility operating conditions. These uncertainties will be explored by constructing a series of small-scale SCR reactors and simultaneously exposing different SCR catalysts to flue gas derived from the combustion of high sulfur U.S. coal. The demonstration will be performed at Gulf Power Company`s Plant Crist Unit No. 5 (75 NM capacity) near Pensacola, Florida. The project will be funded by the U.S. Department of Energy (DOE), Southern Company Services, Inc. (SCS on behalf of the entire Southern electric system), the Electric Power Research Institute (EPRI), and Ontario Hydro. SCS is the participant responsible for managing all aspects of this project.

  15. Optimal design and routing of power lines; ecological, technical and economic perspectives (OPTIPOL). Progress report 2009

    Energy Technology Data Exchange (ETDEWEB)

    Bevanger, K.; Bartzke, G.; Broeseth, H.; Gjershaug, J.O.; Hanssen, F.; Jacobsen, K.-O.; Kvaloey, P.; May, R.; Nygaard, T.; Pedersen, H.C.; Reitan, O.; Refsnaes, S.; Stokke, S.; Vang, R.

    2009-12-15

    From 2009 inclusive, NINA has received economic support for research on power lines and wildlife from the Norwegian Research Council (NFR) through the RENERGI Programme. The project is named 'Optimal design and routing of power lines; ecological, technical and economic perspectives' (OPTIPOL). It is scheduled for 5 years (2009-1013) and is part of the activities within CEDREN, i.e. the Centre for environmental design of renewable energy (cf. http://www.cedren.no). With a grid close to 200 000 km overhead power-lines, the associated rights-of-way (ROW) affect huge land areas in Norway. The overall goal is to develop predict-ing tools for optimal routing of power lines from an environmental perspective and assess technical and economic solutions to minimize conflicts with wildlife and habitat conservation. Thus, the OPTIPOL rationale is based on the belief that the negative effects of electricity transmission and distribution can be reduced with respect to birds and mammals. OPTIPOL has several ambitious objectives, and is divided into sub-projects and specific tasks. From the first of November a PhD-student became part of the project, a position that will be held for 4 years. The main objective of the PhD-activities will be to assess how and why different wildlife species use deforested areas below power lines, evaluate possible positive and negative effects of power-line ROWs, and assess the possibilities for quality improvement. Another part of the project is dedicated the effects of linear structures on movement patterns and distribution in the landscape in native deer species. Here we will examine how different spatial scales influence the processes that guide movement patterns, and responses to linear structures. Another focus will be small game species, with mountain hare, capercaillie, black grouse and hazel grouse as model species. The main objective will be to assess the impact of transforming ROW habitats into attractive small-game foraging

  16. Regulation of macrophage inhibitory factor (MIF) by epidermal growth factor receptor (EGFR) in the MCF10AT model of breast cancer progression.

    Science.gov (United States)

    Lim, Simin; Choong, Lee-Yee; Kuan, Chong Poh; Yunhao, Chen; Lim, Yoon-Pin

    2009-08-01

    Genetic aberration of EGFR is one of the major molecular characteristics of breast cancer. However, the molecular changes associated with EGFR signaling during different stages of breast cancer development have not been studied. In this study, complementary two-dimensional-DIGE and iTRAQ technologies were used to profile the expression level of proteins in 4 isogenic cell lines in the MCF10AT model of breast cancer progression following a time course of EGF stimulation. A total of 80 proteins (67 from iTRAQ, 15 from DIGE, 2 common in both) were identified to be up- or down-regulated by EGF treatment. Following EGF stimulation, the expression level of MIF, a cytokine that has been implicated in many human cancers, was decreased in MCF10A1 normal breast mammary epithelial cells, increased in MCF10AT1k preneoplastic and MCF10CA1h low grade breast cancer cells, but showed no obvious difference in the MCF10CA1a high grade cancer cells. The increase in MIF expression level following EGF treatment could also be observed in A431 cervical cancer cells. EGF-induced increases of MIF expression levels in CA1h breast cancer cells were abrogated when MEK, but not PIK3CA, was knocked down. In addition, silencing of MIF diminished the proliferation of EGF-stimulated CA1h cells when compared to control cells. Taken together, our data suggested an EGFR --> MEK --> MIF proliferative pathway that has never been reported previously and that this pathway "evolves" during disease progression as modeled by the MCF10AT system. Revelation of the novel relationship between MIF and EGF may contribute to an integrated understanding of the roles of these oncogenic factors during breast cancer development.

  17. ANX7 as a Bio-Marker in Prostate and Breast Cancer Progression

    Directory of Open Access Journals (Sweden)

    Meera Srivastava

    2001-01-01

    Full Text Available The ANX7 gene codes for a Ca2+-activated GTPase, which has been implicated in both exocytotic secretion in cells and control of growth. In this review, we summarize information regarding increased tumor frequency in the Anx7 knockout mice, ANX7 growth suppression of human cancer cell lines, and ANX7 expression in human tumor tissue micro-arrays. The loss of ANX7 is significant in metastatic and hormone refractory prostate cancer compared to benign prostatic hyperplasia. In addition, ANX7 expression has prognostic value for predicting survival of breast cancer patients.

  18. Supramolecular structures for photochemical energy conversion. Technical progress report, 1993--1996

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-06-01

    This research project is concerned with the design, synthesis and study by photochemical and spectroscopic methods of complex molecular devices that mimic some important aspects of photosynthetic electron and energy transfer. Properly engineered molecules of this type can functionally mimic photosynthetic light harvesting (singlet-singlet energy transfer between chromophores), photoprotection from light-initiated singlet oxygen damage (triplet-triplet energy transfer from chlorophylls to carotenoid polyenes), and, most importantly, photoinduced multistep electron transfer to generate charge-separated states that preserve some of the photon energy as chemical potential. During the last three years, progress has been made on several fronts, all of which are related to the overall goal. A biomimetic system based on carotenoid-porphyrin-quinone triads has been constructed that demonstrates photoinduced transmembrane charge separation which in turn drives transmembrane proton transfer. Another investigation has focused on the use of proton transfer reactions to stabilize the initial products of photoinduced electron transfer and thereby increase the yield of long-lived charge separation. A third study has investigated the influence of rigid molecular geometries and short donor-acceptor separations on photoinduced electron transfer reactions. Finally, generation and quenching of singlet molecular oxygen by chlorophyll aggregates has been studied. All four studies are described and results are discussed.

  19. Capillary electrokinetic separations with optical detection. Technical progress report, February 1, 1993--January 31, 1994

    Energy Technology Data Exchange (ETDEWEB)

    Sepaniak, M.J.

    1993-10-01

    This program seeks the development of capillary electrokinetic separation techniques and associated optical methods of detection. Fundamental studies of pertinent separation and band broadening mechanisms are being conducted, with the emphasis on understanding systems that include highly-ordered assemblies as running buffer additives. The additives include cyclodextrins, affinity reagents, and soluble (entangled) polymers and are employed with capillary electrophoresis, CE and/or micellar electrokinetic capillary chromatography, MECC modes of separation. The utility of molecular modeling techniques for predicting the effects of highly ordered assemblies on the retention behavior of isomeric compounds is under investigation. The feasibility of performing separations using a non-aqueous solvent/fullerene electrochromatographic system is being explored. The analytical methodologies associated with these capillary separation techniques are being advanced through the development of retention programming instumentation/techniques and new strategies for performing optical detection. The advantages of laser fluorimetry are extended through the inclusion of fluorogenic, reagents in the running buffer. These reagents include oligonucleotide intercalation reagents for detecting DNA fragments. Chemiluminescence detection using post-capillary reactors/flow cells is also in progress. Successful development of these separation and detection systems will fill current voids in the capabilities of capillary separation techniques.

  20. Critical contributions in MHD power generation. Quarterly technical progress report, June 1--August 31, 1977

    Energy Technology Data Exchange (ETDEWEB)

    Louis, J.F.

    1977-10-01

    Current research and development in open-cycle coal-fired MHD power generation at Massachusetts Institute of Technology is presented. Progress is reported on the following tasks: (1) Establish chemical, thermal, and electrical data to guide materials selection, develop improved detail designs, and support performance analyses of MHD electrode modules and insulator materials; (2) Parametrically investigate selected electrode properties of critical design importance in chemical, thermal, and electrical environments simulating a coal-fired MHD generator; (3) Develop combustion data pertinent to the design of MHD combustors; this work is intended to determine the combustion characteristics of selected coal feed stock in terms of devolatilization kinetics, char characteristics, and combustion gas chemistry; (4) Establish techniques for the analysis and understanding of critical MHD phenomena which have an important bearing on MHD generator performance; such phenomena include inter-electrode breakdown, time-dependent behavior, effective plasma properties and plasma inhomogeneities; (5) Establish the operating characteristics of an MHD disk generator; (6) Continue work on computer techniques for modeling and for design and cost analysis of MHD components and the overall system; (7) Integrate the engineering data and design criteria, as applicable, which are developed in the above-listed tasks into a model of the MHD channel.

  1. Critical contributions in MHD power generation. Quarterly technical progress report, June 1--August 31, 1976

    Energy Technology Data Exchange (ETDEWEB)

    Louis, J.F.

    1976-10-01

    Research progress on open-cycle coal-fired MHD power generation at Massachusetts Institute of Technology is detailed. Work is reported in the following areas: (1) Establish chemical, thermal, and electrical data to guide materials selection, develop improved detail designs, and support performance analyses of MHD electrode modules and insulator materials; (2) parametrically investigate selected electrode properties of critical design importance in chemical, thermal, and electrical environments simulating a coal-fired MHD generator; (3) develop combustion data pertinent to the design of MHD combustors; (4) establish techniques for the analysis and understanding of critical MHD phenomena which have an important bearing on MHD generator performance; (5) establish the operating characteristics of an MHD disk generator; (6) continue work on computer techniques for modeling and for design and cost analysis of MHD components and the overall system; (7) integrate the engineering data and design criteria, as applicable, which are developed in the above-listed tasks into a model of the MHD channel; (8) U-25 electrode screening tests.

  2. Dissolved organic matter and lake metabolism. Technical progress report, 1 July 1977--30 June 1978

    Energy Technology Data Exchange (ETDEWEB)

    Wetzel, R.G.

    1978-01-01

    Interactions of dissolved organic matter with inorganic nutrient cycling and regulation of the photosynthetic and decompositional metabolism of micro- and macroflora remains the focal point of these studies. Major efforts are directed towards the sources, fates, pathways, and interactions of dissolved organic matter in inorganic chemical cycling; allochthonous sources, metabolism en route, and inputs to the lake systems of increasing stages of eutrophication; and the relationships of these compounds to the nutrient physiology and metabolism of phytoplankton, sessile algae, macrophytes, and bacterial populations of the littoral zones and wetlands of the drainage basin. Analyses of regulatory mechanisms of growth and rates of carbon cycling center on evaluation of quantitative control interactions among the microflora of the pelagial zones of seversal lakes of progressively greater eutrophy, littoral photosynthetic producer-decomposer complex, and allochthonous inorganic--organic influxes and their biotic processing. The underlying thesis is that quantification of the dynamic carbon fluxes among these components and their rate control mechanisms by physical and chemical factors are fundamental to elucidation of the rate functions of lake eutrophication.

  3. Great Basin paleoenvironmental studies project; Technical progress report, second quarter, September--November, 1993

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1993-12-31

    Progress is described in the four tasks associated with this project. Task 1, Paleobotanical studies in the Great Basin, has as its objective the reconstruction of the response of vegetation to climate in order to identify periods of mesic climate at Yucca Mountain during the last 20,000 to 50,000 years. Past extremes in infiltration rates are expected to serve as estimates of climate that may be expected during the next 10,000 years at Yucca Mtn. Task 2, Paleofaunas, will construct a history of Great Basin vertebrates that will provide empirical evidence of past environmental and climatic conditions. The objective of Task 3, Geomorphology, is to document the responses of surficial processes and landforms to the climatic changes documented by studies of packrat middens, pollen, and faunal distributions. The goal of Task 4, Transportation, is to compare the results from three models that have been suggested as appropriate for evaluating flood flows on alluvial fans with the results obtained from the traditional one-dimensional, stochastic model used in previous research for Yucca Mountain. This research looked at three alluvial fans with rail transportation alignments crossing them.

  4. Advanced converter technology. Technical progress report, May 23, 1979-May 22, 1980

    Energy Technology Data Exchange (ETDEWEB)

    Banic, C. V.; Eckhouse, S. A.; Kornbrust, F. J.; Lipman, K.; Peterson, J. L.; Rosati, R. W.

    1980-01-01

    The overall objective of this program is to define an advanced converter system employing 1980's technology in all subsystem and component areas for use in electrochemical energy storage systems. Additional experimental effort will validate elements of the advanced commutation circuitry on a full-scale breadboard basis. Improved models of battery electrical characteristics are beng defined and experimental apparatus is being designed to measure these characteristics and to enable better definition of the battery-power conditioner interface. Improvement of energy-storage system performance through modification of battery converter characteristics will also be investigated. During this first year of the contract, a new more advanced concept for power conditioning based on a concept defined by United Technologies Corporation for fuel cell use was evaluated. This high switching frequency concept has the potential for significantly reducing the size and cost of battery plant power conditioners. As a result, the Department of Energy authorized redirection of the program to first evaluate this new concept and then to reorient the program to adopt this concept as the primary one. Progress is reported. (WHK)

  5. Technical progress report during Phase 1 of the continuous fiber ceramic composites program

    Energy Technology Data Exchange (ETDEWEB)

    Richerson, D.W.

    1994-03-15

    United States industry has a critical need for materials that are lightweight, strong, tough, corrosion resistant and capable of performing at high temperatures; such materials will enable substantial increase in energy efficiency and reduction in emissions of pollutants. Continuous fiber ceramic composites (CFCCs) are an emerging class of materials which have the potential for the desired combination of properties to meet the industrial needs. A $10 billion annual market has been estimated for CFCC products by the year 2010, which equates to over 100,000 industrial sector jobs. The CFCC program began in the spring of 1992 as a three-phase 10-year effort to assess potential applications of CFCC materials, develop the necessary supporting technologies to design, analyze and test CFCC materials, conduct materials and process development guided by the applications assessment input, fabricate test samples and representative components to evaluate CFCC material capabilities under application conditions, and analyze scaleability and manufacturability plus demonstrate pilot-scale production engineering. DOE awarded 10 Phase I cooperative agreements to industry-lead teams plus identified generic supporting technology projects. This document highlights the broad progress and accomplishments on these contracts and support technology projects during Phase I.

  6. Dissolved organic matter and lake metabolism. Technical progress report, 1 July 1978--30 Jun 1979

    Energy Technology Data Exchange (ETDEWEB)

    Wenzel, R.G.

    1979-01-01

    Progress is reported in continuing investigations focused on integrated studies of the qualitative and quantitative cycling and metabolism of particulate and dissolved organic carbon in lakes and their inflow sources (surface and subsurface). Emphasis is placed on the sources, fates, and interactions of dissolved and particulate organic matter in relation to: (a) inorganic chemical cycling, (b) allochthonous loading to the lake system, and (c) the coupled nutrient physiology and metabolism of phytoplankton, bacterial populations, macrophytes, and attendant sessile algal-bacterial communities. Regulatory mechanisms of growth and rates of carbon and nutrient cycling are being evaluated among the (a) inorganic-organic influxes of allochthonous sources as they are controlled by wetland-littoral communities, (b) the littoral photosynthetic producer-decomposer complex, and (c) the microflora of the pelagial zone. Quantification of carbon fluxes among these components and control mechanisms is fundamental to elucidation of the rate functions of lake eutrophication. The integrated studies addressing these multifacted objectives are summarized in three summary diagrams.

  7. Biomass power for rural development. Technical progress report, April 1, 1997--June 30, 1997

    Energy Technology Data Exchange (ETDEWEB)

    Neuhauser, E.

    1997-08-01

    Detailed task progress reports and schedules are provided for the DOE/USDA sponsored Biomass Power for Rural Development project. The focus of the project is on developing commercial energy crops for power generation by the year 2000. The New York based Salix Consortium project is a multi-partner endeavor, implemented in three stages. Phase-I, Final Design and Project Development, will conclude with the preparation of construction and/or operating permits, feedstock production plans, and contracts ready for signature. Field trials of willow (Salix) have been initiated at several locations in New York (Tully, Lockport, King Ferry, La Fayette, Massena, and Himrod) and co-firing tests are underway at Greenidge Station (NYSEG) and Dunkirk Station (NMPC). Phase-H of the project will focus on scale-up of willow crop acreage, construction of co-firing facilities at Dunkirk Station (NMPC), and final modifications for Greenidge Station. Cofiring willow is also under consideration for GPU`s Seward Station where testing is under way. There will be an evaluation of the energy crop as part of the gasification trials occurring at BED`s McNeill power station. Phase-III will represent fullscale commercialization of the energy crop and power generation on a sustainable basis.

  8. MHD Coal Fired Flow Facility. Quarterly technical progress report, July-September 1980

    Energy Technology Data Exchange (ETDEWEB)

    Altstatt, M. C.; Attig, R. C.; Brosnan, D. A.

    1980-11-01

    Significant activity, task status, planned research, testing, development, and conclusions for the Magnetohydrodynamics (MHD) Coal-Fired Flow Facility (CFFF) and the Energy Conversion Facility (ECF) are described. On Task 1, the first phase of the downstream quench system was completed. On Task 2, all three combustor sections were completed, hydrotested, ASME code stamped, and delivered to UTSI. The nozzle was also delivered. Fabrication of support stands and cooling water manifolds for the combustor and vitiation heater were completed, heat transfer and thermal stress analysis, along with design development, were conducted on the generator and radiant furnace and secondary combustor installation progressed as planned. Under Task 3 an Elemental Analyzer and Atomic Absorption Spectrophotometer/Graphite Furnace were received and installed, sites were prepared for two air monitoring stations, phytoplankton analysis began, and foliage and soil sampling was conducted using all study plots. Some 288 soil samples were combined to make 72 samples which were analyzed. Also, approval was granted to dispose of MHD flyash and slag at the Franklin County landfill. Task 4 effort consisted of completing all component test plans, and establishing the capability of displaying experimental data in graphical format. Under Task 7, a preliminary testing program for critical monitoring of the local current and voltage non-uniformities in the generator electrodes was outlined, electrode metal wear characteristics were documented, boron nitride/refrasil composite interelectrode sealing was improved, and several refractories for downstream MHD applications were evaluated with promising results.

  9. Advanced thermally stable jet fuels: Technical progress report, July 1994--September 1994

    Energy Technology Data Exchange (ETDEWEB)

    Schobert, H.H.; Eser, S.; Song, C.; Hatcher, P.G.; Boehman, A.; Coleman, M.M.

    1994-07-01

    There are five tasks within this project on thermally stable coal-based jet fuels. Progress on each of the tasks is described. Task 1, Investigation of the quantitative degradation chemistry of fuels, has 3 subtasks which are described: Pyrolysis of n-alkylbenzenes; Thermal decomposition of n-tetradecane in near-critical region; and Re-examining the effects of reactant and inert gas pressure on tetradecane pyrolysis--Effect of cold volume in batch reactor. Under Task 2, Investigation of incipient deposition, the subtask reported is Uncertainty analysis on growth and deposition of particles during heating of coal-derived aviation gas turbine fuels; under Task 3, Investigation of the quantitative degradation chemistry of fuels, is subtask, Effects of high surface area activated carbon and decalin on thermal degradation of jet A-1 fuel and n-dodecane; under Task 4, Coal-based fuel stabilization studies, is subtask, Screening potential jet fuel stabilizers using the model compound dodecane; and under Task 5, Exploratory studies on the direct conversion of coal to high quality jet fuels, is subtask, Shape-selective naphthalene hydrogenation for production of thermally stable jet fuels. 25 refs., 64 figs., 22 tabs.

  10. A Catalogue of Altered Salivary Proteins Secondary to Invasive Ductal Carcinoma: A Novel In Vivo Paradigm to Assess Breast Cancer Progression.

    Science.gov (United States)

    Streckfus, Charles F; Bigler, Lenora

    2016-08-01

    The objective of this manuscript is to introduce a catalogue of salivary proteins that are altered secondary to carcinoma of the breast. The catalogue of salivary proteins is a compilation of twenty years of research by the authors and consists of 233 high and low abundant proteins which have been identified by LC-MS/MS mass spectrometry, 2D-gel analysis and by enzyme-linked immunosorbent assay. The body of research suggests that saliva is a fluid suffused with solubilized by-products of oncogenic expression and that these proteins may be useful in the study of breast cancer progress, treatment efficacy and the tailoring of individualized patient care.

  11. 乳腺癌术后上肢水肿研究进展%Progress in study on lymphedema of arm after surgery of breast cancer

    Institute of Scientific and Technical Information of China (English)

    2002-01-01

    @@ Lymphedema of affected arm is a severe complication after surgery of breast cancer.Quality of life and rehabilitation of patients suffered from breast cancer receive more and more attention with increase of incidence and decrease of mortality,longation of survival time.Lymphedema of arm not only affects esthetics but produce pain,dysfunction,deprivation of work ability,and serious psychological issues.In the current paper,we reviewed progress in study on risk factors associated with surgery,evaluation,prevention and management of lymphedema in arm.

  12. Directional backlight liquid crystal autostereoscopic display: technical challenges, research progress, and prospect (Conference Presentation)

    Science.gov (United States)

    Fan, Hang; Li, Kunyang; Zhou, Yangui; Liang, Haowen; Wang, Jiahui; Zhou, Jianying

    2016-09-01

    Recent upsurge on virtual and augmented realities (VR and AR) has re-ignited the interest to the immerse display technology. The VR/AR technology based on stereoscopic display is believed in its early stage as glasses-free, or autostereoscopic display, will be ultimately adopted for the viewing convenience, visual comfort and for the multi-viewer purposes. On the other hand, autostereoscopic display has not yet received positive market response for the past years neither with stereoscopic displays using shutter or polarized glasses. We shall present the analysis on the real-world applications, rigid user demand, the drawbacks to the existing barrier- and lenticular lens-based LCD autostereoscopy. We shall emphasize the emerging autostereoscopic display, and notably on directional backlight LCD technology using a hybrid spatial- and temporal-control scenario. We report the numerical simulation of a display system using Monte-Carlo ray-tracing method with the human retina as the real image receiver. The system performance is optimized using newly developed figure of merit for system design. The reduced crosstalk in an autostereoscopic system, the enhanced display quality, including the high resolution received by the retina, the display homogeneity without Moiré- and defect-pattern, will be highlighted. Recent research progress including a novel scheme for diffraction-free backlight illumination, the expanded viewing zone for autostereoscopic display, and the novel Fresnel lens array to achieve a near perfect display in 2D/3D mode will be introduced. The experimental demonstration will be presented to the autostereoscopic display with the highest resolution, low crosstalk, Moiré- and defect- pattern free.

  13. Methyl chloride via oxyhydrochlorination of methane. Quarterly technical progress report No. 7, April--June 1993

    Energy Technology Data Exchange (ETDEWEB)

    1994-01-01

    The purpose of this contract is to develop a process for converting light alkane gases to methyl chloride via oxyhydrochlorination using highly selective, stable catalysts in fixed-bed reactors designed to remove the large amount of heat generated, so as to control the reaction temperature. Further, the objective is to obtain the engineering data base necessary for developing a commercially feasible process and to evaluate the economics of the process. Several key technology areas were evaluated this quarter. The catalyst definition effort focused on the determination of the role of the Li and La promoters that have been found to be useful in enhancing Cu based oxyhydrochlorination of methane catalysts. Initial experiments show that the La acts to provide a much more active catalyst than the Cu only case. The role of the Li is ambiguous at this point. The Li enhances the stability of the La promoted catalyst, but gives only marginal improvement by itself This work will be continued, with additional emphasis on the analysis of the catalysts to determine the structural role that the promoters may play. The separation unit operation definition made significant progress by demonstrating in a laboratory system that a process solvent may be used to remove the product CH{sub 3}Cl from the reactor effluent stream. To date the data has been qualitative, but clear. Work will continue to gather the information possible in the laboratory to help with PDU design. An extensive amount of testing was performed on the chosen process solvent, Multitherm. A comprehensive review of all the thermal testing and associated FTIR, UV/VIS, and physical property testing is included in this report. This work shows that Multitherm should give the desired stability and solubility that are necessary to make the separation unit operation successful.

  14. Advanced thermally stable jet fuels: Technical progress report, October 1994--December 1994

    Energy Technology Data Exchange (ETDEWEB)

    Schobert, H.H.; Eser, S.; Song, C.; Hatcher, P.G.; Boehman, A.; Coleman, M.M.

    1995-02-01

    There are five tasks within this project on thermally stable coal-based jet fuels. Progress on each of the tasks is described. Task 1, Investigation of the quantitative degradation chemistry of fuels, has 5 subtasks which are described: Literature review on thermal stability of jet fuels; Pyrolytic and catalytic reactions of potential endothermic fuels: cis- and trans-decalin; Use of site specific {sup 13}C-labeling to examine the thermal stressing of 1-phenylhexane: A case study for the determination of reaction kinetics in complex fuel mixtures versus model compound studies; Estimation of critical temperatures of jet fuels; and Surface effects on deposit formation in a flow reactor system. Under Task 2, Investigation of incipient deposition, the subtask reported is Uncertainty analysis on growth and deposition of particles during heating of coal-derived aviation gas turbine fuels; under Task 3, Characterization of solid gums, sediments, and carbonaceous deposits, is subtask, Studies of surface chemistry of PX-21 activated carbon during thermal degradation of jet A-1 fuel and n-dodecane; under Task 4, Coal-based fuel stabilization studies, is subtask, Exploratory screening and development potential of jet fuel thermal stabilizers over 400 C; and under Task 5, Exploratory studies on the direct conversion of coal to high quality jet fuels, are 4 subtasks: Novel approaches to low-severity coal liquefaction and coal/resid co-processing using water and dispersed catalysts; Shape-selective naphthalene hydrogenation for production of thermally stable jet fuels; Design of a batch mode and a continuous mode three-phase reactor system for the liquefaction of coal and upgrading of coal liquids; and Exploratory studies on coal liquids upgrading using mesopores molecular sieve catalysts. 136 refs., 69 figs., 24 tabs.

  15. Nuclear Physics Laboratory, University of Colorado technical progress report, 1976 and proposal for continuation of contract

    Energy Technology Data Exchange (ETDEWEB)

    1976-11-01

    This report summarizes the work carried out at the Nuclear Physics Laboratory of the University of Colorado during the period November 1, 1975 to November 1, 1976. The low energy nuclear physics section is dominated by light-ion reaction studies which span a wide range. These include both two-neutron and two-proton transfer reactions, charge exchange and inelastic scattering, as well as single nucleon transfer reactions. The nuclei studied vary widely in their mass and characteristics. These reaction studies have been aided by the multi-use scattering chamber which now allows the energy-loss-spectrometer beam preparation system (beam swinger) to shift from charged particle studies to neutron time-of-flight studies with a minimum loss of time. The intermediate energy section reflects the increase in activity accompanying the arrival of LAMPF data and the initiation of (p,d) studies at the Indiana separated-sector cyclotron. The nucleon removal results provided by the ..pi.. beam at EPICS previous to completion of the spectrometer have shown that nuclear effects dominate this process, so that the widely used free interaction picture is inadequate. The section entitled ''Other Activities'' reveals continuing activities in new applications of nuclear techniques to problems in medicine and biology. Reactions important to astrophysics continue to be investigated and our trace-element program remains at a high level of activity. The theoretical section reports new progress in understanding magnitudes of two-step reactions by inclusion of finite-range effects. A new finite-range program which is fast and economical has been completed. Intermediate energy results include calculations of ..pi..-..gamma.. angular correlations, low energy ..pi..-nucleus interactions, as well as (p,d) and nucleon scattering calculations for intermediate energies.

  16. Technical Progress Report on Single Pass Flow Through Tests of Ceramic Waste Forms for Plutonium Immobilization

    Energy Technology Data Exchange (ETDEWEB)

    Zhao, P; Roberts, S; Bourcier, W

    2000-12-01

    This report updates work on measurements of the dissolution rates of single-phase and multi-phase ceramic waste forms in flow-through reactors at Lawrence Livermore National Laboratory. Previous results were reported in Bourcier (1999). Two types of tests are in progress: (1) tests of baseline pyrochlore-based multiphase ceramics; and (2) tests of single-phase pyrochlore, zirconolite, and brannerite (the three phases that will contain most of the actinides). Tests of the multi-phase material are all being run at 25 C. The single-phase tests are being run at 25, 50, and 75 C. All tests are being performed at ambient pressure. The as-made bulk compositions of the ceramics are given in Table 1. The single pass flow-through test procedure [Knauss, 1986 No.140] allows the powdered ceramic to react with pH buffer solutions traveling upward vertically through the powder. Gentle rocking during the course of the experiment keeps the powder suspended and avoids clumping, and allows the system to behave as a continuously stirred reactor. For each test, a cell is loaded with approximately one gram of the appropriate size fraction of powdered ceramic and reacted with a buffer solution of the desired pH. The buffer solution compositions are given in Table 2. All the ceramics tested were cold pressed and sintered at 1350 C in air, except brannerite, which was sintered at 1350 C in a CO/CO{sub 2} gas mixture. They were then crushed, sieved, rinsed repeatedly in alcohol and distilled water, and the desired particle size fraction collected for the single pass flow-through tests (SPFT). The surface area of the ceramics measured by BET ranged from 0.1-0.35 m{sup 2}/g. The measured surface area values, average particle size, and sample weights for each ceramic test are given in the Appendices.

  17. Solvent refined coal (SRC) process. Quarterly technical progress report, January 1980-March 1980. [In process streams

    Energy Technology Data Exchange (ETDEWEB)

    1981-01-01

    This report summarizes the progress of the Solvent Refined Coal (SRC) project at the SRC Pilot Plant in Fort Lewis, Wahsington, and the Process Development Unit (P-99) in Harmarville, Pennsylvania. After the remaining runs of the slurry preheater survey test program were completed January 14, the Fort Lewis Pilot Plant was shut down to inspect Slurry Preheater B and to insulate the coil for future testing at higher rates of heat flux. Radiographic inspection of the coil showed that the welds at the pressure taps and the immersion thermowells did not meet design specifications. Slurry Preheater A was used during the first 12 days of February while weld repairs and modifications to Slurry Preheater B were completed. Two attempts to complete a material balance run on Powhatan No. 6 Mine coal were attempted but neither was successful. Slurry Preheater B was in service the remainder of the quarter. The start of a series of runs at higher heat flux was delayed because of plugging in both the slurry and the hydrogen flow metering systems. Three baseline runs and three slurry runs of the high heat flux program were completed before the plant was shut down March 12 for repair of the Inert Gas Unit. Attempts to complete a fourth slurry run at high heat flux were unsuccessful because of problems with the coal feed handling and the vortex mix systems. Process Development Unit (P-99) completed three of the four runs designed to study the effect of dissolver L/D ratio. The fourth was under way at the end of the period. SRC yield correlations have been developed that include coal properties as independent variables. A preliminary ranking of coals according to their reactivity in PDU P-99 has been made. Techniques for studying coking phenomenona are now in place.

  18. Improved methods for water shutoff. Final technical progress report, October 1, 1997--September 30, 1998

    Energy Technology Data Exchange (ETDEWEB)

    Seright, R.S.; Liang, J.T.; Schrader, R.; Hagstrom, J. II; Liu, J.; Wavrik, K.

    1998-10-01

    In the United States, more than 20 billion barrels of salt water are produced each year during oilfield operations. A tremendous economic incentive exists to reduce water production if that can be accomplished without significantly sacrificing hydrocarbon production. This three-year research project had three objectives. The first objective was to identify chemical blocking agents that will (a) during placement, flow readily through fractures without penetrating significantly into porous rock and with screening out or developing excessive pressure gradients and (b) at a predictable and controllable time, become immobile and resistant breakdown upon exposure to moderate to high pressure gradients. The second objective was to identify schemes that optimize placement of the above blocking agents. The third objective was to explain why gels and other chemical blocking agents reduce permeability to one phase (e.g., water) more than that to another phase (e.g., oil or gas). The authors also wanted to identify conditions that maximize this phenomenon. This project consisted of three tasks, each of which addressed one of the above objectives. This report describes work performed during the third and final period of the project. During this three-year project, they: (1) Developed a procedure and software for sizing gelant treatments in hydraulically fractured production wells; (2) Developed a method (based on interwell tracer results) to determine the potential for applying gel treatments in naturally fractured reservoirs; (3) Characterized gel properties during extrusion through fractures; (4) Developed a method to predict gel placement in naturally fractured reservoirs; (5) Made progress in elucidating the mechanism for why some gels can reduce permeability to water more than that to oil; (6) Demonstrated the limitations of using water/oil ratio diagnostic plots to distinguish between channeling and coning; and (7) Proposed a philosophy for diagnosing and attacking water

  19. Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women.

    Directory of Open Access Journals (Sweden)

    Dilek Colak

    Full Text Available Breast cancer in young women is more aggressive with a poorer prognosis and overall survival compared to older women diagnosed with the disease. Despite recent research, the underlying biology and molecular alterations that drive the aggressive nature of breast tumors associated with breast cancer in young women have yet to be elucidated. In this study, we performed transcriptomic profile and network analyses of breast tumors arising in Middle Eastern women to identify age-specific gene signatures. Moreover, we studied molecular alterations associated with cancer progression in young women using cross-species comparative genomics approach coupled with copy number alterations (CNA associated with breast cancers from independent studies. We identified 63 genes specific to tumors in young women that showed alterations distinct from two age cohorts of older women. The network analyses revealed potential critical regulatory roles for Myc, PI3K/Akt, NF-κB, and IL-1 in disease characteristics of breast tumors arising in young women. Cross-species comparative genomics analysis of progression from pre-invasive ductal carcinoma in situ (DCIS to invasive ductal carcinoma (IDC revealed 16 genes with concomitant genomic alterations, CCNB2, UBE2C, TOP2A, CEP55, TPX2, BIRC5, KIAA0101, SHCBP1, UBE2T, PTTG1, NUSAP1, DEPDC1, HELLS, CCNB1, KIF4A, and RRM2, that may be involved in tumorigenesis and in the processes of invasion and progression of disease. Array findings were validated using qRT-PCR, immunohistochemistry, and extensive in silico analyses of independently performed microarray datasets. To our knowledge, this study provides the first comprehensive genomic analysis of breast cancer in Middle Eastern women in age-specific cohorts and potential markers for cancer progression in young women. Our data demonstrate that cancer appearing in young women contain distinct biological characteristics and deregulated signaling pathways. Moreover, our integrative

  20. Savannah River Ecology Laboratory Annual Technical Progress Report of Ecological Research, June 30, 2001

    Energy Technology Data Exchange (ETDEWEB)

    Bertsch, Paul M.; Janecek, Laura; Rosier, Brenda

    2001-06-30

    The Savannah River Ecology Laboratory (SREL) is a research unit of the University of Georgia (UGA) and has been conducting ecological research on the Savannah River Site (SRS) in South Carolina for 50 years. The overall mission of the Laboratory is to acquire and communicate knowledge of ecological processes and principles. SREL conducts fundamental and applied ecological research, as well as education and outreach programs, under a Cooperative Agreement with the U.S. Department of Energy (DOE) SRS near Aiken, South Carolina. The Laboratory's research mission during the 2001 fiscal year was fulfilled with the publication of one book and 83 journal articles and book chapters by faculty, technical staff, students, and visiting scientists. An additional 77 journal articles have been submitted or are in press. Other noteworthy events took place as faculty members and graduate students received awards. These are described in the section Special Accomplishments of Faculty, Staff, Students, and Administration on page 54. Notable scientific accomplishments include work conducted on contaminant transport, global reptile decline, phytoremediation, and radioecology. Dr. Domy Adriano authored the second edition of his book ''Trace Elements in Terrestrial Environments: Biogeochemistry, Bioavailability, and Risks of Metals'', which was recently published by Springer-Verlag. The book provides a comprehensive treatment of many important aspects of trace elements in the environment. The first edition of the book, published in 1986, has become a widely acclaimed and cited reference. International attention was focused on the problem of reptile species decline with the publication of an article on this topic in the journal ''Bioscience'' in August, 2000. The article's authors included Dr. Whit Gibbons and a number of other SREL herpetologists who researched the growing worldwide problem of decline of reptile species. Factors related

  1. Novel CXCR3/CXCR7-Directed Biological Antagonist for Inhibition of Breast Cancer Progression

    Science.gov (United States)

    2012-09-01

    the role of CXCR4 in BrCa progression. 4 Figure 2. CXCR7 (G protein-independent) cell-signaling pathways. The GPCR , CXCR7 is hypothesized to... antibody responses. Aim Two will characterize the mechanisms of mut-CXCL11-Ig that modulate BrCa progression in the presence and absence of docetaxel...and iv) Micromet. Imagestream analysis of protein expression and localization: PE/Cy5 conjugated anti-human CXCR4 antibody (clone#12G5) was purchased

  2. Optimal design and routing of power lines; ecological, technical and economic perspectives (OPTIPOL). Progress report 2012

    Energy Technology Data Exchange (ETDEWEB)

    Bevanger, Kjetil; Bartzke, Gundula; Broeseth, Henrik; Dahl, Espen Lie; Gjershaug, Jan Ove; Hanssen, Frank; Jacobsen, Karl-Otto; Kleven, Oddmund; Kvaloey, Paal; May, Roel; Meaas, Roger; Nygaaard, Torgeir; Resnaes, Steinar; Stokke, Sigbjoern; Thomassen, Joern

    2012-07-01

    birds in the database, compared to only 117 a year earlier. WP5 - 'A Least Cost Path (LCP) toolbox for optimal route routing of power lines', has developed an LCP-pilot to demonstrate the LCP method, based on the impact studies were undertaken prior to construction of a 420 kV transmission line in Central Norway 2005. Relevant economic, ecological and technological environment criteria based on suggestions from interested users (NGOs, government, industry, etc.), was used. LCP-pilot and a fuzzy-logic approach of this was demonstrated in the first dialogue-based workshop, 23.-24. april 2012. The seminar, which had an emphasis on criteria definitions were followed up with a working seminar that focused criterion values ??on 20 november 2012. Lecture - 'A Least Cost Path (LCP) Toolbox for Optimal Routing of Power Lines, -was presented and submitted as contributions to the conference report from 'The 10th ROW Conference' in Arizona, 'The 32nd Annual Conference of the International Association for Impact Assessment (IAIA12) ' in Porto, Portugal, and 'The ESRI European User Conference' in Oslo. WP6 - 'Birds and camouflaging of power lines', has almost completed the final report, 'Power line camouflaging. An assessment of the ecological and technical challenges'. 'Because of the budget situation in CEDREN However, completion of the report postponed until the end of April 2013. WP7 - 'Effect of line marking / modifications remedial measures against bird mortality' has almost completed the final report 'Opportunities and limitations in terms of reducing mortality in birds due to collision and electrocution.' Due to overall budget situation in CEDREN the report deferred to the end of april 2013. WP8, 'guidelines for technological solutions that may reduce mortality in birds because of the power line's', has focused topics relating to the labeling, design, insulation, camouflage and wiring. The results, which are presented in the notes and articles, will be implemented in

  3. Circulating Tumor Cells in Metastatic Breast Cancer:Monitoring Response to Chemotherapy and Predicting Progression-Free Survival

    Institute of Scientific and Technical Information of China (English)

    Jian-ping Cheng; Ying Yan; Xiang-yi Wang; Yuan-li Lu; Yan-hua Yuan; Xiao-li Wang; Jun Jia; Jun Ren

    2010-01-01

    Objective:The purpose of this study is to explore RT-PCR method to set up the examination platform for detecting circulating tumor cells(CTC)in peripheral blood from metastatic breast cancer patients.The primary endpoint is to find out the correlation of existence of CTC with clinical responses and progression-free survival(PFS).Methods:The breast cancer cell line MCF-7 was serially diluted into the peripheral blood from 45 healthy donors to set up the sensitivity of RT-PCR assay.The expression of CK19 mRNA was amplified from both 49patients and 45 healthy donors respectively.The CK19 protein quantity from plasma was measured by competitive inhibition ELISA assay.Results:The sensitivity of RT-PCR could reach 1/106-107 white blood cells with specificity of 95.6%.The objective response rate(ORR)of patients with CK19 mRNA-negative undertaken one cycle chemotherapy was significantly higher than those with positive(P<0.0001).PFS among CK19 mRNA-negative patients was also increased,although there was no significance(P=0.098).The results of ELISA assay showed that CK19 protein was decreased significantly after one cycle chemotherapy,which gave rise to a little higher ORR(P=0.015)and increased PFS(P=0.016).Conclusion:Patients with unamplified CK19 mRNA after one cycle chemotherapy could achieve better radiographic evaluation and increased PFS,which was showed to be of consistency with the CK19 protein assay among the patients treated.

  4. Circulating Tumor Cells in Metastatic Breast Cancer: Monitoring Response to Chemotherapy and Predicting Progression-Free Survival

    Institute of Scientific and Technical Information of China (English)

    Jian-ping Cheng; Ying Yan; Xiang-yi Wang; Yuan-li Lu; Yan-hua Yuan; Xiao-li Wang; Jun Jia; Jun Ren

    2011-01-01

    Objective: The purpose of this study is to explore RT-PCR method to set up the examination platform for detecting circulating tumor cells(CTC) in peripheral blood from metastatic breast cancer patients.The primary endpoint is to find out the correlation of existence of CTC with clinical responses and progression-free survival (PFS).Methods: The breast cancer cell line MCF-7 was serially diluted into the peripheral blood from 45 healthy donors to set up the sensitivity of RT-PCR assay.The expression of CK19 mRNA was amplified from both 49 patients and 45 healthy donors respectively.The CK19 protein quantity from plasma was measured by competitive inhibition ELISA assay.Results: The sensitivity of RT-PCR could reach 1/106-107 white blood cells with specificity of 95.6%.The objective response rate(ORR) of patients with CK19 mRNA-negative undertaken one cycle chemotherapy was significantly higher than those with positive(P<0.0001).PFS among CK19 mRNA-negative patients was also increased,although there was no significance(P=0.098).The results of ELISA assay showed that CK19 protein was decreased significantly after one cycle chemotherapy,which gave rise to a little higher ORR(P=0.015) and increased PFS(P=0.016).Conclusion: Patients with unamplified CK19 mRNA after one cycle chemotherapy could achieve better radiographic evaluation and increased PFS,which was showed to be of consistency with the CK19 protein assay among the patients treated.

  5. The Diagnosis and Treatment Progress of Early Breast Cancer%早期乳腺癌的诊断及治疗进展

    Institute of Scientific and Technical Information of China (English)

    杨阳; 张健; 李爱东

    2012-01-01

    Breast cancer is the worldwide most common malignancy in women and also is the leading cause of cancer-related mortality. Early breast cancer is one of the attentions that mammary gland oncologists focus on. The long-term cure rate of early breast cancer is more than 90%, the improvement of diagnosis rate can increase patients' survival rate, decrease mortality. The risk factors of breast cancer include way of life, the environment factors, genetic and so on. In resent years early breast cancer incidence keeps rising, and tend to be younger. The key of treating early breast cancer is early prevention, early detection and early treatment The treatment of early breast cancer has been improved from traditional surgery to comprehensive therapy, which is conserving surgery combined with adjuvant radiotherapy and chemotherapy. Along with the progress of the society and the development of economy, the treatment of early breast cancer tend to be perfect gradually. In order to guide clinical, now I summarize the diagnosis and treatment progress of early breast cancer.%乳腺癌是全球女性最常见的恶性肿瘤.多年来早期乳腺癌是乳腺肿瘤学家积极关注的焦点之一.早期乳腺癌的长期治愈率达90%以上,其诊断率的提高将大大提高病人的生存率和生存年限,降低病死率.生活方式、环境因素、遗传基因等都是乳腺癌的危险因素.近年来早期乳腺癌发生率不断上升,并趋于年轻化,所以早期预防、早期发现、早期治疗成了治疗早期乳腺癌的关键.早期乳腺癌的治疗从传统的手术治疗发展到以手术为主,放化疗为辅的综合疗法.随着社会的进步和经济的发展,早期乳腺癌的治疗方案渐渐趋于完整.现对早期乳腺癌的诊断和治疗研究进展进行概述,以指导临床.

  6. Distribution of marine birds on Georges Bank and adjacent waters. Technical progress report, 1 January--31 August 1978

    Energy Technology Data Exchange (ETDEWEB)

    Powers, K.D.

    1978-10-01

    The work accomplished during the period covered in this technical progress report demonstrates the importance, interest, and necessity of a distribution study of marine birds in the Georges Bank area on a national and international scale. Cooperation was extended by the U.S. National Marine Fisheries Service, U.S. Fish and Wildlife Service, U.S. Coast Guard, and by the Canadian Wildlife Service, Halifax, N.S., AltantNIRO, Kaliningrad, USSR, and Federal Republic of Germany. Two sampling methods, fixed-area and total bird counts, were effectively employed, which allow comparable data bases with marine bird distribution information being collected in the North Pacific, Bering and Chukchi Seas (Outer Continental Shelf Energy Assessment Program), and in the North Atlantic and Canadian Arctic (CWS and The Seabird Group). A marine bird data retrieval bank is being developed for MBO seabird data at the USFWS Migratory Bird and Habitat Research Laboratory. A food habits bibliography and prey item/bird species summary table for marine birds in the western North Atlantic has been prepared from existing literature. Unpublished NMFS data on zooplankton/ichthyoplankton, and ground fish is being made available for possible correlations in distribution of selected prey items with bird species.

  7. Fundamental characterization of alternate fuel effects in continuous combustion systems. Summary technical progress report, August 15, 1978-January 31, 1980

    Energy Technology Data Exchange (ETDEWEB)

    Blazowski, W.S.; Edelman, R.B.; Wong, E.

    1980-02-27

    The overall objective of this contract is to assist in the development of fuel-flexible combustion systems for gas turbines as well as Rankine and Stirling cycle engines. The primary emphasis of the program is on liquid hydrocarbons produced from non-petroleum resources. Fuel-flexible combustion systems will provide for more rapid transition of these alternative fuels into important future energy utilization centers (especially utility power generation with the combined cycle gas turbine). The specific technical objectives of the program are: (a) develop an improved understanding of relationships between alternative fuel properties and continuous combustion system effects, and (b) provide analytical modeling/correlation capabilities to be used as design aids for development of fuel-tolerant combustion systems. This is the second major report of the program. Key experimental findings during this reporting period concern stirred combustor soot production during operation at controlled temperature conditions, soot production as a function of combustor residence time, an improved measurement technique for total hydrocarbons and initial stirred combustor results of fuel nitrogen conversion. While the results to be presented concern a stirred combustor which utilizes premixed fuel vapor/oxidant mixtures, a new combustor which combusts liquid fuel injected into the reactor as a spray has been developed and will be described. Analytical program progress includes the development of new quasiglobal models of soot formation and assessment of needs for other submodel development.

  8. 钛白粉生产工艺技术进展%Technical progress of titanium dioxide manufacturing processes

    Institute of Scientific and Technical Information of China (English)

    龚家竹

    2012-01-01

    简要介绍了钛白粉全球主要生产商和市场概况、原料加工工艺技术和现有的硫酸法、氯化法钛白粉生产工艺技术;也介绍了最新工艺中钛原料富集的替代金红石工艺(REPTILE)和钛铁矿焙烧磁选分离酸回收工艺(ERMS SR),以及盐酸法的(Altair)生产工艺和碱融法的绿色生产工艺等钛白粉生产工艺技术的最新进展.%Major global producers and markets of titanium dioxide were briefly reviewed.Titanium dioxide's raw material processing techniques and existing manufacturing processes,such as sulfuric acid process and chlorination process,were introduced.Latest titanium dioxide manufacturing processes,such as REPTILE and ERMS SR,as well as the technical progress in production technology of hydrochloric acid process (Altair),and in the green production technology of alkali molten process were also introduced.

  9. High octane ethers from synthesis gas-derived alcohols. Quarterly technical progress report, July--September 1993

    Energy Technology Data Exchange (ETDEWEB)

    Klier, K.; Herman, R.G.; Feeley, O.C.; Johansson, M.A.

    1993-11-01

    The objective of the proposed research is to synthesize oxygenated fuel ethers, primarily methyl isobutyl ether (MIBE) and methyl tertiary butyl ether (MTBE), directly from coal-derived H{sub 2}/CO/CO{sub 2} synthesis via alcohol mixtures that are rich in methanol and 2-methyl-1-proanol (isobutanol). The overall scheme involves gasification of coal, purification and shifting of the synthesis gas, higher alcohol synthesis, and direct synthesis of ethers. Both organic and inorganic catalysts will be investigated, and the better catalysts will be subjected to long term performance studies. The project is divided into the following three tasks: (1) synthesis of high octane ethers from alcohol mixtures containing predominantly methanol and 2-methyl-1-propanol over superacid resins, (2) inorganic catalysts for the synthesis of high octane ethers form alcohols, and (3) long term performance and reaction engineering for scale-up of the alcohols-to-ether process. A summary of technical progress is provided in this report.

  10. Developments in breeding of Agaricus bisporus var. bisporus: progress made and technical and legal hurdles to take.

    Science.gov (United States)

    Sonnenberg, Anton S M; Baars, Johan J P; Gao, Wei; Visser, Richard G F

    2017-03-01

    True breeding of button mushrooms has hardly been done in the last decades, despite this species being one of the most cultivated mushrooms worldwide. Research done in the last 20 years has identified and characterised new germplasm and improved our understanding of the genetic base for some traits. A substantial collection of wild-collected strains is now available and partly characterised for a number of important traits such as disease resistance and yield. Most of the variations found in a number of important agronomic traits have a considerable heritability and are thus useful for breeding. Genetic marker technology has also developed considerably for this mushrooms in the last decade and used to identify quantitative trait loci (QTL) for important agronomic traits. This progress has, except for one example, not resulted so far into new commercially varieties. One of the reasons lies in the typical life cycle of the button mushroom Agaricus bisporus var. bisporus which hampers breeding. Joint investment is needed to solve technical problems in breeding. Special attention is needed for the protection of new varieties. Due to its typical life cycle, it is very easy to generate so called "look-a-likes" from protected cultivars by screening fertile single spore cultures. A consensus has been reached within the mushroom (breeding) industry to consider this method as the generation of essentially derived varieties as defined in plant breeding.

  11. Hot gas cleanup test facility for gasification and pressurized combustion. Quarterly technical progress report, January 1--March 31, 1992

    Energy Technology Data Exchange (ETDEWEB)

    1992-12-01

    This quarterly technical progress report summarizes work completed during the Sixth Quarter of the First Budget Period, January 1 through March 31, 1992, under the Department of Energy (DOE) Cooperative Agreement No. DE-FC21-90MC25140 entitled ``Hot Gas Cleanup Test Facility for Gasification and Pressurized Combustion.`` The objective of this project is to evaluate hot gas particle control technologies using coal-derived gas streams. The major emphasis during this reporting period was expanding the test facility to address system integration issues of hot particulate removal in advanced power generation systems. The conceptual design of the facility was extended to include additional modules for the expansion of the test facility, which is referred to as the Power Systems Development Facility (PSOF). A letter agreement was negotiated between Southern Company Services (SCS) and Foster Wheeler (FW) for the conceptual design of the Advanced Pressurized Fluid-Bed Combustion (APFBC)/Topping Combustor/Gas Turbine System to be added to the facility. The expanded conceptual design also included modifications to the existing conceptual design for the Hot Gas Cleanup Test Facility (HGCTF), facility layout and balance of plant design for the PSOF. Southern Research Institute (SRI) began investigating the sampling requirements for the expanded facility and assisted SCS in contacting Particulate Control Device (PCD) vendors for additional information. SCS also contacted the Electric Power Research Institute (EPRI) and two molten carbonate fuel cell vendors for input on the fuel cell module for the PSDF.

  12. The rs4646 and rs12592697 Polymorphisms in CYP19A1 Are Associated with Disease Progression among Patients with Breast Cancer from Different Racial/ethnic Backgrounds.

    Directory of Open Access Journals (Sweden)

    Reina Armamento-Villareal

    2016-12-01

    Full Text Available Given the racial/ethnic disparities in breast cancer, we evaluated the association between CYP19A1 single nucleotide polymorphisms (SNPs on disease progression in women with breast cancer from different racial/ethnic backgrounds. This is a cross-sectional analysis of data from 327 women with breast cancer in the Expanded Breast Cancer Registry program of the University of New Mexico. Stored DNA samples were analyzed for CYP19A1 SNPs using a custom designed microarray panel. Genotype-phenotype correlations were analyzed. Of the 384 SNPs, 2 were associated with clinically significant outcomes, the rs4646 and rs12592697. The T allele for the rs4646 was associated with advanced stage of the disease at the time of presentation (odds ratio OR:1.8, confidence intervals CI: 1.05-3.13, p<0.05 and a more progressive disease (OR: 2.1 CI: 1.1-4.0, p=0.04. For the rs12592697, the variant T allele was more frequent in Hispanic women and associated with a more progressive disease (OR: 2.05 CI: 1.0-4.0, p=0.04. However, further analysis according to menopausal status showed that the association between these 2 SNPs with disease progression or the stage at diagnosis are confined only to postmenopausal women. The odds ratios of disease progression among postmenopausal women carrying the T allele for the rs4646 and rs12592697 are 3.05 (1.21, 7.74, p=0.02 and 3.80 (1.24, 11.6, p=0.02, respectively. Regardless, differences in disease progression among the different genotypes for both SNPs disappeared after adjustment for treatment. In summary, the rs4646 and the rs12592697 SNPs in CYP19A1 are associated with differences in disease progression in postmenopausal women. However, treatment appears to mitigate the differences in genetic risk.ClinicalTrials.govs Identifier: NCT00322894(https://clinicaltrials.gov/ct2/show/NCT00322894?term=new+mexico+breast+cancer+registry&rank=1

  13. Correlations of differentially expressed gap junction connexins Cx26, Cx30, Cx32, Cx43 and Cx46 with breast cancer progression and prognosis.

    Directory of Open Access Journals (Sweden)

    Ivett Teleki

    Full Text Available Connexins and their cell membrane channels contribute to the control of cell proliferation and compartmental functions in breast glands and their deregulation is linked to breast carcinogenesis. Our aim was to correlate connexin expression with tumor progression and prognosis in primary breast cancers.Meta-analysis of connexin isotype expression data of 1809 and 1899 breast cancers from the Affymetrix and Illumina array platforms, respectively, was performed. Expressed connexins were also monitored at the protein level in tissue microarrays of 127 patients equally representing all tumor grades, using immunofluorescence and multilayer, multichannel digital microscopy. Prognostic correlations were plotted in Kaplan-Meier curves and tested using the log-rank test and cox-regression analysis in univariate and multivariate models.The expression of GJA1/Cx43, GJA3/Cx46 and GJB2/Cx26 and, for the first time, GJA6/Cx30 and GJB1/Cx32 was revealed both in normal human mammary glands and breast carcinomas. Within their subfamilies these connexins can form homo- and heterocellular epithelial channels. In cancer, the array datasets cross-validated each other's prognostic results. In line with the significant correlations found at mRNA level, elevated Cx43 protein levels were linked with significantly improved breast cancer outcome, offering Cx43 protein detection as an independent prognostic marker stronger than vascular invasion or necrosis. As a contrary, elevated Cx30 mRNA and protein levels were associated with a reduced disease outcome offering Cx30 protein detection as an independent prognostic marker outperforming mitotic index and necrosis. Elevated versus low Cx43 protein levels allowed the stratification of grade 2 tumors into good and poor relapse free survival subgroups, respectively. Also, elevated versus low Cx30 levels stratified grade 3 patients into poor and good overall survival subgroups, respectively.Differential expression of Cx43 and Cx

  14. Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression

    Directory of Open Access Journals (Sweden)

    Kasimir-Bauer Sabine

    2011-01-01

    Full Text Available Abstract Background As cell-free circulating DNA exists predominantly as mono- and oligonucleosomes, the focus of the current study was to examine the interplay of circulating nucleosomes, DNA, proteases and caspases in blood of patients with benign and malignant breast diseases. Methods The concentrations of cell-free DNA and nucleosomes as well as the protease and caspase activities were measured in serum of patients with benign breast disease (n = 20, primary breast cancer (M0, n = 31, metastatic breast cancer (M1, n = 32, and healthy individuals (n = 28 by PicoGreen, Cell Death Detection ELISA, Protease Fluorescent Detection Kit and Caspase-Glo®3/7 Assay, respectively. Results Patients with benign and malignant tumors had significantly higher levels of circulating nucleic acids in their blood than healthy individuals (p = 0.001, p = 0.0001, whereas these levels could not discriminate between benign and malignant lesions. Our analyses of all serum samples revealed significant correlations of circulating nucleosome with DNA concentrations (p = 0.001, nucleosome concentrations with caspase activities (p = 0.008, and caspase with protease activities (p = 0.0001. High serum levels of protease and caspase activities associated with advanced tumor stages (p = 0.009. Patients with lymph node-positive breast cancer had significantly higher nucleosome levels in their blood than node-negative patients (p = 0.004. The presence of distant metastases associated with a significant increase in serum nucleosome (p = 0.01 and DNA levels (p = 0.04, and protease activities (p = 0.008. Conclusion Our findings demonstrate that high circulating nucleic acid concentrations in blood are no indicators of a malignant breast tumor. However, the observed changes in apoptosis-related deregulation of proteolytic activities along with the elevated serum levels of nucleosomes and DNA in blood are linked to breast cancer progression.

  15. Expression of Eph receptor A10 is correlated with lymph node metastasis and stage progression in breast cancer patients

    OpenAIRE

    2013-01-01

    Eph receptor A10 (EphA10) is a valuable breast cancer marker that is highly expressed in breast cancer tissues by comparison with normal breast tissues, as we previously reported. However, the role of EphA10 expression in breast cancer is not well understood. Here, we have analyzed the expression of EphA10 at the mRNA- and protein-level in clinical breast cancer tissues and then evaluated the relationship with clinicopathological parameters for each sample. EphA10 mRNA expression was quantifi...

  16. Homocysteine Is an Oncometabolite in Breast Cancer, Which Promotes Tumor Progression and Metastasis

    Science.gov (United States)

    2014-09-01

    diseases and also a pregnancy disorder known as preeclampsia. Polymorphisms in MTHFR that decrease the catalytic activity of the enzyme are common in the...low. Therefore, the nutritional status of individuals in terms of these three vitamins will also have an impact on the growth, progression, and...patients to take vitamin supplements to improve their nutritional status of folic acid, vitamin B12, and pyridoxine so as to reduce the homocysteine

  17. Identification of Substances for Ubiquitin-Dependent Proteolysis During Breast Tumor Progression

    Science.gov (United States)

    2008-10-01

    CENPB CUEDC1 PRKCa* CSNK2A2 PKN2 ANKS4B MATK COPE FLT1* PRKCg* DYRK3 PRKX BTK MCC FES FLT3* PSMD4 EPHA1 ROS1 CCDC69 MINK1 FGFR3 GSK3-beta* RAD23A...TSPAN17 FBXO23, cell adhesion PRRG1 SH3, binds ubiquitin DDR2 RTK, metastasis NEK9 Maintains proper G1 and S progression MYLK2 Cytoskeletal

  18. Genetic Analysis of Ets-2 in Tumor-Associated Macrophages During Breast Cancer Progression

    Science.gov (United States)

    2007-10-01

    The lung lesions were qualitatively analyzed and scored for peripheral macrophage distribution ( pie - chart shown in right) Tahera Zabuawala...similar to that of the controls. Interestingly, the area of the lung lesions is significantly less in the experimentals as compared to those of the...environment cause smaller lung metastatic lesions while having no effects in the primary tumor progression. However, it is not yet clear whether ets-2 is

  19. Index to Nuclear Safety. A technical progress review by chronology, permuted title, and author. Vol 11, No. 1 through Vol. 16, No. 6

    Energy Technology Data Exchange (ETDEWEB)

    Cottrell, W.B.; Klein, A.

    1976-04-01

    This index to Nuclear Safety covers articles in Nuclear Safety Vol. 11, No. 1 (Jan.-Feb. 1970) through Vol. 16, No. 6 (Nov.-Dec. 1975). Included in the index is a chronological list of articles (including abstract) followed by both a KWIC index and an Author Index. Nuclear Safety is a bimonthly technical progress review prepared by the Nuclear Safety Information Center and covers all safety aspects of nuclear power reactors and associated facilities. The index lists over 300 technical articles in the last six years of publication.

  20. Index to Nuclear Safety: a technical progress review by chronology, permuted title, and author. Vol. 11(1)--Vol. 18(6)

    Energy Technology Data Exchange (ETDEWEB)

    Cottrell, W.B.; Klein, A.

    1978-04-11

    This index to Nuclear Safety covers articles published in Nuclear Safety, Vol. 11, No. 1 (January-February 1970), through Vol. 18, No. 6 (November-December 1977). It is divided into three sections: a chronological list of articles (including abstracts) followed by a permuted-title (KWIC) index and an author index. Nuclear Safety, a bimonthly technical progress review prepared by the Nuclear Safety Information Center (NSIC), covers all safety aspects of nuclear power reactors and associated facilities. Over 450 technical articles published in Nuclear Safety in the last eight years are listed in this index.

  1. Index to Nuclear Safety: a technical progress review by chronology, permuted title, and author, Volume 18 (1) through Volume 22 (6)

    Energy Technology Data Exchange (ETDEWEB)

    Cottrell, W.B.; Passiakos, M.

    1982-06-01

    This index to Nuclear Safety covers articles published in Nuclear Safety, Volume 18, Number 1 (January-February 1977) through Volume 22, Number 6 (November-December 1981). The index is divided into three section: a chronological list of articles (including abstracts), a permuted-title (KWIC) index, and an author index. Nuclear Safety, a bimonthly technical progress review prepared by the Nuclear Safety Information Center, covers all safety aspects of nuclear power reactors and associated facilities. Over 300 technical articles published in Nuclear Safety in the last 5 years are listed in this index.

  2. Gr-1+CD11b+ cells are responsible for tumor promoting effect of TGF-β in breast cancer progression.

    Science.gov (United States)

    Li, Zhaoyang; Pang, Yanli; Gara, Sudheer Kumar; Achyut, B R; Heger, Christopher; Goldsmith, Paul K; Lonning, Scott; Yang, Li

    2012-12-01

    One great challenge in our understanding of TGF-β cancer biology and the successful application of TGF-β-targeted therapy is that TGF-β works as both a tumor suppressor and a tumor promoter. The underlying mechanisms for its functional change remain to be elucidated. Using 4T1 mammary tumor model that shares many characteristics with human breast cancer, particularly its ability to spontaneously metastasize to the lungs, we demonstrate that Gr-1+CD11b+ cells or myeloid derived suppressor cells are important mediators in TGF-β regulation of mammary tumor progression. Depletion of Gr-1+CD11b+ cells diminished the antitumor effect of TGF-β neutralization. Two mechanisms were involved: first, treatment with TGF-β neutralization antibody (1D11) significantly decreased the number of Gr-1+CD11b+ cells in tumor tissues and premetastatic lung. This is mediated through increased Gr-1+CD11b+ cell apoptosis. In addition, 1D11 treatment significantly decreased the expression of Th2 cytokines and Arginase 1. Interestingly, the number and property of Gr-1+CD11b+ cells in peripheral blood/draining lymph nodes correlated with tumor size and metastases in response to 1D11 treatment. Our data suggest that the efficacy of TGF-β neutralization depends on the presence of Gr-1+CD11b+ cells, and these cells could be good biomarkers for TGF-β-targeted therapy.

  3. Final Technical Progress Report

    Energy Technology Data Exchange (ETDEWEB)

    J.Y. Hwang; R.C. Greenlund

    2002-12-31

    Michigan Technological University has demonstrated major inroads in establishing the viability of utilizing aluminum smelting by-product waste materials in lightweight concrete product applications. The research identified key elements of producing various forms of lightweight concrete products through utilizing various procedures and mixture components with the by-product materials. A process was developed through pilot plant testing that results in additional aluminum recovery at finer sizes, a clean returnable salt product through spray drying technology, and a low-salt-content oxide product with enough aluminum metal content that it can be used to form lightweight cementitious mixtures. Having three distinct products aids in generating favorable process economics. Revenue projections from aluminum recovery and salt recovery are enough to cover processing costs and create a cost-free oxide product to market for lightweight concrete applications. This supply side commercialization strategy offers aluminum by-product recyclers a potentially no cost product, which has been demonstrated through this project to create desirable and marketable lightweight concrete products of various forms. Environmental benefits to the public are tremendous. At best, all dross and salt cake materials have the potential to be completely recycled and utilized. At worst, disposal sites would see a reduced amount of material: a post processed oxide product with little salt and no hydrogen sulfide or ammonia gas generating capability, which, if isolated from high alkali conditions, would pose no reactivity concerns. The US aluminum industry has historically, along with the steel industry, been a leader in recycling metal. The findings from this project, increased metal recovery, improved salt recycling, and demonstrated end uses for oxide residues, will go a long way in helping the aluminum industry obtain 100% material utilization and zero discharge.

  4. Technical Progress Report

    Energy Technology Data Exchange (ETDEWEB)

    Paul D. Ronney

    2004-08-26

    An ignition source was constructed that is capable of producing a pulsed corona discharge for the purpose of igniting mixtures in a test chamber. The corona generator can also be used as the ignition source for one cylinder on a test engine. The first tests were performed in a cylindrical shaped chamber to study the characteristics of the corona and analyze various electrode geometries. Next a test chamber was constructed that closely represented the dimensions of the combustion chamber of the test engine at USC. Combustion tests were performed in this chamber and various electrode diameters and geometries were tested. Higher peak pressures and faster pressure rise times were realized consistently in all test chambers versus standard spark plug ignition. A test engine was purchased for the project that has two spark plug ports per cylinder to The data acquisition and control system hardware for the USC engine lab was updated with new equipment. New software was also developed to perform the engine control and data acquisition functions including cylinder pressure monitoring. A ceramic corona electrode has been designed that fits in the new test engine and is capable of withstanding the pressures and temperatures encountered inside the combustion chamber. The corona ignition system was tested on the engine and an increase in both peak pressure and IMEP were seen in the initial test. There are issues that must be addressed before on-engine testing can continue such as EMF interference from the corona generator and electrical insulation on portions of the piston and cylinder head to prevent arcing. The EMF issue can be solved with proper shielding and grounding and various ceramic coatings are being researched for electrical insulation.

  5. Botanical inventory of the Rocky Flats AEC site: mapping methods and preliminary maps. Technical progress report, July 31, 1975--April 28, 1976

    Energy Technology Data Exchange (ETDEWEB)

    Webber, P.J.; Clark, S.V.

    1976-01-01

    This Technical Progress Report represents a small but important part of the overall progress and research effort of this contract. It outlines the methods used to produce one 1:12,000 colored vegetation map of the Rocky Flats site and its surrounding area and six black and white 1:500 vegetation maps of intensively studied experimental plots. These maps are already being used by various researchers and it is appropriate that the mapping methods be detailed prior to the final contract report so that their use may be optimised. (auth)

  6. GPHS-RTGs in support of the Cassini Mission. Semi annual technical progress report, 1 April 1996--29 September 1996

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-10-20

    This technical progress report discusses work on the Radioisotope Generators and Ancillary Activities for the Cassini spacecraft. The Cassini spacecraft is expected to launch in October 1997, and will explore Saturn and its moons. This progress report discusses issues in: spacecraft integration and liason, engineering support, safety, qualified unicouple fabrication, ETG fabrication and testing, ground support equipment, RTG shipping and launch support, designs, reviews and mission application. Safety analysis of the RTGs during reentry and launch accidents are covered. This report covers the period of April 1 to September 29, 1996.

  7. Healy clean coal project. Quarterly technical progress report No. 16-19, October 1, 1994--September 30, 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-02-01

    This Quarterly Technical Progress Report is required under U.S. Department of Energy (DOE) Cooperative Agreement, Section XV, {open_quotes}Reporting Requirements{close_quotes} and Attachment C, {open_quotes}Federal Assistance Reporting Checklist{close_quotes}. It covers the period of October 1, 1994 through September 30, 1995. The primary objective of the HCCP is to conduct a cost-sharing project that will demonstrate a new power plant design which features innovative integration of an advanced combustor and heat recovery system coupled with both high and low temperature emission control processes. The parties anticipate that if the demonstration project is successful, the technology could become commercialized in the near term and will be capable of (1) achieving significant reductions in the emissions of sulfur dioxide and the oxides of nitrogen from existing facilities to minimize environmental impacts such as transboundary and interstate pollution and/or (2) providing for future energy needs in an environmentally acceptable manner. The primary equipment elements comprising this new power plant design includes entrained combustion systems coupled with a boiler which will produce low NOx levels, function as a limestone calciner and first stage SO{sub 2} remover in addition to its heat recovery function; a single spray dryer absorber vessel for second stage sulfur removal; a baghouse for third stage sulfur and particulate removal; and a lime activation system which recovers unused reagent from particulate collected in the baghouse. The emission levels Of SO{sub 2}, NOx, and particulate to be demonstrated are expected to be better than the federal New Source Performance Standards (NSPS).

  8. 新世纪不饱和聚酯树脂纵横谈%TECHNICAL PROGRESS OF UNSATURATED POLYESTER RESIN AT HOME AND ABROAD IN THE NEW CENTURY

    Institute of Scientific and Technical Information of China (English)

    蔡永源; 于同福

    2001-01-01

    从国内外不同视角和纵横面,阐述目前国内外不饱和聚酯树脂(UPR)高分子材料发展概况、用途分配、加工及技术进展。%The production capacity,processing technology application and technical progress of unsaturated polyester resins at home and abroad in the new century were discribed in this paper.

  9. 乳腺癌骨转移分子机制研究进展%Research progress on the molecular mechanism of breast cancer bone metastasis

    Institute of Scientific and Technical Information of China (English)

    曾慧娟(综述); 王少华(审校)

    2015-01-01

    Breast cancer is one of the most common malignant tumors in women. Bone is commonly affected in the context of metastatic breast cancer.Once bone metastasis happens, patient would experience poor prognosis and impaired quality of life.However, there is a lack of approaches for more sensitive and specific diagnosis and treatments for breast cancer bone metastasis.Thus, it is im-perative to find new treatment target from molecular mechanism.In this paper, we review the current research progress on the molecular mechanism from several levels including gene profile, proteins and microRNAs.We also review the establishment of animal models of breast cancer bone metastasis.With the achievements acquired in the completed or undergoing researches on breast cancer bone metasta-sis, we hope the finding of the optimal diagnostic and therapeutic targets could lead the breast cancer research into a new era.%乳腺癌是女性最常见的恶性肿瘤之一,骨为其最易发生转移的部位。一旦发生骨转移,患者预后及生活质量明显下降,然而目前仍缺乏有力证据证实的、能够应用于临床的特异性诊疗手段。因此,迫切需要从其分子机制入手,寻找新的分子靶点。文中就乳腺癌骨转移在基因、蛋白及miRNA3个层面机制的研究进展作一综述,并阐述了乳腺癌骨转移动物模型的建立方法。

  10. Evaluation of the expression of stem cell markers in human breast cancer reveals a correlation with clinical progression and metastatic disease in ductal carcinoma.

    Science.gov (United States)

    Martin, Tracey Amanda; Jiang, Wen Guo

    2014-01-01

    The tumor stem cell theory could explain how patients with metastatic disease show clinical relapse several months after starting treatment due to the survival of a small group of cells with unique characteristics. We examined the distribution and expression of a panel of stem cell markers in human breast cancer primary tumors. Human breast tissues were processed for immunohistochemistry, and RNA was extracted for analysis by quantitative-PCR. Immunohistochemical assay revealed that CD44 was strongly expressed in background endothelia and epithelia. CD133 expression was lost in tumor-associated endothelial cells. Conversely, CD49b was strongly stained in the tumors, associated vessels and ducts but was weakly stained in the background epithelia. q-PCR analysis revealed that CD44 and PSCA were reduced in patients with poor outcome (metastatic disease and death from breast cancer), with a marked reduction in ductal carcinoma, particularly with metastasis to bone although these did not reach significant difference. CD133 was significantly reduced in patients with metastatic disease and was also significantly reduced in patients with ductal carcinoma/bone metastasis. Conversely, CD49F was increased in patients with a poor outcome and those with ductal cancer and bone metastases. This is the first study to determine the distribution and expression pattern of these stem cell markers in human breast cancer. There was a significant association between loss of expression and metastatic disease in patients with breast cancer. Such differential expression may play a part in breast cancer disease progression, and suggests that the current stem cell theory may not hold true for all cancer types.

  11. Progress in HER2 testing in breast cancer: multiplex ligation-dependent probe amplification and automated immunohistochemistry

    NARCIS (Netherlands)

    Moelans, C.B.

    2009-01-01

    One of the most frequent genetic changes in sporadic breast cancer is amplification of the HER2 gene, usually resulting in protein overexpression on the cell membrane and growth activation of the cells. Breast cancer patients that have this HER2 amplification have a worse prognosis but can be treate

  12. Inflammatory lipid sphingosine-1-phosphate upregulates C-reactive protein via C/EBPβ and potentiates breast cancer progression

    NARCIS (Netherlands)

    Kim, E.S.; Cha, Y.; Ham, M.; Jung, J.; Kim, S.G.; Hwang, S.; Kleemann, R.; Moon, A.

    2014-01-01

    A crucial role of the inflammatory lipid sphingosine-1-phosphate (S1P) in breast cancer aggressiveness has been reported. Recent clinical studies have suggested that C-reactive protein (CRP) has a role in breast cancer development. However, limited information is available on the molecular basis for

  13. Technical reliability of geological disposal for high-level radioactive wastes in Japan. The second progress report. Part 1. Geological environment of Japan

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1999-11-01

    Based on the Advisory Committee Report on Nuclear Fuel Cycle Backend Policy submitted to the Japanese Government in 1997, JNC documents the progress of research and development program in the form of the second progress report (the first one published in 1992). It summarizes an evaluation of the technical reliability and safety of the geological disposal concept for high-level radioactive wastes (HLW) in Japan. The present document, the part 1 of the progress report, describes first in detail the role of geological environment in high-level radioactive wastes disposal, the features of Japanese geological environment, and programs to proceed the investigation in geological environment. The following chapter summarizes scientific basis for possible existence of stable geological environment, stable for a long period needed for the HLW disposal in Japan including such natural phenomena as volcano and faults. The results of the investigation of the characteristics of bed-rocks and groundwater are presented. These are important for multiple barrier system construction of deep geological disposal. The report furthermore describes the present status of technical and methodological progress in investigating geological environment and finally on the results of natural analog study in Tono uranium deposits area. (Ohno, S.)

  14. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells.

    Science.gov (United States)

    Katdare, Meena; Osborne, Michael; Telang, Nitin T

    2002-10-01

    In the multistep progressive pathogenesis of human breast cancer, comedo ductal carcinoma in situ (DCIS) represents a preinvasive precursor lesion for therapy resistant invasive cancer. Human tissue derived cell culture models exhibiting molecular similarities to clinical DCIS facilitate an important preclinical mechanistic approach for evaluation of preventive efficacy of natural and synthetic chemopreventive compounds. Natural phytochemicals present in fresh fruits, vegetables and grain products are likely to offer protection against cancer. The clinical efficacy of these natural phytochemicals, however, depends on extrapolation, and is therefore equivocal. The present study determined whether the natural soy isoflavone genistein (GEN) inhibited aberrant proliferation in 184-B5/HER cells (a model for human comedo DCIS) and identified possible mechanisms responsible for its efficacy. Human reduction mammoplasty derived HER-2/neu oncogene expressing preneoplastic 184-B5/HER cells represented the experimental system. Flow cytometry and cellular epifluorescence based assays were utilized to quantitate the alterations in cell cycle progression, cellular apoptosis, and in the status of cell cycle regulatory and apoptosis-associated gene product expression. The 184-B5/HER cells exhibited specific immunofluorescence to p185HER, p53, EGFR, but not to ERalpha, thus resembling comedo DCIS. Treatment of 184-B5/HER cells with GEN resulted in a dose-dependent decrease in the viable cell population, increase in the G0/G1:S + G2/M ratio and enhancement of sub G0/G1 (apoptotic population). Exposure to the maximum cytostatic 10 microM dose of GEN down-regulated HER-2/neu mediated signal transduction as evidenced by a 73.9% decrease (p=0.001) in p185HER specific, and a 89.8% decrease (p=0.001) in phosphotyrosine specific immunofluorescence. The increase in G0/G1:S + G2/M ratio in response to the treatment with 10 microM GEN was associated with a 85.5% decrease (p=0.001) in

  15. Research Progress of Breast Reconstruction after Breast Cancer Operation%乳腺癌术后乳房再造整形的研究进展

    Institute of Scientific and Technical Information of China (English)

    王灿

    2013-01-01

    Breast cancer is one of the most common malignant tumors threatening female life, the onset age of which shows a down tendency. The traditional operation treatment of breast cancer destroys the graceful female sexuality and the figure, which causes great psychological trauma to the patients, severely impacting the postoperative quality of life. Europe and the US have more mature experiences in breast reconstruction after breast cancer operation, which not only alleviate the mental stress and mood disorders due to the loss of breast and recover the patients confidence and social participation awareness, but also greatly improve the postoperative quality of life of the breast cancer patients.%乳腺癌是威胁女性生命最常见的恶性肿瘤之一,其发生有年轻化的趋势.传统的乳腺癌手术在治疗的同时也破坏了女性优美的性征和曲线,给患者造成极大的心理创伤,严重影响术后生存质量.欧美国家在乳腺癌术后乳房再造有较成熟的经验,不仅可以缓解患者因失去乳房而导致的心理压力和情绪障碍,恢复患者的自信与和社会参与意识,而且可以极大地提高乳腺癌患者术后的生活质量.

  16. Design, construction, operation and evaluation of a prototype culm combustion boiler/heater unit. Technical progress report, October 1-December 31, 1979

    Energy Technology Data Exchange (ETDEWEB)

    1980-02-01

    This report provides a summary of the work performed on the Prototype Culm Combustion Boiler/Heater Unit, Phase I - Engineering Design and Analysis and Limited Phase II - Prototype Plant Construction during the period October 1, 1979 through December 31, 1979. The objectives of the program as well as the technical progress and problem areas encountered are presented. Progress on the components and system engineering studies is described. The Preliminary Design of Prototype Unit Topical Report was submitted. Final design activity is continuing and the progress on drawing preparation and advanced procurement activity is discussed. Based on authorization for a limited amount of Phase II activity, initial Purchase Orders were released authorizing preparation of certified drawings for fabricated equipment required to support the Phase I final design activity. The Purchase Order for site clearance and installation of boiler foundations was awarded and ground breaking ceremonies were held at the Prototype Culm Combustion Boiler site in Paxinos, Pennsylvania, on December 7, 1979.

  17. Gain-of-function of mutant p53: mutant p53 enhances cancer progression by inhibiting KLF17 expression in invasive breast carcinoma cells.

    Science.gov (United States)

    Ali, Amjad; Shah, Abdus Saboor; Ahmad, Ayaz

    2014-11-01

    Kruppel-like-factor 17 (KLF17) is a negative regulator of metastasis and epithelial-mesenchymal-transition (EMT). However, its expression is downregulated in metastatic breast cancer that contains p53 mutations. Here, we show that mutant-p53 plays a key role to suppress KLF17 and thereby enhances cancer progression, which defines novel gain-of-function (GOF) of mutant-p53. Mutant-p53 interacts with KLF17 and antagonizes KLF17 mediated EMT genes transcription. Depletion of KLF17 promotes cell viability, decreases apoptosis and induces drug resistance in metastatic breast cancer cells. KLF17 suppresses cell migration and invasion by decreasing CD44, PAI-1 and Cyclin-D1 expressions. Taken together, our results show that KLF17 is important for the suppression of metastasis and could be a potential therapeutic target during chemotherapy.

  18. 超声在乳腺癌治疗中应用的研究进展%Progress of ultrasound in treatment of breast cancer

    Institute of Scientific and Technical Information of China (English)

    张群霞

    2011-01-01

    Ultrasound plays an important role in clinical diagnosis of breast cancer. With the rapid development of ultrasonic molecular imaging, ultrasound combined with microbubbles have shown great potential in chemotherapy, gene therapy and other treatment fields of this disease. This article reviews the progress of ultrasound in treatment of breast cancer.%超声在乳腺癌临床诊断中发挥着重要作用.随着超声分子影像学的快速发展,单纯超声及超声联合微泡在乳腺癌化疗、基因治疗等领域显示出巨大潜力.本文就超声在乳腺癌治疗中的研究进展做一简要综述.

  19. A high protein moderate carbohydrate diet fed at discrete meals reduces early progression of N-methyl-N-nitrosourea-induced breast tumorigenesis in rats

    Directory of Open Access Journals (Sweden)

    Singletary Keith W

    2010-01-01

    Full Text Available Abstract Breast cancer is the most prevalent cancer in American women. Dietary factors are thought to have a strong influence on breast cancer incidence. This study utilized a meal-feeding protocol with female Sprague-Dawley rats to evaluate effects of two ratios of carbohydrate:protein on promotion and early progression of breast tissue carcinomas. Mammary tumors were induced by N-methyl-N-nitrosourea (MNU at 52 d of age. Post-induction, animals were assigned to consume either a low protein high carbohydrate diet (LPHC; 15% and 60% of energy, respectively or a high protein moderate carbohydrate diet (HPMC; 35% and 40% of energy, respectively for 10 wk. Animals were fed 3 meals/day to mimic human absorption and metabolism patterns. The rate of palpable tumor incidence was reduced in HPMC relative to LPHC (12.9 ± 1.4%/wk vs. 18.2 ± 1.3%/wk. At 3 wk, post-prandial serum insulin was larger in the LPHC relative to HPMC (+136.4 ± 33.1 pmol/L vs. +38.1 ± 23.4 pmol/L, while at 10 wk there was a trend for post-prandial IGF-I to be increased in HPMC (P = 0.055. There were no differences in tumor latency, tumor surface area, or cumulative tumor mass between diet groups. The present study provides evidence that reducing the dietary carbohydrate:protein ratio attenuates the development of mammary tumors. These findings are consistent with reduced post-prandial insulin release potentially diminishing the proliferative environment required for breast cancer tumors to progress.

  20. Technical reliability of geological disposal for high-level radioactive wastes in Japan. The second progress report. Introductory part and summaries

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1999-11-01

    Based on the Advisory Committee Report on Nuclear Fuel Cycle Backend Policy submitted to the Japanese Government in 1997, JNC documents the progress of research and development program in the form of the second progress report (the first one published in 1992). It summarizes an evaluation of the technical reliability and safety of the geological disposal concept for high-level radioactive wastes (HLW) in Japan and comprises seven chapters. Chapter I briefly describes the importance of HLW management in promoting nuclear energy utilization. According to the long-term program, the HLW separated from spent fuels at reprocessing plants is to be vitrified and stored for a period of 30 to 50 years to allow cooling, then be disposed of in a deep geological formation. Chapter II mainly explains the concepts of geological disposal in Japan. Chapters III to V are devoted to discussions on three important technical elements (the geological environment of Japan, engineering technology and safety assessment of the geological disposal system) which are necessary for reliable realization of the geological disposal concept. Chapter VI demonstrates the technical ground for site selection and for setup of safety standards of the disposal. Chapter VII summarizes together with plans for future research and development. (Ohno, S.)

  1. Three negative breast cancer drug treatment progress%三阴性乳腺癌的药物治疗进展

    Institute of Scientific and Technical Information of China (English)

    李学梅; 周蕾蕾(综述)

    2015-01-01

    乳腺癌是我国女性最常见的恶性肿瘤之一。三阴性乳腺癌(triple negative breast cancer,TNBC)是具有特殊生物学及临床病理学特征的乳腺癌亚型,以雌激素受体(estrogen receptor,ER)、孕激素受体(progesterone receptor,PR)和人类表皮生长因子受体2(human epidermal growth factor receptor 2,HER-2)表达均为阴性为其主要特征。具有侵袭性强、进展快、生存率低和预后较其他类型乳腺癌差的特点。由于缺乏有效的内分泌治疗及靶向治疗,目前以蒽环类为基础的化疗为主,但疗效欠佳,容易早期局部复发和远处转移,同时该组肿瘤具有高度异质性,因此三阴性乳腺癌的治疗成为了研究的热点。本文将近些年来有关TNBC的治疗进展予以综述。%Breast cancer is one of the most common malignant tumor in women in our country. Three negative breast cancer (triple negative breast cancer, TNBC) is a special biological and clinical pathological features of breast cancer subtypes, for estrogen receptors, estrogen receptor, ER) and progesterone receptor, progesterone receptor, PR) and human epidermal growth factor receptor 2 (human epidermal growth factor receptor 2, its ehrs-2) expression were negative for the main features. With strong aggressive, quick progress, low survival rate and prognosis of the characteristics of the poor than other types of breast cancer. Due to the lack of effective endocrine therapy and targeted therapy, is based on the anthracycline-based chemotherapy is given priority to, but poor curative effect, easy early local recurrence and distant metastasis, tumor with high heterogeneity, and the group so three negative treatment for breast cancer has become the research hot spot. This article will review on the treatment of TNBC in recent years.

  2. Great Plains Coal Gasification Project: Quarterly technical progress report, April-June 1988 (Fourth fiscal quarter, 1987-1988)

    Energy Technology Data Exchange (ETDEWEB)

    1988-07-29

    This progress report describes the operation of the Great Plains Gasification Plant, including lignite coal production, SNG production, gas quality, by-products, and certain problems encountered. (LTN)

  3. Salivary Protein Profiles among HER2/neu-Receptor-Positive and -Negative Breast Cancer Patients: Support for Using Salivary Protein Profiles for Modeling Breast Cancer Progression

    Directory of Open Access Journals (Sweden)

    Charles F. Streckfus

    2012-01-01

    Full Text Available Purpose. The objective of this study was to compare the salivary protein profiles from individuals diagnosed with breast cancer that were either HER2/neu receptor positive or negative. Methods. Two pooled saliva specimens underwent proteomic analysis. One pooled specimen was from women diagnosed with stage IIa HER2/neu-receptor-positive breast cancer patients (n=10 and the other was from women diagnosed with stage IIa HER2/neu-receptor-negative cancer patients (n=10. The pooled samples were trypsinized and the peptides labeled with iTRAQ reagent. Specimens were analyzed using an LC-MS/MS mass spectrometer. Results. The results yielded approximately 71 differentially expressed proteins in the saliva specimens. There were 34 upregulated proteins and 37 downregulated proteins.

  4. 动力锂电池隔膜的技术要求及研究进展%Technical Requirements of Power Lithium Battery Diaphragm and Research Progress

    Institute of Scientific and Technical Information of China (English)

    李登科; 王丹

    2014-01-01

    This artical introduced the technical requirements of power lithium battery diaphragm, focused on the research progress of nonwoven membrane at home and abroad, nano fiber membrane, PA diaphragm, organic/inorganic composite film, ceramic coating membrane and other new diaphragm.%介绍了动力锂电池对隔膜的技术要求,重点介绍国内外无纺布隔膜、纳米纤维隔膜、PA隔膜,有机/无机复合膜,陶瓷涂层隔膜等新型隔膜的研究进展。

  5. GPHS-RTGs in support of the Cassini mission. Semi annual technical progress report, 2 October 1995--31 March 1996

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-04-20

    The technical progress achieved during the period 2 October 1995 through 31 March 1996 on Contract No. DE-AC03-91SF18852, Radioisotope Generators and Ancillary Activities is described herein. This report is organized by the program task structure as follows: spacecraft integration and liaison; engineering support; safety; qualified unicouple fabrication; ETG fabrication, assembly, and test; ground support equipment (GSE); RTG shipping and launch support; designs, reviews, and mission applications; project management, quality assurance and reliability, contract changes, non-capital CAGO acquisition, and CAGO maintenance; contract acquired government-owned property (CAGO) acquisition; and program calendars.

  6. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer

    Science.gov (United States)

    Du, Guifang; Gu, Yanan; Hao, Chengcheng; Yuan, Zhu; He, Junqi; Jiang, Wen G.; Cheng, Shan

    2016-01-01

    The oncogenic role of ectopic expression of Na+/H+ exchanger regulatory factor 1 (NHERF1) was recently suggested. Here, we show that NHERF1 was upregulated in high grades compared with low grades. Increased NHERF1 expression was correlated with poor prognosis and poor survival. NHERF1 expression was higher in the nucleus of cancer cells than in contiguous non- mammary epithelial cells. A novel mutation, namely NHERF1 Y24S, was identified in human breast cancer tissues and shown to correspond to a conserved residue in the PDZ-I domain of NHERF1. Truncation and mutation of the PDZ-I domain of NHERF1 increased the nuclear distribution of the NHERF1 protein, and this redistribution was associated with the malignant phenotype of breast cancer cells, including growth, migration, and adhesion. The present results suggest a role for NHERF1 in the progression of breast cancer mediated by the nuclear distribution of the NHERF1 protein, as determined by the truncation or key site mutation of the PDZ-I domain. PMID:27097111

  7. Progress on diagnosis and treatment of early young female breast cancer%年轻女性早期乳腺癌诊治进展

    Institute of Scientific and Technical Information of China (English)

    章颖; 柳光宇(审校)

    2016-01-01

    Breast cancer is the most common cancer in women. Compared with older patients, young breast cancer has unique clinicopathological characteristics, with lower detective rate and worse prognosis. Multidisciplinary individual-based therapy is of great significance in maximizing therapeutic benefits, as well as minimizing their side effects. Today more and more young patients are eager to reserve reproductive functions at the same time. This article reviews the progress on screen⁃ing and diagnostic measures, comprehensive treatments, and reproductive endocrine problems brought by therapies in early young breast cancer.%乳腺癌位于女性癌症发病之首。相较年长患者,年轻乳腺癌有其独特的临床病理特征,检出率较低,预后也更差。个体化、多学科治疗对最大化疗效,减少不良反应尤为重要;且越来越多年轻女性在关注治疗效果的同时要求保留生殖内分泌功能。本文就年轻乳腺癌的诊断筛查方法、综合治疗进展、治疗产生的生殖内分泌问题等方面进行综述。

  8. Technical support services to assist the Office of Environmental Audit in conducting the DOE Environmental Survey and to provide technical assistance on Environmental Compliance issues. Technical progress report, February 16, 1990--August 13, 1990

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-07-01

    NUS received authorization from DOE on August 14, 1987 to provide technical support services to assist the Office of Environmental Audit (OEV) in conducting the DOE Environmental Survey and to provide technical assistance on environmental compliance issues. The overall contract is to accomplish a one-time, no-fault baseline Survey of all DOE operating facilities, and to provide technical assistance and support for the resolution of environmental compliance issues. NUS has completed the Preliminary Reports and continues to support DOE on the Prioritization and Tiger Team Assessment efforts. The project requires a broad range of environmental protection expertise, necessitating senior-level personnel as the primary project staff. Many of the tasks assigned by DOE require quick startup and performance, and several tasks may be active at any one time.

  9. Bench-scale testing of on-line control of column flotation using a novel analyzer. Second quarterly technical progress report, January 1, 1993--March 31, 1993

    Energy Technology Data Exchange (ETDEWEB)

    1993-04-16

    This document contains the second quarterly technical progress report for PTI`s Bench-Scale Testing Project of a circuit integrating PTI`s KEN-FLOTE{trademark} Column Flotation Technology and PTI`s On-Line Quality Monitor and Control System. The twelve-month project involves installation and testing of a 200--300 lb/hr. bench-scale testing circuit at PETC`s Coal Preparation Process Research Facility (CPPRF) for two bituminous coals (Upper Freeport and Pittsburgh No. 8 Seam Raw Coals). The project schedule timeline by task series for the twelve month project, as it was laid out in the initial Project Work Plan. At the present time, all tasks are progressing according to schedule with the exception of the Task 800 Circuit Testing and Sample Prep and Task 1000 Circuit Decommissioning, which have slipped approximately five weeks due to delays incurred within in the project.

  10. Design, construction, operation, and evaluation of a prototype culm-combustion boiler/heater unit. Quarterly technical progress report, October 1-December 31, 1980

    Energy Technology Data Exchange (ETDEWEB)

    1981-02-01

    This report provides a summary of the work performed on the Prototype Culm Combustion Boiler/Heater Unit, Phase I - Engineering Design and Analysis and Phase II - Prototype Plant Construction during the period October 1, 1980 through December 31, 1980. The objectives of the program as well as the technical progress and problem areas encountered during the reporting period are presented. The final detail design effort was completed and the final design report submitted. Progress on procurement activity authorized by full Phase II release on March 20, 1980, is discussed. Following approval by DOE, a purchase order was placed with the Norflor Construction Corporation for the prototype plant construction which began in November. Construction of the access roadway installation of the electric power, sewer and water lines was completed during this reporting period. Boiler construction continued.

  11. Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression.

    Science.gov (United States)

    Zhao, Yingshe; Kumbrink, Joerg; Lin, Bor-Tyh; Bouton, Amy H; Yang, Shi; Toselli, Paul A; Kirsch, Kathrin H

    2013-12-01

    Elevated expression of p130Cas (Crk-associated substrate)/BCAR1 (breast cancer antiestrogen resistance 1) in human breast tumors is a marker of poor prognosis and poor overall survival. p130Cas is a downstream target of the tyrosine kinase c-Src. Signaling mediated by p130Cas through its phosphorylated substrate domain (SD) and interaction with effector molecules directly promotes tumor progression. We previously developed a constitutively phosphorylated p130Cas SD molecule, Src*/SD (formerly referred to as Src*/CasSD), which acts as decoy molecule and attenuates the transformed phenotype in v-crk-transformed murine fibroblasts and human breast cancer cells. To test the function of this molecule in vivo, we established mouse mammary tumor virus (MMTV)-long terminal repeat-Src*/SD transgenic mice in which mammary gland development and tumor formation were analyzed. Transgenic expression of the Src*/SD molecule under the MMTV-long terminal repeat promoter did not interfere with normal mammary gland development or induce tumors in mice observed for up to 11 months. To evaluate the effects of the Src*/SD molecule on tumor development in vivo, we utilized the MMTV-polyoma middle T-antigen (PyMT) murine breast cancer model that depends on c-Src. PyMT mice crossed with Src*/SD mice displayed accelerated tumor formation. The earlier onset of tumors can be explained by the interaction of the Src* domain with PyMT and targeting the fused phosphorylated SD to the membrane. At membrane compartments, it might integrate membrane-associated active signaling complexes leading to increased proliferation measured by phospho-Histone H3 staining. Although these results were unexpected, they emphasize the importance of preventing the membrane association of Src*/SD when employed as decoy molecule.

  12. 疏肝解郁法治疗乳腺癌进展%Progress of Breast Cancer Treatment by Relieving Depression of the Liver-qi

    Institute of Scientific and Technical Information of China (English)

    华琼博; 郭勇

    2015-01-01

    Breast cancer is one of the most common malignant tumor in women.In our country,the incidence of breast cancer shows a rapidly upward trend which has become the female's highest morbidity of malignant tumors.Traditional Chinese medicine( TCM) is one of the important therapeutic method for treating breast cancer.TCM believes that stagnation of liver-qi is closely related to the forma-tion,progression and prognosis of Ru Yan,and it thinks highly of relieving depression of the liver-qi.A large number of ancient physi-cians and modern researches have confirmed the effects of it.In this paper,treating breast cancer by relieving depression of the liver-qi will be preliminarily explored.%乳腺癌是女性最常见的恶性肿瘤之一,在我国,乳腺癌的发病率呈现快速上升的趋势,已然成为女性恶性肿瘤发病率之首。中医药是治疗乳腺癌的重要方法之一,中医认为乳岩的发生、发展、预后与肝气郁结密切相关,中药治以疏肝解郁,疗效显著。大量古代医家和现代研究证实疏肝解郁对于乳腺癌的疗效。本文就疏肝解郁法治疗乳腺癌作初步探讨。

  13. Analysis of the effects of exposure to acute hypoxia on oxidative lesions and tumour progression in a transgenic mouse breast cancer model

    Directory of Open Access Journals (Sweden)

    Lunt Sarah

    2008-05-01

    Full Text Available Abstract Background Tumour hypoxia is known to be a poor prognostic indicator, predictive of increased risk of metastatic disease and reduced survival. Genomic instability has been proposed as one of the potential mechanisms for hypoxic tumour progression. Both of these features are commonly found in many cancer types, but their relationship and association with tumour progression has not been examined in the same model. Methods To address this issue, we determined the effects of 6 week in vivo acute hypoxic exposure on the levels of mutagenic lipid peroxidation product, malondialdehyde, and 8-oxo-7,8-dihydro-2'-deoxyguanosine DNA (8-oxo-dG lesions in the transgenic polyomavirus middle T (PyMT breast cancer mouse model. Results We observed significantly increased plasma lipid peroxidation and 8-oxo-dG lesion levels in the hypoxia-exposed mice. Consumption of malondialdehyde also induced a significant increase in the PyMT tumour DNA lesion levels, however, these increases did not translate into enhanced tumour progression. We further showed that the in vivo exposure to acute hypoxia induced accumulation of F4/80 positive tumour-associated macrophages (TAMs, demonstrating a relationship between hypoxia and macrophages in an experimental model. Conclusion These data suggest that although exposure to acute hypoxia causes an increase in 8-oxo-dG lesions and TAMs in the PyMT tumours, these increases do not translate into significant changes in tumour progression at the primary or metastatic levels in this strong viral oncogene-driven breast cancer model.

  14. Search for major genes with progeny test data to accelerate the development of genetically superior loblolly pine. Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2000-02-15

    This report details the progress of the three tasks of this project. The tasks are: (1) develop genetic models and analytical methods; (2) molecular confirmation of major gene segregation; and (3) develop strategies for marker-assisted breeding.

  15. Quantification of the N-glycosylated secretome by super-SILAC during breast cancer progression and in human blood Samples

    DEFF Research Database (Denmark)

    Boersema, P.J.; Geiger, T.; Wiśniewski, J.R.

    2013-01-01

    that are representative of different stages of breast cancer development by specifically capturing N-glycosylated peptides using the N-glyco FASP technology. For accurate quantification we developed a super-SILAC mix from several labeled breast cancer cell lines and used it as an internal standard for all samples....... In total, 1398 unique N-glycosylation sites were identified and quantified. Enriching for N-glycosylated peptides focused the analysis on classically secreted and membrane proteins. N-glycosylated secretome profiles correctly clustered the different cell lines to their respective cancer stage, suggesting...... that biologically relevant differences were detected. Five different profiles of glycoprotein dynamics during cancer development were detected, and they contained several proteins with known roles in breast cancer. We then used the super-SILAC mix in plasma, which led to the quantification of a large number...

  16. Evaluation of the technical performance of three different commercial digital breast tomosynthesis systems in the clinical environment.

    Science.gov (United States)

    Rodríguez-Ruiz, A; Castillo, M; Garayoa, J; Chevalier, M

    2016-06-01

    The aim of this work was to research and evaluate the performance of three different digital breast tomosynthesis (DBT) systems in the clinical environment (Siemens Mammomat Inspiration, Hologic Selenia Dimensions, and Fujifilm Amulet Innovality). The characterization included the study of the detector, the automatic exposure control, and the resolution of DBT projections and reconstructed planes. The modulation transfer function (MTF) of the DBT projections was measured with a 1mm thick steel edge, showing a strong anisotropy (30-40% lower MTF0.5 frequencies in the tube travel direction). The in-plane MTF0.5, measured with a 25μm tungsten wire, ranges from 1.3 to 1.8lp/mm in the tube-travel direction and between 2.4 and 3.7lp/mm in the chest wall-nipple. In the latter direction, the MTF peak shift is more emphasized for large angular range systems (2.0 versus 1.0lp/mm). In-depth resolution of the planes, via the full width at half maximum (FWHM) from the point spread function of a 25μm tungsten wire, is not only influenced by angular range and yields 1.3-4.6mm among systems. The artifact spread function from 1mm diameter tungsten beads depends mainly on angular range, yielding two tendencies whether large (FWHM is 4.5mm) or small (FWHM is 10mm) angular range is used. DBT delivers per scan a mean glandular dose between 1.4 and 2.7mGy for a 45mm thick polymethyl methacrylate (PMMA) block. In conclusion, we have identified and analysed specific metrics that can be used for quality assurance of DBT systems.

  17. A systematic assessment of the state of hazardous waste clean-up technologies. Quarterly technical progress report, April 1--June 30, 1993

    Energy Technology Data Exchange (ETDEWEB)

    Berg, M.T.; Reed, B.E.; Gabr, M.

    1993-07-01

    West Virginia University (WVU) and the US DOE Morgantown Energy Technology Center (METC) entered into a Cooperative Agreement on August 29, 1992 entitled ``Decontamination Systems Information and Research Programs.`` Stipulated within the Agreement is the requirement that WVU submit to METC a series of Technical Progress Report for Year 1 of the Agreement. This report reflects the progress and/or efforts performed on the following nine technical projects encompassed by the Year 1 Agreement for the period of April 1 through June 30, 1993: Systematic assessment of the state of hazardous waste clean-up technologies; site remediation technologies -- drain-enhanced soil flushing (DESF) for organic contaminants removal; site remediation technologies -- in situ bioremediation of organic contaminants; excavation systems for hazardous waste sites; chemical destruction of polychlorinated biphenyls; development of organic sensors -- monolayer and multilayer self-assembled films for chemical sensors; Winfield lock and dam remediation; Assessments of Technologies for hazardous waste site remediation -- non-treatment technologies and pilot scale test facility implementation; and remediation of hazardous sites with stream reforming.

  18. PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo

    Directory of Open Access Journals (Sweden)

    Chiang KC

    2015-08-01

    Full Text Available Kun-Chun Chiang,1,4 Huang-Yang Chen,1 Shu-Yuan Hsu,2 Jong-Hwei S Pang,3 Shang-Yu Wang,4 Jun-Te Hsu,4 Ta-Sen Yeh,4 Li-Wei Chen,5 Sheng-Fong Kuo,6 Chi-Chin Sun,7 Jim-Ming Lee,1 Chun-Nan Yeh,4 Horng-Heng Juang21Department of General Surgery, Chang Gung Memorial Hospital, Chang Gung University, Keelung, 2Department of Anatomy, 3Graduate Institute of Clinical Medical Sciences, 4Department of General Surgery, 5Department of Gastroenterology, 6Department of Endocrinology and Metabolism, 7Department of Ophthalmology, Chang Gung Memorial Hospital, Chang Gung University, Keelung, Taiwan, Republic of China Abstract: Phosphatase and tensin homolog (PTEN, a well-known tumor suppressor gene and frequently mutated or lost in breast cancer, possesses the negative regulation function over the PI3K/Akt/mTOR pathway. PTEN insufficiency has been associated with advanced breast cancer and poor prognosis of breast cancer patients. Recently, target therapies aimed at PI3K/Akt/mTOR pathway to treat breast cancer have got popularity. However, the exact effect of PTEN on breast cancer cells is still not well understood. This study demonstrated that PTEN knockdown in MCF-7 cells strengthened the downstream gene expressions, including p-Akt, p-ERK1/2, p-mTOR, p-p70s6k, and p-GSK3ß. PTEN knockdown MCF-7 cells had increased cell growth and Ki-67 expression. Further Western blot demonstrated that p27 was repressed obviously with p21 slightly inhibited and CDK1, 2, 4, 6, cyclin A, and Cdc25C were upregulated in MCF-7 PTEN knockdown cells, leading to the higher growth rate. More importantly, PTEN knockdown MCF-7 cells had higher tumorigenesis and tumor growth in vivo. From our current work, we provided more detailed PTEN-mediated mechanisms to stimulate ER+ breast cancer cell growth. Our result may pave the way for further target therapy development used alone or in combination with other drugs for ER+ breast cancer with PTEN insufficiency.Keywords: PTEN, breast cancer, MCF-7

  19. Estrogen-Mediated Upregulation of Noxa Is Associated with Cell Cycle Progression in Estrogen Receptor-Positive Breast Cancer Cells

    OpenAIRE

    2011-01-01

    Noxa is a Bcl-2-homology domain (BH3)-only protein reported to be a proapoptotic member of the Bcl-2 family. Estrogen has been well documented to stimulate cell growth and inhibit apoptosis in estrogen receptor (ER)-positive breast cancer cells. Intriguingly, recent reports have shown that 17β-estradiol (E2) induces Noxa expression, although the mechanisms underlying E2-mediated induction of Noxa and its functional significance are unknown. Using MCF7 human breast cancer cells as an experimen...

  20. Developing and upgrading of solar system thermal energy storage simulation models. Technical progress report, March 1, 1978-August 31, 1978

    Energy Technology Data Exchange (ETDEWEB)

    Kuhn, J K; von Fuchs, G F; Warren, A W; Zob, A P

    1979-07-01

    The objective of the program are: 1) collect, standardize, and link existing TES models from the literature and other STO contractors; 2) correlate TES models with available TES component test data; 3) develop streamlined versions of validated TES component models; and 4) provide DOE and industry with a competent solar TES simulation tool. Progress during the reporting period was concerned primarily with the first and second objectives. A rock bed model was evolved and analytical results were correlated with component test data, and water tank model development was continued in detail. Progress is detailed. (WHK)

  1. Silicon ribbon growth by a capillary action shaping technique. Annual report (Quarterly technical progress report No. 9)

    Energy Technology Data Exchange (ETDEWEB)

    Schwuttke, G.H.; Ciszek, T.F.; Kran, A.

    1977-10-01

    Progress on the technological and economical assessment of ribbon growth of silicon by a capillary action shaping technique is reported. Progress in scale-up of the process from 50 mm to 100 mm ribbon widths is presented, the use of vitreous carbon as a crucible material is analyzed, and preliminary tests of CVD Si/sub 3/N/sub 4/ as a potential die material are reported. Diffusion length measurements by SEM, equipment and procedure for defect display under MOS structure in silicon ribbon for lifetime interpretation, and an assessment of ribbon technology are discussed. (WHK)

  2. Vinorelbine-based salvage therapy in HER2-positive metastatic breast cancer patients progressing during trastuzumab-containing regimens: a retrospective study

    Directory of Open Access Journals (Sweden)

    Viale Giuseppe

    2008-07-01

    Full Text Available Abstract Background The vinka-alkaloyd vinorelbine is a potentially valuable treatment in patients with HER2-positive, trastuzumab-resistant advanced breast cancer. We sought to document the clinical activity of vinorelbine-based salvage treatments in this clinical setting. Methods We analyzed a cohort of 424 consecutive women receiving trastuzumab-based therapy for HER2-positive advanced breast cancer. Of these, 299 were identified as progressing during the initial trastuzumab-based treatment, and 77 received vinorelbine-based therapy as first salvage treatment. Central review of pathological specimens revealed that 70 patients had HER2-amplification detected by FISH. For these patients we determined overall response rate (ORR = complete-CR + partial-PR and clinical benefit (CB = CR+PR+ Stable disease lasting at least 6 months, time to progression (TTP and overall survival (OS from the initiation of vinorelbine-based salvage therapy. Results In 60 patients who were evaluable for tumor response, ORR and CB rates were 28% (95% C.I. 18%-41% and 50% (95% C.I. 38%-62%, respectively. Median follow-up from the initiation of salvage therapy was 15 months (range 1–63 months. Median TTP and OS were 7.1 months (95% C.I. 6.6–7.7 months and 21 months (95% C.I. 14.3–27.7 months, respectively. No differences in clinical outcomes were observed according to whether vinorelbine was administered as a single agent or in combination with other cytostatics, or whether trastuzumab was stopped or continued beyond disease progression. Conclusion our findings suggests that vinorelbine-based combinations are active and should be further evaluated in studies conducted in trastuzumab-resistant patients, including those evaluating newer HER2-targeting agents.

  3. Progressive resistance training and stretching following surgery for breast cancer: study protocol for a randomised controlled trial

    Directory of Open Access Journals (Sweden)

    Ward Leigh C

    2006-12-01

    Full Text Available Abstract Background Currently 1 in 11 women over the age of 60 in Australia are diagnosed with breast cancer. Following treatment, most breast cancer patients are left with shoulder and arm impairments which can impact significantly on quality of life and interfere substantially with activities of daily living. The primary aim of the proposed study is to determine whether upper limb impairments can be prevented by undertaking an exercise program of prolonged stretching and resistance training, commencing soon after surgery. Methods/design We will recruit 180 women who have had surgery for early stage breast cancer to a multicenter single-blind randomized controlled trial. At 4 weeks post surgery, women will be randomly assigned to either an exercise group or a usual care (control group. Women allocated to the exercise group will perform exercises daily, and will be supervised once a week for 8 weeks. At the end of the 8 weeks, women will be given a home-based training program to continue indefinitely. Women in the usual care group will receive the same care as is now typically provided, i.e. a visit by the physiotherapist and occupational therapist while an inpatient, and receipt of pamphlets. All subjects will be assessed at baseline, 8 weeks, and 6 months later. The primary measure is arm symptoms, derived from a breast cancer specific questionnaire (BR23. In addition, range of motion, strength, swelling, pain and quality of life will be assessed. Discussion This study will determine whether exercise commencing soon after surgery can prevent secondary problems associated with treatment of breast cancer, and will thus provide the basis for successful rehabilitation and reduction in ongoing problems and health care use. Additionally, it will identify whether strengthening exercises reduce the incidence of arm swelling. Trial Registration The protocol for this study is registered with the Australian Clinical Trials Registry (ACTRN012606000050550.

  4. DMP1β, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer.

    Science.gov (United States)

    Maglic, Dejan; Stovall, Daniel B; Cline, J Mark; Fry, Elizabeth A; Mallakin, Ali; Taneja, Pankaj; Caudell, David L; Willingham, Mark C; Sui, Guangchao; Inoue, Kazushi

    2015-05-01

    Our recent work has indicated that the DMP1 locus on 7q21, encoding a haplo-insufficient tumour suppressor, is hemizygously deleted at a high frequency in breast cancer. The locus encodes DMP1α protein, an activator of the p53 pathway leading to cell cycle arrest and senescence, and two other functionally undefined isoforms, DMP1β and DMP1γ. In this study, we show that the DMP1 locus is alternatively spliced in ∼30% of breast cancer cases with relatively decreased DMP1α and increased DMP1β expression. RNA-seq analyses of a publicly available database showed significantly increased DMP1β mRNA in 43-55% of human breast cancers, dependent on histological subtypes. Similarly, DMP1β protein was found to be overexpressed in ∼60% of tumours relative to their surrounding normal tissue. Importantly, alteration of DMP1 splicing and DMP1β overexpression were associated with poor clinical outcomes of the breast cancer patients, indicating that DMP1β may have a biological function. Indeed, DMP1β increased proliferation of non-tumourigenic mammary epithelial cells and knockdown of endogenous DMP1 inhibited breast cancer cell growth. To determine DMP1β's role in vivo, we established MMTV-DMP1β transgenic mouse lines. DMP1β overexpression was sufficient to induce mammary gland hyperplasia and multifocal tumour lesions in mice at 7-18 months of age. The tumours formed were adenosquamous carcinomas with evidence of transdifferentiation and keratinized deposits. Overall, we identify alternative splicing as a mechanism utilized by cancer cells to modulate the DMP1 locus through diminishing DMP1α tumour suppressor expression, while simultaneously up-regulating the tumour-promoting DMP1β isoform.

  5. Technical reliability of geological disposal for high-level radioactive wastes in Japan. The second progress report. Part 3. Safety assessment for geological disposal systems

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1999-11-01

    Based on the Advisory Committee Report on Nuclear Fuel Cycle Backend Policy submitted to the Japanese Government in 1997, JNC documents the progress of research and development program in the form of the second progress report (the first one published in 1992). It summarizes an evaluation of the technical reliability and safety of the geological disposal concept for high-level radioactive wastes (HLW) in Japan. The present document, the part 3 of the progress report, concerns safety assessment for geological disposal systems definitely introduced in part 1 and 2 of this series and consists of 9 chapters. Chapter I concerns the methodology for safety assessment while Chapter II deals with diversity and uncertainty about the scenario, the adequate model and the required data of the systems above. Chapter III summarizes the components of the geological disposal system. Chapter IV refers to the relationship between radioactive wastes and human life through groundwater, i.e. nuclide migration. In Chapter V is made a reference case which characterizes the geological environmental data using artificial barrier specifications. (Ohno. S.)

  6. High temperature turbine technology program. Phase II. Technology test and support studies. Annual technical progress report, January 1, 1979-December 31, 1979

    Energy Technology Data Exchange (ETDEWEB)

    1980-01-01

    Work performed on the High Temperature Turbine Technology Program, Phase II - Technology Test and Support Studies during the period from January 1, 1979 through December 31, 1979 is summarized. Objectives of the program elements as well as technical progress and problems encountered during this Phase II annual reporting period are presented. Progress on design, fabrication and checkout of test facilities and test rigs is described. LP turbine cascade tests were concluded. 350 hours of testing were conducted on the LP rig engine first with clean distillate fuel and then with fly ash particulates injected into the hot gas stream. Design and fabrication of the turbine spool technology rig components are described. TSTR 60/sup 0/ sector combustor rig fabrication and testing are reviewed. Progress in the design and fabrication of TSTR cascade rig components for operation on both distillate fuel and low Btu gas is described. The new coal-derived gaseous fuel synthesizing facility is reviewed. Results and future plans for the supporting metallurgical programs are discussed.

  7. Design, construction, operation and evaluation of a Prototype Culm Combustion Boiler/Heater Unit. Quarterly technical progress report, October 1-December 31, 1979

    Energy Technology Data Exchange (ETDEWEB)

    1980-02-01

    This report provides a summary of the work performed on the Prototype Culm Combustion Boiler/Heater Unit, Phase I - Engineering Design and Analysis and Limited Phase II - Prototype Plant Construction during the period October 1, 1979 through December 31, 1979. The objectives of the program as well as the technical progress and problem areas encountered during the reporting period are presented. Progress on the components and system engineering studies is described. The Preliminary Design of Prototype Unit Topical Report was submitted during this reporting period. Final design activity is continuing and the progress on drawing preparation and advanced procurement activity is discussed. Based on authorization for a limited amount of Phase II activity, initial purchase orders were released authorizing preparation of certified drawings for fabricated equipment required to support the Phase I final design activity. The Purchase Order for site clearance and installation of boiler foundations was awarded during this reporting period and ground breaking ceremonies were held at the Prototype Culm Combustion Boiler site in Paxinos, Pennsylvania on December 7, 1979.

  8. Technical reliability of geological disposal for high-level radioactive wastes in Japan. The second progress report. Part 2. Engineering technology for geological disposal

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1999-11-01

    Based on the Advisory Committee Report on Nuclear Fuel Cycle Backend Policy submitted to the Japanese Government in 1997, JNC documents the progress of research and development program in the form of the second progress report (the first one published in 1992). It summarizes an evaluation of the technical reliability and safety of the deep geological disposal concept for high-level radioactive wastes (HLW) in Japan. The present document, part 2 of the progress report, concerns engineering aspect with reference to Japanese geological disposal plan, according to which the vitrified HLW will be disposed of into a deep, stable rock mass with thick containers and surrounding buffer materials at the depth of several hundred meters. It discusses on multi-barrier systems consisting of a series of engineered and natural barriers that will isolate radioactive nuclides effectively and retard their migrations to the biosphere environment. Performance of repository components, including specifications of containers for vitrified HLW and their overpacks under design as well as buffer material such as Japanese bentonite to be placed in between are described referring also to such possible problems as corrosion arising from the supposed system. It also presents plans and designs for underground disposal facilities, and the presumed management of the underground facilities. (Ohno, S.)

  9. Research progress sentinel lymph node micrometastasis in breast cancer%乳腺癌前哨淋巴结微转移研究进展

    Institute of Scientific and Technical Information of China (English)

    陈政; 王晨; 左文述; 杨莉

    2012-01-01

    目的:综述乳腺癌前哨淋巴结(SLN)微转移研究进展和临床应用价值.方法:以“乳腺癌、前哨淋巴结、微转移”为关键词,检索PubMed、万方医学网和中国知网数据库2003-2012年发表的相关文献,共检索到中文文献40条,英文文献226条.纳入标准:1)乳腺癌SLN微转移的病例对照和前瞻性研究;2)SLN微转移检测万法的研究;3)SLN微转移的研究现况.根据纳入标准,共纳入分析30条文献.结果:腋淋巴结阴性的早期乳腺癌,前哨淋巴结活检(SLNB)可以替代腋淋巴结清除术(ALND)判断腋淋巴结状态.连续切片(SS)方法、IHC技术和分子分析技术均可以增加微转移的检出率.SLN微转移可能代表了渐进性的病情进展和非前哨淋巴结转移的高风险性.结论:SLN微转移的临床意义存在争论,随着SLNB技术的成熟,可以提高阳性淋巴结的检出率,进一步提高SLN的预测能力.%OBJECTIVE; To summarize research progress of sentinel lymph node (SLN) micrometastasis in breast cancer and clinical application value. METHODS: Literatures, published from 2003 -2012) were searched.in Medline and PubMed databases, with breast cancer, SLN and micrometastasis as key words. Totally 40 Chinese literatures and 226 English literatures were got. Inclusion criteria;Case control study and prospective study of SLN micrometastasis in breast cancer (Study about research assay of SLN micrometaslasis; Research status of SLN micrometastasis. According to the criteria 30 literatures were involved. RESULTS; In early breast cancer with negative axillary nodes, the SLN biopsy(SL-NB) can be used to replace axillary lymph node dissectionCALND) to determine the status of axillary nodes. The SLN micrometastasis can be detected with serial section.IHC technique,and-molecule technique.besides the conventional pathology assay. CONCLUSION. For SLN micrometastasis in patients with breast cancer prognosis should not be considered to be the same. SLN

  10. Technical progress report of biological research on the Volcanic Island Surtsey and its environs for the period 1965--1978

    Energy Technology Data Exchange (ETDEWEB)

    Fridriksson, S.

    1978-01-01

    Progress is reported on the following research projects: changes in shoreline and surface of the island due to volcanic activity; colonization of microorganisms, algae, lichens, and vascular plants; introduction of insects and other arthropods by wind, water, and man; transport of invertebrates to the island by flotsam of the sea; species and nesting habits of birds on the island; behavior of seals on beaches of the island; and future trends of Surtsey ecosystems. (HLW)

  11. Effects of simultaneous knockdown of HER2 and PTK6 on malignancy and tumor progression in human breast cancer cells.

    Science.gov (United States)

    Ludyga, Natalie; Anastasov, Natasa; Rosemann, Michael; Seiler, Jana; Lohmann, Nadine; Braselmann, Herbert; Mengele, Karin; Schmitt, Manfred; Höfler, Heinz; Aubele, Michaela

    2013-04-01

    Breast cancer is the most common malignancy in women of the Western world. One prominent feature of breast cancer is the co- and overexpression of HER2 and protein tyrosine kinase 6 (PTK6). According to the current clinical cancer therapy guidelines, HER2-overexpressing tumors are routinely treated with trastuzumab, a humanized monoclonal antibody targeting HER2. Approximately, 30% of HER2-overexpressing breast tumors at least initially respond to the anti-HER2 therapy, but a subgroup of these tumors develops resistance shortly after the administration of trastuzumab. A PTK6-targeted therapy does not yet exist. Here, we show for the first time that the simultaneous knockdown in vitro, compared with the single knockdown of HER2 and PTK6, in particular in the trastuzumab-resistant JIMT-1 cells, leads to a significantly decreased phosphorylation of crucial signaling proteins: mitogen-activated protein kinase 1/3 (MAPK 1/3, ERK 1/2) and p38 MAPK, and (phosphatase and tensin homologue deleted on chromosome ten) PTEN that are involved in tumorigenesis. In addition, dual knockdown strongly reduced the migration and invasion of the JIMT-1 cells. Moreover, the downregulation of HER2 and PTK6 led to an induction of p27, and the dual knockdown significantly diminished cell proliferation in JIMT-1 and T47D cells. In vivo experiments showed significantly reduced levels of tumor growth following HER2 or PTK6 knockdown. Our results indicate a novel strategy also for the treatment of trastuzumab resistance in tumors. Thus, the inhibition of these two signaling proteins may lead to a more effective control of breast cancer.

  12. Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins.

    Science.gov (United States)

    Dandachi, N; Hauser-Kronberger, C; Moré, E; Wiesener, B; Hacker, G W; Dietze, O; Wirl, G

    2001-02-01

    Loss of epithelial morphology and the acquisition of mesenchymal characteristics are typical for carcinoma cells in tumour progression. In human breast carcinomas, up-regulation of tenascin-C (TN-C) and vimentin (Vim) is frequently observed in cancer cells and correlates with increased malignancy. Thus, it is possible that TN-C is co-expressed with Vim, representing cancer cells that have undergone epithelial-mesenchymal transition (EMT). This study examined 128 breast carcinomas using immunohistochemical techniques to demonstrate that mammary cancer cells are a prominent source of both TN-C and Vim. Statistical analysis revealed a significant association between TN-C and Vim expression in cancer cells. TN-C expression also correlated positively with overexpression of c-erbB-2 oncoprotein and down-regulation of oestrogen receptors (ERs). Eleven human mammary cancer cell lines and two 'normal' cell lines were examined by western blotting and immunohistochemistry. Co-expression of TN-C and Vim was detected in the carcinosarcoma cell line HS 578T, SK-BR-3 (B), fibroblast-like MDA-MB-231 cells, and the myoepithelial cell line HBL 100. These findings suggest that TN-C and Vim, when co-expressed in mammary carcinoma cells, represent regulator genes likely to be involved in EMT during mammary carcinogenesis.

  13. A Randomized Controlled Trial for the Effectiveness of Progressive Muscle Relaxation and Guided Imagery as Anxiety Reducing Interventions in Breast and Prostate Cancer Patients Undergoing Chemotherapy

    Directory of Open Access Journals (Sweden)

    Andreas Charalambous

    2015-01-01

    Full Text Available Objective. To test the effectiveness of guided imagery (GI and progressive muscle relaxation (PMR as stress reducing interventions in patients with prostate and breast cancer who undergo chemotherapy. Methods. Patients were randomly assigned to either the control group or the intervention group (PMR and GI. Patients were observed for a total duration of 3 weeks and assessed with the SAS and BECK-II questionnaires for anxiety and depression, respectively, in addiotion to two biological markers (saliva cortisol and saliva amylase (trial registration number: NCT01275872. Results. 256 patients were registered and 236 were randomly assigned. In total 104 were randomised to the control group and 104 to the intervention group. Intervention’s mean anxiety score and depression score changes were significantly different compared to the control’s (b=-29.4, p<0.001; b=-29.4, p<0.001, resp.. Intervention group’s cortisol levels before the intervention (0.30±0.25 gradually decreased up to week 3 (0.16±0.18, whilst the control group’s cortisol levels before the intervention (0.21±0.22 gradually increased up to week 3 (0.44±0.35. The same interaction appears for the Amylase levels (p<0.001. Conclusions. The findings showed that patients with prostate and breast cancer undergoing chemotherapy treatment can benefit from PMR and GI sessions to reduce their anxiety and depression.

  14. An Investigation of the Mechanism of IGA/SCC of Alloy 600 in Corrosion Accelerating Heated Crevice Environments. Technical Progress Report

    Energy Technology Data Exchange (ETDEWEB)

    Lumsden, Jesse

    1999-01-01

    OAK-B135 An Investigation of the Mechanism of IGA/SCC of Alloy 600 in Corrosion Accelerating Heated Crevice Environments. Technical Progress Report. This program focuses on understanding the mechanisms causing corrosion damage to steam generator tubes in a pressurized water reactor (PWR) and the effects of the proposed remedial measures. The crevice formed by the tube/tube support plate (T/TSP) intersection in a PWR steam generator is a concentration site for nonvolatile impurities (referred to as hideout) in the steam generator water. The restricted mass transport in the small crevice volume prevents the species, which concentrate during the generation of steam, from quickly dispersing into the bulk water. The concentrated solutions in crevices have been a contributing cause of several forms of corrosion of steam generator tubes including intergranular attack/stress corrosion cracking (IGA/SCC), pitting, and wastage.

  15. Humic substances in performance assessment of nuclear waste disposal: Actinide and iodine migration in the far-field. Second technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Buckau, G. (ed.)

    2004-07-01

    The present report describes progress within the second year of the EC-project ''Humic Substances in Performance Assessment of Nuclear Waste Disposal: Actinide and Iodine Migration in the Far-Field''. Without being a formal requirement of the commission or co-funding bodies, this report documents results in great technical detail. It is an open report and thus makes the detailed results available to a broad scientific community. The report contains an executive summary written by the coordinator. More detailed results are given as individual contributions in the form of 23 annexes. Not all results are discussed or referred to in the executive summary report and thus readers with a deeper interest also need to consult the annexes. (orig.)

  16. Increased oil production and reserves from improved completion techniques in the Bluebell Field, Uinta Basin, Utah. Seventh quarterly technical progress report, April 1, 1995--June 30, 1995

    Energy Technology Data Exchange (ETDEWEB)

    Morgan, C.D.

    1995-09-01

    The objective of this project is to increase oil production and reserves in the Uinta Basin by demonstrating improved completion techniques. Low productivity of Uinta Basin wells is caused by gross production intervals of several thousand feet that contain perforated thief zones, water-bearing zones, and unperforated oil-bearing intervals. Geologic and engineering characterization and computer simulation of the Green River and Wasatch formations in the Bluebell field will determine reservoir heterogeneities related to fractures and depositional trends. This will be followed by drilling and recompletion of several wells to demonstrate improved completion techniques based on the reservoir characterization. Transfer of the project results will be an ongoing component of the project. Technical progress for this quarter are discussed for subsurface and engineering studies.

  17. POC-scale testing of an advanced fine coal dewatering equipment/technique. Quarterly technical progress report 2, January 1995--March 1995

    Energy Technology Data Exchange (ETDEWEB)

    Groppo, J.G.; Parekh, B.K.

    1995-05-05

    Froth flotation technique is an effective and efficient process for recovering of ultra-fine (minus 74 {mu}m) clean coal. Economical dewatering of an ultra-fine clean coal product to a 20 percent level moisture will be an important step in successful implementation of the advanced cleaning processes. This project is a step in the Department of Energy`s program to show that ultra-clean coal could be effectively dewatered to 20 percent or lower moisture using either conventional or advanced dewatering techniques. The cost-sharing contract effort is for 36 months beginning September 30, 1994. This report discusses technical progress made during the quarter from January 1 to March 31, 1995.

  18. The main technical progress directions in air-jet engine design branch, which are worked out by the “Single theory of continuous flow propulsions”

    Directory of Open Access Journals (Sweden)

    Борис Шамшадович Мамедов

    2016-03-01

    Full Text Available The main technical progress directions in air-jet engine design branch, which are worked out by the “Single theory of continuous flow propulsions” are highlighted. They are connected with providing the fly security by air-jet engines gas-dynamic work steady increasing with full elimination zone of rigid (spring stroke in the cross section B-B of the air-jet engines, with bypass turbojet engine’s thrust increasing with simultaneously fuel consumption lowering, with inlet and outlet decibel characteristic and radial dementias lowering, with high pressure compressor’s last working wheels blades increasing, with regulating law air-jet engine’s introduction to provide maximum thrust with the purpose of flying (thrust efficiency increasing

  19. Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer

    NARCIS (Netherlands)

    Burzykowski, Tomasz; Buyse, Marc; Piccart-Gebhart, Martine J.; Sledge, George; Carmichael, James; Lueck, Hans-Joachim; Mackey, John R.; Nabholtz, Jean-Marc; Paridaens, Robert; Biganzoli, Laura; Jassem, Jacek; Bontenbal, Marijke; Bonneterre, Jacques; Chan, Stephen; Basaran, Gul Atalay; Therasse, Patrick

    2008-01-01

    Purpose Overall survival (OS) can be observed only after prolonged follow-up, and any potential effect of first-line therapies on OS may be confounded by the effects of subsequent therapy. We investigated whether tumor response, disease control, progression-free survival (PFS), or time to progressio

  20. High-temperature liquid-metal technology review. A Bimonthly Technical Progress Review, Volume 7, Number 2, April 1969

    Energy Technology Data Exchange (ETDEWEB)

    None, None

    1969-04-01

    The purpose of the High-Temperature Liquid-Metal Technology Review is to provide up-to-date information on the various research and development programs in the United States in the field of high-temperature liquid-metal technology. The method is to publish reviews prepared by members of the Department of Applied Science of the Brookhaven National Laboratory on current topical and progress reports submitted by contracting organizations. When results and conclusions are reported, it is intended that the individual reviews become both summaries and critiques. Thirteen reviews are presented in this issue.

  1. Direct probing of chromatography columns by laser-induced fluorescence. Technical progress report, September 1, 1989--February 28, 1993

    Energy Technology Data Exchange (ETDEWEB)

    McGuffin, V.L.

    1992-12-07

    This report summarizes the progress and accomplishments of this research project from September 1, 1989 to February 28, 1993. During this period, we have accomplished all of the primary scientific objectives of the research proposal: (1) constructed and evaluated a laser-induced fluorescence detection system that allows direct examination of the chromatographic column, (2) examined nonequilibrium processes that occur upon solute injection and elution, (3) examined solute retention in liquid chromatography as a function of temperature and pressure, (4) examined solute zone dispersion in liquid chromatography as a function of temperature and pressure, and (5) developed appropriate theoretical models to describe these phenomena. In each of these studies, substantial knowledge has been gained of the fundamental processes that are responsible for chromatographic separations. In addition to these primary research objectives, we have made significant progress in three related areas: (1) examined pyrene as a fluorescent polarity probe insupercritical fluids and liquids as a function of temperature and pressure, (2) developed methods for the class-selective identification of polynuclear aromatic hydrocarbons in coal-derived fluids by microcolumn liquid chromatography with fluorescence quenching detection, and (3) developed methods for the determination of saturated and unsaturated (including omega-3) fatty acids in fish oil extracts by microcolumn liquid chromatography with laser-induced fluorescence detection. In these studies, the advanced separation and detection techniques developed in our laboratory are applied to practical problems of environmental and biomedical significance.

  2. Development of a new technic for breast attenuation correction in myocardial perfusion scintigraphy using computational methods; Desenvolvimento de uma nova tecnica para correcao da atenuacao por tecidos moles em cintilografia de perfusao miocardica utilizando metodos computacionais

    Energy Technology Data Exchange (ETDEWEB)

    Oliveira, Anderson de

    2015-07-01

    Introduction: One of the limitations of nuclear medicine studies are false-positive results that lead to unnecessary exams and procedures associated to morbidity and costs to the individual and society. One of the most frequent causes for reducing the specificity of myocardial perfusion imaging (MPI) is photon attenuation, especially by breast in women. Objective: To develop a new technique to compensate the photon attenuation by women breasts in myocardial perfusion imaging with {sup 99m}Tc-sestamibi, using computational methods. Materials and methods: A procedure was proposed which integrates Monte Carlo simulation, computational methods and experimental techniques. Initially, were obtained the chest attenuation correction percentages using a phantom Jaszczak and breast attenuation percentages by Monte Carlo simulation method, using the EGS4 program. The percentages of attenuation correction were linked to individual patients' characteristics by an artificial neural network and a multivariate analysis. A preliminary technical validation was done by comparing the results of the MPI and catheterism (CAT), before and after applying the technique to 4 patients. The t test for parametric data, Wilcoxon, Mann-Whitney and X{sup 2} for the others were used. Probability values less than 0.05 were considered statistically significant. Results: Each increment of 1 cm in the thickness of breast was associated to an average increment of 6% on photon attenuation, while the maximum increase related to breast composition was about 2%. The average chest attenuation percentage per unit was 2.9%. Both, the artificial neural network and linear regression, showed an error less than 3% as predictive models for percentage of female attenuation. The anatomical-functional correlation between MPI and CAT was maintained after the use of the technique. Conclusion: Results suggest that the proposed technique is promising and could be a possible alternative to other conventional methods

  3. Brown Seaweed Fucoidan Inhibits Cancer Progression by Dual Regulation of mir-29c/ADAM12 and miR-17-5p/PTEN Axes in Human Breast Cancer Cells

    Science.gov (United States)

    Wu, Szu-Yuan; Yan, Ming-De; Wu, Alexander T.H.; Yuan, Kevin Sheng-Po; Liu, Shing Hwa

    2016-01-01

    In this study, we observed that brown seaweed fucoidan inhibited human breast cancer progression by upregulating microRNA (miR)-29c and downregulating miR-17-5p, thereby suppressing their target genes, a disintegrin and metalloproteinase 12 (ADAM12) and phosphatase and tensin homolog (PTEN), respectively. Moreover, fucoidan reduced the luciferase activity of 3'-untranslated region reporter; treatment of cells with the miR-29c mimic or miR-17-5p inhibitor also produced similar results. These effects of fucoidan inhibited the epithelial-mesenchymal transition in breast cancer cells, as evidenced by an increase in E-cadherin and a drop in N-cadherin, and inhibited breast cancer cell survival, as evidenced by the activation of the phosphoinositide 3-kinase/Akt pathway. Taken together, these findings demonstrate that fucoidan inhibits breast cancer progression by regulating the miR-29c/ADAM12 and miR-17-5p/PTEN axes. Fucoidan is a potential chemopreventive/chemotherapeutic agent for breast cancer. PMID:27994679

  4. Immunohistochemical analysis of aldehyde dehydrogenase isoforms and their association with estrogen-receptor status and disease progression in breast cancer

    Directory of Open Access Journals (Sweden)

    Opdenaker LM

    2014-12-01

    Full Text Available Lynn M Opdenaker,1,2 Kimberly M Arnold,1,3 Ryan T Pohlig,3,4 Jayasree S Padmanabhan,1 Daniel C Flynn,1,3 Jennifer Sims-Mourtada1–3 1Center for Translational Cancer Research, Helen F Graham Cancer Center, Christiana Care Health Services, Inc., Newark, Delaware, USA; 2Department of Biological Sciences, 3Department of Medical Laboratory Sciences, 4Biostatistics Core Facility, University of Delaware, Newark, Delaware, USA Abstract: In many types of tumors, especially breast tumors, aldehyde dehydrogenase (ALDH activity has been used to identify cancer stem-like cells within the tumor. The presence and quantity of these cells are believed to predict the response of tumors to chemotherapy. Therefore, identification and eradication of these cells would be necessary to cure the patient. However, there are 19 different ALDH isoforms that could contribute to the enzyme activity. ALDH1A1 and ALDH1A3 are among the isoforms mostly responsible for the increased ALDH activity observed in these stem-like cells, although the main isoforms vary in different tissues and tumor types. In the study reported here, we attempted to determine if ALDH1A1 or ALDH1A3, specifically, correlate with tumor stage, grade, and hormone-receptor status in breast-cancer patients. While there was no significant correlation between ALDH1A1 and any of the parameters tested, we were able to identify a positive correlation between ALDH1A3 and tumor stage in triple-negative cancers. In addition, ALDH1A3 was negatively correlated with estrogen-receptor status. Our data suggest that ALDH1A3 could be utilized as a marker to identify stem-like cells within triple-negative tumors. Keywords: breast tumor, ALDH, ALDH1A1, ALDH1A3, stem-like cells, triple-negative cancer

  5. Advanced liquefaction using coal swelling and catalyst dispersion techniques. Quarterly technical progress report, April--June 1992

    Energy Technology Data Exchange (ETDEWEB)

    Curtis, C.W. [Auburn Univ., AL (United States); Gutterman, C. [Foster Wheeler Development Corp., Livingston, NJ (United States); Chander, S. [Pennsylvania State Univ., University Park, PA (United States)

    1992-08-26

    Research in this project centers upon developing a new approach to the direct liquefaction of coal to produce an all-distillate product slate at a sizable cost reduction over current technology. The approach integrates all aspects of the coal liquefaction process including coal selection, pretreatment, coal swelling with catalyst impregnation, coal liquefaction experimentation, product recovery with characterization, alternate bottoms processing, and a technical assessment including an economic evaluation. The project is being carried out under contract to the United States Department of Energy. On May 28, 1992, the Department of Energy authorized starting the experimental aspects of this projects; therefore, experimentation at Amoco started late in this quarterly report period. Research contracts with Auburn University, Pennsylvania State University, and Foster Wheeler Development Corporation were signed during June, 1992, so their work was just getting underway. Their work will be summarized in future quarterly reports. A set of coal samples were sent to Hazen Research for beneficiation. The samples were received and have been analyzed. The literature search covering coal swelling has been up-dated, and preliminary coal swelling experiments were carried out. Further swelling experimentation is underway. An up-date of the literature on the liquefaction of coal using dispersed catalysts is nearing completion; it will be included in the next quarterly report.

  6. Combustion characteristics of Douglas Fir planer shavings. Technical progress report No. 4, September 16, 1977--September 15, 1978

    Energy Technology Data Exchange (ETDEWEB)

    Junge, D.C.

    1978-12-01

    Significant quantities of wood residue fuels are presently being used in industrial steam generating facilities. Recent studies indicate that substantial additional quantities of wood residue fuels are available for energy generation in the form of steam and/or electricity. A limited data base on the combustion characteristics of wood residue fuels has resulted in the installation and operation of inefficient combustion systems for these fuels. This investigation of the combustion characteristics of wood residue fuels was undertaken to provide a data base which could be used to optimize the combustion of such fuels. Optimization of the the combustion process in industrial boilers serves to improve combustion efficiency and to reduce air pollutant emissions generated in the combustion process. This report presents data on the combustion characteristics of Douglas Fir planer shavings. The data were obtained in a pilot scale combustion test facility at Oregon State Univerisity. Other technical reports present data on the combustion characteristics of: Douglas Fir bark, Red Alder sawdust, Red Alder bark, Ponderosa pine bark, Hemlock bark, and Eastern White Pine bark. An executive summary report is also available which compares the combustion characteristics of the various fuel species.

  7. Technical progress and energy substitutions in transport sector; Progres techniques et substitutions energetiques dans le secteur des transports

    Energy Technology Data Exchange (ETDEWEB)

    Florane, Philippe

    2002-11-15

    Alternative motorization technologies have been proposed in order to achieve energy diversification and a reduction in pollutant emissions. Fuel cell vehicles are, among others, at the centre of research carried out by car manufacturers and oil companies. The use of fuel cell vehicles could contribute, first, to a less stringent long-term energy dependence of oil importing countries and, second, to pollutant reduction in the transport sector. First of all, we propose the definition of 'innovation' and its treatment in the frame of mainstream economic theories. Then we proceed to a retrospective analysis of diesel motorization of the car market. In the second part of our work, we conduct a survey among French households aiming to obtain up-to-date information about their degree of acceptance of fuel cell technology. We are concerned about highlighting the determining factors of fuel cell vehicle adoption by consumers. For this, we set up a discrete choice model linking the individual decision to the whole group of technical or socio-economical factors and characteristics. Finally, we develop patterns of fuel cell equipment of passenger cars which differ according to type of vehicle and possible purchase assistance. These patterns lead us to the analysis of long-term fuel cell vehicle development on the French car market. (author)

  8. Progression of luminal breast tumors is promoted by ménage à trois between the inflammatory cytokine TNFα and the hormonal and growth-supporting arms of the tumor microenvironment.

    Science.gov (United States)

    Weitzenfeld, Polina; Meron, Nurit; Leibovich-Rivkin, Tal; Meshel, Tsipi; Ben-Baruch, Adit

    2013-01-01

    Breast cancer progression is strongly linked to inflammatory processes, aggravating disease course. The impacts of the inflammatory cytokine TNF α on breast malignancy are not fully substantiated, and they may be affected by cooperativity between TNF α and other protumoral mediators. Here, we show that together with representatives of other important arms of the tumor microenvironment, estrogen (hormonal) and EGF (growth-supporting), TNF α potently induced metastasis-related properties and functions in luminal breast tumor cells, representing the most common type of breast cancer. Jointly, TNFα + Estrogen + EGF had a stronger effect on breast cancer cells than each element alone, leading to the following: (1) extensive cell spreading and formation of FAK/paxillin-enriched cellular protrusions; (2) elevated proportion of tumor cells coexpressing high levels of CD44 and β 1 and VLA6; (3) EMT and cell migration; (4) resistance to chemotherapy; (5) release of protumoral factors (CXCL8, CCL2, MMPs). Importantly, the tumor cells used in this study are known to be nonmetastatic under all conditions; nevertheless, they have acquired high metastasizing abilities in vivo in mice, following a brief stimulation by TNFα + Estrogen + EGF. These dramatic findings indicate that TNF α can turn into a strong prometastatic factor, suggesting a paradigm shift in which clinically approved inhibitors of TNFα would be applied in breast cancer therapy.

  9. Progression of Luminal Breast Tumors Is Promoted by Ménage à Trois between the Inflammatory Cytokine TNFα and the Hormonal and Growth-Supporting Arms of the Tumor Microenvironment

    Directory of Open Access Journals (Sweden)

    Polina Weitzenfeld

    2013-01-01

    Full Text Available Breast cancer progression is strongly linked to inflammatory processes, aggravating disease course. The impacts of the inflammatory cytokine TNFα on breast malignancy are not fully substantiated, and they may be affected by cooperativity between TNFα and other protumoral mediators. Here, we show that together with representatives of other important arms of the tumor microenvironment, estrogen (hormonal and EGF (growth-supporting, TNFα potently induced metastasis-related properties and functions in luminal breast tumor cells, representing the most common type of breast cancer. Jointly, TNFα + Estrogen + EGF had a stronger effect on breast cancer cells than each element alone, leading to the following: (1 extensive cell spreading and formation of FAK/paxillin-enriched cellular protrusions; (2 elevated proportion of tumor cells coexpressing high levels of CD44 and β1 and VLA6; (3 EMT and cell migration; (4 resistance to chemotherapy; (5 release of protumoral factors (CXCL8, CCL2, MMPs. Importantly, the tumor cells used in this study are known to be nonmetastatic under all conditions; nevertheless, they have acquired high metastasizing abilities in vivo in mice, following a brief stimulation by TNFα + Estrogen + EGF. These dramatic findings indicate that TNFα can turn into a strong prometastatic factor, suggesting a paradigm shift in which clinically approved inhibitors of TNFα would be applied in breast cancer therapy.

  10. Measurements of scattering processes in negative ion: Atom collisions. Technical progress report, 1 September 1991--31 December 1994

    Energy Technology Data Exchange (ETDEWEB)

    Kvale, T.J.

    1994-09-27

    This report describes the progress made on the research objectives during the past three years of the grant. This research project is designed to study various scattering processes which occur in H{sup {minus}} collisions with atomic (specifically, noble gas and atomic hydrogen) targets in the intermediate energy region. These processes include: elastic scattering, single- and double-electron detachment, and target excitation/ionization. For the elastic and target inelastic processes where H{sup {minus}} is scattered intact, the experimental technique of Ion Energy-Loss Spectroscopy (IELS) will be employed to identify the final target state(s). In most of the above processes, cross sections are unknown both experimentally and theoretically. The measurements will provide total cross sections (TCS) initially, and once the angular positioning apparatus is installed, will provide angular differential cross sections (ADCS).

  11. Technical progress report for the Magnetohydrodynamics Coal-Fired Flow Facility: October 1, 1992--December 31, 1992

    Energy Technology Data Exchange (ETDEWEB)

    1993-06-01

    Progress is reported on a multitask contract to develop technology for steam bottoming cycle of a Combined Cycle MHD Steam Power Plant. The report describes a 314 hour proof-of-concept (POC) test completed during the quarter. Results include secondary combustion and effect of potassium on the light-off temperature, fouling of heat transfer surfaces, particulate clean-up device performance and advanced diagnostic system performance. Test results on ceramic materials and tubes directed toward the development of a high temperature recuperative air heater are summarized. Results of data analysis of previous tests that are reported include the continuing analysis of tube materials that were exposed to 1500 and 2000 hours of eastern coal fired operation during the previously completed 2000 hour POC test series on eastern, high sulfur coal.

  12. High resolution, low cost solar cell contact development. Quarterly technical progress and schedule report, September 28, 1980

    Energy Technology Data Exchange (ETDEWEB)

    Mardesich, N.

    1980-01-01

    The scope of the contract covers the development and evaluation of forming solar cell collector grid contacts by the MIDFILM process. This is a proprietary process developed by the Ferro Corporation which is a subcontractor for the program. The MIDFILM process attains line resolution characteristics of photoresist methods with processing related to screen printing. The surface to be processed is first coated with a thin layer of photoresist material. Upon exposure to ultraviolet light through a suitable mask, the resist in the non-pattern area cross-links and becomes hard. The unexposed pattern areas remain tacky. The conductor material is applied in the form of a dry mixture of metal and frit particles which adhere to the tacky pattern area. The assemblage is then fired to ash the photopolymer and sinter the fritted conductor powder. Effort was concentrated during this period on the establishment, optimization and identification of problem areas of the MIDFILM process. Progress is reported. (WHK)

  13. SIMS three year study on statistics and environmental factors in health. Technical progress report No. 1. [Hazards of air pollution

    Energy Technology Data Exchange (ETDEWEB)

    None

    1976-12-01

    Progress is reported for the activities of the Siam Institute for mathematics and society (SIMS), Columbia University, and Stanford University. The SIMS report is concerned with the use of animal experiments in establishing tolerance limits for human exposure to environmental toxicants; valid assessment of the health consequences of occupational and other specialized toxic exposures; mathematical theories for the kinetics of carcinogenesis; data coding, storage, access, and analysis, relationship between air pollution and respiratory diseases; and air pollution assessment. The Columbia University report is concerned with development of statistical methods and models for describing the effects of the environment, measured by pollution and weather variables, on respiratory diseases. The Stanford University report is concerned with spatial distribution of air pollutants, relation of pollutant concentrations to morbidity and mortality statistics, and other topics. (HLW)

  14. Low-rank coal research under the UND/DOE cooperative agreement. Quarterly technical progress report, April 1983-June 1983

    Energy Technology Data Exchange (ETDEWEB)

    Wiltsee, Jr., G. A.

    1983-01-01

    Progress reports are presented for the following tasks: (1) gasification wastewater treatment and reuse; (2) fine coal cleaning; (3) coal-water slurry preparation; (4) low-rank coal liquefaction; (5) combined flue gas cleanup/simultaneous SO/sub x/-NO/sub x/ control; (6) particulate control and hydrocarbons and trace element emissions from low-rank coals; (7) waste characterization; (8) combustion research and ash fowling; (9) fluidized-bed combustion of low-rank coals; (10) ash and slag characterization; (11) organic structure of coal; (12) distribution of inorganics in low-rank coals; (13) physical properties and moisture of low-rank coals; (14) supercritical solvent extraction; and (15) pyrolysis and devolatilization.

  15. Innovative Clean Coal Technology (ICCT). Technical progress report, second & third quarters, 1993, April 1993--June 1993, July 1993--September 1993

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-09-01

    The objective of this project is to demonstrate and evaluate commercially available Selective Catalytic Reduction (SCR) catalysts from U.S., Japanese, and European catalyst suppliers on a high-sulfur U.S. coal-fired boiler. SCR is a post-combustion nitrogen oxide (NOx) control technology that involves injecting ammonia into the flue gas generated from coal combustion in an electric utility boiler. The flue gas containing ammonia is then passed through a reactor that contains a specialized catalyst. In the presence of the catalyst, the ammonia reacts with NOx to convert it to nitrogen and water vapor. Although SCR is widely practiced in Japan and Europe on gas-, oil-, and low-sulfur coal-fired boilers, there are several technical uncertainties associated with applying SCR to U.S. coals. These uncertainties include: (1) potential catalyst deactivation due to poisoning by trace metal species present in U.S. coals that are not present in other fuels; (2) performance of the technology and effects on the balance-of-plant equipment in the presence of high amounts of SO{sub 2} and SO{sub 3}; and (3) performance of a wide variety of SCR catalyst compositions, geometries and methods of manufacture under typical high-sulfur coal-fired utility operating conditions. These uncertainties are being explored by constructing and operating a series of small-scale SCR reactors and simultaneously exposing different SCR catalysts to flue gas derived from the combustion of high sulfur U.S. coal. The demonstration is being performed at Gulf Power Company`s Plant Crist Unit No. 5 (75 MW capacity) near Pensacola, Florida. The project is funded by the U.S. Department of Energy (DOE), Southern Company Services, Inc. (SCS on behalf of the entire Southern electric system), the Electric Power Research Institute (EPRI), and Ontario Hydro. SCS is the participant responsible for managing all aspects of this project.

  16. Coal-fired combustion system for industrial process heating applications. Quarterly technical progress report, April 1995--June 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-08-01

    PETC has implemented a number of advanced combustion research projects that will lead to the establishment of a broad, commercially acceptable engineering data base for the advancement of coal as the fuel of choice for boilers, furnaces, and process heaters. This includes new installations and those existing installations that were originally designed for oil or gas firing. The data generated by these projects must be sufficient for private-sector decisions on the feasibility of using coal as the fuel of choice. This work should also provide incentives for the private sector to continue and expand the development, demonstration, and application of these combustion systems. Vortec Corporation`s Coal-Fired Combustion System for Industrial Process Heating Applications is being developed under contract DE-AC22-91PC91161 as part of this DOE development program. The current contract represents the third phase of a three-phase development program. Phase I of the program addressed the technical and economic feasibility of the process, and was initiated in 1987 and completed 1989. Phase II was initiated in 1989 and completed in 1990. During Phase II of the development, design improvements were made to critical components and the test program addressed the performance of the process using several different feedstocks. Phase III of the program was initiated September 1991 and is scheduled for completion in 1994. The Phase III research effort is being focused on the development of a process heater system to be used for producing value-added vitrified glass products from boiler/incinerator ashes and selected industrial wastes.

  17. Estrogen-induced SDF-1α production promotes the progression of ER-negative breast cancer via the accumulation of MDSCs in the tumor microenvironment

    Science.gov (United States)

    Ouyang, Liquan; Chang, Weilong; Fang, Bin; Qin, Jieting; Qu, Xincai; Cheng, Fanjun

    2016-01-01

    Estrogen plays a role in the processes of tumorigenesis, metastasis, and drug resistance in estrogen receptor (ER)-positive breast cancer (BC). Whether estrogen contributes to ER-negative BC is unclear. Here, we aimed to investigate whether estrogen could stimulate the secretion of stromal-derived factor-1 (SDF-1α) by cancer-associated fibroblasts (CAFs) to promote the progression of ER-negative BC. We transplanted ER-negative BC cells into ovariectomized mice, which was followed by continuous injection of estrogen, and found that estrogen promoted the tumorigenesis of BC. Furthermore, High levels of SDF-1α and tumor-infiltrating myeloid-derived suppressor cells (MDSCs) were detected in the estrogen treatment group. Estrogen stimulates secretion of SDF-1α by CAFs extracted from BC patients. Recombinant SDF-1α could recruit MDSCs isolated from bone marrow cells of mice. In addition, the co-culture of CAFs and MDSCs demonstrated that the recruitment of MDSCs was increased when CAFs were exposed to estrogen. Using AMD3100 to block the SDF-1α/CXCR4 axis or gemcitabine to delete MDSCs, we observed that both of these agents could neutralize the effect of estrogen on tumorigenesis. Together, these results suggest that estrogen may promote the progression of ER-negative BC by stimulating CAFs to secrete SDF-1α, which can recruit MDSCs to the tumor microenvironment to exert tumor-promoting effects. PMID:27996037

  18. Estrogen-induced SDF-1α production promotes the progression of ER-negative breast cancer via the accumulation of MDSCs in the tumor microenvironment.

    Science.gov (United States)

    Ouyang, Liquan; Chang, Weilong; Fang, Bin; Qin, Jieting; Qu, Xincai; Cheng, Fanjun

    2016-12-20

    Estrogen plays a role in the processes of tumorigenesis, metastasis, and drug resistance in estrogen receptor (ER)-positive breast cancer (BC). Whether estrogen contributes to ER-negative BC is unclear. Here, we aimed to investigate whether estrogen could stimulate the secretion of stromal-derived factor-1 (SDF-1α) by cancer-associated fibroblasts (CAFs) to promote the progression of ER-negative BC. We transplanted ER-negative BC cells into ovariectomized mice, which was followed by continuous injection of estrogen, and found that estrogen promoted the tumorigenesis of BC. Furthermore, High levels of SDF-1α and tumor-infiltrating myeloid-derived suppressor cells (MDSCs) were detected in the estrogen treatment group. Estrogen stimulates secretion of SDF-1α by CAFs extracted from BC patients. Recombinant SDF-1α could recruit MDSCs isolated from bone marrow cells of mice. In addition, the co-culture of CAFs and MDSCs demonstrated that the recruitment of MDSCs was increased when CAFs were exposed to estrogen. Using AMD3100 to block the SDF-1α/CXCR4 axis or gemcitabine to delete MDSCs, we observed that both of these agents could neutralize the effect of estrogen on tumorigenesis. Together, these results suggest that estrogen may promote the progression of ER-negative BC by stimulating CAFs to secrete SDF-1α, which can recruit MDSCs to the tumor microenvironment to exert tumor-promoting effects.

  19. Molluscs and echinoderms aquaculture: biological aspects, current status, technical progress and future perspectives for the most promising species in Italy

    Directory of Open Access Journals (Sweden)

    Antonio Pais

    2012-10-01

    Full Text Available Shellfish aquaculture is a widespread activity in the Italian peninsula. However, only two bivalve species are mainly cultured along the coastline of that country: the Mediterranean mussel Mytilus galloprovincialis and the Manila clam Venerupis philippinarum (Ruditapes philippinarum. By contrast, just a few other mollusc species of commercial interest are scarcely reared at a small-scale level. After analysing the current status of Italian shellfish production, this paper reports and discusses the potential for culturing several different invertebrate species [i.e., the European flat oyster Ostrea edulis, the grooved carpet shell Venerupis decussata (Ruditapes decussatus, the razor clams Ensis minor and Solen marginatus, the cephalopod Octopus vulgaris, and the purple sea urchin Paracentrotus lividus] in this country. In addition, a detailed overview of the progress made in aquacultural techniques for these species in the Mediterranean basin is presented, highlighting the most relevant bottlenecks and the way forward to shift from the experimental to the aquaculture phase. Finally, an outlook of the main economic and environmental benefits arising from these shellfish culture practices is also given.

  20. 1991 Technical progress report of the University of South Carolina`s High Energy Physics Group, February 1990--July 1991

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1991-12-31

    The high energy physics group at the University of South Carolina includes five teaching faculty members, one research faculty member, and five graduate students. Profs. Childers, Darden, and Wilson devote most of their research effort to Fermilab experiment E789, which is designed to observe charmless two-body decays of b-flavored mesons and baryons. Prof. Wilson works on Fermilab experiment E687 which studies charm physics in the wide-band photon beam. Profs. Rosenfeld and Wang participate in the AMY collaboration, which studies electron-positron interactions using the TRISTAN collider at KEK. Prof. Rosenfeld and one student collaborate with personnel from KEK and INS, Tokyo, on an experiment to detect a 17 keV neutrino in the {beta}-decay spectrum of {sup 63}Ni. Members of the group also participate in Fermilab Proposal P803 which will search for the oscillation of muon neutrino to tau neutrino with sensitivity better than a factor of 40 than previously achieved and in Superconducting Super Collider activities which include the development of an imaging preradiator. A brief discussion is given on progress made for each program.

  1. Establishment of an Institute for Fusion Studies. Technical progress report, 1 November 1993--31 October 1994

    Energy Technology Data Exchange (ETDEWEB)

    Hazeltine, R.D.

    1994-07-01

    The Institute for Fusion Studies is a national center for theoretical fusion plasma physics research. Its purposes are: (1) to conduct research on theoretical questions concerning the achievement of controlled fusion energy by means of magnetic confinement--including both fundamental problems of long-range significance, as well as shorter-term issues; (2) to serve as a national and international center for information exchange by hosting exchange visits, conferences, and workshops; (3) and to train students and postdoctoral research personnel for the fusion energy program and plasma physics research areas. The theoretical research results obtained by the Institute contribute to the progress of nuclear fusion research, whose goal is the development of fusion power as a basic energy source. Close collaborative relationships have been developed with other university and national laboratory fusion groups, both in the US and abroad. In addition to its primary focus on mainstream fusion physics, the Institute is also involved with research in fusion-sidestream fields, such as advanced computing techniques, nonlinear dynamics, space plasmas and astrophysics, statistical mechanics, fluid dynamics, and accelerator physics. Important research discoveries are briefly described.

  2. Identification of sulfur heterocycles in coal liquids and shale oils. Technical progress report, August 1, 1980-May 1, 1981

    Energy Technology Data Exchange (ETDEWEB)

    Lee, M. L.; Castle, R. N.

    1981-01-01

    The sulfur heterocycle separation scheme which was described in the last progress report was evaluated for quantitative recovery of individual components. The results indicate that recoveries can range from 10% to approx. 30% depending on the structure of the compound. During this period, 23 unsubstituted sulfur-containing heterocyclic ring systems were synthesized in oder to confirm GC/MS identifications and for biological testing. The four possible 3-ring heterocycles and the thirteen possible 4-ring heterocycles were tested for mutagenic activity in the histidine reversion (Ames assay) system. One of the 3-ring isomers, naphtho(1,2-b)-thiophene, and six of the 4-ring isomers induced mutations in Salmonella test strains. One of these compounds, phenanthro(3,4-b)thiophene, displayed approximately the same mutagenic activity as benzo(a)pyrene. A two-step adsorption chromatographic procedure was developed in order to fractionate synthetic fuels into various chemical-type classes for studying the relative concentrations and mutagenic activities of the various types. An SRC-II Heavy Distillate was fractionated into aliphatic hydrocarbons, polycyclic aromatic hydrocarbons, sulfur heterocycles, indoles and carbazoles, azaarenes, and amino polycyclic aromatic hydrocarbons. It was found that the amino-PAH fraction contained most of the mutagenic activity. A survey was made for compounds containing both nitrogen and sulfur heteroatoms in their structures. A number of these compounds were detected by GC using nitrogen- and sulfur-selective detection.

  3. Technical Progress Report for PEPCO: Turbo-Z Battery Charging System. Calendar Quarter Ending March 31, 1999

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2000-04-01

    The project is proceeding at a rapid pace now. The software is in development for the control board and the test stand. Portions of the writing and debugging of this software have been in conjunction with the hardware development. The software now interfaces with all the measurement instruments and displays the measurements on the screen, and it saves the measurements to a disc file. There is still cleanup work to do on the display items. Work must still be imparted to the code to control a charging sequence while taking measurements of the results. The test stand hardware has received a good development effort this quarter. The timer-counter board is working in the computer. This board paces the measurement cycle and times the discharge pulse (whine circuit). The thermocouple multiplexer is scanning at the same time the analog to digital converter is taking measurements. We have made a good number of hardware modifications to solve problems revealed while writing the software. The power factor correction for the charger power section is still in development. The engineers have found additional sources for the PFC chips, and they have obtained more technical data sheets and acquired samples. The control board schematics are complete, and the software is far along in the development phase. The functions of the control board have been detailed. The control board must next be integrated with the power supply unit. The next phase of development will concentrate on integrating the components together. At this time, the final debugging of the hardware and software will begin. Additionally, the capacitive coupler development is proceeding. The annual DARPA/DoT Advanced Transportation review will be held on May 16, 1999. We expect to learn the status of our project proposal during this conference. Should we more forward, UL has agreed to help us determine the design requirements of the complete charging system at their EV testing facility, prior to manufacturing. This

  4. Heterogeneous kinetics of coal gasification. Quarterly technical progress report, 1 May 1982-31 July 1982. [Equipment design

    Energy Technology Data Exchange (ETDEWEB)

    Calo, J.M.

    1982-08-01

    During the reporting period significant progress was made on two fronts: (1) the steam addition system for transient steam-char kinetic experiments; and (2) the automated data acquisition system for rapid mass programming (control) of the mass spectrometer and data logging. Steam Addition System: Although it is a relatively straightforward matter to produce steam for the reactor, we found that it is quite a challenge to develop a system capable of maintaining a steady and accurately-known flow rate of steam-argon mixtures at high pressure and temperature in alternate flow circuits (i.e., the reactor and purge lines), while simultaneously protecting downstream valving and instrumentation. Thus, the scheme originally proposed has been modified to eliminate potential operating problems associated with the preliminary design. Automated Data Acquisition System: Although the CO/sub 2/ gasification data were obtained manually, the ultimate objective of the project to develop a quantitative understanding of the complete gasification rate process in the complex synthesis gas milieux calls for automated programming (control) of the mass spectrometer. In addition, the current mass spectrometer signal processing technique requires the use of a lock-in amplifier to extract the modulated portion of the total signal due to the beam species only, in an analog mode. In order to allow fast scanning of a number of species, the characteristic dwell time required by the lock-in amplifier on a particular mass peak must be decreased. These requirements are being met by implementing automated mass programming and data collection, and direct digital, phase-sensitive pulse counting.

  5. Continuous Fiber Wound Ceramic Composite (CFCC) for Commercial Water Reactor Fuel. Technical progress report for period ending April 1, 2000

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2000-04-01

    Our program began on August 1, 1999. As of April 1, 2000, the progress has been in materials selection and test planning. Three subcontracts are in place (McDermott Technologies Inc. for continuous fiber reinforced ceramic tubing fabrication, Swales Aerospace for LOCA testing of tubes, and Massachusetts Institute of Technology for In Reactor testing of tubes). With regard to materials selection we visited McDermott Technologies Inc. a number of times, including on February 23, 2000 to discuss the Draft Material Selection and Fabrication Report. The changes discussed at this meeting were implemented and the final version of this report is attached (attachment 1). McDermott Technologies Inc. will produce one type of tubing: Alumina oxide (Nextel 610) fiber, a carbon coating (left in place), and alumina-yttria matrix. A potentially desirable CFCC material of silicon carbide fiber with spinel matrix was discussed. That material selection was not adopted primarily due to material availability and cost. Gamma Engineering is exploring the available tube coatings at Northwestern University as a mechanism for reducing the permeability of the tubes, and thus, will use coating as a differentiating factor in the testing of tubing in the LOCA test as well as the In-Reactor Test. The conclusion of the Material Selection and Fabrication Report lists the possible coatings under evaluation. With regard to Test Planning, the MIT and Swales Aerospace have submitted draft Test Plans. MIT is attempting to accommodate an increased number of test specimens by evaluating alternative test configurations. Swales Aerospace held a design review at their facilities on February 24, 2000 and various engineering alternatives and safety issues were addressed. The final Test Plans are not expected until just before testing begins to allow for incorporation of changes during ''dry runs.''

  6. Dual-wavelength imaging of tumor progression by activatable and targeting near-infrared fluorescent probes in a bioluminescent breast cancer model.

    Directory of Open Access Journals (Sweden)

    Bang-Wen Xie

    Full Text Available Bioluminescence imaging (BLI has shown its appeal as a sensitive technique for in vivo whole body optical imaging. However, the development of injectable tumor-specific near-infrared fluorescent (NIRF probes makes fluorescence imaging (FLI a promising alternative to BLI in situations where BLI cannot be used or is unwanted (e.g., spontaneous transgenic tumor models, or syngeneic mice to study immune effects.In this study, we addressed the questions whether it is possible to detect tumor progression using FLI with appropriate sensitivity and how FLI correlates with BLI measurements. In addition, we explored the possibility to simultaneously detect multiple tumor characteristics by dual-wavelength FLI (~700 and ~800 nm in combination with spectral unmixing. Using a luciferase-expressing 4T1-luc2 mouse breast cancer model and combinations of activatable and targeting NIRF probes, we showed that the activatable NIRF probes (ProSense680 and MMPSense680 and the targeting NIRF probes (IRDye 800CW 2-DG and IRDye 800CW EGF were either activated by or bound to 4T1-luc2 cells. In vivo, we implanted 4T1-luc2 cells orthotopically in nude mice and were able to follow tumor progression longitudinally both by BLI and dual-wavelength FLI. We were able to reveal different probe signals within the tumor, which co-localized with immuno-staining. Moreover, we observed a linear correlation between the internal BLI signals and the FLI signals obtained from the NIRF probes. Finally, we could detect pulmonary metastases both by BLI and FLI and confirmed their presence histologically.Taken together, these data suggest that dual-wavelength FLI is a feasible approach to simultaneously detect different features of one tumor and to follow tumor progression with appropriate specificity and sensitivity. This study may open up new perspectives for the detection of tumors and metastases in various experimental models and could also have clinical applications, such as image

  7. Research progression of exosome in breast cancer%外泌体在乳腺癌中的研究进展

    Institute of Scientific and Technical Information of China (English)

    张艳; 申娴娟; 鞠少卿

    2016-01-01

    Exosomes are small (30 -100 nm) membrane vesicles secreted by various cell types , they mediate cell-to-cell communication by transferring mRNAs , miRNAs, and proteins.As a hotspot in the research of oncology , exosomes have potential values in the research of development , diagnosis and treatment of cancer. This paper briefly reviews the relationship between breast cancer microenvironment , drug resistance and exosomes and its progress in breast cancer diagnosis and treatment , in order to propose new diagnostic and therapeutic strategies .%外泌体是由不同类型细胞释放的膜性囊泡,直径约30~100 nm,能够通过mRNAs、miRNAs和蛋白质等的传递介导细胞间相互作用。外泌体作为肿瘤学研究的热点,其在肿瘤发生、发展、临床诊断和治疗方面具有重要的研究价值。本文对外泌体与乳腺癌微环境、耐药的关系及其在乳腺癌诊断和治疗中的研究进展进行综述,以期为寻找乳腺癌诊断与治疗新靶点提供思路。(中华检验医学杂志,2016,39:466-469)

  8. Vitamin D delays breast cancer progression in the PyVMT transgenic mouse model: local conversion of the precursor 25(OH)D3 into 1,25(OH)2D3 is safer and more effective than systemic administration of 1,25(OH)2D3

    Science.gov (United States)

    Metabolic activation of 1,25(OH)2D3 occurs at extra renal sites in several organs, including the breast. The purpose of this study was to determine if this local tumoral 25OHD3-1alphahydroxylase expression modulates any or all of the stages of breast tumor progression. For this purpose we used the...

  9. Bench-scale testing of on-line control of column flotation using a novel analyzer. Quarterly technical progress report, September 21, 1992--December 31, 1992

    Energy Technology Data Exchange (ETDEWEB)

    1992-01-22

    This document contains the first quarterly technical progress report for PTI`s Bench-Scale Testing Project of a circuit integrating PTI`s KEN-FLOTETM Column Flotation Technology and PTI`s On-Line Quality Monitor Control System. The twelve-month project will involve installation of a 300 lb/hr. bench-scale testing circuit at PETC`s Coal Preparation Process Research Facility (CPPRF) and testing of two bituminous coals (Upper Freeport and Pittsburgh No. 8 Seam Raw Coals). Figure 1 contains the project plan as well as the approach to completing the major tasks within the twelvemonth project. The project is broken down into three phases, which include: Phase I - Preparation: The preparation phase was performed principally at PTI`s Calumet offices from October through December, 1992. It involved building of the equipment and circuitry, as well as some preliminary design and equipment testing. Phase II - ET Circuit Installation and Testing: This installation and testing phase of the project will be performed at PETC`s CPPRF from January through May, 1993, and will be the major focus of the project. It will involve testing of the continuous 300 lb/hr. circuit. Phase II - Project Finalization: The project finalization phase will occur from June through September, 1993, at PTI`s Calumet offices and will involve finalizing analytical work and data evaluation, as well as final project reporting. This quarterly progress report principally summarizes the results from the Phase I preparation work and the plan for the early portions of the Phase 11 installation and commissioning, which will occur in January and the first week of February, 1993.

  10. Development of the instrumentation and modeling for heat transfer characteristics in CFBC. Technical progress report No. 2, April 1, 1996--September 30, 1996

    Energy Technology Data Exchange (ETDEWEB)

    Lee, Seong W.

    1996-11-01

    This technical report summarizes the research conducted and progress achieved during the period of April 1, 1996 to September 30, 1996. Auxiliary subsystems tests of the circulating fluidized bed were conducted and included the characteristics of a regenerative blower, a gas distributor, and a cyclone. When the air flow rate increases, the pressure at the blower outlet is decreased. The air flow rate in the riser is a function of the pressure in the wind box. The cyclone pressure drop and gas distributor pressure drop are functions of the primary air flow rate input. The higher gas pressure drop indicates primary air in the riser column with a uniform superficial velocity. The CFB primary test was conducted using glass beads as one of the CFB bed materials. Three typical tests with different sizes of glass were conducted. The pressure sensor data acquisition system was developed for the systematic instrumentation of flow measurements in the CFB system. Two types of sensors were used, a single pressure sensor, and a differential pressure sensor, respectively. The software used to control the analog/digital board was Paragon 500. The CFB experimental studies for hydrodynamics will be continued with the improved data acquisition system.

  11. Design, construction, operation, and evaluation of a prototype culm combustion boiler/heater unit. Quarterly technical progress report, October 1-December 21, 1981

    Energy Technology Data Exchange (ETDEWEB)

    1982-01-01

    This report provides a summary of the work performed on the Prototype Culm Combustion Boiler/Heater Unit, Phase I - Engineering Design and Analysis, Phase II - Prototype Plant Construction and Phase III - Start-Up and Operation during the period October 1, 1981 through December 31, 1981. The objectives of the program as well as the technical progress and problem areas encountered during the reporting period are presented. Seven shakedown tests were run. Start-up and shakedown testing was completed. Four parametric tests were run. Performance data are presented with the exception of boiler efficiency which will be reported once chemical analyses are completed. Total boiler operation time through the end of this quarter - 1225 h, 50 min; operating time on culm and culm/limestone - 682 h, 43 min. Inspection revealed no problems with boiler tube wear. Sulfur capture greater than 94% was demonstrated (design is 88%). A turndown of better than 4 to 1 was shown (design is 2.5 to 1). Computer control of most of the loops has been successful and manual control was also demonstrated.

  12. Development of vanadium-phosphate catalysts for methanol production by selective oxidation of methane. Quarterly technical progress report 10, July 1, 1995--September 31, 1995

    Energy Technology Data Exchange (ETDEWEB)

    McCormick, R.L.

    1995-12-07

    This document is the tenth quarterly technical progress report under Contract No. DE-AC22-92PC92110 {open_quotes}Development of Vanadium-Phosphate Catalysts for Methanol Production by Selective Oxidation of Methane{close_quotes}. Activities focused on testing of additional modified and promoted catalysts and characterization of these materials. Attempts at improving the sensitivity of our GC based analytical systems were also made with some success. Methanol oxidation studies were initiated. These results are reported. Specific accomplishments include: (1) Methane oxidation testing of a suite of catalysts promoted with most of the first row transition metals was completed. Several of these materials produced low, difficult to quantify yields of formaldehyde. (2) Characterization of these materials by XRD and FTIR was performed with the goal of correlating activity and selectivity with catalyst properties. (3) We began to characterize catalysts prepared via modified synthesis methods designed to enhance acidity using TGA measurements of acetonitrile chemisorption and methanol dehydration to dimethyl ether as a test reaction. (4) A catalyst prepared in the presence of naphthalene methanol as a structural disrupter was tested for activity in methane oxidation. It was found that this material produced low yields of formaldehyde which were difficult to quantify. (5) Preparation of catalysts with no Bronsted acid sites. This was accomplished by replacement of exchangeable protons with potassium, and (6) Methanol oxidation studies were initiated to provide an indication of catalyst activity for decomposition of this desired product and as a method of characterizing the catalyst surface.

  13. Non-intrusive measurement of particle charge: Electrostatic dry coal cleaning. Technical progress report No. 8, April 1, 1993--June 30, 1993

    Energy Technology Data Exchange (ETDEWEB)

    1993-09-01

    As we reported in the Technical Progress Report No. 7, there are surges of electric current in the charging loop during triboelectrification of all particles. A high speed data acquisition and analysis system was developed to monitor and record the current pattern. There is no known report on such charge-discharge surges in the literature. The mechanism for it is yet to be understood. The on-line computerized electric current measurement also leads to an observation of charging effects as a function of particle feeding rate. It is shown that feed rate greatly alters particle charge. Such an effect is mostly overlooked by researchers and it could have a important role in process design where the feed rate would be maximized. The initial results for coal and mineral particles demonstrated that the average charge was lower when the feed rate was increased. Further investigation is scheduled to identify potential controlling factors, eg, the solid volume fraction and particle number density could be important process factors. The study of charging velocity and particle size was continued. It was found that particle charge was linearly dependent on the charging velocity for all samples investigated. However, the slope of this linear dependence varied for particles having different diameters. In addition, the charge-velocity relationships were dependent on feeding rates. Hence, the data discussed below include these interrelationships.

  14. 三阴乳腺癌研究进展%Progression of triple-negative breast cancer

    Institute of Scientific and Technical Information of China (English)

    夏春强; 郑如珍; 王晓稼

    2009-01-01

    三阴乳腺癌(TNBC)具有独特的生物学行为和临床特征,目前尚没有针对TNBC的标准治疗.近年来在TNBC的流行病学、分子特征、化学治疗和靶向治疗等方面进行了许多研究与探索,特别是Ⅱ期或Ⅲ期临床研究初步结果显示,新的化疗方案和靶向治疗对TNBC可能具有很好的疗效.%Triple-negative breast cancer(TNBC) has distinct biological and clinical characteristics. Therapeutic strategies for TNBC remain a challenge. Studies about epidemiology,molecular characteristics,chemotherapy and targeted-therapy are ongoing,In particular,preliminary results of stage II or III clinical trials indicate new chemotherapy or combination targeted therapy may have a good efficacy.

  15. The research progress of radionuclide molecular imaging for breast cancer%乳腺癌放射性核素分子成像研究进展

    Institute of Scientific and Technical Information of China (English)

    王健; 宋秀宇; 徐文贵; 周雯

    2015-01-01

    随着新型特异性显像剂和成像设备的出现,乳腺癌分子成像技术得以快速发展。乳腺癌放射性核素分子成像技术主要包括单光子发射体层成像(SPECT)、正电子发射体层成像(PET)、PET/CT以及正电子发射乳腺成像(PEM)。显像剂包括临床应用最广泛的正电子示踪剂18F-氟代脱氧葡萄糖(18F-FDG )、用于研究肿瘤细胞增殖显像的5-18F-氟尿嘧啶(5-FU)及3-脱氧-3-氟胸腺嘧啶(FLT)、通过肿瘤氨基酸代谢显像的精氨酸-甘氨酸-天冬氨酸(RGD)类,还包括受体类的靶向显像剂如雌激素受体相关的16α-[18F]-17β-雌二醇(FES)、放射性标记的人表皮生长因子受体2(HER2)及表皮生长因子受体(EGFR)等。目前用于乳腺显像的PEM技术对乳腺癌的早期诊断及疗效预测效果显著,就乳腺癌放射性核素分子成像技术的研究进展予以综述。%With the developments of new type specific imaging agent and imaging device, the molecular imaging technology of breast cancer is being developed rapidly. Radionuclide molecular imaging techniques for breast cancer include single photon emission tomography (SPECT) and positron emission body tomography (PET), PET/CT and positron emission (PEM) imaging. In addition to the most widely used radiotracer 18F -FDG, for study of tumor cell proliferation imaging 5-18F-FU and FLT can be used. For imaging tumor amino acid metabolism, RGD-based tracers are available. The receptor-targeted agents include estrogen receptor related FES, radiolabeled human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR). At present, the PEM technique had an important clinical value in the early diagnosis and prognosis prediction of breast cancer. We reviewed the research progress of the radionuclide molecular imaging for breast cancer.

  16. The research progress of relationship between breast density,sex hormone,and breast cancer%乳腺密度、性激素和乳腺癌关系的研究进展

    Institute of Scientific and Technical Information of China (English)

    付小娜; 王丽; 康欣梅

    2015-01-01

    Mammographic breast density( BD)is independent risk factor for breast cancer,sex hormones also play a role in the development of breast cancer,but it is unclear whether mammographic breast density associate with sex hormone. In this review,we describe the association of BD and sex hormone with breast cancer.%乳腺密度( mammographic breast density,BD)是乳腺癌危险性独立的预测指标,性激素也在乳腺癌的发展中扮演重要角色,而乳腺密度与性激素的关系仍不明确。本文将对乳腺密度,性激素,乳腺癌的关系进行综述。

  17. Research progress of Chinese medicine to reverse the breast cancer resistance%中药逆转乳腺癌耐药研究进展

    Institute of Scientific and Technical Information of China (English)

    孙文吉

    2015-01-01

    肿瘤多药耐药(MDR)的产生是一个多机制联合作用的结果,包括耐药基因的异常表达、药物作用靶点下调等.MDR是肿瘤化疗失败的主要原因之一,以致MDR逆转剂的研究已成为国内外研究热点.由于化学药逆转剂毒副作用较大、靶点单一,应用受到限制,中药具有安全有效、多靶点且成本低等优势,文章就近年来中药逆转乳腺癌MDR的研究进展进行综述.%Multidrug resistance (multidrug,resistance,MDR) is the result of joint action of a multi mechanism results,including the abnormal expression of multidrug resistance gene,drug targets down etc.MDR is one of the main reasons for the failure of cancer chemotherapy,so the study of MDR reversal agents has become a research hotspot at home and abroad.Due to chemical medicine reversal agent toxicity,target is single,limited application,Traditional Chinese medicine is safe and effective,multi targets and low cost advantage,This paper summarizes the research progress of Chinese medicine to reverse MDR in breast cancer.

  18. Fusion transcript discovery in formalin-fixed paraffin-embedded human breast cancer tissues reveals a link to tumor progression.

    Science.gov (United States)

    Ma, Yan; Ambannavar, Ranjana; Stephans, James; Jeong, Jennie; Dei Rossi, Andrew; Liu, Mei-Lan; Friedman, Adam J; Londry, Jason J; Abramson, Richard; Beasley, Ellen M; Baker, Joffre; Levy, Samuel; Qu, Kunbin

    2014-01-01

    The identification of gene fusions promises to play an important role in personalized cancer treatment decisions. Many rare gene fusion events have been identified in fresh frozen solid tumors from common cancers employing next-generation sequencing technology. However the ability to detect transcripts from gene fusions in RNA isolated from formalin-fixed paraffin-embedded (FFPE) tumor tissues, which exist in very large sample repositories for which disease outcome is known, is still limited due to the low complexity of FFPE libraries and the lack of appropriate bioinformatics methods. We sought to develop a bioinformatics method, named gFuse, to detect fusion transcripts in FFPE tumor tissues. An integrated, cohort based strategy has been used in gFuse to examine single-end 50 base pair (bp) reads generated from FFPE RNA-Sequencing (RNA-Seq) datasets employing two breast cancer cohorts of 136 and 76 patients. In total, 118 fusion events were detected transcriptome-wide at base-pair resolution across the 212 samples. We selected 77 candidate fusions based on their biological relevance to cancer and supported 61% of these using TaqMan assays. Direct sequencing of 19 of the fusion sequences identified by TaqMan confirmed them. Three unique fused gene pairs were recurrent across the 212 patients with 6, 3, 2 individuals harboring these fusions respectively. We show here that a high frequency of fusion transcripts detected at the whole transcriptome level correlates with poor outcome (Parchival FFPE tissues, and the potential prognostic value of the fusion transcripts detected.

  19. Ultrasound - Breast

    Science.gov (United States)

    ... Physician Resources Professions Site Index A-Z Ultrasound - Breast Ultrasound imaging of the breast uses sound waves ... the Breast? What is Ultrasound Imaging of the Breast? Ultrasound is safe and painless, and produces pictures ...

  20. Breast pain

    Science.gov (United States)

    Pain - breast; Mastalgia; Mastodynia; Breast tenderness ... There are many possible causes for breast pain. For example, hormone level changes from menstruation or pregnancy often cause breast tenderness. Some swelling and tenderness just before your period ...

  1. A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers.

    LENUS (Irish Health Repository)

    Hennessy, Bryan T

    2010-12-01

    INTRODUCTION: The lack of large panels of validated antibodies, tissue handling variability, and intratumoral heterogeneity potentially hamper comprehensive study of the functional proteome in non-microdissected solid tumors. The purpose of this study was to address these concerns and to demonstrate clinical utility for the functional analysis of proteins in non-microdissected breast tumors using reverse phase protein arrays (RPPA). METHODS: Herein, 82 antibodies that recognize kinase and steroid signaling proteins and effectors were validated for RPPA. Intraslide and interslide coefficients of variability were <15%. Multiple sites in non-microdissected breast tumors were analyzed using RPPA after intervals of up to 24 h on the benchtop at room temperature following surgical resection. RESULTS: Twenty-one of 82 total and phosphoproteins demonstrated time-dependent instability at room temperature with most variability occurring at later time points between 6 and 24 h. However, the 82-protein functional proteomic "fingerprint" was robust in most tumors even when maintained at room temperature for 24 h before freezing. In repeat samples from each tumor, intratumoral protein levels were markedly less variable than intertumoral levels. Indeed, an independent analysis of prognostic biomarkers in tissue from multiple tumor sites accurately and reproducibly predicted patient outcomes. Significant correlations were observed between RPPA and immunohistochemistry. However, RPPA demonstrated a superior dynamic range. Classification of 128 breast cancers using RPPA identified six subgroups with markedly different patient outcomes that demonstrated a significant correlation with breast cancer subtypes identified by transcriptional profiling. CONCLUSION: Thus, the robustness of RPPA and stability of the functional proteomic "fingerprint" facilitate the study of the functional proteome in non-microdissected breast tumors.

  2. IRIS Final Technical Progress Report

    Energy Technology Data Exchange (ETDEWEB)

    M. D. Carelli

    2003-11-03

    OAK-B135 This NERI project, originally started as the Secure Transportable Autonomous Light Water Reactor (STAR-LW) and currently known as the International Reactor Innovative and Secure (IRIS) project, had the objective of investigating a novel type of water-cooled reactor to satisfy the Generation IV goals: fuel cycle sustainability, enhanced reliability and safety, and improved economics. The research objectives over the three-year (1999-2002) program were as follows: First year: Assess various design alternatives and establish main characteristics of a point design; Second year: Perform feasibility and engineering assessment of the selected design solutions; Third year: Complete reactor design and performance evaluation, including cost assessment These objectives were fully attained and actually they served to launch IRIS as a full fledged project for eventual commercial deployment. The program did not terminate in 2002 at the end of the NERI program, and has just entered in its fifth year. This has been made possible by the IRIS project participants which have grown from the original four member, two-countries team to the current twenty members, nine countries consortium. All the consortium members work under their own funding and it is estimated that the value of their in-kind contributions over the life of the project has been of the order of $30M. Currently, approximately 100 people worldwide are involved in the project. A very important constituency of the IRIS project is the academia: 7 universities from four countries are members of the consortium and five more US universities are associated via parallel NERI programs. To date, 97 students have worked or are working on IRIS; 59 IRIS-related graduate theses have been prepared or are in preparation, and 41 of these students have already graduated with M.S. (33) or Ph.D. (8) degrees. This ''final'' report (final only as far as the NERI program is concerned) summarizes the work performed in the first four years of IRIS, from October 1999 to October 2003. It provides a panoramic of the project status and design effort, with emphasis on the current status, since two previous reports have very extensively documented the work performed, from inception to early 2002.

  3. Beta-endorphin neuron regulates stress response and innate immunity to prevent breast cancer growth and progression.

    Science.gov (United States)

    Sarkar, Dipak K; Zhang, Changqing

    2013-01-01

    Body and mind interact extensively with each other to control health. Emerging evidence suggests that chronic neurobehavioral stress can promote various tumor growth and progression. The biological reaction to stress involves a chemical cascade initiated within the central nervous system and extends to the periphery, encompassing the immune, endocrine, and autonomic systems. Activation of sympathetic nervous system, such as what happens in the "fight or flight" response, downregulates tumor-suppressive genes, inhibits immune function, and promotes tumor growth. On the other hand, an optimistic attitude or psychological intervention helps cancer patients to survive longer via increase in β-endorphin neuronal suppression of stress hormone levels and sympathetic outflows and activation of parasympathetic control of tumor suppressor gene and innate immune cells to destroy and clear tumor cells.

  4. Modality-dependent dose requirements in the Austrian breast cancer early detection program. First results from technical quality assurance; Geraeteabhaengiger Dosisbedarf im Oesterreichischen Brustkrebsfrueherkennungsprogramm. Erste Ergebnisse aus der technischen Qualitaetssicherung

    Energy Technology Data Exchange (ETDEWEB)

    Osanna-Elliott, A.; Semturs, F.; Menhart, S.; Schloegl, C.; Wildner, S.; Zwettler, G. [AGES, Wien (Austria). Referenzzentrum fuer technische Qualitaetssicherung im Brustkrebsfrueherkennungsprogramm

    2015-07-01

    The Austrian Breast Cancer Early Detection Program (BKFP) has officially started in January 2014. In order to ensure that all participating women can rely on a sufficient cancer detection rate while at the same time the required dose is as low as reasonably achievable, all participating radiology institutes (approx. 200) have to fulfill strict quality assurance requirements. The control and certification is performed by the Reference Center for Technical Quality Assurance (RefZQS), which has been developing the methods and tolerances in a pilot project since 2007. The limits are defined in the EUREF-Oeprotocol which is based on the European EPQC guidelines. From the requirement for optimized image quality while simultaneously following the ALARA principle, we found modality-dependent dose requirements, which we had expected but which have now been compiled for the first time for Austria.

  5. MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression.

    Science.gov (United States)

    Christenson, Jessica L; Butterfield, Kiel T; Spoelstra, Nicole S; Norris, John D; Josan, Jatinder S; Pollock, Julie A; McDonnell, Donald P; Katzenellenbogen, Benita S; Katzenellenbogen, John A; Richer, Jennifer K

    2017-04-01

    Triple-negative breast cancer (TNBC) has a faster rate of metastasis compared to other breast cancer subtypes, and no effective targeted therapies are currently FDA-approved. Recent data indicate that the androgen receptor (AR) promotes tumor survival and may serve as a potential therapeutic target in TNBC. Studies of AR in disease progression and the systemic effects of anti-androgens have been hindered by the lack of an AR-positive (AR+) immunocompetent preclinical model. In this study, we identified the transgenic MMTV-PyMT (mouse mammary tumor virus-polyoma middle tumor-antigen) mouse mammary gland carcinoma model of breast cancer and Met-1 cells derived from this model as tools to study the role of AR in breast cancer progression. AR protein expression was examined in late-stage primary tumors and lung metastases from MMTV-PyMT mice as well as in Met-1 cells by immunohistochemistry (IHC). Sensitivity of Met-1 cells to the AR agonist dihydrotestosterone (DHT) and anti-androgen therapy was examined using cell viability, migration/invasion, and anchorage-independent growth assays. Late-stage primary tumors and lung metastases from MMTV-PyMT mice and Met-1 cells expressed abundant nuclear AR protein, while negative for estrogen and progesterone receptors. Met-1 sensitivity to DHT and AR antagonists demonstrated a reliance on AR for survival, and AR antagonists inhibited invasion and anchorage-independent growth. These data suggest that the MMTV-PyMT model and Met-1 cells may serve as valuable tools for mechanistic studies of the role of AR in disease progression and how anti-androgens affect the tumor microenvironment.

  6. 技术进步对就业人力资本结构的影响%The Impact of Technical Progress on Human Capital Structure of Employment

    Institute of Scientific and Technical Information of China (English)

    黄犚

    2012-01-01

    利用2003-2010年省际面板数据,研究不同类型的技术进步对我国就业人力资本结构的影响.结果表明:总就业与就业结构的调整是矛盾的统一体;自主创新的技术进步对总就业的创造作用大于摧毁作用;外商直接投资和进出口贸易产生的引进技术进步有利于促进我国对外经济体转型升级,增加高人力资本需求;我国对外直接投资作为贸易的补充有利于增加我国总就业,但由于技术获取动力不足,吸收技术溢出的效果不明显,不具有高人力资本偏态效应.同时,该影响也表现出一定程度的区域差异.%Using the provincial panel data from 2003 to 2010, this paper studies the influence of different types of technical progress of the human capital structure of employment in China. The result shows that: total employment and employment structure adjustment are the unity of contradiction; independent innovation benefits job creation; FDI and foreign trade promote the transformation and upgrading of Chinas foreign economy, and thus increase the demand of high human capital; China's technology sourcing OFDI is underpowered; as a supplement to trade, it will be beneficial to increase total employment; but the technology spillover effect is not obvious. Meanwhile, the effect is different in areas.

  7. The economical production of alcohol fuels from coal-derived synthesis gas. Quarterly technical progress report No. 5, October 1, 1992--December 31, 1992

    Energy Technology Data Exchange (ETDEWEB)

    1993-01-01

    Two base case flow sheets have now been prepared. In the first, which was originally presented in TPR4, a Texaco gasifier is used. Natural gas is also burned in sufficient quantity to increase the hydrogen to carbon monoxide ratio of the synthesis gas to the required value of 1. 1 for alcohol synthesis. Acid gas clean up and sulfur removal are accomplished using the Rectisol process followed by the Claus and Beavon processes. About 10% of the synthesis gas is sent to a power generation unit in order to produce electric power, with the remaining 90% used for alcohol synthesis. For this process, the estimated installed cost is $474.2 mm. The estimated annual operating costs are $64.5 MM. At a price of alcohol fuels in the vicinity of $1. 00/gal, the pay back period for construction of this plant is about four years. The details of this case, called Base Case 1, are presented in Appendix 1. The second base case, called Base Case 2, also has a detailed description and explanation in Appendix 1. In Base Case 2, a Lurgi Gasifier is used. The motivation for using a Lurgi Gasifier is that it runs at a lower temperature and pressure and, therefore, produces by-products such as coal liquids which can be sold. Based upon the economics of joint production, discussed in Technical Progress Report 4, this is a necessity. Since synthesis gas from natural gas is always less expensive to produce than from coal, then alcohol fuels will always be less expensive to produce from natural gas than from coal. Therefore, the only way to make coal- derived alcohol fuels economically competitive is to decrease the cost of production of coal-derived synthesis gas. one method for accomplishing this is to sell the by-products from the gasification step. The details of this strategy are discussed in Appendix 3.

  8. Thin films of gallium arsenide on low-cost substrates. Quarterly technical progress report No. 8 and topical report No. 3, April 2-July 1, 1978

    Energy Technology Data Exchange (ETDEWEB)

    Ruth, R.P.; Dapkus, P.D.; Dupuis, R.D.; Johnson, R.E.; Manasevit, H.M.; Moudy, L.A.; Yang, J.J.; Yingling, R.D.

    1978-07-01

    The seventh quarter of work on the contract is summarized. The metalorganic chemical vapor deposition (MO-CVD) technique has been applied to the growth of thin films of GaAs and GaAlAs on inexpensive polycrystalline or amorphous substrate materials (primarily glasses and metals) for use in fabrication of large-area low-cost photovoltaic device structures. Trimethylgallium (TMG), arsine (AsH/sub 3/), and trimethylaluminum (TMAl) are mixed in appropriate concentrations at room temperature in the gaseous state and pyrolyzed at the substrate, which is heated in a vertical reactor chamber to temperatures of 725 to 750/sup 0/C, to produce the desired film composition and properties. The technical activities during the quarter were concentrated on (1) a continuing evaluation of various graphite materials as possible substrates for MO-CVD growith of the polycrystalline GaAs solar cells; (2) attempts to improve the quality (especially the grain size) of polycrystalline GaAs films on Mo sheet and Mo/glass substrates by using HCl vapor during the MO-CVD growith process; (3) further studies of the transport properties of polycrystalline GaAs films, wth emphasis on n-type films; (4) continuing investigations of the properties of p-n junctions in polycrystalline GaAs, with emphasis on the formation and properties of p/sup +//n/n/sup +/ deposited structures; and (5) assembling apparatus and establishing a suitable technique for producing TiO/sub 2/ layers for use as AR coatings on GaAs cells. Progress is reported. (WHK)

  9. Breast cancer statistics, 2011.

    Science.gov (United States)

    DeSantis, Carol; Siegel, Rebecca; Bandi, Priti; Jemal, Ahmedin

    2011-01-01

    In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including trends in incidence, mortality, survival, and screening. Approximately 230,480 new cases of invasive breast cancer and 39,520 breast cancer deaths are expected to occur among US women in 2011. Breast cancer incidence rates were stable among all racial/ethnic groups from 2004 to 2008. Breast cancer death rates have been declining since the early 1990s for all women except American Indians/Alaska Natives, among whom rates have remained stable. Disparities in breast cancer death rates are evident by state, socioeconomic status, and race/ethnicity. While significant declines in mortality rates were observed for 36 states and the District of Columbia over the past 10 years, rates for 14 states remained level. Analyses by county-level poverty rates showed that the decrease in mortality rates began later and was slower among women residing in poor areas. As a result, the highest breast cancer death rates shifted from the affluent areas to the poor areas in the early 1990s. Screening rates continue to be lower in poor women compared with non-poor women, despite much progress in increasing mammography utilization. In 2008, 51.4% of poor women had undergone a screening mammogram in the past 2 years compared with 72.8% of non-poor women. Encouraging patients aged 40 years and older to have annual mammography and a clinical breast examination is the single most important step that clinicians can take to reduce suffering and death from breast cancer. Clinicians should also ensure that patients at high risk of breast cancer are identified and offered appropriate screening and follow-up. Continued progress in the control of breast cancer will require sustained and increased efforts to provide high-quality screening, diagnosis, and treatment to all segments of the population.

  10. TECHNICAL COORDINATION

    CERN Multimedia

    A. Ball and W. Zeuner

    2011-01-01

    In this report we will review the main achievements of the Technical Stop and the progress of several centrally-managed projects to support CMS operation and maintenance and prepare the way for upgrades. Overview of the extended Technical Stop  The principal objectives of the extended Technical Stop affecting the detector itself were the installation of the TOTEM T1 telescopes on both ends, the readjustment of the alignment link-disk in YE-2, the replacement of the light-guide sleeves for all PMs of both HFs, and some repairs on TOTEM T2 and CASTOR. The most significant tasks were, however, concentrated on the supporting infrastructure. A detailed line-by-line leak search was performed in the C6F14 cooling system of the Tracker, followed by the installation of variable-frequency drives on the pump motors of the SS1 and SS2 tracker cooling plants to reduce pressure transients during start-up. In the electrical system, larger harmonic filters were installed in ...

  11. Nuclear cathepsin D enhances TRPS1 transcriptional repressor function to regulate cell cycle progression and transformation in human breast cancer cells.

    Science.gov (United States)

    Bach, Anne-Sophie; Derocq, Danielle; Laurent-Matha, Valérie; Montcourrier, Philippe; Sebti, Salwa; Orsetti, Béatrice; Theillet, Charles; Gongora, Céline; Pattingre, Sophie; Ibing, Eva; Roger, Pascal; Linares, Laetitia K; Reinheckel, Thomas; Meurice, Guillaume; Kaiser, Frank J; Gespach, Christian; Liaudet-Coopman, Emmanuelle

    2015-09-29

    The lysosomal protease cathepsin D (Cath-D) is overproduced in breast cancer cells (BCC) and supports tumor growth and metastasis formation. Here, we describe the mechanism whereby Cath-D is accumulated in the nucleus of ERα-positive (ER+) BCC. We identified TRPS1 (tricho-rhino-phalangeal-syndrome 1), a repressor of GATA-mediated transcription, and BAT3 (Scythe/BAG6), a nucleo-cytoplasmic shuttling chaperone protein, as new Cath-D-interacting nuclear proteins. Cath-D binds to BAT3 in ER+ BCC and they partially co-localize at the surface of lysosomes and in the nucleus. BAT3 silencing inhibits Cath-D accumulation in the nucleus, indicating that Cath-D nuclear targeting is controlled by BAT3. Fully mature Cath-D also binds to full-length TRPS1 and they co-localize in the nucleus of ER+ BCC where they are associated with chromatin. Using the LexA-VP16 fusion co-activator reporter assay, we then show that Cath-D acts as a transcriptional repressor, independently of its catalytic activity. Moreover, microarray analysis of BCC in which Cath-D and/or TRPS1 expression were silenced indicated that Cath-D enhances TRPS1-mediated repression of several TRPS1-regulated genes implicated in carcinogenesis, including PTHrP, a canonical TRPS1 gene target. In addition, co-silencing of TRPS1 and Cath-D in BCC affects the transcription of cell cycle, proliferation and transformation genes, and impairs cell cycle progression and soft agar colony formation. These findings indicate that Cath-D acts as a nuclear transcriptional cofactor of TRPS1 to regulate ER+ BCC proliferation and transformation in a non-proteolytic manner.

  12. Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han women.

    Directory of Open Access Journals (Sweden)

    Ji-Yuan Han

    Full Text Available BACKGROUND: Somatic alterations of cyclin-dependent kinase 2 (CDK2-cyclin E complex have been shown to contribute to breast cancer (BC development and progression. This study aimed to explore the effects of single nucleotide polymorphisms (SNPs in CDK2 and CCNE1 (a gene encoding G1/S specific cyclin E1 protein, formerly called cyclin E on BC risk, progression and survival in a Chinese Han population. METHODOLOGY/PRINCIPAL FINDINGS: We herein genotyped 6 haplotype-tagging SNPs (htSNPs of CCNE1 and 2 htSNPs of CDK2 in 1207 BC cases and 1207 age-matched controls among Chinese Han women, and then reconstructed haplotype blocks according to our genotyping data and linkage disequilibrium status of these htSNPs. For CCNE1, the minor allele homozygotes of three htSNPs were associated with BC risk (rs3218035: adjusted odds ratio [aOR] = 3.35, 95% confidence interval [CI] = 1.69-6.67; rs3218038: aOR = 1.81, 95% CI = 1.22-2.70; rs3218042: aOR = 2.64, 95% CI = 1.31-5.34, and these three loci showed a dose-dependent manner in increasing BC risk (P(trend = 0.0001. Moreover, the 5-SNP haplotype CCGTC, which carried none of minor alleles of the 3 at-risk SNPs, was associated with a favorable event-free survival (hazard ratio [HR] = 0.53, 95% CI = 0.32-0.90. Stratified analysis suggested that the minor-allele homozygote carriers of rs3218038 had a worse event-free survival among patients with aggressive tumours (in tumour size>2 cm group: HR = 2.06, 95% CI = 1.06-3.99; in positive lymph node metastasis group: HR = 2.41, 95% CI = 1.15-5.03; in stage II-IV group: HR = 2.03, 95% CI = 1.09-3.79. For CDK2, no significant association was found. CONCLUSIONS/SIGNIFICANCE: This study indicates that genetic variants in CCNE1 may contribute to BC risk and survival in Chinese Han population. They may become molecular markers for individual evaluation of BC susceptibility and prognosis. Nevertheless, further validation studies are needed.

  13. Interleukin-19 in Breast Cancer

    Directory of Open Access Journals (Sweden)

    Ying-Yin Chen

    2013-01-01

    Full Text Available Inflammatory cytokines within the tumor microenvironment are linked to progression in breast cancer. Interleukin- (IL- 19, part of the IL-10 family, contributes to a range of diseases and disorders, such as asthma, endotoxic shock, uremia, psoriasis, and rheumatoid arthritis. IL-19 is expressed in several types of tumor cells, especially in squamous cell carcinoma of the skin, tongue, esophagus, and lung and invasive duct carcinoma of the breast. In breast cancer, IL-19 expression is correlated with increased mitotic figures, advanced tumor stage, higher metastasis, and poor survival. The mechanisms of IL-19 in breast cancer have recently been explored both in vitro and in vivo. IL-19 has an autocrine effect in breast cancer cells. It directly promotes proliferation and migration and indirectly provides a microenvironment for tumor progression, which suggests that IL-19 is a prognostic marker in breast cancer and that antagonizing IL-19 may have therapeutic potential.

  14. 癌症相关性视网膜病变在乳腺癌中的研究进展%Progress in the study of cancer-associated retinopathy in breast cancer patients

    Institute of Scientific and Technical Information of China (English)

    Guangyan Ji; Lei Xing; Jianbo Huang; Lingquan Kong; Ziwei Wang; Guosheng Ren; Kainan Wu

    2012-01-01

    Cancer-associated retinopathy (CAR) typically has a sudden or progressive onset of severe visual loss and an ominous association with an occult malignancy which contains breast cancer. Pathologically, CAR is the degeneration of photoreceptors. But the precise mechanism has not been fully established, CAR may result from autoimmune mediated apoptosis. And in recent years, there also have been some results demonstrating that tumor derived angiogenic factors such as VEGF may also confer the development of CAR, which may offer novel avenues for the therapeutic intervention in CAR.Early initiation of immunosuppressive therapy is critical for vision preservation. Future developments in rapid identification and longitudinal quantification of antibody levels would enable individualized management in these patients. The goal of this review was to analyze the epidemiology, the clinical features, the diagnosis and management of retinopathy in the context of recent advances in the elucidation of breast cancer-associated retinopathy (BCAR) pathogenesis.

  15. Drug treatment status and research progress on triple-negative breast cancer%三阴性乳腺癌的药物治疗现状及研究进展

    Institute of Scientific and Technical Information of China (English)

    罗佳宁; 葛晓峰

    2015-01-01

    三阴性乳腺癌(Triple-negative breast cancer,TNBC)是缺少雌激素受体(ER)、孕激素受体( PR)及人表皮生长因子受体( HER-2)表达的乳腺癌,虽对放化疗敏感,但缺乏相应的靶向治疗及内分泌治疗,具有侵袭性强、复发风险高、预后差的特点。因此近些年来,三阴性乳腺癌受到越来越多的国际肿瘤学界的关注,对三阴性乳腺癌的深入研究,将有助于该病的预防、早期诊断、判断疾病进展以及改善预后。本文将近几年来有关三阴乳腺癌的药物治疗现状及研究进展予以综述。%Triple negative breast cancer ( TNBC) is defined by the lack of expressions of the estrogen re-ceptor(ER)、progesterone receptor(PR)and human epidermal growth factor receptor 2(HER-2).Although it is sensitive to radiation and chemotherapy ,it lacks of appropriate targeted therapy and endocrine therapy .It performs characteristics of the strong invasion ,high risk of recurrence and poor prognosis .So in recent years ,triple negative breast cancer gets more and more attention from international oncology community .In-depth study of triple nega-tive breast cancer will help the prevention ,early diagnosis ,judge the progress of the disease and improve progno-sis.TNBC drug treatment and relevant research progress are reviewed in the present article .

  16. Humic substances in performance assessment of nuclear waste disposal: Actinide and iodine migration in the far-field. Third technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Buckau, G.

    2005-04-01

    The present report describes progress within the third and final year of the EC-project 'Humic Substances in Performance Assessment of Nuclear Waste Disposal: Actinide and Iodine Migration in the Far-Field'. The work conducted within the present project builds on a number of previous activities/project supported by the Commission. It finds its continuation within different EC FP 6 instruments and also provides for additional continued cooperation through network structures resulting from the broad cooperation within the project. Without being a formal requirement of the Commission or co-funding bodies, this report documents results in great technical detail and makes the results available to a broad scientific community. The report contains an executive summary written by the coordinator. More detailed results are given as individual contributions in the form of 12 annexes. Not all results are discussed or referred to in the executive summary report and thus readers with a deeper interest also need to consult the annexes. The overall objectives were to generate knowledge about the impact of humic substances on the migration of actinides and iodine in the far-field of a nuclear waste repository. In the beginning, focus was rather on the potential enhancement due to humic colloid mediated radionuclide transport. Thereby, sources, inventory, stability and mobility of dissolved humic substances in their colloidal form formed a key topic. Other key topics were the interaction with actinides and iodine, transport studies under near-natural conditions in the laboratory, rationalization of knowledge in models and application to three migration cases for visualization of the overall outcome. Changes relative to the original objectives were given by moving emphasis of natural chemical analogue studies from the question of kinetic exchange constants for different inventories in natural and laboratory systems to the study of anthropogenic actinide contaminants in the

  17. A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression.

    Science.gov (United States)

    Anastas, J N; Biechele, T L; Robitaille, M; Muster, J; Allison, K H; Angers, S; Moon, R T

    2012-08-09

    By analyzing public data sets of gene expression in human breast cancers we observed that increased levels of transcripts encoding the planar cell polarity (PCP) proteins SCRIB and VANGL1 correlate with increased risk of patient relapse. Experimentally, we found that reducing expression of SCRIB by short-hairpin RNAs (shRNAs) reduces the growth of human breast cancer cells in xenograft assays. To investigate SCRIB-associated proteins that might participate in the responses of breast cancer cells to altered levels of SCRIB, we used mass spectrometry and confocal microscopy. These studies reveal that SCRIB is present in at least two unique protein complexes: (1) a complex of SCRIB, ARHGEF, GIT and PAK (p21-activated kinase), and (2) a complex of SCRIB, NOS1AP and VANGL. Focusing on NOS1AP, we observed that NOS1AP colocalizes with both SCRIB and VANGL1 along cellular protrusions in metastatic breast cancer cells, but does not colocalize with either SCRIB or VANGL1 at cell junctions in normal breast cells. We investigated the effects of shRNA-mediated knockdown of NOS1AP and SCRIB in vitro, and found that reducing NOS1AP and SCRIB slows breast cancer cell migration and prevents the establishment of leading-trailing polarity. We also find that reduction of NOS1AP enhances anchorage-independent growth. Collectively these data point to the relevance of NOS1AP and SCRIB protein complexes in breast cancer.

  18. Research Progress of Early-stage Breast Cancer Breast-conserving Surgery Treatment%早期乳腺癌保乳手术治疗的研究进展

    Institute of Scientific and Technical Information of China (English)

    温健

    2011-01-01

    随着病理及生物免疫学的不断发展,对乳腺癌的认识也进一步地加深.乳腺癌患者对生存质量的要求不断提高,势必推动乳腺癌外科的不断发展.尤其早期乳腺癌患者,保乳术及前哨淋巴结活检术的出现及临床应用进展迅猛发展,明显替代传统的乳癌根治术及全腋窝淋巴结清扫术.但是,如何使局部复发率及转移率降到最低,仍是保乳术发展的主要研究目标.%Along with pathological and hiological immuunology 's unceasing development, the understanding of breast cancer is also further deepened. The requirements for quality of life of breast cancer sufferers are increasing continuously as well,which inevitahly promotes the growth of breast cancer surgery. Especially for earlv breast cancer,the occurrence and rapid development of breast-conserving surgery and sentinel lymph node biopsy has ohviously replaced the traditional radical mastectomy and full axillary lymph node dissection.However,how to lower the local recurrence and metastasis to the optimal still remains the major research objective of breast-conserving surgery development.

  19. New Progress on Markers for Breast Cancer%乳腺癌肿瘤标志物新的研究进展

    Institute of Scientific and Technical Information of China (English)

    吕晓娟

    2012-01-01

    目前乳腺癌已成为危害女性健康的第一大恶性肿瘤,且发病率呈逐年递增趋势,其早期诊断、治疗及预后成为当下研究的热点.乳腺癌肿瘤标志物对于其早期诊断、个体化治疗及预后均具有重要的临床实践指导意义.分子生物学的不断发展,为乳腺癌肿瘤标志物的基础与临床研究奠定了良好的基础.近年来,乳腺癌的诊断治疗手段逐渐增多,肿瘤标志物的应用也不断受到青睐,经典的肿瘤标志物已不足以更好的指导临床实践,因此不断有新的肿瘤标志物出现.为了解乳腺肿瘤标志物在乳腺癌诊治中的重要作用及其相关最新研究,本文结合国内外最新研究报道,对乳腺肿瘤标志物新的研究进展做一简要综述.%Breast cancer has become the first major female cancer that has increasingly threatened the health of women worldwide. The incidence of breast cancer has been reported to increase yearly. Thus, early diagnosis, individual treatment, and prognosis of breast cancer have currently been given more focus. Breast tumor biomarkers are significant guide for the early diagnosis, individual treatment, and prognosis of breast cancer. With the rapid development of molecular biology, very important foundations for basic and clinic research on breast cancer have been conducted. In recent years, various methods for the diagnosis and treatment of breast cancer have been proposed, and doctors who work in clinics daily have increasingly favored the use of breast tumor biomarkers. However, the use of classic tumor markers is insufficient in dealing with breast cancer. Thus, many studies constantly develop new biomarkers to improve the techniques for the treatment and therapy of breast cancer, to relieve the pain of patients with breast cancer, and to reduce the social and personal economic burden. This article discusses the new developments on breast tumor biomarkers.

  20. [Breast self-examination as main technique for breast cancer prevention].

    Science.gov (United States)

    Guerrero Mercedes, Rocío; Llamas Muñoz, M Carmen

    2013-04-01

    Breast cancer is the most common malignancy in women. Breast self-examination stands out as the main preventive measure, since almost 95% of breast tumours are detected by the woman herself through this technique. Nursing is the group most closely related to health education appropriate guidelines to perform the technique correctly: monthly technical realization, recognition of abnormalities in the breast, go to the doctor for possible doubt about changes in them, etc.

  1. Specific expression of the human voltage-gated proton channel Hv1 in highly metastatic breast cancer cells, promotes tumor progression and metastasis

    Energy Technology Data Exchange (ETDEWEB)

    Wang, Yifan [The Key Laboratory of Bioactive Materials, Ministry of Education, School of Physics Science, Nankai University, Tianjin 300071 (China); Li, Shu Jie, E-mail: shujieli@nankai.edu.cn [The Key Laboratory of Bioactive Materials, Ministry of Education, School of Physics Science, Nankai University, Tianjin 300071 (China); Pan, Juncheng [The Key Laboratory of Bioactive Materials, Ministry of Education, School of Physics Science, Nankai University, Tianjin 300071 (China); Che, Yongzhe, E-mail: cheli@nankai.edu.cn [The Key Laboratory of Bioactive Materials, Ministry of Education, School of Medicine, Nankai University, Tianjin 300071 (China); Yin, Jian [Cancer Institute and Hospital, Tianjin Medical University, Tianjin 300060 (China); Zhao, Qing [The Key Laboratory of Bioactive Materials, Ministry of Education, School of Physics Science, Nankai University, Tianjin 300071 (China)

    2011-08-26

    Highlights: {yields} Hv1 is specifically expressed in highly metastatic human breast tumor tissues. {yields} Hv1 regulates breast cancer cytosolic pH. {yields} Hv1 acidifies extracellular milieu. {yields} Hv1 exacerbates the migratory ability of metastatic cells. -- Abstract: The newly discovered human voltage-gated proton channel Hv1 is essential for proton transfer, which contains a voltage sensor domain (VSD) without a pore domain. We report here for the first time that Hv1 is specifically expressed in the highly metastatic human breast tumor tissues, but not in poorly metastatic breast cancer tissues, detected by immunohistochemistry. Meanwhile, real-time RT-PCR and immunocytochemistry showed that the expression levels of Hv1 have significant differences among breast cancer cell lines, MCF-7, MDA-MB-231, MDA-MB-468, MDA-MB-453, T-47D and SK-BR-3, in which Hv1 is expressed at a high level in highly metastatic human breast cancer cell line MDA-MB-231, but at a very low level in poorly metastatic human breast cancer cell line MCF-7. Inhibition of Hv1 expression in the highly metastatic MDA-MB-231 cells by small interfering RNA (siRNA) significantly decreases the invasion and migration of the cells. The intracellular pH of MDA-MB-231 cells down-regulated Hv1 expression by siRNA is obviously decreased compared with MDA-MB-231 with the scrambled siRNA. The expression of matrix metalloproteinase-2 and gelatinase activity in MDA-MB-231 cells suppressed Hv1 by siRNA were reduced. Our results strongly suggest that Hv1 regulates breast cancer intracellular pH and exacerbates the migratory ability of metastatic cells.

  2. Palbociclib for Advanced Breast Cancer

    Science.gov (United States)

    An interim analysis of the PALOMA3 trial shows that women with hormone receptor-positive metastatic breast cancer who received palbociclib plus fulvestrant had longer progression-free survival rates than women who received a placebo plus fulvestrant.

  3. Research progress of RNA interference in breast cancer gene therapy%RNA干扰技术在乳腺癌基因治疗中的研究进展

    Institute of Scientific and Technical Information of China (English)

    薛荣泉

    2011-01-01

    RNA干扰技术作为一种简单、有效的代替基因敲除的手段为肿瘤的基因治疗提供了新思路,文章综述RNA干扰的机制、特点及在乳腺癌基因治疗等方面的应用进展。%RNA interference provides a new idea for the gene therapy of cancer as a simple and effective means to replace the gene knockout. This article summarise research progress of RNA interference mechanism, characteristics and application in breast cancer gene therapy.

  4. Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer

    OpenAIRE

    Hoenerhoff, M J; Shibata, M. A.; Bode, A.; Green, J. E.

    2010-01-01

    The C3(1) component of the rat prostate steroid binding protein has been used to target expression of the SV40 T/t-antigen to the mammary epithelium of mice resulting in pre-neoplastic lesions that progress to invasive and metastatic cancer with molecular features of human basal-type breast cancer. However, there are major differences in the histologic architecture of the stromal and epithelial elements between the mouse and human mammary glands. The rat mammary gland is more enriched with ep...

  5. TECHNICAL COORDINATION

    CERN Multimedia

    Austin Ball

    Summary of progress since last CMS week. Ten years of construction work have been completed. CMS is closed, in very close to the ideal low luminosity configuration, and performed well in the first tests with LHC beam. Behind this encouraging news is the story of a summer of intense commitment by many teams (from the collaboration and 3 CERN departments) working together, against the clock and despite many minor setbacks, to ensure that the experiment was ready to play a leading role in the excitement of September 10. Following beampipe bakeout and refill with pure neon, a magnificent effort by the ECAL group and the pt 5 technical crew made it possible to install and commission all 4 ECAL endcap Dees before the end of August. In the shadow of this activity, the barrel and forward pixel trackers and part of the beam monitoring were installed within the vac tank. The pt 5 technical teams then succeeded in safely removing the 20t installation tables and their support blocks from beneath the already installed ...

  6. Fibroadenoma - breast

    Science.gov (United States)

    Breast lump - fibroadenoma; Breast lump - noncancerous; Breast lump - benign ... The cause of fibroadenomas is not known. There may be a connection to a problem with genes. Fibroadenoma is the most common benign ...

  7. Breast Implants

    Science.gov (United States)

    ... Medical Procedures Implants and Prosthetics Breast Implants Breast Implants Share Tweet Linkedin Pin it More sharing options Linkedin Pin it Email Print Breast implants are medical devices that are implanted under the ...

  8. What Is Breast Cancer?

    Science.gov (United States)

    ... Research? Breast Cancer About Breast Cancer What Is Breast Cancer? Breast cancer starts when cells in the breast ... spread, see our section on Cancer Basics . Where breast cancer starts Breast cancers can start from different parts ...

  9. TECHNICAL COORDINATION

    CERN Multimedia

    Austin Ball

    2013-01-01

      Since the last report, much visible progress has been made, as the LS1 programme approaches the halfway point. From early October, technical and safety shift-crew have been present around the clock, allowing detectors to stay switched on overnight, ensuring that safety systems are operational and instructions for non-expert shift-crew are clear. LS1 progress Throughout the summer, whilst the solenoid vacuum tank and YB0 surfaces were accessible, an extensive installation programme took place to prepare for Tracker colder operation and the PLT installation, in 2014, the Phase 1 Pixel Tracker installation, in 2016–’17, and the HCAL Phase 1 upgrade completion, ending in LS2. This included pipework for N2 or dry air to flush the Tracker bulkhead region, many sensors to monitor temperature and dew point in the Tracker and its service channels, heating wires outside the Tracker cooling bundles, supports for the new vacuum-jacketed, concentric, CO2 Pixel cooling lines, the PLT cool...

  10. Volumetric breast density from full-field digital mammograms and its association with breast cancer risk factors: a comparison with a threshold method.

    NARCIS (Netherlands)

    Lokate, M.; Kallenberg, M.G.J.; Karssemeijer, N.; Bosch, M.H.J. van den; Peeters, P.H.M.; Gils, C.H. van

    2010-01-01

    INTRODUCTION: Breast density, a strong breast cancer risk factor, is usually measured on the projected breast area from film screen mammograms. This is far from ideal, as breast thickness and technical characteristics are not taken into account. We investigated whether volumetric density measurement

  11. Progress of Hormone Replacement Therapy and Breast Cancer%激素替代疗法与乳腺癌关系的研究进展

    Institute of Scientific and Technical Information of China (English)

    孙芳芳; 史惠蓉

    2014-01-01

    Hormone replacement therapy (HRT) can alleviate postmenopausal women′menopausal symptoms,prevent osteoporosis and reduce fractures with a consensus,but its influence on breast cancer,cardiovascular disease and other chronic diseases is still controversial. Using estrogen alone may not increase the risk of breast cancer ,while combining estrogen with progesterone may increase breast cancer′s risk. Different breast disease patients may suffer different risks of breast cancer after HRT,the relationship between Chinese women HRT and breast cancer are uncertain. Benefits exceed risks when applying HRT on women who have indications close to post menopause ,different types and occupy pathways of HRT may result in different breast cancer risks. Summarize the relationship between HRT and breast cancer as well as HRT applications in patients with different breast disease.%激素替代疗法(hormone replacement therapy,HRT)在改善妇女绝经症状、预防骨质疏松、减少骨折发生等方面的作用已成共识,但其对乳腺癌、心脑血管疾病及其他慢性疾病的影响尚存在争议。单用雌激素可能不增加乳腺癌风险,雌孕激素联合应用可能增加乳腺癌风险。不同乳腺疾病患者应用HRT后乳腺癌发病风险不同,中国女性HRT与乳腺癌的关系尚未完全明确。在近绝经期有适应证的妇女中应用HRT的收益大于风险,且HRT的种类与使用途径对乳腺癌的发病风险可能不同。综述HRT与乳腺癌的关系以及HRT在不同乳腺疾病患者中的应用。

  12. Materials compatibility and lubricants research on CFC-refrigerant substitutes. Quarterly MCLR program technical progress report, January 1, 1995--March 31, 1995

    Energy Technology Data Exchange (ETDEWEB)

    Szymurski, S.R.; Hourahan, G.C.; Godwin, D.S.

    1995-04-01

    The Materials Compatibility and Lubricants Research (MCLR) program supports critical research to accelerate the introduction of CFC and HCFC refrigerant substitutes. The MCLR program addresses refrigerant and lubricant properties and materials compatibility. The primary elements of the work include data collection and dissemination, materials compatibility testing, and methods development. The work is guided by an Advisory Committee consisting of technical experts from the refrigeration and air-conditioning industry and government agencies. The Air-Conditioning and Refrigeration Technology Institute, Inc., (ARTI) manages and contracts multiple research projects and a data collection and dissemination effort. Detailed results from these projects are reported in technical reports prepared by each subcontractor.

  13. Research Progress on the Relationship between Metabolic Syndrome and Triple-Negative Breast Cancer%代谢综合征与三阴性乳腺癌关系的研究进展

    Institute of Scientific and Technical Information of China (English)

    田垚; 王毅; 朱科云; 汪百川; 曹旭晨

    2014-01-01

    代谢综合征(MS)、乳腺癌是女性常见疾病,三阴性乳腺癌(TNBCs)是近年来备受关注的乳腺癌的一个类型。MS的重要组分向心性肥胖、高血糖、高甘油三酯和低高密度脂蛋白胆固醇(HDL-C)增加了TNBCs的患病风险。MS的常见生物标志物胰岛素、脂联素和瘦素等在乳腺癌特别是TNBCs的发生发展中起到重要作用。胰岛素样生长因子-ⅡmRNA结合蛋白3(IMP3)是一种癌胚蛋白,可能是TNBCs浸润性癌新的生物标志物。本文对MS与TNBCs关系的研究进展进行综述。%Metabolic syndrome (MS) and breast cancer are common diseases of women. Triple negative breast cancer (TNBCs) is one type of breast cancer, which is of much attention in recent years. Important components of MS include central obesity, high blood sugar, high triglycerides and low level of high-density lipoprotein (HDL-C), which increased the inci-dence risk of TNBCs. Common biomarkers of MS including insulin, adiponectin and leptin play an important role in the oc-currence and development of breast cancer, especially TNBCs. Insulin-like growth factor-IImRNA binding protein 3 (IMP3, an oncofetal protein) may be TNBCs’new invasive cancer biomarkers. In this paper, the research progress on the relation-ship between MS and TNBCs is reviewed.

  14. 乳腺癌改良根治术后胸壁放射治疗的研究进展%Research Progression in Chest Wall Radiotherapy after Modified Radical Mastectomy for Breast Cancer

    Institute of Scientific and Technical Information of China (English)

    林菲; 谢作飘; 张芬(综述); 杨毅(审校)

    2016-01-01

    乳腺癌改良根治术后有较高的胸壁复发率,术后胸壁放疗是进一步减少局部复发最直接和最有效的方法。随着放疗设备更新和放疗技术的不断进步,乳腺癌改良根治术后胸壁的放射治疗技术也日趋完善。文章就近年来乳腺癌改良根治术后胸壁的放射治疗进展作综述。%There is a high chest wall recurrence rate after the modified radical mastectomy for breast cancer.Postoperative chest wall radiotherapy is considered to be the most direct and effec-tive method for further reducing the local recurrence.With the renewal of radiotherapy equipment and the continuous progress of radiotherapy technique,the chest wall radiotherapy after the modi-fied radical mastectomy has been increasingly improved.This paper reviews the research progress in chest wall radiotherapy after the modified radical mastectomy for breast cancer.

  15. The research progress of Chinese medicine's treatment to precocious puberty simple early breast development%性早熟单纯乳房早发育中医药研究进展

    Institute of Scientific and Technical Information of China (English)

    褚艾妮

    2014-01-01

    文章通过收集整理近十年来中医药治疗性早熟单纯乳房早发育的进展和研究概况,得出结论为中医药治疗单纯乳房早发育的效果确实显著。其优点又在于无特殊不良反应。中医在辨证论治的基础上采用各种有效方药、中成药和外治疗法,研究治疗上,取得了可喜的进展,呈现着向内治与外治相结合的趋势发展。为中医药防治性早熟研究的进一步标准化提供了理论的支持和起到了指导作用。%The research of Chinese medicine treatment of precocious puberty simple early breast development is done by collecting materias including research and progress of this symptom in recent ten years. The conclusion of this research is that Chinese treatment effective .Having no special adverse reactions is the advantage of Chinese treatment. The early development of traditional Chinese medicine treatment of pure breast is based on syndrome differentiation, using a variety of effective prescription, Chinese medicine and external therapy, which has made a gratifying progress and presente a developing trend of combination of internal and external treatment. As a Chinese traditional medicine for the treatment of precocious puberty can provides theoretical support and guidance for the further standardization of precocious puberty simple early breast development study.

  16. Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer.

    Science.gov (United States)

    Hoenerhoff, M J; Shibata, M A; Bode, A; Green, J E

    2011-04-01

    The C3(1) component of the rat prostate steroid binding protein has been used to target expression of the SV40 T/t-antigen to the mammary epithelium of mice resulting in pre-neoplastic lesions that progress to invasive and metastatic cancer with molecular features of human basal-type breast cancer. However, there are major differences in the histologic architecture of the stromal and epithelial elements between the mouse and human mammary glands. The rat mammary gland is more enriched with epithelial and stromal components than the mouse and more closely resembles the cellular composition of the human gland. Additionally, existing rat models of mammary cancer are typically estrogen receptor positive and hormone responsive, unlike most genetically engineered mouse mammary cancer models. In an attempt to develop a mammary cancer model that might more closely resemble the pathology of human breast cancer, we generated a novel C3(1)/SV40 T/t-antigen transgenic rat model that developed progressive mammary lesions leading to highly invasive adenocarcinomas. However, aggressive tumor development prevented the establishment of transgenic lines. Characterization of the tumors revealed that they were primarily estrogen receptor and progesterone receptor negative, and either her2/neu positive or negative, resembling human triple-negative or Her2 positive breast cancer. Tumors expressed the basal marker K14, as well as the luminal marker K18, and were negative for smooth muscle actin. The triple negative phenotype has not been previously reported in a rat mammary cancer model. Further development of a C3(1)SV40 T/t-antigen based model could establish valuable transgenic rat lines that develop basal-type mammary tumors.

  17. The need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury?

    Science.gov (United States)

    Khasraw, Mustafa; Brogi, Edi; Seidman, Andrew D

    2011-02-01

    Knowledge of estrogen receptor (ER), progesterone receptor (PgR) and human epidermal growth factor receptor-2 (HER2) status is necessary for determining the optimal treatment of breast cancer patients. At the same time, the discordance between marker profiles (ER/PR and HER2) of primary and metastatic breast cancer is well documented. Whether discordant cases are secondary to "clonal selection" in the face of targeted anti-estrogen or anti-HER2 therapy or whether they are a laboratory artifact is still debated; both scenarios are likely. This article outlines current modalities for ER, PR, and HER2 testing in primary breast carcinoma and its metastases and reviews prospective and retrospective studies that have addressed these issues, as well as recent advances in the field.

  18. Federal Assistance Program Quarterly Project Progress Report. Geothermal Energy Program: Information Dissemination, Public Outreach, and Technical Analysis Activities. Reporting Period: January 1 - March 31, 2001 [Final report

    Energy Technology Data Exchange (ETDEWEB)

    Lund, John W.

    2002-03-22

    The final report of the accomplishments of the geothermal energy program: information dissemination, public outreach and technical analysis activities by the project team consisting of the Geo-Heat Center, Geothermal Resources Council, Geothermal Education Office, Geothermal Energy Association and the Washington State University Energy Program.

  19. Increased oil production and reserves utilizing secondary/tertiary recovery techniques on small reservoirs in the Paradox Basin, Utah. Technical progress report, January 1--March 31, 1996

    Energy Technology Data Exchange (ETDEWEB)

    Allison, M.L.

    1996-04-30

    The primary objective of this project is to enhance domestic petroleum production by demonstration and technology transfer of an advanced oil recovery technology in the Paradox basin, southeastern Utah. If this project can demonstrate technical and economic feasibility, the technique can be applied to approximately 100 additional small fields in the Paradox basin alone, and result in increased recovery of 150 to 200 million barrels of oil. This project is designed to characterize five shallow-shelf carbonate reservoirs in the Pennsylvanian (Desmoinesian) Paradox Formation and choose the best candidate for a pilot demonstration project for either a waterflood or carbon dioxide-(CO{sub 2}-)flood project. The field demonstration, monitoring of field performance, and associated validation activities will take place in the Paradox basin within the Navajo Nation. The results of this project will be transferred to industry and other researchers through a petroleum extension service, creation of digital databases for distribution, technical workshops and seminars, field trips, technical presentations at national and regional professional meetings, and publication in newsletters and various technical or trade journals.

  20. Increased oil production and reserves utilizing secondary/tertiary recovery techniques on small reservoirs in the Paradox basin, Utah. Final technical progress report, October 1--December 31, 1995

    Energy Technology Data Exchange (ETDEWEB)

    Allison, M.L.

    1996-01-15

    The primary objective of this project is to enhance domestic petroleum production by demonstration and technology transfer of an advanced oil recovery technology in the Paradox basin, southeastern Utah. If this project can demonstrate technical and economic feasibility, the technique can be applied to approximately 100 additional small fields in the Paradox basin alone, and result in increased recovery of 150 to 200 million barrels of oil. This project is designed to characterize five shallow-shelf carbonate reservoirs in the Pennsylvanian (Desmoinesian) Paradox Formation and choose the best candidate for a pilot demonstration project for either a waterflood or carbon dioxide-(CO{sub 2}) flood project. The field demonstration, monitoring of field performance, and associated validation activities will take place in the Paradox basin within the Navajo Nation. The results of this project will be transferred to industry and other researchers through a petroleum extension service, creation of digital databases for distribution, technical workshops and seminars, field trips, technical presentations at national and regional professional meeting, and publication in newsletters and various technical or trade journals. Five activities continued this quarter as part of the geological and reservoir characterization of carbonate mound buildups in the Paradox basin: (1) regional facies evaluation, (2) evaluation of outcrop analogues, (3) field-scale geologic analysis, (4) reservoir analysis, and (5) technology transfer.

  1. 三阴乳腺癌的特点及研究进展%Features and research progressions in triple negative breast cancer

    Institute of Scientific and Technical Information of China (English)

    杜娟; 阮祥燕

    2015-01-01

    Triple negative breast cancer( TNBC ) is defined as one of the subtypes of breast cancer, which has been attracted much attention in recent years because of the aggressive behavior and inferior prognosis. This review summarizes clinical pathologic features, molecular biologic features and treatments of TNBC. Clinical pathologic features include epidemiologic, clinical and pathobiologic features. Molecular biologic features demonstrate the relationship between TNBC and basal-like breast cancer, breast cancer 1(BRCA1) and p53 gene. Treatments include surgery, neoadjuvant chemotherapy, high dose chemotherapy and targeted therapy. Further research in TNBC may provide more effective therapies.%三阴乳腺癌( triple negative breast cancer,TNBC)是一种特殊的乳腺癌亚型,侵袭性强、预后差,近年来受到广泛关注。本文综述了TNBC的临床病理学、分子生物学特征及治疗进展。临床病理学包括流行病学、临床特点及病理生物学特征。分子生物学特征包括TNBC与Basal-like乳腺癌、乳腺癌1号基因(breast cancer 1,BRCA1)、p53等基因间的关系。治疗包括手术治疗、新辅助化学治疗、高剂量化学治疗及靶向治疗。深入研究TNBC的特征可为其治疗提供更多新思路。

  2. Breast ultrasound.

    Science.gov (United States)

    Ueno, E

    1996-03-01

    to the diagnosis of breast cancer. Breast cancer is rich in blood vessels. The feeding arteries flow directly into the tumor and are characterized by tortuosity and flexion. Since the intraductal spread of breast cancer can easily be evaluated, ultrasound has come to play an important role in breast conserving treatment. Breast cancer with intraductal spreading causes dilation of the mammary ducts, and the resolution of ultrasound at present has been improved to the degree that this dilation is shown as a tubular hypoechoic area. With the progress made in imaging diagnosis, nonpalpable breast cancer has increased and ultrasonically-guided aspiration cytology and biopsy techniques have been developed to obtain definite diagnoses of these lesions. In cases of micro-calcification detected by mammography, ultrasonically guided biopsy is recommended when identification by ultrasound is possible. Since this is a simple technique, it should be mastered.

  3. Development of automated welding process for field fabrication of thick walled pressure vessels. Fourth quarter technical progress report for period ending September 30, 1979

    Energy Technology Data Exchange (ETDEWEB)

    None

    1979-01-01

    Progress in developing an automated welding process for the field fabrication of thick walled pressure vessels is reported. Plans for the demonstration facility, for nondestructive testing, and for the procurement of materials are discussed. (LCL)

  4. The development of coal-based technologies for Department of Defense facilities. Volume 2, Appendices. Semiannual technical progress report, September 28, 1994--March 27, 1995

    Energy Technology Data Exchange (ETDEWEB)

    Miller, B.G.; Bartley, D.A.; Hatcher, P. [Pennsylvania State Univ., University Park, PA (United States). Energy and Fuels Research Center] [and others

    1996-10-15

    This semiannual progress report contains the following appendices: description of the 1,000 lb steam/h watertube research boiler; the Pennsylvania CGE model; Phase II, subtask 3.9 coal market analysis; the CGE model; and sector definition.

  5. Breast Diseases

    Science.gov (United States)

    ... bumps, and discharges (fluids that are not breast milk). If you have a breast lump, pain, discharge or skin irritation, see your health care provider. Minor and serious breast problems have similar symptoms. Although many women fear cancer, most breast problems are not cancer. Some common ...

  6. Inflammatory breast cancer: what are the treatment options?

    Science.gov (United States)

    Iniesta, Maria D; Mooney, Colin J; Merajver, Sofia D

    2009-12-01

    An otherwise healthy, 68-year-old woman presents to her primary-care physician complaining of right breast enlargement, warmth, and progressive pink to dark red skin changes over the past month. She denies fever, pain, or breast discharge. Physical examination reveals erythema of the whole right breast, warmth, swelling, induration, and nipple retraction. Palpable axillary lymphadenopathy is appreciated on the right only. The left breast is uninvolved. The physician is concerned that she may have inflammatory breast cancer.

  7. Research Progress on Estrogen Relationship With breast cancer%雌激素与乳腺癌关系的研究进展

    Institute of Scientific and Technical Information of China (English)

    胡蕾蕾; 吴东恩

    2014-01-01

    Estrogen is a steroid hormone,ER is widely spread in tissues including reproductive system ,skeleton and cardiovas-cular system,could induce breast cancer.Complete mechanism of estrogen cause breast cancer remains unclear,but One important mechanism which is known to stimulate the growth of breast cancer and inhibition of apoptosis.Here is to review the full text on estro-gen,estrogen receptor and breast cancer relationship.%雌激素是一种甾体激素,具有广泛的组织分布,包括生殖系统、骨骼、心血管系统等,可诱导乳腺肿瘤的发生。雌激素导致乳腺癌的完全机制仍不明确,但已知其中重要的机制之一就是刺激乳腺癌组织的生长和抑制凋亡。本文就雌激素,雌激素受体与乳腺癌的关系进行综述。

  8. 乳腺癌的MRI诊断及临床应用进展%Diagnosis and clinical application progress of MRI on breast cancer

    Institute of Scientific and Technical Information of China (English)

    杨秀

    2015-01-01

    Objective:To explore the diagnosis and clinical application of MRI on breast cancer.Methods:Compared the MRI test results and pathological results in 120 patients with breast disease,and also compared their TNM staging and pTNM stage based on the MRI before the surgery,to explore the accuracy of MRI examination,and its accuracy of MRI diagnosed on TNM staging. Results:The diagnostic accuracy of MRI on diagnosis of breast cancer and benign disease was 88.9% and 87.5% respectively. Conclusion:MRI can diagnosis of TNM staging of breast cancer accurately.%目的:探究乳腺癌的MRI诊断及临床应用进展。方法:比较120例乳腺疾病患者MRI检查结果与病理结果以及术前乳腺癌患者以MRI为基础的TNM分期与pTNM分期,探讨MRI检查的准确性以及MRI诊断TNM分期的准确性。结果:MRI诊断乳腺癌以及良性疾病的准确率分别为88.9%、87.5%。结论:MRI能够较准确地诊断乳腺癌的TNM分期情况。

  9. Optimal breast cancer pathology manifesto.

    Science.gov (United States)

    Tot, T; Viale, G; Rutgers, E; Bergsten-Nordström, E; Costa, A

    2015-11-01

    This manifesto was prepared by a European Breast Cancer (EBC) Council working group and launched at the European Breast Cancer Conference in Glasgow on 20 March 2014. It sets out optimal technical and organisational requirements for a breast cancer pathology service, in the light of concerns about variability and lack of patient-centred focus. It is not a guideline about how pathology services should be performed. It is a call for all in the cancer community--pathologists, oncologists, patient advocates, health administrators and policymakers--to check that services are available that serve the needs of patients in a high quality, timely way.

  10. Materials Compatibility and Lubricants Research of CFC-refrigerant substitutes. Quarterly technical progress report, 1 April 1993--30 June 1993

    Energy Technology Data Exchange (ETDEWEB)

    Godwin, D.S.; Hourahan, G.C.; Szymurski, S.R.

    1993-07-01

    The Materials Compatibility and Lubricants Research (MCLR) program supports critical research to accelerate the introduction of CFC and HCFC refrigerant substitutes. The DCLR program addresses refrigerant and lubricant properties and materials compatibility. The primary elements of the work include data collection and dissemination, materials compatibility testing, and methods development. The work is guided by an Advisory Committee consisting of technical experts from the refrigeration and air-conditioning industry and government agencies. Under the current MCLR program the Air-Conditioning and Refrigeration Technology Institute, Inc., (ARTI) is contracting and managing multiple research projects and a data collection and dissemination effort. Detailed results from these projects are reported in technical reports prepared by each researcher.

  11. Research Progress on Posttraumatic Growth of the Breast Cancer Patients%乳腺癌患者“创伤后成长”的研究进展

    Institute of Scientific and Technical Information of China (English)

    陆靖; 史铁英

    2014-01-01

    In recent years , the incidence of breast cancer is rising , and breast cancer almost becomes the most serious malignant tumor for women .The operation brings a lot of harm to both the body and the mind of patients .But some researchers finds that the patients will have a positive psychological change in the process of fighting with breast cancer . This is posttraumatic growth which has been studied in the field of positive psychology .This paper reviews the connotation of the posttraumatic growth ,current situation in China and other countries ,assessment tools ,influencing factors and intervention methods in women with breast cancer ,in order to provide evidence for the development of clinical breast cancer patients'psychological care .%近年来,乳腺癌的发病率不断上升,乳腺癌已逐渐成为危害女性健康的首位恶性肿瘤。手术给患者的身心带来很大伤害,但研究者发现,在与乳腺癌这一疾病做斗争的过程中患者会产生一种正向的心理变化,这就是积极心理学领域研究的创伤后成长。本文从创伤后成长内涵、国内外研究现状、测量工具、影响因素、干预方法等几方面对乳腺癌创伤后成长研究现状进行文献综述,为乳腺癌患者心理护理提供依据。

  12. An Empirical Analysis on Internal and External Effects of Technical Progress in Equipment Manufacturing Industry%装备制造业技术进步内外部效应的实证分析

    Institute of Scientific and Technical Information of China (English)

    刘震; 张宏

    2016-01-01

    In the realistic context of“Made in China by 2025”and“Industrial 4.0”,this paper,based on the analysis of the do⁃mestic and international effect mechanism of technical progress in equipment manufacturing industry,empirically verifies the internal and external effects of technical progress in China’s equipment manufacturing industry with the aid of the panel and the VAR model. The study finds that:In the internal effect,the equipment manufacturing industry’s income and energy effi⁃ciency have a two-way positive impact on technical level,profit has a one-way positive impact on technical level,and employ⁃ment and technology level show a two-way negative impact;In the external effect,the equipment manufacturing industry’s FDI quality and technical level present a two-way positive impact,international division of labor and technical level present a one-way positive impact,and trade competitiveness and technical level present a two-way negative impact. Therefore,China should increase investment and improve productivity at home,and deepen the international division of labor and actively par⁃ticipate in the construction of value chain in order to improve the technical level of equipment manufacturing industry.%文章以“中国制造2025”“、工业4.0”时代来临为现实背景,在分析装备制造业技术进步的国内及国际效应作用机理的基础上,借助面板和VAR模型从实证角度验证我国装备制造业技术进步的内外部效应。研究发现,内部效应中,装备制造业收入及能耗效率指标与技术水平呈现双向正面影响,利润与技术水平为单向正面,就业与技术水平为双向负面;外部效应中,装备制造业引进外资质量与技术水平呈现双向正面影响,国际分工程度与技术水平为单向正面,贸易竞争力与技术水平为双向负面。因此为提升装备制造业技术水平,国内应加大投入,提高

  13. The role of clinical breast examination and breast self-examination.

    Science.gov (United States)

    Miller, Anthony B; Baines, Cornelia J

    2011-09-01

    The efficacy of screening by clinical breast examination (CBE) and/or breast self-examination (BSE) is reviewed using indirect evidence from randomized breast screening trials and that from observational studies. In countries where breast cancer is diagnosed at an advanced stage, screening by CBE with the teaching of BSE as an integral component will probably be effective in reducing breast cancer mortality. However, in technically advanced countries where adequate treatment is given, no screening modality is likely to be sufficiently beneficial to outweigh the harms of screening, especially false positives and over-diagnosis.

  14. Research and development of methods/utilities and rules for managing cooperation for performance improvement in government offices. Second Technical progress report, September 1, 1992--January 31, 1993

    Energy Technology Data Exchange (ETDEWEB)

    Kurstedt, H.A.

    1993-03-01

    Purpose is to help managers approach their responsibilities proactively, so that they can anticipate problems and take actions to alleviate or eliminate those problems. Continuous performance improvement, the philosophy behind total quality management, requires working cooperatively to do a little better each day. The most effective tools are working through a closed set of 9 methods: setting expectations, charting, defining indicators and standards, collecting and logging data, converting data to information, organizing and presenting information, reviewing status and progress, self-management, and appraising. In addition, there are 8 rules: focus on what you can do, supply physical evidence of progress, pay attention to detail, inspect (don`t expect), review progress routinely and frequently, face ``success/fail`` squarely, communicate crisply, and conduct honest, open appraisals. Scope and plans of the draft research plan (study areas) are described.

  15. Research and development of a unified approach to operations scheduling for electric power under uncertainty. Technical progress report, June 1979-June 1980

    Energy Technology Data Exchange (ETDEWEB)

    Larson, R.E.

    1980-06-01

    The objective of this study was to develop a unified approach for operations schedulng in electric power systems that explicitly takes into account sources of uncertainty present at all levels in this problem. This objective requires formulating the operations scheduling problem as a single, integrated problem, and developing solution methodologies that start from this integrated formulation and progress to subproblem solution methods that are consistent with it. Progress for the first year of the project is reported. Information is included on: problem definition; time-scale decomposition; stochastic optimization of both parallel and series reservoir systems; stochastic production simulation; maintenance scheduling and nuclear refueling; and short-term resource scheduling. (LCL)

  16. A Case Report of Breast Sparganosis in a Patient with Ipsilateral Breast Cancer: MRI and Ultrasonographic Findings

    Energy Technology Data Exchange (ETDEWEB)

    Lee, Yoo Jin; Bae, Young Tae; Kim, Jee Yeon [Pusan National University Hospital, Pusan National University School of Medicine, Busan (Korea, Republic of); Choo, Ki Seok [Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan (Korea, Republic of)

    2010-12-15

    Sparganosis of the breast is a quite rare parasitic infection of humans and presents as soft tissue masses that mimic breast malignancy or benign tumor, such as fibroadenoma. We present here a case of histologically confirmed breast sparganosis in the upper inner quadrant of the right breast with coexisting breast cancer in the ipsilateral breast upper outer quadrant. Ultrasonography of breast sparganosis showed a well defined, tubular hypoechoic mass with discrete multilayered wall and tubule-in tubule appearance, surrounded by heterogenous hyperechoic areas in the subcutaneous fat layer of the breast. MRI revealed an elongated tubular structure with persistent and progressive enhancement. This is the second report concerned with the MRI and ultrasonographic findings of breast sparganosis and the first report of breast sparganosis in a patient with ipsilateral breast cancer

  17. Progress in the clinical treatment based on breast cancer stem cells%基于乳腺癌干细胞的临床治疗进展

    Institute of Scientific and Technical Information of China (English)

    任远; 李泽桂

    2011-01-01

    背景:肿瘤干细胞在肿瘤的发生、发展、转移和复发等方面发挥着重要的作用.由于常规疗法无法消灭乳腺癌干细胞,故乳腺癌干细胞已被假定为乳腺癌治疗失败的根源.目的:阐明乳腺癌干细胞的生物学特性及一些乳腺癌靶向治疗药物的疗效,为制定提高乳腺癌患者生存率的治疗方案提供一些建议.方法:应用计算机检索PubMed数据库2000-01/2010-08有关乳腺癌干细胞的标志物与鉴定、新型药物针对乳腺癌干细胞靶向治疗方面的相关文献,检索词为"breast cancer,cancer stem cells,therapy",限定文章语言种类为English.检索文献包括临床研究、基础研究及综述类文章,初检得到文献总计203篇,排除重复性研究,保留33篇文献进一步分析.结果与结论:乳腺癌干细胞是第一个在实体瘤中被鉴定的肿瘤干细胞,人们采用多种策略成功分离出乳腺癌干细胞,对其生物学行为的认识正逐渐深入.乳腺癌干细胞的自我更新、分化等特性受到微环境和许多信号转导通路的调控.如何靶向治疗乳腺癌干细胞,最终根治乳腺癌,正逐渐成为肿瘤靶向治疗研究的一个热点.%BACKGROUND: Tumor stem cell plays an important role in the occurrence, development, metastasis and recurrence of tumor.However, due to conventional treatment cannot eliminate breast cancer stem cells, breast cancer stem cells have been assumed to be the origin of treatment failure in breast cancer.OBJECTIVE:To clarify the biological characteristics of breast cancer stem cells and the curative effects of targeted therapy for breast cancer by some drugs targeting, and then provides some advice for developing treatment strategies that may improve survival rate of breast cancer patients.METHODS: The articles related to the maker of breast cancer stem cells and identification, new drug for the targeting treatment of breast cancer stem cell from PubMed database between January 2000

  18. Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib.

    Directory of Open Access Journals (Sweden)

    Darrell C Bessette

    Full Text Available Basal-like and triple negative breast cancer (TNBC share common molecular features, poor prognosis and a propensity for metastasis to the brain. Amplification of epidermal growth factor receptor (EGFR occurs in ~50% of basal-like breast cancer, and mutations in the epidermal growth factor receptor (EGFR have been reported in up to ~ 10% of Asian TNBC patients. In non-small cell lung cancer several different mutations in the EGFR tyrosine kinase domain confer sensitivity to receptor tyrosine kinase inhibitors, but the tumourigenic potential of EGFR mutations in breast cells and their potential for targeted therapy is unknown.Constructs containing wild type, G719S or E746-A750 deletion mutant forms of EGFR were transfected into the MCF10A breast cells and their tumorigenic derivative, MCF10CA1a. The effects of EGFR over-expression and mutation on proliferation, migration, invasion, response to gefitinib, and tumour formation in vivo was investigated. Copy number analysis and whole exome sequencing of the MCF10A and MCF10CA1a cell lines were also performed.Mutant EGFR increased MCF10A and MCF10CA1a proliferation and MCF10A gefitinib sensitivity. The EGFR-E746-A750 deletion increased MCF10CA1a cell migration and invasion, and greatly increased MCF10CA1a xenograft tumour formation and growth. Compared to MCF10A cells, MCF10CA1a cells exhibited large regions of gain on chromosomes 3 and 9, deletion on chromosome 7, and mutations in many genes implicated in cancer.Mutant EGFR enhances the oncogenic properties of MCF10A cell line, and increases sensitivity to gefitinib. Although the addition of EGFR E746-A750 renders the MCF10CA1a cells more tumourigenic in vivo it is not accompanied by increased gefitinib sensitivity, perhaps due to additional mutations, including the PIK3CA H1047R mutation, that the MCF10CA1a cell line has acquired. Screening TNBC/basal-like breast cancer for EGFR mutations may prove useful for directing therapy but, as in non

  19. 乳腺癌保乳术后加速部分乳腺照射研究进展%Accelerated partial breast irradiation after breast conserving surgery:a review of techniques and progress

    Institute of Scientific and Technical Information of China (English)

    张勇乾; 王雅棣

    2013-01-01

    Breast-conserving surgery with postoperative whole-breast irradiation (WBI) has become one of the standard treat-ments for early breast cancer. However, traditional WBI has a large radiation field and lengthy course of treatment. Accelerated par-tial-breast irradiation (APBI) has been recognized as an alternative treatment to WBI. Three main techniques constitute APBI: intraoper-ative radiation therapy, external radiation therapy, and brachytherapy. Intraoperative radiation therapy involves the application of thera-peutic levels of radiation during surgery. This technique allows for the exact delivery of radiation beams to the tumor bed; strict preci-sion is observed for equipment in this technique. External radiation therapy is performed by radiotherapists and physicists. This tech-nique is easy to implement. Furthermore, the target dose distribution can be achieved because of the implementation of a treatment plan-ning system. Brachytherapy includes multi-catheter interstitial brachytherapy and mammosite therapy. Presently, mammosite therapy is widely used because of its facile procedure. However, clinical follow-up data are limited because of the short duration of APBI therapy. The selection of appropriate patients and optimal dosimetric distribution is needed before APBI application to reduce the risk of breast cancer recurrence.%  保乳手术加术后全乳腺放疗(whole breast irradiation,WBI)已成为早期乳腺癌的标准治疗模式之一,但是传统的WBI照射范围大,疗程长.近年来,缩小照射范围、缩短总疗程的加速部分乳腺照射(accelerated partial breast irradiation,APBI)作为保乳术后WBI的替代治疗方法,得到了广泛的认同.APBI常用的治疗方式有术中放疗、外照射和近距离放疗三种.术中放疗为保乳手术中给予一次性照射,照射范围准确,但是对设备的要求较高.外照射由专业的放疗科医师和物理师执行,相对容易实现,而且可以通过治疗计划系

  20. Development of automated welding process for field fabrication of thick walled pressure vessels. Fourth quarter technical progress report for period ending September 28, 1980

    Energy Technology Data Exchange (ETDEWEB)

    1980-01-01

    Progress is reported in research aimed at optimizing an automated welding process for the field fabrication of thick-walled pressure vessels and for evaluating the welded joints. Information is included on the welding equipment, mechanical control of the process, joint design, filler wire optimization, in-process nondestructive testing of welds, and repair techniques. (LCL)